Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
ABO	"A3GALNT, A3GALT1"	ENSG00000175164	"ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase"		9	133250401-133275219	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"intestine: 28.2"	"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 56.2;Collecting duct cells: 45.4;Enterocytes: 68.1;Mucus-secreting cells: 54.8;Paneth cells: 49.5;Undifferentiated cells: 61.3"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in some"	8	"basophil: 2.1;eosinophil: 3.0;naive B-cell: 2.2"	"Group enriched"	"Detected in many"	8	"B-cells: 2.2;granulocytes: 3.0"	"Group enriched"	"Detected in some"	6	"K-562: 20.4;RT4: 8.0"	"Not detected"	"Not detected"												"Secreted to blood"						"unprognostic (2.78e-3)"	"unprognostic (2.56e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.87e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.84e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.69e-2)"	"unprognostic (8.51e-2)"	"unprognostic (9.30e-3)"	"unprognostic (7.23e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.57e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.34e-1)"	"unprognostic (9.04e-2)"	1.6	1.0	0.1	5.8	0.1	0.3	0.4	0.0	0.6	1.0	15.0	0.0	2.3	1.7	1.6	0.8	3.0	0.3	7.6	0.3	0.0		10.7	0.3	3.6	0.3	0.0	0.0	3.2	2.6	0.3	0.0	0.3	0.2	1.5	2.4	1.0	2.2	0.3	1.4	0.3	28.2	0.6	0.0	0.3	0.3	2.0	0.0	0.0	10.1	4.2	5.8	1.0	1.4	2.2	0.1	3.0	0.3	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	3.0	0.0	0.3	0.0	0.0	0.2	0.0	0.1	2.2	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.2											29.8	22.2	0.5	3.6	0.0	0.0	2.8	17.8	56.2	27.3	45.4	0.0	0.7	0.0	3.7	3.3	6.8	68.1	0.0	0.3	0.2	0.8	6.5	0.0	0.0	0.2	0.0	24.6	3.1	0.6	6.7	14.1	0.3	0.0	1.0	54.8	0.0	8.2	49.5	6.3	19.5	0.1	6.5	0.6	0.5	1.5	0.0	0.6	0.0	61.3	15.2
ACE	"ACE1, CD143, DCP1"	ENSG00000159640	"Angiotensin I converting enzyme"	P12821	17	63477061-63498380	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 205.6"	"Group enriched"	"Detected in many"	25	"Early spermatids: 470.5;Late spermatids: 1015.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.7"	"Group enriched"	"Detected in many"	23	"B-cells: 3.7;monocytes: 2.0;T-cells: 1.9"	"Group enriched"	"Detected in some"	4	"ASC TERT1: 36.7;HUVEC TERT2: 18.7"									"CAB002426, CAB002921, HPA029298, HPA069790"	Enhanced		Approved	Vesicles	"Secreted to blood"	104000000	92000000	Vesicles		"CAB002426: AB_442052, CAB002921: , HPA029298: AB_10960255, HPA069790: AB_2686197"	"unprognostic (4.72e-2)"	"unprognostic (4.16e-1)"	"unprognostic (1.93e-3)"	"unprognostic (6.06e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.37e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.13e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.66e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.76e-2)"	6.8	2.0	0.5	2.4	4.2	0.0	2.9	0.5	1.1	5.3	83.2	0.7	37.7	46.4	4.5	5.1	1.7	1.5	4.4	4.7	0.6	0.7	2.6	1.4	16.3	2.2	0.4	0.7	1.4	3.0	3.6	3.6	3.6	0.8	3.4	1.4	1.7	2.5	20.1	3.6	1.3	205.6	2.4	0.6	1.4	1.9	32.6	1.3	0.5	6.9	3.1	2.2	1.7	1.6	3.7	0.1	0.0	2.0	0.0	1.9	0.4	0.0	0.0	0.0	0.0	1.5	36.7	0.4	1.3	2.7	0.0	0.0	0.5	3.2	0.7	1.1	6.2	0.0	0.0	1.7	0.0	0.0	0.0	0.7	3.5	0.0	0.0	0.8	0.0	0.0	2.4	0.0	0.0	0.0	0.6	18.7	0.0	3.1	0.0	0.0	0.6	0.0	0.8	0.3	6.3	0.4	0.1	0.2	0.5	0.0	0.0	4.6	3.2	0.0	0.0	0.0	0.7	1.6	0.2	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.4	0.6	0.9	3.7	1.9	1.4	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.4	0.5	4.2	0.5	1.1	0.6	0.7	0.4	0.7	0.8	1.3	0.0	3.5	0.0	1.5	1.3	3.1	1.4	0.0	0.0	1.2	0.0	0.0	0.1	0.0	3.4	470.5	13.5	29.6	0.0	0.4	0.1	1.0	6.0	6.9	0.0	4.4	0.0	17.3	2.5	18.5	1015.1	4.0	5.1	3.3	0.0	8.7	1.9	0.7	10.2	2.5	10.7	1.0	0.0	0.9	8.1	3.4	0.1	0.1	0.9	8.6	2.1
ACE2		ENSG00000130234	"Angiotensin I converting enzyme 2"	Q9BYF1	X	15561033-15602148	"Enzymes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction"	"Carboxypeptidase, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 122.0"	"Cell type enhanced"	"Detected in many"	13	"Cholangiocytes: 61.1;Enterocytes: 38.8;Proximal tubular cells: 45.6;Sertoli cells: 19.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 26.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.4;HaCaT: 4.1;Hep G2: 2.5;NB-4: 2.2;RPMI-8226: 2.1;RT4: 2.5;SH-SY5Y: 2.8;SuSa: 1.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA000288, CAB026174, CAB026213, CAB080024, CAB080025, CAB080027, CAB080028"	Enhanced				"Secreted to blood"		85000			"CAB026174: , CAB026213: , CAB080024: AB_10864415, CAB080025: AB_2809589, CAB080027: AB_2665870, CAB080028: AB_2665871, HPA000288: AB_1078160"	"unprognostic (1.40e-1)"	"unprognostic (7.26e-2)"	"unprognostic (2.76e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.26e-2)"	"prognostic favorable (4.21e-4)"	"unprognostic (2.34e-2)"	"unprognostic (6.74e-3)"	"unprognostic (2.54e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (2.12e-5)"	"unprognostic (1.94e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.11e-1)"	"unprognostic (7.10e-2)"	4.5	0.4	0.2	0.8	0.2	0.0	2.3	0.2	0.2	0.4	49.1	0.2	2.3	46.0	0.4	2.7	1.2	0.6	16.4	10.5	0.2	0.1	23.2	1.2	0.8	0.6	0.2	0.2	1.3	1.6	0.0	0.2	1.0	0.2	0.5	1.3	0.2	1.1	1.2	0.7	0.2	122.0	0.3	0.2	0.2	0.5	17.9	0.2	0.2	4.5	0.5	0.2	0.4	0.9	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.2	0.0	0.4	0.0	0.7	0.0	2.4	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.7	0.0	0.4	4.1	0.2	0.1	0.0	0.1	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.2	0.2	0.0	0.0	2.1	0.4	2.5	0.6	2.8	0.1	0.3	0.2	1.9	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.3	2.2	0.5	0.1	0.0	9.8	61.1	0.0	0.0	0.0	0.0	2.9	3.3	0.5	0.4	0.0	38.8	0.0	0.7	0.2	0.0	0.4	0.0	0.8	0.7	0.0	6.9	0.0	0.0	1.1	7.8	0.0	0.0	0.0	1.2	0.0	0.9	4.2	5.6	45.6	0.0	19.4	0.0	1.1	0.7	0.1	10.6	0.0	3.3	1.6
ACPP	"ACP-3, ACP3, PAP"	ENSG00000014257	"Acid phosphatase, prostate"	P15309	3	132317367-132368298	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"prostate: 345.2"	"Cell type enriched"	"Detected in many"	135	"Glandular cells: 2098.0"	"Cancer enriched"	"Detected in many"	275	"prostate cancer: 1227.2"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"eosinophil: 43.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 10.2;OE19: 12.7;RPMI-8226: 32.4;U-698: 9.4;U-87 MG: 9.0"	"Low region specificity"	"Detected in some"							"CAB000071, HPA004335, HPA063916"	Enhanced				"Secreted to blood"	460000	9200			"CAB000071: , HPA004335: AB_1079684, HPA063916: AB_2685152"	"unprognostic (6.67e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.78e-3)"	"unprognostic (2.14e-1)"	"unprognostic (5.95e-2)"	"unprognostic (9.38e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.71e-1)"	0.4	0.6	0.4	0.7	1.6	1.4	0.8	0.3	0.7	3.9	0.4	0.2	0.0	0.4	0.3	2.5	14.7	0.6	0.2	0.9	0.3	0.3	6.2	0.3	2.0	2.7	0.6	0.8	0.4	0.8	0.5	0.3	5.3	0.7	345.2	0.7	0.8	9.1	0.2	0.3	2.5	0.4	0.4	2.2	1.0	0.5	1.0	0.6	0.2	1.3	6.6	6.8	0.5	1.5	0.2	11.2	43.1	9.7	0.9	0.0	2.9	0.2	0.0	0.0	0.0	0.1	0.6	7.0	0.1	10.2	0.0	0.0	0.2	0.2	5.7	0.4	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.3	1.2	0.2	0.1	0.1	4.1	0.1	0.6	0.8	0.0	0.0	0.1	0.0	0.0	0.1	1.6	0.1	0.1	0.0	7.8	0.4	12.7	1.2	0.0	0.0	32.4	3.1	3.8	0.0	2.5	0.0	1.2	0.3	1.1	0.2	3.7	0.0	0.0	0.1	1.5	0.0	0.4	0.2	9.4	9.0	7.3	0.1	0.0	9.7	43.1	0.0	8.6	0.0	0.2	0.0	0.0	11.2	0.0	0.0	0.0	8.5	0.9	7.7	0.8	0.0	2.9	0.4	1.6	0.3	0.7	0.3	0.3	0.6	0.8	0.7	0.6	0.0	10.7	0.0	13.0	0.8	0.0	0.5	0.0	0.0	4.5	7.0	0.0	9.6	0.0	1.1	0.0	0.0	1.0	0.0	1.6	1.0	0.8	2098.0	0.0	0.0	4.1	0.0	15.5	0.0	9.2	0.0	0.0	2.8	0.0	0.0	2.4	0.3	1.2	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.0	7.4	0.0	1.0	11.5
ADAM12	"MCMPMltna, MLTN"	ENSG00000148848	"ADAM metallopeptidase domain 12"	O43184	10	126012381-126388455	"Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Cell adhesion"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	50	"placenta: 487.4"	"Cell type enhanced"	"Detected in many"	24	"Cone photoreceptor cells: 96.2;Extravillous trophoblasts: 348.4;Syncytiotrophoblasts: 108.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in some"	5	"MAIT T-cell: 9.8"	"Lineage enriched"	"Detected in single"	98	"T-cells: 9.8"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 47.3;hTEC/SVTERT24-B: 29.7;U-2197: 29.3;U-251 MG: 26.2;U-87 MG: 22.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA030866, HPA030867, HPA030868"	Enhanced		Supported	"Plasma membrane"	"Secreted in female reproductive system"			"Plasma membrane"		"HPA030866: AB_2673636, HPA030867: AB_10602428, HPA030868: AB_2673638"	"unprognostic (3.35e-1)"	"unprognostic (1.05e-3)"	"unprognostic (3.52e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.91e-6)"	"unprognostic (2.17e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.39e-14)"	"unprognostic (3.11e-3)"	"unprognostic (9.06e-3)"	"unprognostic (4.70e-3)"	"unprognostic (3.47e-3)"	6.0	0.0	0.6	2.1	2.8	0.0	5.9	0.6	0.6	8.0	0.5	0.5	0.4	0.0	2.6	0.5	0.5	0.1	4.6	0.7	0.6	0.7	1.0	0.4	1.1	1.0	0.8	0.5	8.2	0.6	0.0	1.1	487.4	0.8	0.7	0.1	0.9	1.1	0.4	0.5	0.3	0.4	1.5	0.7	0.5	0.1	0.7	0.6	0.5	0.4	0.5	1.2	4.5	0.8	0.0	0.0	0.0	0.0	0.0	9.8	0.1	5.0	0.7	2.0	0.0	6.0	12.4	0.0	13.2	1.1	4.5	11.3	0.0	0.0	0.0	0.0	47.3	9.5	0.0	0.0	0.4	4.9	0.5	0.1	0.0	8.0	0.0	0.9	0.0	10.5	15.2	0.0	29.7	0.9	8.6	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.5	1.3	0.1	13.5	0.1	9.0	1.5	0.0	0.2	0.8	0.0	0.0	0.0	16.3	5.4	29.3	26.2	0.0	0.1	0.0	22.5	0.0	10.0	0.0	0.0	0.0	0.5	0.0	9.8	0.0	0.4	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.6	2.8	0.6	0.6	0.6	0.7	0.8	0.5	0.8	0.6	0.0	3.4	0.0	0.4	1.3	0.8	1.4	0.0	1.4	0.0	0.0	96.2	12.1	0.0	7.6	6.3	1.1	0.4	0.0	1.0	348.4	2.0	0.6	49.5	0.0	14.2	6.4	0.0	2.5	0.3	1.1	15.5	0.7	1.7	15.4	0.2	5.5	1.9	0.0	0.7	0.0	31.5	0.0	1.2	5.1	5.5	0.5	108.0	3.1	0.7	0.5
ADAM28	"ADAM23, eMDCII, MDC-Lm, MDC-Ls"	ENSG00000042980	"ADAM metallopeptidase domain 28"	Q9UKQ2	8	24294040-24359018	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 133.1"	"Cell type enhanced"	"Detected in many"	15	"B-cells: 115.5;Club cells: 62.6;Macrophages: 32.1;Pancreatic endocrine cells: 32.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 24.9;naive B-cell: 32.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 24.8;OE19: 7.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA074034	Enhanced		Approved	"Plasma membrane,Mitochondria"	"Secreted to blood"			"Plasma membrane"	Mitochondria	"HPA074034: AB_2686654"	"unprognostic (4.23e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.06e-2)"	"prognostic favorable (3.17e-4)"	"unprognostic (2.89e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.77e-3)"	"unprognostic (7.77e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.62e-1)"	2.0	1.7	7.7	17.4	8.8	3.5	2.1	0.9	5.8	6.7	5.8	12.7	2.0	3.7	3.1	133.1	2.7	5.1	16.7	1.1	8.9	5.0	3.1	1.1	3.1	10.1	12.4	3.7	1.8	2.7	1.0	22.5	1.9	10.8	3.3	5.0	1.9	12.6	5.1	0.7	1.8	17.9	1.7	26.0	15.5	38.7	0.9	12.1	0.8	1.8	0.4	19.9	7.4	1.6	32.2	7.5	12.5	0.9	0.9	0.0	0.9	0.0	0.4	0.1	0.0	0.0	0.4	0.1	0.1	0.2	0.0	0.0	1.0	24.8	0.2	0.8	0.0	0.8	0.1	0.0	0.8	0.1	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.2	3.2	0.6	7.6	0.1	0.1	0.0	0.3	0.6	0.7	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.3	0.1	0.1	1.1	2.1	0.1	1.9	0.9	0.2	12.5	0.9	6.4	0.0	0.2	0.0	24.9	0.0	0.0	7.5	32.2	0.0	0.0	1.6	0.9	0.0	0.4	0.0	0.9	7.7	8.8	0.9	5.8	8.9	5.0	12.4	3.7	10.8	12.1	3.0	5.9	115.5	2.2	0.8	0.0	0.9	25.5	17.4	62.6	3.5	0.0	0.3	0.0	7.1	0.9	0.7	0.5	0.0	3.1	8.1	1.1	2.0	2.3	0.0	9.0	0.0	0.0	0.0	12.3	1.8	0.6	32.1	5.0	5.4	0.1	0.0	32.8	0.0	0.4	3.6	0.0	6.5	0.3	0.2	0.1	0.5	0.5	6.9	0.9	6.3
ADAM9	"CORD9, KIAA0021, MCMP, MDC9, Mltng"	ENSG00000168615	"ADAM metallopeptidase domain 9"	Q13443	8	38996869-39105144	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Cone-rod dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Pancreatic endocrine cells: 140.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 11.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004000			Approved	"Endoplasmic reticulum,Vesicles"	"Secreted - unknown location"		640000	Vesicles	"Endoplasmic reticulum"	"HPA004000: AB_1844584"	"prognostic unfavorable (1.14e-4)"	"prognostic unfavorable (2.25e-4)"	"unprognostic (1.32e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (7.21e-6)"	"unprognostic (5.77e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (2.52e-5)"	"unprognostic (5.83e-2)"	"prognostic unfavorable (3.99e-4)"	"unprognostic (2.80e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.23e-2)"	36.7	25.0	14.7	21.7	13.6	10.4	17.1	20.9	14.4	21.8	24.4	13.2	21.8	19.4	24.9	19.8	24.1	15.5	31.7	28.5	12.5	10.1	29.4	11.6	39.2	20.3	19.2	12.9	17.6	11.1	37.5	10.4	30.1	15.8	23.8	23.8	15.4	44.5	21.4	18.3	12.8	25.4	32.8	22.0	25.7	33.2	13.7	12.7	2.4	24.0	14.9	11.7	34.8	19.2	0.6	8.1	3.4	11.4	3.1	0.8	2.8	41.2	29.9	11.8	7.2	19.2	61.9	15.4	56.1	61.4	31.5	29.5	14.2	30.0	2.1	21.2	38.6	32.2	17.7	5.0	39.6	61.1	2.0	5.1	2.2	20.8	12.2	38.8	1.6	4.8	47.5	23.5	31.0	35.3	60.1	42.9	3.6	4.3	14.1	65.5	4.0	1.6	1.0	1.7	29.5	9.7	1.4	21.4	7.2	51.2	11.8	1.6	2.4	14.9	18.0	13.6	13.3	14.5	3.0	73.6	24.1	23.2	45.5	25.6	4.5	6.9	2.3	40.0	2.7	16.4	1.4	11.4	2.2	0.6	6.1	0.3	0.1	0.3	0.8	8.1	0.6	0.1	0.6	3.4	3.1	2.6	2.7	0.4	2.8	14.7	13.6	20.9	14.4	12.5	10.1	19.2	12.9	15.8	12.7	44.7	35.4	8.2	50.9	31.9	18.5	45.6	25.5	14.7	39.8	33.2	19.6	17.9	3.3	80.4	10.3	23.6	20.8	0.0	100.4	80.2	38.5	85.4	4.7	6.7	104.9	4.8	10.3	26.4	54.2	5.1	26.4	39.7	20.3	22.6	26.3	15.2	140.3	25.9	23.3	36.6	23.8	12.9	32.5	4.3	2.0	18.7	28.7	4.1	25.8	75.5
ADAMTS1	"C3-C5, KIAA1346, METH1"	ENSG00000154734	"ADAM metallopeptidase with thrombospondin type 1 motif 1"	Q9UHI8	21	26835747-26845409	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Heparin-binding, Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 112.8"	"Cell type enhanced"	"Detected in many"	9	"Extravillous trophoblasts: 211.3;Sertoli cells: 207.0;Smooth muscle cells: 366.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"gdT-cell: 8.0;NK-cell: 9.0"	"Group enriched"	"Detected in many"	85	"NK-cells: 9.0;T-cells: 8.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 62.1;BJ: 72.4;hTEC/SVTERT24-B: 49.9;hTERT-HME1: 45.5;RPTEC TERT1: 42.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"CAB016394, HPA031498"	Approved		Approved	"Plasma membrane"	"Secreted to extracellular matrix"		1900000	"Plasma membrane"		"CAB016394: AB_626637, HPA031498: AB_2673907"	"unprognostic (6.82e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.37e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.55e-2)"	"unprognostic (9.70e-3)"	"unprognostic (8.27e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.76e-2)"	"unprognostic (1.57e-1)"	70.6	13.4	8.2	18.7	14.0	0.7	29.0	6.3	9.2	22.0	18.2	9.5	4.8	3.3	27.7	25.8	30.0	45.8	62.3	40.9	7.6	4.8	15.4	22.8	25.0	10.9	12.7	3.7	112.8	9.3	6.3	7.6	56.8	13.2	23.3	16.5	7.8	5.8	8.1	25.7	6.1	16.2	46.4	10.2	7.2	16.8	12.8	11.4	0.0	14.3	18.1	2.7	32.7	45.3	0.0	0.0	0.0	0.0	9.0	8.0	1.4	0.0	0.0	1.1	0.0	62.1	15.4	3.8	72.4	25.3	12.5	8.3	0.0	0.0	0.0	5.0	22.9	0.3	1.3	0.8	3.7	22.1	0.0	23.0	0.0	7.5	0.0	11.9	2.9	0.0	17.2	0.0	49.9	45.5	3.0	5.1	0.7	1.2	0.0	37.1	0.0	0.3	0.0	4.1	0.0	2.9	0.0	28.6	0.2	42.4	4.0	0.0	5.6	3.4	0.0	0.4	2.7	0.1	0.7	5.2	17.8	0.9	27.8	10.7	0.1	0.0	0.0	14.7	0.0	5.4	0.0	0.0	0.0	8.0	0.0	0.8	0.0	0.3	0.6	0.0	0.0	0.0	1.5	0.0	9.0	0.0	0.0	0.0	1.4	8.2	14.0	6.3	9.2	7.6	4.8	12.7	3.7	13.2	11.4	6.0	31.4	0.0	31.2	107.6	0.5	151.1	7.6	5.3	14.8	54.1	0.0	44.4	1.7	29.9	1.3	165.7	0.0	0.0	18.6	211.3	148.2	23.5	2.3	1.3	14.7	0.0	0.0	124.0	6.0	2.2	100.9	4.8	50.6	1.0	0.0	31.7	24.2	0.0	39.3	2.2	2.2	207.0	366.0	0.5	1.0	36.4	45.9	5.0	0.0	13.3
ADAMTS4	"ADAMTS-2, ADMP-1, KIAA0688"	ENSG00000158859	"ADAM metallopeptidase with thrombospondin type 1 motif 4"	O75173	1	161184308-161199056	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 58.0"	"Cell type enriched"	"Detected in many"	7	"Smooth muscle cells: 356.4"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basal ganglia: 20.7;cerebral cortex: 10.0;midbrain: 28.6;pons and medulla: 20.5;thalamus: 15.7"	"Cell type enriched"	"Detected in some"	8	"plasmacytoid DC: 8.0"	"Lineage enriched"	"Detected in many"	8	"dendritic cells: 8.0"	"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 10.9;HUVEC TERT2: 13.2;SH-SY5Y: 7.4;TIME: 11.1;U-138 MG: 6.9;U-251 MG: 9.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB025876, HPA051296, HPA068374"	Uncertain		Supported	"Nuclear speckles"	"Secreted to extracellular matrix"			"Nuclear speckles"		"CAB025876: , HPA051296: AB_2681426, HPA068374: AB_2685978"	"unprognostic (2.70e-2)"	"unprognostic (8.10e-3)"	"unprognostic (3.00e-3)"	"unprognostic (2.75e-1)"	"unprognostic (9.95e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (5.00e-4)"	"unprognostic (1.20e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (7.27e-7)"	"unprognostic (1.10e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.44e-3)"	"unprognostic (3.13e-2)"	58.0	9.7	2.6	18.1	20.7	1.8	14.6	1.5	10.7	7.8	6.3	33.4	0.0	1.9	5.8	2.0	7.7	14.2	16.4	19.5	3.4	2.3	3.1	11.0	15.7	2.7	28.6	3.5	35.7	10.6	4.7	4.9	4.4	20.5	5.8	3.4	0.0	1.7	1.7	7.7	1.7	3.0	12.0	15.5	1.9	8.1	1.7	15.7	0.0	7.5	1.2	1.4	8.7	4.0	0.5	8.0	1.0	0.2	0.4	0.6	0.2	0.0	0.0	0.2	0.1	6.1	3.9	0.6	4.9	0.2	0.4	2.8	0.2	0.1	0.2	4.1	1.5	0.0	0.1	0.0	0.0	1.7	0.1	0.3	0.1	0.4	1.2	0.6	0.0	0.1	4.3	0.0	10.9	0.1	0.0	13.2	0.1	0.1	0.3	0.3	0.1	0.0	0.2	4.9	0.0	0.0	0.1	4.8	0.1	0.0	0.1	0.1	7.4	0.0	0.1	0.1	0.3	0.2	0.5	11.1	6.9	0.1	0.3	9.8	0.2	0.1	0.1	2.1	0.1	0.1	0.7	0.2	0.2	0.6	0.1	0.3	0.3	0.3	0.3	0.1	0.5	0.4	0.4	1.0	0.4	0.1	8.0	0.3	0.2	2.6	20.7	1.5	10.0	3.4	2.3	28.6	3.5	20.5	15.7	0.0	5.5	0.0	2.3	27.7	2.2	2.8	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.3	0.0	43.0	0.0	0.0	0.0	0.2	33.3	8.7	0.0	0.8	0.8	3.2	0.0	48.5	1.5	0.0	0.3	6.0	33.7	1.8	0.0	0.3	0.0	0.0	1.1	0.0	1.0	51.8	356.4	2.3	0.6	16.7	0.3	1.5	0.0	4.4
ADGRB1	BAI1	ENSG00000181790	"Adhesion G protein-coupled receptor B1"	O14514	8	142449430-142545009	"Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Innate immunity, Myogenesis, Neurogenesis, Phagocytosis"	"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 27.4"	"Cell type enriched"	"Detected in some"	9	"Horizontal cells: 119.2"	"Cancer enhanced"	"Detected in many"		"glioma: 11.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 11.8;MCF7: 4.3;NB-4: 5.8;RPMI-8226: 16.3;U-2 OS: 11.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted in brain"						"unprognostic (9.57e-4)"	"unprognostic (1.28e-1)"	"unprognostic (3.87e-3)"	"unprognostic (8.50e-3)"	"unprognostic (9.98e-2)"	"unprognostic (5.87e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.55e-1)"	"unprognostic (6.48e-2)"	"unprognostic (3.43e-1)"	"unprognostic (7.30e-11)"	"unprognostic (6.27e-2)"	"unprognostic (7.42e-2)"	"unprognostic (4.52e-3)"	"unprognostic (3.29e-2)"	1.0	3.4	13.6	1.4	18.1	0.9	1.1	5.4	27.4	2.0	1.0	3.1	0.1	1.4	1.8	2.3	0.9	1.4	0.9	0.9	11.0	11.9	1.1	0.8	1.2	1.6	8.7	9.2	1.6	1.1	0.9	2.7	2.5	9.1	1.3	0.9	0.9	2.6	1.9	0.7	3.1	1.4	1.0	2.3	3.7	1.5	2.1	3.2	0.0	0.9	0.0	1.0	0.9	0.4	0.2	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.1	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.1	0.0	0.9	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	5.8	1.8	0.2	0.0	0.1	0.0	16.3	0.0	0.0	3.1	3.1	0.0	0.0	0.2	0.2	0.1	0.3	0.0	0.1	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	18.1	5.4	19.5	11.0	11.9	8.7	9.2	9.1	3.2	0.0	0.0	0.0	0.2	0.0	13.1	5.3	2.5	0.0	0.0	0.0	0.0	0.0	1.7	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	119.2	0.0	0.0	0.0	0.6	0.3	0.0	0.0	1.0	0.0	3.8	0.1	0.0	12.7	0.0	0.6	6.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1
ADGRE3	EMR3	ENSG00000131355	"Adhesion G protein-coupled receptor E3"	Q9BY15	19	14619117-14690027	"G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"blood: 70.7;lung: 26.3"	"Cell type enhanced"	"Detected in some"	17	"Alveolar cells type 2: 3.7;Ciliated cells: 1.4;granulocytes: 2.3;Macrophages: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"basophil: 36.3;eosinophil: 69.6;neutrophil: 70.7"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 70.7"	"Cell line enriched"	"Detected in single"	38	"HMC-1: 32.5"					"Not detected"	"Not detected"			HPA015638	Uncertain				"Secreted to blood"					"HPA015638: AB_1848039"	"unprognostic (2.11e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.69e-2)"	"unprognostic (5.63e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.07e-2)"	"unprognostic (9.61e-2)"	"unprognostic (9.11e-4)"	"unprognostic (4.68e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.06e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.67e-2)"	1.7	0.2	0.3	8.5	0.8	4.0	0.3	0.2	0.7	0.2	0.4	0.3	0.1	2.1	0.2	0.7	0.4	0.6	1.2	0.6	0.3	0.3	0.4	1.1	26.3	5.9	0.4	0.1	0.5	0.3	0.0	0.3	1.7	0.7	0.6	0.5	0.7	6.2	0.1	0.9	0.2	3.2	0.7	0.6	8.1	0.4	0.8	0.3	0.8	0.5	0.9	3.4	2.6	0.4	0.0	0.7	70.7	8.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.3	3.2	69.6	0.0	7.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	70.7	0.0	8.0	0.0	0.0	0.9	0.3	0.8	0.2	0.7	0.3	0.3	0.4	0.1	0.7	0.3	0.0	3.7	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	4.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADGRE5	"CD97, TM7LN1"	ENSG00000123146	"Adhesion G protein-coupled receptor E5"	P48960	19	14380501-14408725	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Cell adhesion"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 95.3"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 2: 102.4;Kupffer cells: 83.8;T-cells: 152.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA013707	Enhanced		Approved	Cytosol	"Secreted to blood"	10000000	930000	Cytosol		"HPA013707: AB_1846345"	"unprognostic (3.16e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.10e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.85e-2)"	"unprognostic (7.24e-2)"	"prognostic unfavorable (3.73e-5)"	"unprognostic (7.51e-2)"	"unprognostic (6.06e-3)"	"unprognostic (3.14e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (1.87e-6)"	"unprognostic (2.08e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.44e-2)"	"unprognostic (6.41e-2)"	17.7	8.9	2.5	23.0	4.0	55.3	14.3	1.1	5.2	21.7	15.9	12.9	0.5	12.9	56.9	18.5	11.6	19.1	27.1	16.4	3.0	2.4	10.7	15.5	30.3	41.1	6.3	3.2	10.7	16.2	2.4	3.3	18.2	5.9	11.3	9.0	6.9	17.0	3.6	12.5	6.0	22.2	36.2	4.2	56.9	15.0	6.9	4.9	24.3	8.6	3.7	22.5	34.7	12.4	3.9	13.3	95.3	43.2	22.8	25.8	23.3	30.8	21.9	0.2	21.0	9.3	15.3	3.3	21.4	34.5	15.4	16.9	6.2	31.3	3.5	21.7	27.5	22.0	7.3	5.7	10.4	6.9	19.2	6.4	6.9	32.5	2.7	11.5	14.9	32.3	6.7	0.3	15.7	5.4	5.0	1.5	6.1	9.0	27.7	16.8	6.9	0.9	20.0	0.6	24.5	27.3	2.0	9.2	16.1	5.2	2.7	0.2	0.7	12.2	17.5	15.2	0.5	4.5	13.8	3.7	5.2	8.7	21.7	35.2	0.0	0.1	0.2	18.7	26.7	19.5	42.0	18.6	95.3	25.8	36.7	17.3	3.9	13.1	17.8	13.3	2.6	9.4	12.8	82.7	22.8	43.2	6.4	9.0	23.3	2.5	4.0	1.1	5.2	3.0	2.4	6.3	3.2	5.9	4.9	32.8	102.4	15.9	7.4	0.0	0.2	3.1	12.7	50.9	31.8	0.0	0.0	2.7	0.0	15.1	0.0	4.5	10.2	23.3	19.1	36.8	4.8	9.8	70.9	1.5	47.0	0.0	4.7	26.4	83.8	1.0	6.1	50.6	0.0	2.8	34.7	2.3	17.9	21.0	4.6	0.7	1.2	25.8	17.2	0.5	5.7	0.0	6.6	152.3	31.8	14.1
ADGRF1	"GPR110, hGPCR36, PGR19"	ENSG00000153292	"Adhesion G protein-coupled receptor F1"	Q5T601	6	46997703-47042363	"G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 27.4"	"Cell type enhanced"	"Detected in some"	24	"Collecting duct cells: 102.9;Pancreatic endocrine cells: 59.1;Urothelial cells: 305.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 10.6;CAPAN-2: 40.0;HaCaT: 8.9;PC-3: 13.0;RPTEC TERT1: 18.3;RT4: 45.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA038438	Approved				"Secreted - unknown location"					"HPA038438: AB_10672645"	"unprognostic (4.83e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.64e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.95e-3)"	"unprognostic (3.02e-3)"	"unprognostic (7.76e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.20e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.99e-1)"	"prognostic favorable (1.35e-5)"	"unprognostic (7.41e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.08e-2)"	0.1	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	6.5	6.1	0.0	3.7	0.1	1.3	4.2	15.7	0.8	10.0	0.0	0.0	0.0	27.4	0.1	5.4	0.0	0.1	0.0	0.2	0.2	0.0	0.1	0.6	0.0	7.5	0.2	0.0	3.2	1.9	0.1	0.1	5.5	2.1	0.1	0.1	1.5	1.3	0.0	0.0	11.3	5.6	12.3	16.2	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.0	0.0	0.7	0.0	0.0	8.9	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	13.0	0.0	0.0	0.0	18.3	45.7	0.0	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	17.9	0.0	12.6	0.0	0.0	0.4	15.3	26.8	25.0	102.9	0.0	0.0	19.9	25.6	0.0	0.0	0.0	0.0	16.7	0.0	0.0	30.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	59.1	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.4	305.8
ADGRG1	"GPR56, TM7LN4, TM7XN1"	ENSG00000205336	"Adhesion G protein-coupled receptor G1"	Q9Y653	16	57610652-57665580	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Differentiation, Neurogenesis"	"Developmental protein, G-protein coupled receptor, Heparin-binding, Receptor, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 182.4;Exocrine glandular cells: 149.7;Proximal tubular cells: 129.8;Syncytiotrophoblasts: 156.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 48.1"	"Lineage enriched"	"Detected in many"	6	"T-cells: 48.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 41.7;SK-BR-3: 54.1;SK-MEL-30: 55.7;TIME: 44.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046065	Uncertain				"Secreted to blood"		22000			"HPA046065: AB_2679521"	"unprognostic (4.91e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.26e-3)"	"prognostic unfavorable (2.53e-4)"	"unprognostic (4.87e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.82e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.36e-2)"	"prognostic favorable (5.52e-7)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.98e-1)"	18.9	5.6	39.3	5.1	32.3	6.5	19.7	9.1	70.9	15.2	14.2	28.2	14.6	10.3	10.0	34.5	16.8	20.3	26.7	8.7	33.4	15.9	82.1	1.9	15.4	2.2	24.2	22.8	3.1	25.2	13.5	6.7	38.1	27.2	13.0	13.4	6.3	34.3	24.7	5.7	32.6	7.7	7.8	32.0	4.9	18.1	22.1	28.9	12.1	81.4	8.7	7.2	17.8	14.2	0.1	0.1	1.0	0.2	8.7	48.1	8.4	7.7	8.5	2.5	0.1	0.0	0.0	25.0	1.4	0.8	2.5	0.5	6.4	41.7	0.0	20.9	1.3	36.3	28.5	0.0	19.4	1.0	0.3	0.0	0.8	10.4	7.3	0.0	0.0	0.4	0.5	28.0	4.5	1.9	3.1	20.6	0.2	0.0	0.3	0.5	9.7	20.6	0.1	0.3	26.8	8.3	0.7	0.2	5.7	39.2	24.6	7.2	0.2	0.4	54.1	55.7	1.8	23.9	0.1	44.7	4.7	7.7	0.3	17.3	0.0	0.3	0.1	38.7	0.1	11.3	0.6	0.2	0.0	48.1	0.1	0.5	0.1	3.3	18.3	0.0	0.0	1.7	14.1	1.0	8.7	0.1	0.1	0.0	8.4	39.3	32.3	9.1	35.0	33.4	15.9	24.2	22.8	27.2	28.9	8.9	14.0	0.5	24.7	0.0	0.6	2.8	20.4	30.8	39.8	75.0	0.0	182.4	23.2	27.8	68.9	52.5	2.5	0.0	149.7	10.0	3.2	15.7	4.7	0.6	19.2	0.0	19.9	30.7	3.3	24.2	2.8	4.6	0.0	0.0	32.9	3.5	83.2	3.5	0.0	129.8	0.5	0.0	3.9	1.6	0.7	0.0	156.0	24.9	29.5	13.1
AGER	"RAGE, SCARJ1"	ENSG00000204305	"Advanced glycosylation end-product specific receptor"	Q15109	6	32180968-32184324	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Inflammatory response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"lung: 178.6"	"Cell type enriched"	"Detected in many"	18	"Alveolar cells type 1: 2224.3"	"Cancer enhanced"	"Detected in all"		"lung cancer: 27.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HEK 293: 4.9;JURKAT: 8.1;MCF7: 4.2;RPTEC TERT1: 5.1;U-266/70: 6.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB011682, HPA064436, HPA069474"	Enhanced		Approved	"Nucleoli fibrillar center,Plasma membrane,Cell Junctions"	"Secreted in other tissues"	5360000	140000	"Plasma membrane, Cell Junctions"	"Nucleoli fibrillar center"	"CAB011682: AB_2258049, HPA064436: AB_2685264, HPA069474: "	"unprognostic (9.37e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.59e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (9.01e-7)"	"unprognostic (3.57e-1)"	"unprognostic (3.70e-2)"	"unprognostic (4.44e-2)"	"prognostic favorable (2.74e-6)"	0.2	0.3	0.2	0.3	0.2	0.2	0.2	0.9	0.2	0.3	0.3	0.2	0.2	0.2	0.3	0.6	0.4	0.4	0.2	0.2	0.2	0.0	0.5	0.2	178.6	0.2	0.2	0.2	0.5	0.3	0.1	0.7	0.4	0.4	0.5	0.3	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	1.0	0.2	0.2	0.2	0.2	22.6	0.2	0.2	0.2	0.3	0.7	0.7	1.0	0.3	0.1	0.5	0.1	0.2	0.2	0.0	0.6	0.2	1.9	2.7	0.1	0.2	0.1	0.2	0.1	0.4	0.2	2.1	0.5	0.0	2.2	0.2	1.1	0.3	0.4	4.9	1.3	0.1	0.0	0.0	0.6	2.2	0.3	0.3	0.1	0.2	0.3	0.3	8.1	0.0	0.8	0.2	4.2	0.3	1.5	0.0	0.2	0.0	0.1	0.2	0.3	5.1	0.1	0.1	0.5	0.1	0.0	1.9	0.1	1.2	0.1	0.2	0.0	1.5	1.5	0.1	6.1	3.2	2.2	2.2	0.5	0.5	0.0	0.3	0.0	0.5	0.0	0.1	0.0	0.3	0.2	0.0	0.7	0.4	0.3	1.0	0.1	0.2	0.7	0.0	0.1	0.2	0.2	0.9	0.2	0.2	0.0	0.2	0.2	0.4	0.2	2224.3	120.3	1.7	1.1	0.8	4.8	3.4	5.1	8.1	37.5	1.8	0.0	0.9	0.0	1.5	0.0	2.6	0.5	0.0	0.8	0.8	1.6	2.3	16.3	1.8	1.2	6.4	0.0	2.5	9.0	0.2	1.7	4.9	1.7	2.8	1.4	7.4	0.8	2.9	1.1	0.2	4.1	6.5	1.7	0.0	0.7	1.6	1.8	5.0	0.9	0.8
AGRN	AGRIN	ENSG00000188157	Agrin	O00468	1	1020123-1056118	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Differentiation	"Developmental protein"	"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Cholangiocytes: 79.0;Collecting duct cells: 148.3;Ductal cells: 85.5;Pancreatic endocrine cells: 62.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 46.4;EFO-21: 54.1;HaCaT: 47.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040090	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"		15000000	Cytosol	"Plasma membrane"	"HPA040090: AB_10805603"	"unprognostic (8.04e-2)"	"unprognostic (8.25e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.41e-2)"	"prognostic unfavorable (4.62e-4)"	"unprognostic (2.82e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.33e-2)"	"unprognostic (9.49e-3)"	"unprognostic (1.06e-1)"	"unprognostic (8.46e-2)"	"unprognostic (8.49e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.31e-2)"	10.2	2.8	13.0	5.3	12.4	2.9	8.3	2.3	24.0	11.3	8.5	20.5	8.9	9.8	8.2	14.5	8.8	11.4	37.2	8.1	10.9	8.3	36.0	9.3	18.1	2.3	9.3	7.0	7.6	25.2	5.7	5.0	11.0	12.7	8.7	2.5	13.6	26.5	10.8	4.7	18.6	11.2	3.9	7.7	7.2	14.1	7.5	8.1	6.4	27.0	9.5	7.6	13.7	6.2	0.0	0.1	0.0	0.5	0.0	1.1	0.1	27.0	16.8	3.3	10.9	0.5	0.7	29.4	13.7	4.4	9.2	5.6	14.1	46.4	0.5	54.1	2.1	4.5	47.1	1.1	16.9	1.1	1.0	6.4	0.0	22.0	14.8	3.9	0.3	5.5	2.4	7.3	2.9	6.4	12.8	1.6	0.4	5.6	0.1	0.7	22.2	0.2	3.8	7.0	8.7	12.3	4.3	6.4	4.0	16.1	12.1	0.8	6.5	27.8	30.1	26.5	3.3	26.5	2.1	23.9	11.3	40.0	1.5	11.0	0.3	0.2	1.0	7.1	2.5	3.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.1	13.0	12.4	2.3	22.0	10.9	8.3	9.3	7.0	12.7	8.1	23.8	9.1	2.4	7.5	13.4	0.8	2.2	79.0	5.3	14.8	148.3	7.9	1.1	1.7	85.5	0.1	17.9	18.6	0.0	14.5	4.6	5.6	15.4	2.3	8.9	3.9	4.8	6.4	13.5	2.1	0.8	5.2	3.1	23.6	27.1	10.4	10.0	62.9	14.0	2.5	11.3	5.4	6.5	8.5	0.5	9.6	5.3	1.0	1.0	18.4	13.7
APOL1	APOL	ENSG00000100342	"Apolipoprotein L1"	O14791	22	36253010-36267530	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 82.9;Pancreatic endocrine cells: 64.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 63.8;HDLM-2: 41.2;HHSteC: 31.5;RPTEC TERT1: 24.4;RT4: 37.8"									"HPA018885, CAB056156"	Supported				"Secreted to blood"	1640000000	19000000000			"CAB056156: AB_2665576, HPA018885: AB_1844953"	"unprognostic (1.05e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.98e-3)"	"unprognostic (1.67e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (5.35e-4)"	"unprognostic (4.41e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.07e-3)"	"unprognostic (5.15e-2)"	"prognostic unfavorable (7.43e-6)"	"unprognostic (1.93e-1)"	"unprognostic (3.15e-2)"	"unprognostic (5.05e-3)"	"prognostic favorable (2.01e-5)"	22.4	7.1	2.5	16.5	3.2	0.7	11.8	1.7	2.6	16.6	13.0	1.8	11.6	9.1	19.9	15.6	15.9	11.5	25.8	11.5	3.5	2.4	22.8	66.4	23.8	9.9	3.6	2.0	21.6	7.8	1.3	6.5	39.3	4.7	26.4	7.8	13.0	9.5	24.1	6.5	3.1	22.9	17.9	4.6	23.1	17.5	6.1	2.4	9.6	21.9	10.0	9.7	25.9	46.3	2.0	3.3	12.7	7.1	17.2	10.9	4.9	5.3	1.1	0.0	0.1	12.2	11.8	3.6	0.5	2.3	3.4	10.0	0.1	8.6	1.7	63.8	5.9	7.9	1.3	0.0	4.9	0.9	41.2	0.0	1.4	0.8	10.0	31.5	0.6	5.2	2.1	0.4	10.0	0.2	0.5	6.8	0.3	6.1	21.8	0.6	0.0	2.0	0.4	0.1	0.1	0.0	3.3	0.5	0.7	24.4	37.8	0.5	0.0	2.5	1.4	0.5	0.0	0.1	1.9	6.3	7.5	3.2	0.8	0.3	1.7	0.9	0.3	4.2	3.0	1.2	9.8	4.6	3.9	10.9	5.2	8.7	2.0	6.7	9.0	3.3	1.2	4.0	5.4	12.7	17.2	7.1	0.4	4.1	4.9	2.5	3.2	1.7	2.6	3.5	2.4	3.6	2.0	4.7	2.4	53.6	33.0	11.1	14.0	1.4	0.6	3.2	17.8	34.8	22.7	17.4	2.0	9.1	0.0	33.0	0.5	36.5	7.3	0.0	17.5	4.8	20.8	22.5	10.5	82.9	8.3	0.0	7.5	40.5	15.0	0.0	25.3	6.5	0.0	22.6	15.5	0.0	64.3	23.0	22.6	1.2	0.7	6.5	7.1	0.4	0.4	1.9	5.6	15.2	2.3	48.8
APOL4	APOLIV	ENSG00000100336	"Apolipoprotein L4"	Q9BPW4	22	36189124-36204840	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 7.9;Intestinal endocrine cells: 14.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"classical monocyte: 4.3;intermediate monocyte: 2.3;myeloid DC: 3.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.8;monocytes: 4.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 8.3;HDLM-2: 46.5;HSkMC: 7.6;K-562: 9.9;SCLC-21H: 21.4"									"HPA049797, HPA055435"	Uncertain		Supported	Vesicles	"Secreted to blood"			Vesicles		"HPA049797: AB_2680887, HPA055435: AB_2682816"	"unprognostic (2.73e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.31e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.91e-1)"	"prognostic favorable (3.45e-4)"	"unprognostic (1.33e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (2.00e-5)"	"unprognostic (4.26e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.18e-2)"	"prognostic favorable (2.40e-6)"	2.3	0.8	1.1	2.7	1.3	0.0	2.3	0.9	1.0	2.4	1.2	0.7	0.7	2.2	2.0	0.7	2.4	3.1	3.2	2.8	0.8	1.0	10.3	1.1	7.3	1.7	1.0	0.7	4.2	0.9	0.0	1.9	3.0	1.2	9.0	1.5	1.8	2.9	1.6	1.0	1.6	5.4	2.1	2.3	1.1	2.3	0.7	1.2	7.1	1.1	0.7	2.3	7.4	1.4	0.4	3.8	0.6	4.3	0.8	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.9	8.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	46.5	0.0	2.5	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.3	0.0	9.9	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.4	21.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	4.3	0.0	0.0	2.3	0.0	0.4	0.0	0.0	3.8	0.3	0.0	0.0	0.2	0.8	0.2	0.0	0.0	1.2	1.1	1.3	0.9	1.0	0.8	1.0	1.0	0.7	1.2	1.2	0.0	7.9	0.0	0.9	1.1	0.2	1.1	2.5	4.0	3.4	0.0	0.0	0.4	3.3	0.1	0.0	3.8	0.0	0.0	0.6	0.6	6.3	1.2	2.3	0.0	2.4	1.6	14.3	1.3	4.5	0.0	2.6	5.3	0.0	1.8	0.3	0.0	0.2	0.0	0.4	0.3	0.0	0.0	1.4	0.0	0.0	1.0	5.1	0.0	0.1	1.4
APOO	"FAM121B, MGC4825, Mic23, MIC26, My025"	ENSG00000184831	"Apolipoprotein O"	Q9BUR5	X	23833353-23907934	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Distal tubular cells: 152.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA003187	Supported		Approved	Mitochondria,Cytosol	"Secreted to blood"			Mitochondria	Cytosol	"HPA003187: AB_1079375"	"unprognostic (2.53e-2)"	"prognostic favorable (3.77e-4)"	"unprognostic (4.86e-2)"	"unprognostic (6.38e-3)"	"unprognostic (3.45e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.18e-2)"	"unprognostic (2.95e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.22e-1)"	"prognostic favorable (2.56e-6)"	"unprognostic (2.53e-2)"	"unprognostic (5.21e-2)"	"unprognostic (3.48e-1)"	"unprognostic (5.88e-3)"	5.6	13.1	25.5	5.4	21.2	4.4	9.0	18.5	30.9	9.1	10.9	8.5	5.5	9.2	7.2	13.5	7.2	13.6	6.1	38.4	26.0	23.8	29.5	12.2	5.5	6.6	24.9	17.5	7.1	9.0	20.1	15.8	7.1	21.5	9.3	12.5	11.7	14.6	10.4	26.0	4.3	7.6	7.8	18.1	5.4	10.3	10.5	6.8	7.7	13.3	10.4	7.2	6.3	5.8	9.8	14.2	8.5	13.3	7.8	15.0	6.6	14.7	13.5	22.7	15.8	3.8	8.7	3.6	7.4	9.1	15.8	16.7	8.0	7.1	12.8	9.3	6.8	20.6	12.2	28.6	14.8	17.6	13.5	20.3	6.5	13.4	12.6	9.0	16.3	7.3	9.7	8.8	17.4	13.0	8.5	11.0	16.1	9.1	14.5	14.6	13.9	16.4	17.6	20.7	19.4	21.9	12.7	11.3	30.7	30.9	7.6	15.4	11.2	16.1	15.4	15.8	23.3	26.6	7.3	2.7	10.2	6.2	36.5	11.2	11.3	19.8	11.6	16.5	8.1	14.9	8.5	4.2	1.5	11.5	13.3	15.0	9.8	12.7	11.3	12.0	8.3	10.3	10.1	2.5	7.8	12.6	14.2	11.5	6.6	25.5	21.2	18.5	30.9	26.0	23.8	24.9	17.5	21.5	6.8	14.9	7.8	15.6	14.2	12.5	19.3	55.7	25.5	87.0	9.1	22.7	13.7	16.6	152.5	24.6	16.8	8.7	14.4	0.0	14.1	7.3	12.6	14.5	3.5	11.9	20.3	19.1	6.9	9.8	10.1	11.7	10.6	11.2	27.0	55.9	17.6	40.5	12.0	18.4	14.9	67.7	23.7	6.5	6.2	14.0	50.7	6.0	10.4	10.0	20.9	15.4
ARSF		ENSG00000062096	"Arylsulfatase F"	P54793	X	3041471-3112726	"Predicted membrane proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.3;kidney: 11.5;skin 1: 8.3"	"Cell type enhanced"	"Detected in some"	31	"Distal tubular cells: 1.7;Proximal tubular cells: 4.6"	"Cancer enhanced"	"Detected in some"		"glioma: 2.9"					"Cell type enhanced"	"Detected in some"		"basophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.0;U-266/70: 1.1"									HPA000549			Uncertain	Cytosol	"Secreted in other tissues"			Cytosol		"HPA000549: AB_1845055"	"unprognostic (2.19e-2)"	"unprognostic (8.88e-2)"		"unprognostic (2.87e-1)"	"unprognostic (5.41e-3)"	"unprognostic (3.83e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.72e-2)"	"unprognostic (4.70e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.48e-1)"	0.0	4.6	2.7	0.0	5.3	0.0	0.1	0.0	1.9	0.4	0.0			0.0	0.0	2.5	3.1	0.0	0.0	0.0	1.3	0.5	11.5	1.7	0.0	0.0	1.5		0.0	0.2	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.0	8.3	0.0	0.0	0.2	0.0	0.0	0.0			0.0		0.5	0.6	1.5	0.3	0.2	1.9	0.3	0.8	0.3	0.0	0.2	0.4	0.5	0.7	0.0	0.2	2.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.2	0.3	0.0	0.0	0.3	0.4	0.0	0.4	0.2	0.3	0.2	0.0	0.0	0.4	0.3	0.0	0.0	0.4	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.2	0.1	0.3	0.0	0.1	0.5	0.1	0.1	1.1	0.1	0.1	0.8	0.4	0.3	1.9	0.3	0.4	0.2	0.3	0.3	0.1	0.3	0.2	0.0	0.3	0.3	0.3	1.2	0.8	0.1	0.2	0.1	0.0											0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3
ART4	"CD297, DO, DOK1"	ENSG00000111339	"ADP-ribosyltransferase 4 (Dombrock blood group)"	Q93070	12	14825569-14843533	"Blood group antigen proteins, CD markers, Enzymes, Predicted membrane proteins, Predicted secreted proteins"		"Blood group antigen, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 33.7;lymphoid tissue: 17.8;placenta: 17.8"	"Cell type enhanced"	"Detected in many"	20	"Erythroid cells: 93.5;Hepatocytes: 21.3;Ito cells: 55.3"	"Cancer enhanced"	"Detected in some"		"liver cancer: 3.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.2;HEL: 10.3;Hep G2: 6.1;HUVEC TERT2: 23.4"	"Region enhanced"	"Detected in single"		"olfactory region: 2.2"	"Low region specificity"	"Detected in single"			HPA075664			Approved	"Rods & Rings"	"Secreted to blood"		11000000	"Rods & Rings"		"HPA075664: "	"unprognostic (2.50e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.62e-3)"	"unprognostic (4.33e-3)"	"unprognostic (1.25e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.71e-1)"	2.7	2.0	0.2	1.7	0.2	2.4	2.1	0.2	0.2	1.4	1.3	0.1	1.9	0.0	1.1	3.7	3.1	1.9	6.1	10.1	0.2	0.2	6.6	33.7	2.1	17.0	0.2	0.0	1.3	1.9	0.0	0.4	17.8	0.3	0.8	0.2	0.0	0.7	0.4	1.9	0.5	0.8	1.5	0.2	17.8	0.5	1.4	0.0	0.1	4.6	1.3	1.3	1.3	1.2	0.6	0.6	1.4	0.4	0.6	1.3	0.3	0.0	0.0	0.2	5.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	6.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.6	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.4	0.5	0.3	0.4	0.5	0.3	0.3	0.2	0.6	0.5	1.3	1.4	0.6	0.2	0.6	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.3	0.0	0.0	0.6	0.0	0.8	0.2	1.8	1.4	12.7	0.0	0.0	1.8	11.8	0.1	0.0	0.7	0.4	2.8	0.0	93.5	1.8	1.4	1.9	0.1	0.0	21.3	0.1	0.0	0.0	55.3	7.5	0.0	1.7	0.6	1.7	0.0	0.0	0.2	0.3	0.0	0.0	0.0	12.6	6.5	0.8	0.0	0.0	0.1	0.2	0.0	0.0	0.3
ATRN	"DPPT-L, MGCA"	ENSG00000088812	Attractin	O75882	20	3471040-3651122	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Inflammatory response"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008853	Approved		Approved	Cytosol	"Secreted to blood"		39000000000	Cytosol		"HPA008853: AB_1078248"	"unprognostic (6.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.52e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.99e-2)"	"unprognostic (4.28e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.59e-1)"	"prognostic favorable (2.19e-6)"	"unprognostic (3.71e-2)"	"unprognostic (9.49e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.91e-2)"	12.1	22.8	14.9	7.4	20.7	5.7	13.0	18.4	29.3	13.5	22.8	18.3	7.4	39.9	12.2	12.2	9.3	9.2	12.4	14.8	13.6	14.7	18.4	45.2	10.6	7.1	12.8	18.9	11.5	17.7	40.3	13.4	16.5	16.1	10.1	9.5	12.2	14.0	10.7	11.7	13.6	31.1	11.3	15.2	9.7	17.1	16.2	12.3	5.4	24.1	7.5	7.1	12.0	9.8	3.6	5.7	5.7	6.5	3.0	4.8	1.9	17.9	16.9	10.1	8.4	17.9	29.3	12.9	12.0	17.1	12.7	10.8	7.2	12.3	0.0	8.1	16.8	15.6	25.2	6.8	26.2	17.0	2.0	5.8	5.6	4.7	15.6	10.8	11.9	3.8	15.6	21.3	13.4	13.0	15.9	16.4	3.9	8.8	8.8	12.3	5.1	4.8	4.5	6.7	5.9	10.2	4.0	23.4	13.4	11.6	12.8	6.0	9.3	12.0	22.4	16.4	10.3	12.0	11.4	20.1	13.5	8.0	14.2	11.8	6.2	8.7	0.0	8.3	8.0	13.5	5.7	6.5	3.6	4.8	5.6	2.3	2.8	2.7	3.0	5.7	3.6	4.4	3.7	0.0	3.0	5.7	5.3	3.4	1.9	14.9	20.7	18.4	29.3	13.6	14.7	12.8	18.9	16.1	12.3	14.9	7.2	7.3	3.8	5.7	22.1	10.4	22.9	6.7	5.7	10.4	35.3	6.4	1.7	6.4	6.3	8.4	6.1	0.0	12.5	7.2	9.3	6.1	6.9	39.5	9.6	35.0	9.2	20.9	13.9	2.5	11.5	6.3	6.8	6.4	10.2	12.7	10.7	15.3	7.4	7.9	18.2	32.3	5.2	16.7	21.7	6.4	4.2	5.0	10.5	3.1
BDNF		ENSG00000176697	"Brain derived neurotrophic factor"	P23560	11	27654893-27722058	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.5;smooth muscle: 10.5"	"Cell type enhanced"	"Detected in some"	23	"Alveolar cells type 1: 35.7;Cardiomyocytes: 9.6;Smooth muscle cells: 6.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ: 22.7;BJ hTERT+ SV40 Large T+: 17.4;BJ hTERT+ SV40 Large T+ RasG12V: 13.2;HBF TERT88: 16.7;U-138 MG: 24.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009564, HPA031440, HPA056104"	Enhanced		Supported	"Nuclear speckles,Mitochondria"	"Secreted to blood"	16000000		"Nuclear speckles, Mitochondria"		"CAB009564: AB_2064213, HPA031440: AB_2673883, HPA056104: AB_2683038"	"unprognostic (1.25e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.88e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.84e-3)"	0.9	1.3	5.0	0.6	4.5	0.5	0.6	9.4	14.5	1.6	0.8	0.6	0.7	0.8	0.7	8.2	1.4	0.5	2.1	5.8	8.5	5.7	0.9	0.5	4.1	0.4	2.5	4.7	1.2	1.0	0.2	2.3	3.7	12.7	4.9	0.4	3.0	0.9	4.2	1.3	2.1	0.5	10.5	1.0	0.6	0.9	1.3	0.0	0.0	2.3	0.0	0.4	3.2	1.2	0.1	0.4	0.0	0.2	0.1	1.0	0.1	1.6	6.7	0.2	0.0	2.4	1.9	0.0	22.7	4.4	17.4	13.2	0.0	2.6	0.0	2.1	8.2	0.3	1.0	0.1	0.2	16.7	0.1	0.1	0.0	2.2	0.0	10.1	0.1	0.1	5.9	2.2	3.8	2.2	10.6	0.7	0.0	0.0	0.0	2.7	0.0	0.0	0.0	2.1	0.0	1.8	0.0	1.3	0.0	2.5	0.0	0.1	0.6	4.3	0.0	0.0	1.0	0.1	0.0	7.5	24.4	4.1	9.4	5.0	0.3	0.0	0.0	9.4	0.6	1.3	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.6	0.2	0.1	0.7	0.4	0.0	0.1	0.0	0.4	1.0	0.1	5.0	4.5	9.4	9.4	8.5	5.7	2.5	4.7	12.7	0.0	35.7	0.3	0.0	0.2	0.6	4.7	9.6	0.0	0.0	0.0	1.8	3.9	0.2	0.0	0.8	0.9	0.0	0.0	0.0	0.0	0.3	4.1	0.4	1.1	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.3	0.0	1.7	0.0	0.0	0.1	0.2	0.0	0.0	0.3	1.5	0.0	6.6	0.4	0.7	0.0	0.6	0.0	0.0	0.0
BTC		ENSG00000174808	Betacellulin	P35070	4	74744759-74794686	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Growth factor, Mitogen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 23.5"	"Cell type enhanced"	"Detected in many"	12	"Ciliated cells: 45.5;Club cells: 17.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	17	"plasmacytoid DC: 1.7"	"Lineage enriched"	"Detected in single"	17	"dendritic cells: 1.7"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 16.4;MCF7: 5.8;RPTEC TERT1: 9.9;SK-BR-3: 6.6"	"Not detected"	"Not detected"												"Secreted to blood"	314000					"unprognostic (7.36e-2)"	"unprognostic (4.99e-2)"	"unprognostic (7.04e-2)"	"unprognostic (7.76e-3)"	"unprognostic (3.87e-3)"	"unprognostic (1.01e-3)"	"unprognostic (1.05e-1)"	"unprognostic (7.17e-3)"	"unprognostic (2.68e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.50e-2)"	"unprognostic (5.35e-1)"	"prognostic favorable (6.10e-5)"	"unprognostic (2.33e-1)"	"unprognostic (2.45e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.31e-3)"	3.0	1.2	1.0	5.2	2.2	0.0	3.7	0.3	2.8	2.2	23.5	1.2	3.1	3.0	2.4	5.6	9.9	6.1	10.3	2.5	1.3	1.3	3.7	0.8	3.4	0.2	0.8	1.0	3.6	2.9	5.2	4.5	0.9	2.1	3.7	5.9	7.0	6.8	3.6	0.6	12.4	11.3	8.3	0.6	0.4	6.9	0.8	0.9	0.4	5.2	1.9	2.3	5.6	3.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	3.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.0	1.2	0.0	16.4	0.0	3.5	0.0	2.4	0.5	0.0	0.1	0.0	0.0	0.3	0.1	0.6	0.0	0.2	0.0	0.0	0.0	1.2	0.4	0.1	2.7	0.1	0.0	0.0	0.1	0.4	5.8	0.1	0.0	0.1	1.7	2.5	0.0	0.0	0.0	9.9	4.7	0.2	0.0	2.4	6.6	0.0	0.0	0.4	0.0	0.0	0.3	0.1	0.3	2.8	0.3	0.0	0.0	2.7	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	1.0	2.2	0.3	2.8	1.3	1.3	0.8	1.0	2.1	0.9	8.9	6.7	0.0	3.8	0.6	1.7	0.5	0.0	45.5	17.0	10.4	2.0	0.3	0.0	3.2	1.4	0.2	3.6	0.0	5.1	0.0	0.6	3.9	0.0	0.2	0.1	0.0	11.5	3.1	0.0	0.0	0.3	0.0	0.0	0.0	9.0	10.6	3.4	6.5	0.0	1.1	5.2	0.0	3.8	0.0	0.0	2.6	0.2	0.0	6.8	6.0
BTN1A1	"BT, BTN, BTN1"	ENSG00000124557	"Butyrophilin subfamily 1 member A1"	Q13410	6	26501221-26510422	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"breast: 27.4"	"Cell type enhanced"	"Detected in single"	32	"B-cells: 1.9"	"Cancer enhanced"	"Detected in single"		"breast cancer: 0.6"					"Cell type enhanced"	"Detected in some"		"memory B-cell: 5.6;naive B-cell: 2.6"	"Lineage enriched"	"Detected in many"	4	"B-cells: 5.6"	"Cell line enriched"	"Detected in some"	5	"CACO-2: 10.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA011126, CAB037340"	Supported				"Secreted in female reproductive system"					"CAB037340: , HPA011126: AB_1845491"	"unprognostic (4.07e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.77e-2)"		"unprognostic (5.50e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.35e-10)"	"unprognostic (4.62e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.14e-2)"	"unprognostic (5.31e-4)"	0.0	0.0	0.0	0.2	0.0	0.0	27.4	0.4	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.3		0.1	0.0	0.0	0.0	0.0		0.0	0.0		0.1	0.1	0.0	0.0	0.6	0.0	1.0	1.6	0.0	1.3			0.0		0.6	0.1	0.0	5.6	0.0	0.7	1.2	0.0	0.5	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	5.6	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2											0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
CATSPERG	"C19orf15, DKFZp434A1022, FLJ46353"	ENSG00000099338	"Cation channel sperm associated auxiliary subunit gamma"	Q6ZRH7	19	38335775-38370943	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 35.7"	"Group enriched"	"Detected in many"	7	"Early spermatids: 23.9;Enterocytes: 14.0;Late spermatids: 27.8;Spermatocytes: 31.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 4.8;monocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.2;HMC-1: 5.3;MCF7: 4.3"					"Low region specificity"	"Detected in all"			HPA052777			Approved	Nucleoplasm,Nucleoli,Cytosol	"Secreted in male reproductive system"			Nucleoli	"Nucleoplasm, Cytosol"	"HPA052777: "	"unprognostic (8.50e-5)"	"unprognostic (5.12e-2)"	"unprognostic (3.57e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.37e-4)"	"unprognostic (9.99e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.07e-3)"	0.9	0.8	2.9	0.8	7.7	1.1	1.3	4.3	5.8	1.2	1.1	6.5	1.9	1.2	1.2	1.8	0.9	1.4	0.9	0.8	3.9	1.0	1.0	1.0	1.1	1.0	7.4	2.2	1.3	1.0	1.0	1.2	0.8	5.2	1.3	1.0	0.4	2.0	1.1	1.0	2.0	1.1	0.9	3.2	0.9	1.0	35.7	6.5	2.2	1.3	0.0	1.0	0.9	3.3	0.1	0.6	4.8	1.8	0.2	0.5	0.2	0.2	0.5	0.2	1.8	0.8	0.0	4.2	0.2	0.0	0.0	0.0	1.3	0.8	0.3	0.0	0.0	0.7	0.6	0.5	0.1	0.0	0.9	0.2	0.1	0.2	0.0	0.1	0.3	5.3	0.0	0.8	0.0	0.5	0.5	0.1	0.8	0.0	1.4	0.0	4.3	0.0	0.0	0.0	1.1	0.8	0.1	0.0	0.8	2.0	0.1	0.4	0.6	0.4	0.9	0.2	0.7	0.4	0.0	0.3	0.0	1.0	0.7	0.0	0.8	0.9	0.0	0.2	0.2	0.0	0.3	0.8	1.8	0.4	0.9	0.2	0.0	0.1	0.2	0.6	0.1	0.5	0.2	4.8	0.2	1.8	0.4	0.3	0.2	2.9	7.7	4.3	5.8	3.9	1.0	7.4	2.2	5.2	6.5	0.0	2.4	1.7	1.9	2.3	1.1	2.4	2.5	0.0	0.0	1.8	0.0	1.0	0.0	0.8	23.9	1.5	14.0	0.0	0.6	0.2	1.5	1.8	1.1	0.5	2.8	1.6	1.7	1.8	0.8	27.8	1.7	2.6	0.0	1.8	1.5	1.9	0.5	3.5	2.1	1.1	1.1	0.0	1.0	31.9	2.7	1.6	1.1	2.5	2.0	1.4
CCL5	"D17S136E, MGC17164, RANTES, SCYA5, SISd, TCP228"	ENSG00000271503	"C-C motif chemokine ligand 5"	P13501	17	35871491-35880793	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"blood: 169.0"	"Cell type enriched"	"Detected in many"	5	"T-cells: 1814.4"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"gdT-cell: 157.7;memory CD8 T-cell: 169.0"	"Lineage enriched"	"Detected in many"	4	"T-cells: 169.0"	"Cell line enriched"	"Detected in some"	4	"NB-4: 73.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			CAB078447	Enhanced				"Secreted to blood"	20100000	8200000			"CAB078447: AB_223462"	"unprognostic (3.91e-3)"	"unprognostic (1.50e-3)"	"unprognostic (8.63e-2)"	"prognostic favorable (1.34e-5)"	"unprognostic (1.36e-3)"	"unprognostic (6.37e-3)"	"unprognostic (8.70e-2)"	"unprognostic (2.64e-2)"	"prognostic favorable (2.42e-4)"	"unprognostic (3.26e-3)"	"unprognostic (1.64e-2)"	"unprognostic (2.88e-1)"	"prognostic unfavorable (3.61e-7)"	"unprognostic (1.70e-2)"	"unprognostic (7.55e-2)"	"unprognostic (8.56e-3)"	"unprognostic (3.73e-2)"	3.6	2.4	0.0	28.8	0.1	17.1	2.6	0.0	0.2	6.0	14.7	1.0	0.6	7.1	5.0	7.2	5.2	1.7	20.5	7.5	0.0		2.7	4.7	29.8	33.5	2.8	0.0	5.9	2.3	0.0	0.1	4.8	1.7	7.8	4.0	8.0	5.5	6.4	2.8	0.0	38.7	2.3	2.2	38.8	6.9	1.9	0.0	12.2	1.6	5.5	27.9	11.5	0.0	1.2	1.1	9.9	0.6	40.8	169.0	106.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	2.4	2.9	0.0	0.3	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.2	0.7	0.0	0.0	0.2	0.0	0.1	11.5	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	73.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.1	1.7	0.1	0.0	17.1	0.0	0.1	0.0	0.1	0.0	2.2	0.8	0.1	0.0	15.7	0.2	9.9	0.6	0.7	157.7	0.4	103.8	1.2	36.7	169.0	1.1	0.7	8.8	99.3	4.6	40.8	0.5	0.9	0.5	106.5											92.3	350.0	25.5	1.0	6.5	1.1	2.5	0.0	52.2	76.2	1.8	0.0	1.4	1.7	0.8	0.8	18.0	2.6	46.7	0.2	0.7	6.0	1.5	74.4	4.7	28.5	0.0	1.7	48.5	34.1	0.0	0.3	29.5	11.8	2.8	0.3	0.8	1.7	3.5	0.4	5.3	0.4	0.0	7.1	1.0	0.7	5.5	13.4	1814.4	1.1	1.6
CCL7	"FIC, MARC, MCP-3, MCP3, NC28, SCYA6, SCYA7"	ENSG00000108688	"C-C motif chemokine ligand 7"	P80098	17	34270221-34272242	"Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	"Cytokine, Heparin-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"adipose tissue: 11.5;bone marrow: 22.3"	"Cell type enriched"	"Detected in some"	8	"Hofbauer cells: 60.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"classical monocyte: 1.1"	"Lineage enriched"	"Detected in single"	12	"monocytes: 1.1"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 15.5;BJ hTERT+ SV40 Large T+: 3.2;BJ hTERT+ SV40 Large T+ RasG12V: 4.0;HSkMC: 4.7"	"Low region specificity"	"Detected in many"												"Secreted to blood"	29700					"unprognostic (7.66e-2)"	"unprognostic (1.05e-2)"	"unprognostic (8.53e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.54e-2)"	"unprognostic (9.54e-2)"		"unprognostic (4.18e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.27e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.99e-8)"	"unprognostic (2.83e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.79e-2)"	11.5	0.6	0.0	2.6	0.0	22.3	0.3	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.3	0.0	0.1	0.5	0.7	0.9	0.1	0.1	0.5	0.2	1.2	0.0	0.1	0.0	1.3	0.4	0.0	0.1	1.7	0.3	0.5	1.0	0.0	0.2	0.0	0.1	0.2	0.2	2.2	0.1	0.1	1.2	0.5	0.0	1.4	0.3	0.0	0.0	0.5	0.4	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	2.4	0.0	1.7	15.5	3.2	4.0	0.0	0.0	0.0	0.5	1.1	0.0	1.4	0.0	0.0	1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.9	4.7	0.0	1.3	0.0	0.0	1.4	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	7.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.5	0.0	0.0	60.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.6
CD163	"M130, MM130, SCARI1"	ENSG00000177575	"CD163 molecule"	Q86VB7	12	7470813-7503893	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Acute phase, Inflammatory response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 113.6"	"Cell type enriched"	"Detected in many"	7	"Kupffer cells: 1509.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"classical monocyte: 28.2;myeloid DC: 25.3"	"Group enriched"	"Detected in many"	40	"dendritic cells: 25.3;monocytes: 28.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 1.8;CACO-2: 1.7;GAMG: 5.4;HSkMC: 5.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"CAB002432, HPA046404, HPA051974"	Enhanced		Supported	"Plasma membrane"	"Secreted to blood"	903000000	1600000000	"Plasma membrane"		"CAB002432: AB_563510, HPA046404: AB_2679655, HPA051974: AB_2681678"	"unprognostic (1.13e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.72e-1)"	"unprognostic (6.17e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (7.27e-4)"	"unprognostic (1.04e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.84e-2)"	"unprognostic (8.77e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.20e-2)"	66.7	23.8	2.1	44.6	7.2	4.1	23.2	2.8	4.9	11.3	25.3	1.6	1.4	3.5	7.2	16.8	11.3	20.1	13.2	15.7	2.8	1.8	43.9	38.9	81.0	99.8	6.9	0.5	10.3	6.7	3.1	11.7	31.9	9.9	6.8	6.5	9.8	8.6	2.2	15.2	4.0	12.5	37.2	5.7	113.6	10.2	19.6	4.3	3.4	15.5	2.9	3.5	20.1	8.3	0.0	25.3	0.6	28.2	0.0	0.0	6.3	0.0	0.0	0.0	0.0	1.8	1.0	0.4	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	5.4	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.5	0.3	5.3	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.5	0.1	0.0	0.1	0.9	0.1	0.0	0.0	0.2	0.5	0.1	0.1	0.0	0.5	0.0	0.3	0.0	0.9	0.3	0.2	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.5	28.2	0.1	0.0	2.5	0.0	0.0	0.0	0.0	25.3	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	6.3	2.1	7.2	2.8	2.4	2.8	1.8	6.9	0.5	9.9	4.3	3.0	8.8	9.3	0.2	1.3	0.0	3.4	10.2	2.7	9.1	0.0	2.0	1.3	0.0	0.0	2.5	1.9	0.0	0.0	0.0	1.5	1.6	0.1	4.7	5.9	221.9	0.0	0.0	28.3	1509.4	3.9	4.6	104.2	0.0	0.0	0.0	0.8	0.0	0.0	1.1	0.0	0.1	116.4	0.3	3.9	1.7	0.9	2.5	5.0	0.0	0.0
CD40	"Bp50, p50, TNFRSF5"	ENSG00000101017	"CD40 molecule"	P25942	20	46118272-46129863	"Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins"	Immunity	Receptor	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"monocytes: 413.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 36.1;naive B-cell: 41.3"	"Group enriched"	"Detected in many"	6	"B-cells: 41.3;monocytes: 10.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 27.3;EFO-21: 47.9;U-2 OS: 15.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002495, HPA031567, HPA031568, CAB072868"	Enhanced				"Secreted to blood"	705000	16000			"CAB002495: AB_563562, CAB072868: AB_2665719, HPA031567: AB_2673936, HPA031568: AB_2673937"	"unprognostic (6.41e-2)"	"unprognostic (1.55e-2)"	"unprognostic (7.08e-3)"	"unprognostic (6.21e-2)"	"unprognostic (4.23e-3)"	"unprognostic (1.25e-1)"	"unprognostic (7.64e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.15e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.48e-2)"	"unprognostic (7.04e-2)"	"prognostic unfavorable (4.48e-4)"	"unprognostic (1.22e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.28e-2)"	13.0	4.6	3.6	38.6	4.7	1.1	11.6	9.7	4.4	11.3	9.2	3.6	7.8	6.5	9.6	8.6	9.9	9.7	8.6	9.5	4.5	2.6	10.0	10.0	18.8	34.7	3.3	3.2	14.8	14.0	12.1	5.9	6.5	5.4	14.7	5.2	13.7	13.0	11.6	7.5	9.0	11.8	10.0	4.6	30.1	8.4	4.4	4.4	11.5	16.5	6.7	46.0	12.5	13.8	41.3	4.1	1.0	10.8	0.6	1.4	4.8	9.2	1.4	0.0	4.6	1.7	1.0	1.8	1.7	0.5	1.4	1.3	0.0	27.3	14.8	47.9	0.3	6.8	1.1	0.8	5.8	1.4	9.9	0.0	3.5	0.0	2.5	13.7	0.0	4.7	6.1	2.2	5.6	0.0	0.0	10.3	0.0	1.2	0.0	0.2	0.0	0.0	0.0	0.6	3.2	0.0	0.3	0.3	1.5	12.0	0.1	0.0	0.0	8.1	4.5	0.0	0.0	0.9	4.9	0.0	0.0	15.3	0.0	0.0	0.0	0.0	10.1	3.4	1.8	0.0	1.0	7.7	0.1	1.3	10.8	0.9	36.1	0.7	0.5	4.1	41.3	1.4	1.0	0.7	0.6	7.5	2.1	1.0	4.8	3.6	4.7	9.7	4.4	4.5	2.6	3.3	3.2	5.4	4.4	11.9	15.9	94.5	51.6	38.7	1.0	3.6	40.8	2.7	23.9	14.0	0.0	0.2	0.0	50.8	9.8	40.9	2.4	0.0	26.1	1.1	18.2	33.2	3.5	13.5	37.2	0.0	1.2	39.3	11.9	9.1	23.9	46.8	27.0	413.8	5.3	8.2	33.6	3.6	21.2	4.4	0.0	32.3	36.1	0.9	5.1	29.7	0.3	5.0	5.7	54.0
CD40LG	"CD154, CD40L, gp39, hCD40L, HIGM1, IMD3, TNFSF5, TRAP"	ENSG00000102245	"CD40 ligand"	P29965	X	136648193-136660390	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 29.2;intestine: 8.7;lymphoid tissue: 33.7"	"Cell type enriched"	"Detected in some"	4	"T-cells: 24.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"gdT-cell: 9.4;MAIT T-cell: 22.9;memory CD4 T-cell: 29.2;naive CD4 T-cell: 28.1"	"Lineage enriched"	"Detected in single"	58	"T-cells: 29.2"	"Cell line enriched"	"Detected in some"	14	"MOLT-4: 22.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA045827, HPA072480"	Enhanced				"Secreted to blood"	776000				"HPA045827: AB_10959606, HPA072480: "	"unprognostic (1.94e-5)"	"unprognostic (1.24e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.27e-3)"	"unprognostic (4.71e-2)"	"unprognostic (3.56e-5)"	"unprognostic (3.66e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.14e-4)"	"unprognostic (1.87e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.70e-4)"	"unprognostic (2.15e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.36e-3)"	"unprognostic (2.92e-2)"	2.0	0.5	0.3	22.4	0.3	1.4	1.2	0.3	0.3	2.0	3.3	0.1	0.0	1.7	1.5	1.3	1.6	1.6	2.6	1.1	0.4	0.4	1.6	1.1	4.0	14.6	0.4	0.0	0.7	0.6	0.0	0.4	0.2	0.3	1.0	3.1	1.0	4.9	1.3	0.4	1.1	8.7	0.5	0.6	9.9	1.7	0.6	0.1	33.7	1.4	2.0	26.1	3.0	1.4	0.0	0.0	0.5	0.0	0.2	29.2	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	22.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	9.4	0.0	22.9	0.0	29.2	4.1	0.0	0.0	28.1	0.2	0.5	0.2	0.0	0.0	3.3	4.7	0.3	0.3	0.3	0.3	0.4	0.4	0.4	0.0	0.3	0.1	0.0	3.7	0.0	0.0	1.1	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.6	5.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	1.8	0.0	24.5	0.0	0.0
CD44	"CD44R, CSPG8, HCELL, IN, MC56, MDU2, MDU3, MIC4, Pgp1"	ENSG00000026508	"CD44 molecule (Indian blood group)"	P16070	11	35138870-35232402	"Blood group antigen proteins, Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Blood group antigen, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Basal keratinocytes: 888.0;Ductal cells: 858.7;Suprabasal keratinocytes: 895.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 139.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB000112, CAB000316, HPA005785"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Secreted - unknown location"		2400000000	"Plasma membrane"	"Golgi apparatus"	"CAB000112: , CAB000316: AB_2076596, HPA005785: AB_1078467"	"unprognostic (5.33e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.97e-2)"	"unprognostic (9.90e-3)"	"unprognostic (3.50e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.51e-3)"	"unprognostic (4.63e-2)"	"prognostic unfavorable (1.78e-8)"	"unprognostic (6.41e-2)"	"unprognostic (4.14e-2)"	"unprognostic (3.93e-2)"	"unprognostic (7.98e-2)"	45.5	9.0	10.5	42.5	21.7	53.0	35.6	4.7	13.4	43.2	19.5	26.3	8.3	10.6	80.5	20.3	66.5	18.6	48.0	11.7	14.9	9.3	12.4	9.1	43.4	48.4	31.5	6.1	12.8	83.9	0.8	3.8	19.4	40.7	30.1	24.5	30.2	148.2	22.4	15.9	107.7	18.9	44.5	100.5	30.9	19.9	7.2	20.3	17.9	20.6	53.9	53.7	55.0	54.2	22.7	41.0	19.1	65.2	54.6	53.1	59.9	39.7	35.9	0.3	0.0	21.7	60.0	0.1	77.9	60.9	43.4	24.2	2.4	12.5	0.0	10.4	110.3	89.3	68.5	0.8	84.7	59.6	8.5	0.4	1.4	17.7	0.0	21.4	20.2	93.5	27.0	66.8	58.3	47.4	139.4	15.1	0.0	0.3	13.0	41.6	0.2	1.8	13.3	0.7	0.7	10.6	0.1	7.4	0.6	63.6	11.5	0.1	0.1	14.7	0.4	35.2	3.4	2.1	1.2	43.5	54.1	9.8	66.3	80.0	22.5	24.3	0.2	82.1	11.4	78.6	19.1	65.2	6.0	26.2	45.7	37.0	22.7	39.8	34.9	41.0	16.2	34.5	28.7	16.4	54.6	59.3	14.2	53.1	59.9	10.5	21.7	4.7	13.4	14.9	9.3	31.5	6.1	40.7	20.3	89.3	339.9	168.9	263.7	888.0	0.0	4.0	25.5	18.7	135.4	19.2	2.0	4.0	1.7	858.7	30.1	53.0	5.0	23.3	741.5	3.7	143.9	293.1	733.4	2.5	234.7	0.0	96.2	20.3	427.0	13.8	20.8	611.7	573.6	514.0	84.8	26.6	787.6	8.6	0.4	0.6	1.6	155.2	254.2	0.4	0.4	895.8	15.0	244.8	66.1	304.0
CD55	"CR, CROM, DAF, TC"	ENSG00000196352	"CD55 molecule (Cromer blood group)"	P08174	1	207321376-207386804	"Blood group antigen proteins, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"	"Blood group antigen, Host cell receptor for virus entry, Receptor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 2069.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 101.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 79.2;HMC-1: 105.8;PC-3: 63.1;U-2197: 64.2"									"HPA002190, CAB010454, HPA024386"	Enhanced				"Secreted to blood"	32300000	310000000			"CAB010454: AB_2075970, HPA002190: AB_1078472, HPA024386: AB_1846319"	"unprognostic (4.08e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (9.36e-4)"	"unprognostic (3.41e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.70e-2)"	"unprognostic (2.33e-2)"	21.8	63.2	5.8	27.2	20.2	31.9	17.9	4.6	10.5	34.0	14.8	13.8	7.8	12.8	16.3	11.9	36.1	10.4	18.0	32.0	7.5	10.1	9.6	16.7	114.6	41.1	16.7	4.7	31.3	9.1	8.1	12.8	107.0	11.9	9.7	12.4	8.2	82.3	12.8	108.8	37.5	26.0	23.5	11.4	30.4	17.7	10.2	18.8	4.2	13.2	31.4	19.1	39.3	19.1	18.6	18.3	101.4	31.6	19.0	16.9	20.3	4.8	6.6	0.0	2.2	8.5	9.1	34.6	9.2	16.2	5.3	5.7	20.8	6.9	9.4	7.7	5.4	19.8	2.8	10.6	2.0	4.9	4.3	3.9	12.2	79.2	3.4	27.6	7.4	105.8	4.3	25.0	6.5	28.7	21.0	27.3	1.5	13.1	4.5	3.0	5.2	0.7	5.1	6.7	11.4	63.1	1.1	6.6	7.4	8.8	4.7	2.6	0.0	49.8	10.1	8.0	15.5	8.6	6.3	11.9	2.7	5.1	64.2	3.5	3.7	4.4	6.3	7.2	2.9	12.1	39.3	26.9	35.9	5.5	26.3	8.2	16.9	7.4	5.8	18.3	18.6	16.9	16.4	101.4	19.0	31.6	9.8	5.0	20.3	5.8	20.2	4.6	10.5	7.5	10.1	16.7	4.7	11.9	18.8	2069.5	358.8	93.2	172.8	626.3	1.3	63.2	2.5	389.5	704.1	22.7	0.0	192.2	3.3	54.9	311.7	62.4	158.4	0.0	162.7	371.1	199.2	136.1	142.1	6.6	62.3	1.6	16.6	41.1	161.1	60.3	30.2	161.4	151.8	53.3	67.0	5.8	238.8	150.8	8.5	3.3	2.5	6.5	60.8	7.7	4.1	669.5	708.9	76.1	69.0	491.7
CD6	Tp120	ENSG00000013725	"CD6 molecule"	P30203	11	60971680-61020377	"CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Cell adhesion, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 23.0;lymphoid tissue: 58.1"	"Group enriched"	"Detected in some"	5	"B-cells: 10.7;T-cells: 34.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	34	"gdT-cell: 12.4;MAIT T-cell: 11.1;memory CD4 T-cell: 23.0;memory CD8 T-cell: 21.4;naive CD4 T-cell: 15.5;naive CD8 T-cell: 11.1;T-reg: 10.1"	"Lineage enriched"	"Detected in single"	52	"T-cells: 23.0"	"Group enriched"	"Detected in some"	12	"JURKAT: 7.8;MOLT-4: 28.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"CAB002489, CAB016252"	Enhanced				"Secreted to blood"	5270000	110000			"CAB002489: AB_563605, CAB016252: AB_631163"	"prognostic favorable (1.95e-4)"	"prognostic favorable (1.57e-5)"	"unprognostic (4.47e-2)"	"prognostic favorable (2.41e-4)"	"unprognostic (2.06e-2)"	"prognostic favorable (5.10e-6)"	"unprognostic (8.45e-3)"	"unprognostic (8.21e-3)"	"unprognostic (2.87e-3)"	"unprognostic (5.32e-3)"	"unprognostic (2.07e-1)"	"unprognostic (5.35e-1)"	"prognostic unfavorable (1.82e-4)"	"unprognostic (1.77e-1)"	"unprognostic (4.95e-2)"	"unprognostic (6.19e-2)"	"unprognostic (5.96e-2)"	1.5	0.5	0.8	26.4	0.4	5.5	0.9	0.5	1.4	1.3	3.3	0.6	0.8	2.2	1.4	1.5	1.9	1.3	5.0	1.3	0.7	1.8	1.6	1.1	6.9	25.6	1.7	0.5	0.7	0.8	0.0	0.6	0.6	0.4	1.2	1.6	1.2	7.0	0.3	0.3	0.9	13.0	0.7	0.9	18.4	3.4	0.9	0.1	58.1	1.6	1.9	42.0	3.7	1.3	0.4	0.1	0.3	0.0	0.0	23.0	5.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.1	0.0	0.0	0.0	28.9	0.0	0.1	0.1	0.1	0.1	0.0	0.6	0.0	0.1	0.1	0.2	0.0	0.3	0.0	0.3	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	12.4	0.0	11.1	0.4	23.0	21.4	0.1	0.4	15.5	11.1	0.3	0.0	0.0	0.0	10.1	5.1	0.8	0.4	0.5	1.4	0.7	1.8	1.7	0.5	0.4	0.1	0.0	4.5	10.7	0.2	1.8	1.4	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.8	0.4	0.0	0.0	0.6	0.1	0.3	0.1	0.0	0.9	2.1	1.6	0.0	1.3	1.2	0.0	0.3	2.0	3.3	1.0	0.0	0.0	0.7	0.0	0.0	0.1	0.2	0.0	0.9	0.3	0.8	1.3	0.2	34.6	0.1	0.3
CDCP2		ENSG00000157211	"CUB domain containing protein 2"	Q5VXM1	1	54132968-54153770	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"CACO-2: 1.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"basal ganglia: 0.4"	HPA031143	Uncertain				"Secreted - unknown location"					"HPA031143: AB_10611819"	"unprognostic (1.08e-1)"	"unprognostic (5.16e-2)"		"unprognostic (1.71e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.25e-2)"	"unprognostic (4.73e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.67e-2)"	"unprognostic (7.67e-6)"	"unprognostic (2.37e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.12e-1)"	"unprognostic (2.21e-2)"	0.5	0.3	0.1	0.1	0.5	0.3	0.9	0.1	0.6	1.1	0.2			0.0	0.1	0.0	0.1	0.4	0.0	0.2	0.1	0.0	0.1	0.4	0.3	0.0	0.0		0.1	0.0	0.0	0.0	0.0		0.1	0.0		0.2	0.5	0.0	0.6	0.3	0.2	0.0	2.2	0.2	0.1			0.6		0.0	0.7	0.3	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.4	0.0	0.7	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CKLF	"C32, CKLF1, CKLF3, CKLF4, HSPC224, UCK-1"	ENSG00000217555	"Chemokine like factor"	Q9UBR5	16	66552563-66566251	"Predicted membrane proteins, Predicted secreted proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 142.0"	"Cell type enhanced"	"Detected in many"	5	"granulocytes: 334.0;Macrophages: 289.2;Spermatocytes: 349.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 142.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA062779			Approved	Vesicles	"Secreted to blood"			Vesicles		"HPA062779: AB_2684867"	"unprognostic (1.64e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.97e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (5.67e-5)"	"unprognostic (2.72e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.79e-2)"	"unprognostic (8.05e-3)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (1.06e-9)"	"unprognostic (2.36e-1)"	"unprognostic (2.65e-1)"	"prognostic favorable (2.22e-4)"	"unprognostic (1.07e-1)"	18.8	21.1	16.1	27.7	16.9	29.9	18.8	19.0	14.9	14.8	20.6	11.0	9.1	15.7	14.8	15.2	12.5	16.4	22.8	11.0	14.9	13.4	15.0	14.6	28.9	41.2	23.1	11.0	14.5	12.0	11.4	13.5	14.6	15.0	14.6	22.0	10.9	13.0	9.7	6.8	9.0	26.5	16.9	20.8	44.4	12.2	42.5	18.6	40.2	12.3	11.7	24.6	17.6	13.0	9.4	32.2	142.0	39.6	17.7	25.6	34.2	35.7	31.9	6.7	19.3	18.1	14.8	4.9	17.9	13.6	19.6	29.3	29.7	43.9	14.1	22.7	15.3	20.5	19.3	13.3	10.7	27.6	17.4	6.7	10.3	28.4	36.3	10.9	32.0	27.8	10.1	8.7	24.4	8.7	23.5	23.3	43.6	16.4	40.7	24.4	11.9	30.9	31.8	2.2	21.1	51.8	53.1	35.4	39.2	65.4	19.9	9.4	11.4	54.8	3.6	16.6	4.7	10.6	21.7	14.2	28.4	25.7	9.8	21.0	19.3	39.7	71.8	23.9	28.2	22.9	64.6	39.6	74.8	20.6	19.8	25.6	9.4	19.2	20.0	32.2	8.8	10.2	14.1	142.0	17.7	18.6	16.3	22.9	34.2	16.1	16.9	19.0	14.9	14.9	13.4	23.1	11.0	15.0	18.6	17.9	66.2	46.2	20.8	24.3	8.2	0.8	101.9	65.6	35.2	54.1	0.0	40.5	14.9	120.7	24.7	44.8	58.0	23.3	113.2	92.3	41.3	13.1	334.0	34.2	227.1	1.6	31.7	66.9	154.7	20.5	45.8	289.2	38.8	30.7	61.5	19.0	153.7	40.3	28.3	75.1	6.4	32.3	33.5	349.8	69.4	20.1	14.5	215.8	65.0	23.3
CNMD	"BRICD3, CHM-I, CHM1, LECT1, MYETS1"	ENSG00000136110	Chondromodulin	O75829	13	52703264-52739812	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Chondrogenesis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.1;salivary gland: 15.1;thyroid gland: 8.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"glioma: 1.5;lung cancer: 6.0;testis cancer: 5.8;thyroid cancer: 4.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	33	"NTERA-2: 33.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010510	Uncertain				"Secreted to extracellular matrix"					"HPA010510: AB_10602021"	"unprognostic (7.52e-3)"		"unprognostic (1.34e-1)"		"unprognostic (7.36e-2)"			"unprognostic (1.45e-2)"		"unprognostic (1.15e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.96e-1)"		0.3	0.3	3.1	0.3	11.1	0.3	0.4	0.9	2.5	0.3	0.5	4.3	0.0	0.3	0.3	0.3	0.6	0.4	0.3	0.4	3.0	2.6	0.3	0.3	3.9	0.3	3.7	0.9	0.4	1.1	0.3	2.5	0.5	3.1	1.6	0.5	6.1	15.1	0.4	0.5	0.5	0.4	0.3	4.4	1.0	0.4	4.2	4.1	0.0	8.0	0.0	0.6	0.3	0.0	0.0	0.6	0.0	0.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	33.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.0	3.1	11.1	0.9	2.3	3.0	2.6	3.7	0.9	3.1	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
COL17A1	"BP180, BPAG2"	ENSG00000065618	"Collagen type XVII alpha 1 chain"	Q9UMD9	10	104031286-104086002	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"			"Cancer-related genes, Disease mutation, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 85.8;skin 1: 123.2;tongue: 64.0"	"Cell type enriched"	"Detected in many"	4	"Basal keratinocytes: 520.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 227.4"	"Region enriched"	"Detected in single"	4	"basal ganglia: 1.2"	"Cell type enriched"	"Detected in single"	15	"neutrophil: 3.7"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 3.7"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 24.8;HaCaT: 56.6;HBEC3-KT: 90.6;hTCEpi: 117.8;hTERT-HME1: 100.3"	"Region enriched"	"Detected in single"	4	"cerebellum: 1.1"	"Not detected"	"Not detected"			"HPA043673, HPA052963"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Secreted to extracellular matrix"			"Plasma membrane"	"Golgi apparatus"	"HPA043673: AB_10960893, HPA052963: AB_2681999"	"prognostic favorable (1.38e-4)"	"unprognostic (1.33e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.75e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.82e-3)"	"unprognostic (1.63e-1)"	"unprognostic (7.85e-3)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.35e-2)"	0.2	0.0	0.2	4.4	1.2	7.5	8.1	0.2	0.2	15.2	9.3	0.2	0.9	2.0	0.6	2.6	31.5	0.1	1.2	0.2	0.2	0.1	0.4	0.2	0.7	0.2	0.2	0.2	0.2	0.2	0.0	0.6	85.8	0.2	5.0	5.4	0.2	15.5	7.3	0.5	123.2	23.2	0.8	0.2	0.3	3.9	4.0	0.2	18.1	2.0	64.0	24.7	3.0	17.3	0.0	0.0	3.7	0.2	0.0	0.0	0.8	3.1	0.0	0.1	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	24.8	0.0	0.7	0.0	0.5	56.6	0.1	90.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	117.8	0.0	100.3	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.6	0.3	0.0	0.0	0.0	5.1	3.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.2	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.2	0.0	0.0	0.8	0.2	1.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.6	0.0	12.4	520.3	0.6	0.8	0.0	2.7	20.5	0.0	0.0	3.5	0.0	0.7	8.5	1.0	105.8	0.0	0.8	8.3	2.1	0.6	0.0	0.0	1.2	0.0	2.4	0.0	0.0	2.6	0.3	1.0	32.1	0.0	5.9	0.4	45.8	16.1	0.7	0.0	0.4	0.0	1.7	8.3	1.1	121.8	4.7	0.0	14.5	8.0
CRHR2	"CRF-RB, CRF2, HM-CRF"	ENSG00000106113	"Corticotropin releasing hormone receptor 2"	Q13324	7	30651943-30700129	"G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 11.7"	"Cell type enriched"	"Detected in single"	13	"Horizontal cells: 12.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.3;HeLa: 1.8;NTERA-2: 3.0;SCLC-21H: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted - unknown location"						"unprognostic (7.14e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.24e-3)"	"unprognostic (5.69e-2)"	"unprognostic (8.58e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.86e-4)"	"unprognostic (2.01e-1)"	"unprognostic (3.07e-1)"	"unprognostic (5.90e-4)"	"unprognostic (4.02e-2)"	"unprognostic (8.29e-4)"	"unprognostic (3.73e-3)"	"unprognostic (2.84e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.84e-1)"	1.4	0.7	0.9	0.5	4.1	0.4	1.6	0.5	11.7	0.8	0.6	0.0	3.6	2.1	1.1	0.5	1.7	2.1	1.0	3.2	4.3	3.2	0.8	0.4	0.6	0.6	0.9	3.2	1.0	3.9	0.9	8.0	0.4	3.1	0.9	0.9	1.7	0.7	6.2	5.5	0.8	1.2	1.1	0.8	0.3	1.0	1.8	1.0	0.0	1.7	3.2	0.6	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.2	1.3	0.0	1.8	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.3	0.0	0.0	0.2	0.2	3.0	0.0	0.4	0.0	0.0	0.6	0.0	0.9	1.7	0.1	0.2	0.0	0.2	0.6	0.1	0.0	0.5	0.4	1.0	0.3	0.2	0.8	0.3	0.0	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	4.1	0.5	11.7	4.3	3.2	0.9	3.2	3.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
CSF1	"M-CSF, MCSF, MGC31930"	ENSG00000184371	"Colony stimulating factor 1"	P09603	1	109910242-109930992	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Immunity, Inflammatory response, Innate immunity"	"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 2: 47.6;granulocytes: 111.9;Ito cells: 54.0;Sertoli cells: 58.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	11	"basophil: 7.0;eosinophil: 16.5"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 16.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 46.5;ASC TERT1: 29.2;BJ hTERT+: 30.6;GAMG: 29.0;HHSteC: 70.7;HSkMC: 45.2;hTERT-RPE1: 32.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA076624			Supported	"Nuclear bodies,Plasma membrane"	"Secreted to blood"	270000	17000000	"Plasma membrane"	"Nuclear bodies"	"HPA076624: AB_2686810"	"unprognostic (2.35e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.19e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.64e-2)"	"prognostic unfavorable (4.25e-5)"	"unprognostic (1.04e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.10e-2)"	"prognostic unfavorable (1.00e-11)"	"unprognostic (2.03e-1)"	"unprognostic (1.88e-2)"	"unprognostic (4.01e-1)"	"unprognostic (3.16e-2)"	38.1	21.4	11.5	14.6	16.7	10.1	36.5	4.3	14.6	13.8	12.8	28.2	3.6	8.5	12.0	10.1	11.3	15.7	20.6	16.0	11.4	5.8	10.7	10.3	23.5	16.9	24.3	5.4	16.9	11.3	6.7	5.2	26.0	19.2	16.3	11.0	12.2	12.4	11.6	12.7	10.4	12.7	16.0	21.9	25.8	11.9	7.5	20.3	2.9	12.4	7.8	11.0	20.6	29.2	0.0	0.0	16.5	0.0	0.0	1.0	0.1	1.5	5.7	2.9	1.1	46.5	29.2	1.0	6.6	30.6	5.3	4.9	0.2	0.8	0.0	8.4	16.3	29.0	1.2	1.2	2.2	2.0	18.5	0.9	2.0	3.3	1.9	70.7	0.0	2.6	45.2	0.6	11.6	7.0	32.5	1.0	0.5	0.4	1.1	6.3	0.1	0.0	0.3	0.9	0.4	0.5	0.2	1.5	0.1	2.1	1.5	0.1	0.3	1.9	0.5	2.3	3.7	0.4	0.2	3.5	5.5	1.9	24.4	3.7	0.5	0.2	0.0	14.0	0.0	20.6	7.0	0.0	16.5	0.2	0.0	0.5	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.0	0.1	11.5	16.7	4.3	14.6	11.4	5.8	24.3	5.4	19.2	20.3	8.9	47.6	2.4	5.4	6.5	0.2	2.4	22.9	0.0	5.7	3.5	0.0	0.5	0.0	23.8	0.3	19.0	0.6	0.0	2.0	0.4	28.2	4.8	111.9	2.5	9.2	0.0	7.5	54.0	3.5	0.0	23.3	11.7	10.1	2.8	0.8	1.9	8.1	0.9	8.1	1.1	0.1	58.2	25.9	0.6	0.6	4.8	0.7	8.5	0.6	1.8
CSF2RA	"alphaGMR, CD116, CSF2R"	ENSG00000198223	"Colony stimulating factor 2 receptor alpha subunit"	P15509	X	1268800-1310381	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 60.2;placenta: 79.5"	"Cell type enhanced"	"Detected in many"	26	"Cytotrophoblasts: 215.8;monocytes: 954.0;Syncytiotrophoblasts: 261.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 30.0;eosinophil: 36.0;intermediate monocyte: 17.7;myeloid DC: 31.9;neutrophil: 60.2;plasmacytoid DC: 30.5"	"Group enriched"	"Detected in many"	28	"dendritic cells: 31.9;granulocytes: 60.2;monocytes: 30.0"	"Group enriched"	"Detected in some"	7	"BEWO: 60.4;HMC-1: 18.2;SK-MEL-30: 42.3"									CAB016148	Uncertain				"Secreted to blood"		9400000			"CAB016148: AB_626868"	"unprognostic (4.19e-2)"	"prognostic favorable (2.38e-5)"	"unprognostic (5.47e-2)"	"unprognostic (4.33e-2)"	"unprognostic (4.88e-2)"	"prognostic favorable (2.81e-4)"	"unprognostic (8.24e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.55e-2)"	"unprognostic (8.48e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.89e-2)"	"unprognostic (8.91e-3)"	"prognostic unfavorable (5.53e-4)"	"unprognostic (3.60e-1)"	"unprognostic (9.44e-2)"	8.7	2.3	11.8	11.1	11.1	8.9	17.7	3.4	9.6	3.1	2.2	0.6	0.6	2.2	4.4	0.6	2.1	2.2	5.7	3.7	15.0	4.7	2.4	1.7	11.2	8.3	18.8	6.5	3.5	1.0	0.2	2.1	79.5	13.2	1.5	3.3	0.6	3.1	1.0	0.6	1.8	3.3	2.9	25.5	12.6	1.7	0.6	16.3	0.6	2.5	0.6	10.4	4.2	1.5	0.3	31.9	60.2	30.0	1.4	0.2	10.1	0.1	3.5	0.2	0.0	0.0	0.0	60.4	0.0	0.1	0.1	0.0	1.2	0.3	0.0	3.9	0.0	3.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	2.4	0.0	0.0	1.3	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	5.6	0.5	0.5	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	1.0	0.0	42.3	5.0	2.8	5.0	0.0	0.0	1.7	0.3	0.0	0.1	0.1	0.1	0.0	5.5	0.0	2.4	30.0	36.0	0.0	17.7	0.2	0.3	0.0	0.0	31.9	0.1	0.0	0.0	60.2	1.4	8.4	30.5	0.1	10.1	11.8	11.1	3.4	9.6	15.0	4.7	18.8	6.5	13.2	16.3	0.0	8.2	11.1	1.0	6.9	0.6	1.1	5.1	4.0	5.7	1.8	0.0	215.8	0.0	0.2	0.5	1.4	0.0	0.0	1.5	101.6	5.3	0.5	9.3	0.0	66.0	0.0	0.0	1.3	66.8	0.0	0.9	146.7	8.5	954.0	0.0	0.5	0.3	0.0	0.4	0.0	1.1	6.5	2.1	0.2	0.4	4.5	261.3	0.0	0.0	2.1
CX3CL1	"ABCD-3, C3Xkine, CXC3, CXC3C, fractalkine, neurotactin, NTN, SCYD1"	ENSG00000006210	"C-X3-C motif chemokine ligand 1"	P78423	16	57372458-57385048	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Chemotaxis"	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Basal glandular cells: 39.3;Endothelial cells: 39.1;Glandular cells: 28.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"EFO-21: 13.7;HDLM-2: 37.3;Hep G2: 27.8;RPTEC TERT1: 16.6;SK-BR-3: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026192, HPA040361"	Approved		Supported	"Plasma membrane"	"Secreted to blood"	1870000		"Plasma membrane"		"CAB026192: , HPA040361: AB_10796453"	"unprognostic (6.89e-3)"	"prognostic favorable (9.46e-4)"	"unprognostic (1.52e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.12e-2)"	"unprognostic (2.08e-3)"	"unprognostic (4.49e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.06e-2)"	"prognostic favorable (8.52e-7)"	"unprognostic (5.19e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.11e-2)"	"unprognostic (9.33e-2)"	24.3	3.6	13.4	4.7	26.6	0.7	42.5	3.8	45.1	12.4	5.9	6.9	8.7	4.2	12.1	7.0	10.7	11.7	14.9	12.0	16.4	13.8	14.5	11.2	35.3	6.0	9.2	18.0	5.2	9.6	3.8	4.5	3.4	11.7	22.3	4.5	12.2	39.9	34.4	9.2	9.9	5.0	21.7	6.6	1.5	5.0	3.8	3.9	0.8	12.0	5.7	4.9	19.7	6.7	1.0	0.8	2.1	0.7	0.8	0.6	0.2	0.0	0.3	3.6	3.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	1.4	0.0	0.0	13.7	0.0	1.9	0.1	0.0	0.0	0.0	37.3	0.2	0.0	0.0	27.8	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.5	0.0	16.6	0.1	0.1	3.2	0.0	9.7	0.8	2.4	0.0	0.1	0.0	0.1	2.2	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.6	1.4	0.7	0.5	0.6	0.4	0.3	0.6	0.4	0.3	0.2	1.0	0.4	0.6	2.1	0.8	0.4	0.8	0.2	0.2	13.4	26.6	3.8	37.3	16.4	13.8	9.2	18.0	11.7	3.9	3.0	5.8	0.0	39.3	3.9	5.4	7.0	25.5	10.7	25.0	3.5	3.9	0.0	0.0	25.9	0.3	39.1	0.2	0.0	1.6	0.0	3.3	28.6	1.1	10.0	0.0	4.8	1.7	3.1	0.6	0.0	4.4	0.0	0.0	1.0	0.0	0.8	6.6	0.0	26.2	10.2	1.7	12.9	14.4	0.1	0.1	2.3	0.2	0.0	0.7	24.6
CXCL16	"CXCLG16, SR-PSOX, SRPSOX"	ENSG00000161921	"C-X-C motif chemokine ligand 16"	Q9H2A7	17	4733526-4739922	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	22	"Early spermatids: 715.4;Late spermatids: 3190.9;monocytes: 938.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 18.3;intermediate monocyte: 29.3;myeloid DC: 10.7;neutrophil: 25.9;non-classical monocyte: 37.7"	"Group enriched"	"Detected in many"	7	"dendritic cells: 10.7;granulocytes: 25.9;monocytes: 37.7"	"Cell line enhanced"	"Detected in many"		"A-431: 35.0;CACO-2: 24.1;CAPAN-2: 19.0;HaCaT: 39.2;T-47d: 18.9"									"HPA053253, HPA066315"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	1100000	4000000	"Golgi apparatus"	Vesicles	"HPA053253: AB_2682091, HPA066315: AB_2685657"	"unprognostic (4.64e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.05e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.78e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.37e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.60e-1)"	32.5	9.5	8.2	18.7	9.7	16.3	9.7	2.0	6.6	8.0	17.2	15.8	3.4	19.1	4.8	10.5	13.1	9.5	23.0	5.2	9.9	6.9	12.5	34.8	41.9	28.8	13.3	5.1	10.6	11.0	34.6	8.6	9.7	10.0	9.8	8.3	12.7	26.6	5.9	3.3	11.3	29.5	5.2	16.5	34.1	18.7	51.9	10.0	4.5	8.1	8.5	10.1	9.7	7.4	3.4	10.7	25.9	37.7	0.0	0.3	6.9	35.0	4.8	0.0	11.3	0.1	0.9	4.5	0.4	3.4	3.4	4.6	24.1	19.0	0.0	4.2	0.2	2.1	39.2	5.6	4.0	1.2	3.6	6.4	0.0	0.5	10.6	2.4	0.0	5.2	0.2	6.7	1.8	0.2	1.3	0.9	0.1	0.0	0.2	0.3	7.4	0.1	0.6	0.0	10.1	3.0	0.4	0.0	5.2	7.2	5.8	0.0	0.4	7.1	2.9	1.8	0.4	18.9	0.4	0.1	0.5	2.5	0.8	2.0	1.2	1.6	0.0	0.1	0.1	0.9	0.0	18.3	4.0	0.1	29.3	0.1	2.9	0.3	0.2	10.7	3.4	0.1	0.3	25.9	0.0	37.7	4.6	0.0	6.9	8.2	9.7	2.0	6.6	9.9	6.9	13.3	5.1	10.0	10.0	68.5	50.1	21.2	107.8	62.3	2.0	0.7	40.8	14.7	37.5	38.4	2.0	2.4	3.3	146.2	715.4	13.4	32.3	0.0	129.6	1.8	13.6	179.9	71.7	5.9	190.7	3.2	29.6	160.8	160.8	3190.9	22.7	246.0	25.3	938.6	23.4	6.8	134.1	45.6	28.3	6.8	0.8	19.4	18.9	20.7	11.8	66.9	2.4	10.0	19.3	257.2
DPP4	"ADCP2, CD26, DPPIV"	ENSG00000197635	"Dipeptidyl peptidase 4"	P27487	2	161992241-162074542	"CD markers, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Aminopeptidase, Hydrolase, Protease, Receptor, Serine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 133.1;parathyroid gland: 75.5"	"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 134.1;Proximal tubular cells: 80.1;Syncytiotrophoblasts: 143.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 26.7"	"Lineage enriched"	"Detected in many"	10	"T-cells: 26.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 42.8;ASC TERT1: 43.4;BJ hTERT+: 39.8;RPTEC TERT1: 58.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB045970, HPA068778, HPA071236"	Enhanced				"Secreted in other tissues"		170000000			"CAB045970: AB_11140529, HPA068778: , HPA071236: "	"unprognostic (4.47e-2)"	"unprognostic (4.47e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.36e-1)"	"unprognostic (7.25e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.58e-1)"	"unprognostic (4.73e-1)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (1.98e-4)"	"prognostic favorable (1.35e-6)"	"unprognostic (4.68e-2)"	"unprognostic (6.33e-2)"	"prognostic favorable (4.99e-4)"	"unprognostic (1.21e-2)"	9.5	2.9	0.3	3.2	0.5	0.0	5.0	0.3	1.4	2.2	50.0	0.2	36.9	19.1	2.2	3.5	1.2	1.2	5.2	2.1	0.4	0.3	29.1	12.2	5.4	2.1	0.4	0.2	2.7	1.8	75.5	0.3	24.0	0.2	21.1	2.8	0.6	46.9	38.8	2.4	4.4	133.1	0.9	0.8	5.0	1.2	0.6	0.1	6.2	1.0	1.4	1.1	1.0	2.6	0.1	2.1	0.3	0.0	2.6	26.7	2.5	0.0	0.0	0.1	0.0	42.8	43.4	0.1	7.9	39.8	2.2	7.7	8.0	0.2	0.0	3.0	13.7	7.4	0.2	0.1	0.0	1.3	2.5	0.1	0.0	0.0	11.9	17.4	0.0	0.0	4.9	0.0	13.4	0.1	2.0	1.3	0.1	0.0	0.0	0.7	0.0	0.7	0.1	0.4	0.3	16.4	0.0	0.0	0.1	58.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	7.1	4.6	0.2	0.2	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	3.2	0.0	26.7	0.1	8.3	5.2	0.6	0.0	8.3	3.3	0.3	2.6	0.0	2.1	0.9	2.5	0.3	0.5	0.3	1.4	0.4	0.3	0.4	0.2	0.2	0.1	6.0	17.5	0.0	0.3	3.7	1.7	4.0	12.7	4.0	4.5	14.0	9.8	134.1	1.7	3.1	13.0	3.9	21.3	0.0	0.0	52.7	45.7	38.3	12.8	39.9	12.7	0.0	53.0	12.3	1.6	6.2	0.0	4.6	5.0	1.0	11.0	0.0	0.9	11.4	0.0	80.1	0.0	0.0	1.0	2.1	0.8	3.6	143.8	11.4	12.8	0.3
EFNA4	"EPLG4, LERK4"	ENSG00000243364	"Ephrin A4"	P52798	1	155063731-155069553	"Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 72.2;Paneth cells: 37.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			CAB021350	Uncertain				"Secreted to blood"					"CAB021350: "	"unprognostic (4.65e-2)"	"unprognostic (8.07e-2)"	"unprognostic (3.43e-2)"	"unprognostic (7.04e-2)"	"unprognostic (7.91e-2)"	"unprognostic (4.81e-1)"	"prognostic unfavorable (1.00e-5)"	"unprognostic (1.37e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.17e-2)"	"unprognostic (2.87e-2)"	"unprognostic (7.97e-3)"	"prognostic unfavorable (3.14e-4)"	"prognostic favorable (3.60e-5)"	"unprognostic (3.35e-2)"	"unprognostic (1.97e-1)"	"unprognostic (6.29e-2)"	5.5	10.8	3.5	6.1	1.9	0.9	16.8	2.0	2.1	12.0	18.9	1.9	13.2	9.7	9.4	12.3	20.0	4.9	9.6	6.5	3.0	1.3	8.4	12.8	5.3	10.8	2.4	2.5	16.1	6.3	4.2	2.7	9.7	2.6	11.5	11.5	7.5	20.1	9.5	2.2	25.3	27.0	4.0	1.9	7.0	5.0	5.1	2.2	6.4	12.0	13.5	16.3	6.6	11.5	17.1	18.2	7.8	9.2	2.6	9.5	4.7	6.1	4.6	11.5	16.9	6.8	4.4	9.5	2.7	5.3	5.5	5.1	6.8	10.3	7.9	15.9	2.8	4.3	14.6	6.8	4.2	2.2	3.6	2.0	0.7	4.2	9.5	2.4	1.7	12.5	2.6	13.0	2.7	3.3	4.8	10.9	6.6	3.2	5.3	3.0	13.6	4.0	4.4	21.0	23.5	9.7	14.0	4.5	7.7	8.5	5.3	2.8	12.6	5.5	20.9	2.4	8.7	13.6	5.5	5.6	3.2	9.7	6.5	4.1	5.4	5.6	7.7	3.1	4.2	3.3	0.0	7.4	5.0	5.9	6.6	6.1	17.1	6.5	6.7	6.0	14.1	9.5	6.3	7.8	2.6	9.2	18.2	6.2	4.7	3.5	1.9	2.0	2.1	3.0	1.3	2.4	2.5	2.6	2.2	0.0	4.6	5.4	6.7	22.2	0.2	1.2	7.6	5.3	4.5	15.7	0.0	7.9	1.7	23.3	0.0	5.8	20.0	0.0	12.2	72.2	10.5	12.9	1.1	1.8	10.8	0.0	2.9	4.9	5.1	0.0	7.2	5.4	16.9	7.2	17.5	5.2	17.8	37.9	5.3	3.8	0.0	0.0	5.1	0.4	2.7	28.5	8.2	7.4	25.2	8.4
EGFR	"ERBB, ERBB1"	ENSG00000146648	"Epidermal growth factor receptor"	P00533	7	55019021-55211628	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Host-virus interaction"	"Developmental protein, Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 102.3"	"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 207.2;Syncytiotrophoblasts: 315.1"	"Cancer enhanced"	"Detected in all"		"glioma: 136.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	12	"A-431: 345.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000035, HPA001200, HPA018530, CAB068186, CAB073534"	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"	"Secreted to blood"	4740000	93000000	"Plasma membrane, Cell Junctions"		"CAB000035: , CAB068186: AB_2665679, CAB073534: , HPA001200: AB_1078723, HPA018530: AB_1848044"	"unprognostic (2.62e-2)"	"unprognostic (9.56e-3)"	"unprognostic (1.59e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (6.11e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.30e-3)"	"unprognostic (1.78e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.93e-3)"	"unprognostic (6.98e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.62e-2)"	"prognostic unfavorable (2.04e-5)"	16.2	8.4	4.9	7.5	6.8	0.1	39.8	5.1	8.5	13.8	7.8	3.3	10.7	3.6	8.2	11.7	15.6	8.8	8.5	4.8	6.8	2.7	7.6	23.5	14.2	2.3	4.1	3.9	10.4	10.1	1.8	2.1	102.3	5.6	10.9	6.7	9.2	15.4	12.9	10.7	32.5	6.3	15.5	3.5	3.3	7.8	5.5	5.9	3.2	12.8	15.5	8.0	10.2	28.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	345.9	4.4	1.1	1.5	7.1	4.4	1.2	3.4	4.6	2.1	1.6	0.8	3.7	0.2	0.8	2.9	9.0	13.9	0.0	15.3	2.5	0.1	0.2	0.0	1.9	0.2	1.8	0.0	0.0	2.1	14.0	5.3	28.6	3.1	0.2	0.0	0.0	0.0	4.5	0.2	0.0	0.0	0.3	1.3	2.2	0.0	0.6	0.0	2.6	3.7	0.0	1.3	2.9	3.5	0.7	1.2	0.3	0.8	1.0	1.9	0.5	14.9	3.2	0.0	0.3	0.2	2.6	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	6.8	5.1	6.6	6.8	2.7	4.1	3.9	5.6	5.9	89.3	37.5	4.2	67.7	76.2	1.5	7.3	53.5	16.0	59.1	21.0	5.9	207.2	0.0	30.6	4.6	10.9	15.9	23.3	21.0	36.6	45.3	37.8	0.0	77.4	24.2	0.0	4.1	6.7	7.0	2.2	118.8	1.3	16.9	2.8	25.3	106.1	41.7	17.3	125.5	14.0	2.3	77.6	23.1	1.6	2.7	78.5	315.1	0.0	20.0	46.4
EMC10	"C19orf63, HSM1, HSS1, INM02"	ENSG00000161671	"ER membrane protein complex subunit 10"	Q5UCC4	19	50476400-50490870	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	Angiogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 147.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 52.1;PC-3: 37.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053905	Uncertain				"Secreted to blood"					"HPA053905: AB_2682303"	"unprognostic (2.48e-1)"	"unprognostic (1.93e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.65e-1)"	"unprognostic (6.94e-2)"	"unprognostic (8.38e-3)"	"unprognostic (3.23e-2)"	"unprognostic (9.87e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.99e-1)"	"prognostic favorable (4.39e-4)"	"unprognostic (5.01e-2)"	"prognostic favorable (6.64e-6)"	"unprognostic (2.81e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.44e-1)"	17.8	24.4	21.9	12.4	21.2	17.2	11.1	10.8	32.1	14.5	22.4	41.1	23.1	23.4	17.4	24.9	14.4	22.7	24.9	21.9	21.8	19.2	33.8	43.2	15.3	19.8	23.0	20.0	22.4	25.6	32.5	48.2	21.1	22.2	20.5	8.7	29.8	29.4	19.0	147.8	13.9	28.7	8.5	31.4	14.6	33.1	24.3	19.1	15.4	34.0	13.7	16.4	12.6	11.7	12.2	10.8	11.2	10.5	4.7	10.3	6.8	17.2	21.4	0.8	8.3	2.4	3.0	0.2	16.8	3.1	1.5	1.6	0.2	11.9	5.7	0.2	3.0	2.7	14.5	1.0	2.7	0.5	22.0	52.1	1.2	9.5	0.0	4.1	4.9	33.5	3.7	3.1	1.5	1.2	1.4	3.6	5.0	11.0	12.2	3.0	12.1	7.8	0.1	0.0	6.8	37.2	13.5	2.6	18.4	6.8	15.8	13.3	29.6	24.8	8.0	8.8	1.0	8.4	9.1	6.9	1.0	23.0	6.3	9.1	13.6	33.8	4.7	6.8	3.5	8.3	7.8	10.5	11.2	8.1	8.0	6.9	9.4	8.6	8.6	7.7	12.2	10.3	10.0	4.5	4.7	5.9	10.8	6.8	6.8	21.9	21.2	10.8	32.1	21.8	19.2	23.0	20.0	22.2	19.1	59.6	135.5	78.7	47.6	26.4	78.3	8.1	86.6	29.4	64.8	66.3	76.6	114.1	19.9	150.7	157.7	33.8	118.0	0.0	98.3	126.3	46.9	69.4	51.9	61.8	121.6	35.0	203.6	53.4	97.1	29.5	63.9	74.5	79.2	85.6	93.3	93.2	107.1	129.8	108.2	56.1	61.3	6.5	41.2	14.0	52.6	27.4	126.3	73.4	108.6	54.5
ENDOD1	KIAA0830	ENSG00000149218	"Endonuclease domain containing 1"	O94919	11	95089810-95132645	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 62.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008932, HPA010517"	Enhanced		Approved	"Nuclear membrane"	"Secreted - unknown location"		19000000	"Nuclear membrane"		"HPA008932: AB_2262252, HPA010517: AB_1852351"	"unprognostic (8.81e-3)"	"unprognostic (1.92e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.78e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.65e-1)"	"prognostic unfavorable (8.86e-4)"	"unprognostic (2.84e-1)"	"prognostic favorable (6.64e-7)"	"unprognostic (5.92e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.62e-3)"	"prognostic unfavorable (3.27e-4)"	14.9	13.8	20.3	7.9	27.9	4.1	15.0	14.3	31.0	17.6	25.4	52.6	9.7	8.4	13.7	12.2	19.0	13.1	12.2	14.4	24.0	22.3	18.9	4.9	10.6	7.3	33.5	20.1	12.0	4.7	48.8	11.8	12.1	40.6	36.5	29.4	15.5	12.5	22.9	34.4	20.6	14.5	16.2	40.4	22.9	8.3	9.3	25.5	0.5	12.6	12.3	6.7	9.0	16.5	7.3	2.9	1.3	5.4	3.1	5.9	6.1	1.1	1.7	2.2	1.3	62.5	20.0	9.2	8.3	1.8	2.2	2.3	8.6	15.1	8.0	10.3	6.6	5.0	11.1	2.1	11.4	0.8	6.3	1.6	17.3	0.8	3.6	6.8	3.1	22.4	18.1	14.9	1.3	4.2	15.3	7.7	7.7	3.5	5.2	8.3	2.9	1.3	0.1	0.5	12.4	5.6	5.8	0.0	3.3	6.6	9.3	1.1	0.9	3.5	3.5	6.2	3.1	3.6	0.9	5.5	12.2	3.6	8.1	3.5	4.3	3.2	0.6	3.7	1.7	27.2	1.3	1.3	0.9	5.9	3.2	5.5	7.2	3.9	5.0	2.9	7.3	3.2	3.8	0.6	3.1	5.4	1.3	2.2	6.1	20.3	27.9	14.3	31.0	24.0	22.3	33.5	20.1	40.6	25.5	8.9	14.2	11.5	14.8	7.1	2.1	4.4	17.8	1.4	11.4	10.4	0.0	4.6	1.7	4.5	2.5	22.4	35.5	23.3	7.7	6.5	8.6	20.7	13.9	2.9	2.9	0.0	15.5	38.1	4.3	2.6	9.5	5.5	27.0	1.0	22.5	1.9	6.1	40.2	14.2	9.3	0.6	38.8	19.1	0.3	3.6	10.9	10.4	5.1	18.4	8.6
ENPP1	"M6S1, NPPS, PC-1, PCA1, PDNP1"	ENSG00000197594	"Ectonucleotide pyrophosphatase/phosphodiesterase 1"	P22413	6	131808016-131895155	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins"	Biomineralization	Hydrolase	"Diabetes mellitus, Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	12	"Hepatocytes: 80.9;Peritubular cells: 65.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"NK-cell: 4.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 23.1;LHCN-M2: 13.8;U-138 MG: 18.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB032904, HPA062066"	Enhanced				"Secreted - unknown location"		2500000			"CAB032904: AB_2099635, HPA062066: AB_2684674"	"unprognostic (1.47e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.60e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.60e-2)"	"unprognostic (7.22e-3)"	"unprognostic (8.96e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.28e-3)"	17.2	2.1	0.5	1.9	0.5	0.0	30.5	0.6	0.4	8.5	2.8	1.6	8.3	1.1	25.7	7.1	1.5	6.4	2.6	1.9	0.5	0.7	10.9	19.4	2.0	0.7	1.1	0.0	7.3	17.5	22.2	27.0	28.9	0.8	3.3	1.2	13.4	5.4	6.5	2.1	1.7	2.6	6.8	2.0	1.2	1.7	4.6	0.3	2.0	13.2	6.9	1.4	3.2	7.7	0.6	2.2	1.4	0.3	4.6	1.7	0.1	0.0	0.8	0.8	0.0	23.1	3.6	0.0	6.0	6.1	2.3	6.4	2.6	0.7	0.0	0.5	3.8	4.8	0.0	0.8	0.1	9.9	0.2	1.1	0.0	0.7	7.7	0.7	0.0	2.8	5.9	0.2	6.4	0.2	2.7	2.8	0.5	0.0	1.2	13.8	1.6	0.0	0.0	5.2	1.0	0.9	0.0	6.7	0.1	0.1	0.3	2.3	0.0	0.1	0.8	2.7	4.0	2.5	0.0	1.8	18.5	0.7	1.3	5.8	2.2	0.0	0.0	8.4	0.0	2.3	1.4	0.2	0.3	0.3	0.2	1.7	0.3	0.3	0.3	2.2	0.6	0.3	0.3	1.0	4.6	0.3	0.3	0.2	0.1	0.5	0.5	0.6	0.4	0.5	0.7	1.1	0.0	0.8	0.3	0.0	1.7	1.5	10.5	1.3	4.0	2.8	5.1	0.0	0.0	1.8	0.0	2.0	5.0	0.1	3.9	1.9	7.7	0.0	8.8	1.3	25.4	3.4	0.0	80.9	4.3	1.6	0.0	2.5	3.3	4.7	23.3	1.3	1.7	0.0	8.6	4.4	7.9	3.5	65.7	15.6	0.3	12.9	10.5	1.4	1.3	1.1	5.1	0.0	1.7	1.6
ENTPD6	"CD39L2, dJ738P15.3, IL6ST2, NTPDase-6"	ENSG00000197586	"Ectonucleoside triphosphate diphosphohydrolase 6 (putative)"	O75354	20	25195693-25226729	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 76.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015491, HPA069555"	Approved		Supported	"Golgi apparatus"	"Secreted to blood"		18000	"Golgi apparatus"		"HPA015491: AB_2669200, HPA069555: AB_2686152"	"unprognostic (3.24e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.44e-1)"	"unprognostic (2.10e-3)"	"unprognostic (7.41e-3)"	"unprognostic (2.74e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.14e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.86e-2)"	"unprognostic (4.48e-2)"	12.7	19.7	21.8	11.3	46.5	6.7	12.8	33.1	49.1	9.8	31.3	12.1	12.8	31.6	9.4	10.1	9.0	12.5	18.3	27.5	24.9	25.0	13.4	12.9	11.0	7.4	15.1	29.2	16.1	25.6	11.7	20.5	13.2	15.4	25.5	24.5	9.0	36.8	9.7	15.1	6.8	32.2	9.9	8.2	8.3	24.7	16.1	10.5	9.4	10.4	6.1	8.3	10.2	7.1	7.2	17.1	3.0	16.0	8.8	17.9	12.9	20.7	32.9	9.0	17.3	11.4	14.3	19.4	17.1	12.4	14.8	13.7	17.6	16.1	12.6	25.8	16.4	29.0	27.2	11.0	26.0	9.9	7.7	9.8	10.2	5.0	39.7	17.1	13.6	15.8	13.4	14.5	18.7	14.2	10.9	11.9	12.3	13.3	22.0	11.0	19.9	12.7	8.4	5.7	17.3	25.8	7.2	28.2	28.8	18.6	13.0	14.4	7.5	4.7	28.9	76.8	8.7	21.1	11.5	12.8	17.3	18.0	14.2	20.1	13.8	11.1	5.5	12.4	9.0	32.5	0.0	16.0	3.0	12.7	10.7	17.9	6.1	11.4	10.4	17.1	7.2	12.2	10.6	0.7	8.8	4.8	12.0	10.6	12.9	21.8	46.5	33.1	49.1	24.9	25.0	15.1	29.2	15.4	10.5	17.9	31.6	13.4	14.5	8.8	16.7	4.3	28.1	8.1	7.9	17.4	9.8	53.2	8.3	33.5	18.1	5.8	66.6	0.0	35.1	18.5	10.3	22.0	3.5	13.0	22.9	23.8	32.6	17.2	15.4	46.1	19.0	16.9	10.1	17.2	55.2	3.9	28.8	57.5	39.6	11.0	7.9	6.5	5.9	3.2	9.1	5.3	50.0	8.4	60.2	10.1
EPGN	"ALGV3072, EPG, epigen, PRO9904"	ENSG00000182585	"Epithelial mitogen"	Q6UW88	4	74308473-74315307	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"epididymis: 14.3;esophagus: 39.6;tongue: 25.7"	"Cell type enhanced"	"Detected in some"	14	"Basal glandular cells: 3.2;Basal keratinocytes: 5.4;Early spermatids: 1.7;Late spermatids: 2.2;Melanocytes: 1.7;Urothelial cells: 2.2"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 7.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"hTCEpi: 62.6;U-2197: 28.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA014420			Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted in other tissues"			"Nucleoplasm, Cytosol"	Vesicles	"HPA014420: AB_10601551"	"unprognostic (7.51e-2)"	"unprognostic (8.08e-3)"	"unprognostic (1.09e-1)"		"unprognostic (1.07e-1)"	"unprognostic (1.77e-1)"		"unprognostic (2.38e-4)"	"unprognostic (2.20e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.06e-4)"	"unprognostic (3.84e-1)"		"unprognostic (7.89e-2)"	"prognostic unfavorable (2.40e-4)"	1.1	0.0	0.0	1.3	0.0	0.1	1.0	0.0	0.0	7.9	0.3	0.0	1.0	0.0	0.0	14.3	39.6	1.2	0.3	0.6	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.5	0.0	1.0	0.0	1.7	0.0	0.3	0.0	0.0	2.5	2.8	0.0	2.3	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.4	0.0	25.7	5.4	0.6	6.5	0.4	0.1	0.0	0.6	0.0	1.9	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.6	0.1	1.2	0.0	1.0	0.0	0.0	0.0	0.1	7.4	0.0	0.0	0.0	0.1	0.0	62.6	1.0	4.6	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	1.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	3.3	1.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	28.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.4	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	3.2	5.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	2.2
ERBB3	"HER3, LCCS2"	ENSG00000065361	"Erb-b2 receptor tyrosine kinase 3"	P21860	12	56076799-56103505	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Cholangiocytes: 180.9;Enterocytes: 163.1;Paneth cells: 165.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 5.3"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.3"	"Cell line enhanced"	"Detected in many"		"Hep G2: 30.9;MCF7: 20.2;OE19: 31.8;RT4: 24.2;SK-BR-3: 28.4;SK-MEL-30: 37.9;T-47d: 31.5;WM-115: 40.2"	"Low region specificity"	"Detected in many"							"CAB025331, HPA045396"	Uncertain		Supported	"Plasma membrane,Actin filaments"	"Secreted - unknown location"		420000	"Plasma membrane"	"Actin filaments"	"CAB025331: , HPA045396: AB_2679312"	"unprognostic (2.97e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.91e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.31e-3)"	"unprognostic (2.66e-2)"	"unprognostic (9.89e-2)"	"unprognostic (4.30e-2)"	"unprognostic (4.76e-3)"	"unprognostic (5.77e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.07e-2)"	1.1	1.4	11.6	12.6	16.5	0.6	26.8	2.0	16.7	6.8	40.5	40.3	12.0	37.7	2.8	7.5	29.4	5.7	22.9	3.4	18.6	9.0	16.5	33.9	13.4	0.5	23.5	9.3	0.9	21.5	11.4	1.0	15.4	14.9	16.8	29.7	5.5	36.8	22.3	1.1	30.7	41.3	3.2	27.4	0.5	32.9	1.2	23.8	0.0	4.5	7.4	8.5	11.8	14.4	0.9	0.7	5.3	0.6	1.2	1.2	0.2	10.0	0.6	0.8	0.3	0.0	0.0	16.4	0.8	1.9	1.1	1.1	5.5	18.2	0.0	0.2	0.2	0.1	8.6	1.2	1.9	0.6	0.2	0.8	0.0	0.3	30.9	0.0	0.0	0.1	0.4	2.5	0.2	0.0	0.2	0.0	0.1	0.7	0.3	0.1	20.2	0.1	0.3	2.8	31.8	0.4	0.1	1.9	0.5	2.1	24.2	0.9	0.3	0.7	28.4	37.9	2.7	31.5	0.1	0.0	0.1	1.1	0.6	0.1	0.2	0.1	0.1	0.1	0.0	40.2	5.3	0.4	0.8	0.9	0.4	0.4	0.4	0.7	0.3	0.3	0.9	0.6	1.2	3.3	1.2	0.6	0.7	0.8	0.2	11.6	16.5	2.0	16.7	18.6	9.0	23.5	9.3	14.9	23.8	110.2	61.2	1.3	13.0	16.3	1.5	1.4	180.9	21.4	61.4	33.2	2.0	44.4	1.7	41.9	0.9	2.2	163.1	0.0	77.1	73.6	2.7	83.4	1.1	83.9	5.5	0.0	89.5	6.7	1.9	0.0	1.4	1.7	52.3	2.8	134.3	11.3	75.9	165.5	0.0	31.8	1.1	6.5	1.7	2.4	2.3	32.2	84.1	1.5	124.3	62.5
EREG	ER	ENSG00000124882	Epiregulin	O14944	4	74365143-74388751	"Predicted membrane proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Mitogen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 52.1;tongue: 44.0"	"Cell type enhanced"	"Detected in many"	13	"Enterocytes: 44.2;Kupffer cells: 56.9;Macrophages: 122.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 11.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 60.3;CAPAN-2: 17.1;hTEC/SVTERT24-B: 19.0;U-2197: 41.1;U-87 MG: 70.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA054373			Approved	Vesicles	"Secreted to blood"	46000		Vesicles		"HPA054373: "	"unprognostic (1.26e-2)"	"prognostic unfavorable (1.67e-7)"	"unprognostic (4.56e-3)"	"unprognostic (3.94e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (1.45e-5)"	"unprognostic (1.07e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (6.57e-5)"	"unprognostic (2.94e-1)"	"unprognostic (1.70e-6)"	"unprognostic (2.42e-2)"	"unprognostic (1.13e-2)"	"unprognostic (6.59e-3)"	"unprognostic (3.16e-3)"	2.2	0.0	0.1	4.6	0.3	52.1	1.2	0.0	0.1	5.0	1.2	0.1	0.0	0.0	0.1	0.5	15.3	1.2	7.3	0.8	0.0	0.0	0.4	0.2	6.7	1.1	0.0	0.2	0.5	0.1	0.0	0.0	2.0	0.3	0.2	1.6	0.1	1.6	0.0	0.5	10.7	1.0	1.3	0.1	1.9	0.3	0.3	0.0	0.2	0.0	44.0	7.2	4.1	4.6	0.6	1.3	2.6	1.2	0.4	0.3	0.3	0.3	9.1	0.0	0.0	0.9	1.5	0.0	2.0	60.3	0.6	0.3	7.1	17.1	0.0	10.1	0.0	4.6	0.5	0.0	13.1	0.6	0.0	0.0	0.2	0.3	0.2	0.2	0.0	0.0	0.9	4.6	19.0	10.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	41.1	0.0	0.0	0.0	0.0	70.5	0.0	0.0	1.9	1.2	2.6	0.3	1.0	0.2	0.2	0.2	0.2	1.3	0.6	0.3	0.2	1.0	0.4	0.2	0.4	0.2	0.3	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.0	6.0	11.1	1.9	4.9	4.7	0.0	15.7	2.5	4.0	29.6	0.0	0.0	0.5	0.0	0.0	3.1	2.2	44.2	0.0	0.2	0.7	6.1	2.0	6.9	0.0	28.2	0.0	3.5	0.6	56.9	0.4	0.3	122.8	6.8	29.7	24.7	0.0	0.4	17.5	0.0	0.1	0.0	0.0	2.2	0.5	0.2	8.2	0.6	1.0	27.7	6.7
ERVMER34-1	envMER34	ENSG00000226887	"Endogenous retrovirus group MER34 member 1, envelope"	Q9H9K5	4	52722618-52751640	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"parathyroid gland: 32.0;placenta: 26.9"	"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 66.3;Extravillous trophoblasts: 80.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 28.2;hTCEpi: 20.3;RPTEC TERT1: 15.1"									"HPA011423, HPA024053"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted to blood"		5000000	Nucleoplasm	Cytosol	"HPA011423: AB_2668510, HPA024053: "	"unprognostic (5.34e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.91e-3)"	"unprognostic (5.86e-2)"	"unprognostic (4.08e-4)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (5.88e-4)"	"unprognostic (5.28e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.39e-3)"	"unprognostic (2.62e-3)"	"unprognostic (4.23e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.82e-1)"	0.3	1.3	1.2	0.4	0.7	0.2	2.8	0.5	3.0	1.3	0.5	0.0	1.4	0.5	0.9	1.3	3.7	0.7	0.4	6.2	0.8	1.0	4.4	0.3	1.8	1.9	0.6	0.2	3.9	1.7	32.0	0.2	26.9	0.8	0.7	0.7	0.8	1.3	3.0	0.2	1.0	0.5	0.4	1.5	1.9	1.1	1.7	0.3	0.0	2.5	3.7	1.2	1.0	1.8	0.6	0.4	1.2	0.1	0.4	0.3	0.0	4.5	0.2	0.9	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	28.2	6.0	0.0	0.6	0.1	0.4	0.3	0.0	2.0	0.0	0.0	0.2	0.0	0.0	0.2	0.4	0.0	0.0	1.3	20.3	0.0	3.0	0.0	0.0	0.0	1.6	0.0	0.1	0.3	0.0	0.0	1.9	1.8	0.8	0.0	0.0	0.0	15.1	0.4	1.2	0.3	1.9	0.8	0.0	3.0	2.5	0.4	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.1	0.5	0.3	0.1	0.2	0.3	0.3	0.2	0.1	0.6	0.3	0.2	1.1	0.4	0.1	0.4	0.2	0.0	1.2	0.7	0.5	3.0	0.8	1.0	0.6	0.2	0.8	0.3	0.0	0.0	0.0	1.1	0.5	0.0	2.4	0.0	0.0	0.0	7.0	0.0	66.3	0.0	2.3	3.2	0.1	0.0	0.0	0.7	80.6	1.3	1.2	0.0	0.0	6.3	0.0	0.0	0.0	0.0	2.5	2.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.4	0.0	0.0	0.3	0.2	0.4	0.1	14.5	0.0	0.4	1.1
F3	"CD142, TF"	ENSG00000117525	"Coagulation factor III, tissue factor"	P13726	1	94529225-94541800	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Basal glandular cells: 636.0;Exocrine glandular cells: 410.4;Muller glia cells: 389.7;Pancreatic endocrine cells: 1078.7;Peritubular cells: 498.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 117.4;HaCaT: 55.6;HBEC3-KT: 144.4;U-2197: 54.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009438, HPA049292, HPA069132"	Uncertain		Approved	Vesicles	"Secreted to blood"	603000		Vesicles		"CAB009438: AB_668005, HPA049292: AB_2680701, HPA069132: AB_2686092"	"unprognostic (3.86e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.23e-3)"	"unprognostic (4.93e-2)"	"unprognostic (8.00e-2)"	"unprognostic (5.88e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.07e-4)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (2.02e-8)"	"unprognostic (4.84e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.08e-1)"	45.5	9.8	27.0	14.1	42.9	2.1	55.1	3.4	27.9	14.8	18.7	20.9	18.7	18.3	30.5	23.7	21.3	25.4	30.9	18.8	26.9	14.5	6.6	2.8	31.4	5.8	14.1	20.3	41.6	35.0	6.1	28.8	65.4	39.2	29.7	22.2	49.9	29.2	33.0	2.4	17.7	19.2	5.9	46.3	2.9	18.2	16.4	16.0	0.0	21.8	17.3	11.9	24.7	22.3	0.5	0.9	2.8	0.8	0.7	0.4	0.2	117.4	0.2	0.2	0.0	12.8	6.3	6.6	16.7	10.0	18.1	19.7	2.1	25.2	0.0	8.6	20.7	3.9	55.6	1.5	144.4	29.9	0.1	0.1	0.0	3.6	0.3	4.2	0.0	0.0	10.9	3.2	8.5	41.9	34.4	0.1	0.1	0.1	0.1	12.6	0.2	0.1	2.4	1.1	0.7	0.2	0.1	1.2	0.0	2.2	0.3	0.1	0.3	13.3	5.5	0.4	3.6	0.1	1.6	0.0	11.0	0.3	54.8	5.0	0.1	0.1	0.1	8.4	0.6	0.4	1.7	0.8	0.1	0.3	0.3	0.4	0.2	0.3	0.2	0.2	0.5	0.3	0.3	2.8	0.7	0.2	0.9	0.2	0.2	27.0	42.9	3.4	27.1	26.9	14.5	14.1	20.3	39.2	16.0	122.1	188.9	0.5	636.0	14.4	1.5	21.1	7.6	72.3	238.8	14.0	0.0	13.6	0.0	120.9	5.6	10.5	10.3	0.0	410.4	4.8	48.3	85.3	2.3	0.6	5.4	3.2	12.6	12.3	4.0	9.8	260.4	4.9	3.3	3.6	40.9	389.7	1078.7	11.0	498.9	0.3	13.3	6.5	7.2	1.1	3.4	6.6	6.4	0.8	9.5	358.5
FAM3A	"2-19, DXS560S, XAP-7"	ENSG00000071889	"Family with sequence similarity 3 member A"	P98173	X	154506159-154516242	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 43.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025016, HPA035268, HPA056991"	Uncertain		Approved	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"	"Secreted - unknown location"			"Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"CAB025016: , HPA035268: , HPA056991: AB_2683303"	"unprognostic (1.60e-1)"	"unprognostic (2.72e-2)"	"prognostic unfavorable (1.76e-4)"	"unprognostic (3.19e-2)"	"unprognostic (4.73e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.53e-1)"	"unprognostic (6.27e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.04e-1)"	"unprognostic (9.71e-2)"	18.9	18.9	18.9	14.7	20.9	13.7	17.3	13.4	25.7	22.3	21.2	31.1	16.3	37.0	18.2	16.2	19.3	19.1	25.3	31.4	21.3	18.7	19.8	28.5	16.1	16.7	23.0	16.4	29.1	35.5	18.2	22.1	21.0	18.5	20.6	9.9	17.3	29.4	34.7	33.4	15.3	33.7	14.4	25.4	18.4	23.6	10.7	16.8	13.5	28.8	16.1	12.2	16.9	16.9	8.0	13.3	21.2	11.5	8.5	13.3	8.9	16.6	16.0	4.0	13.5	12.2	6.2	11.4	8.5	5.9	5.9	7.0	7.3	10.1	10.8	43.4	14.2	11.5	12.1	6.3	7.5	1.4	8.8	8.6	4.2	14.0	5.1	19.1	2.8	6.8	7.7	6.8	12.1	8.5	7.0	4.1	7.0	8.0	8.0	6.7	17.4	5.2	12.3	1.7	18.1	20.1	6.5	4.0	29.7	6.4	6.9	8.0	6.1	3.9	9.5	14.0	3.1	7.2	4.4	4.5	7.9	4.8	21.4	11.5	30.8	16.8	13.2	14.6	7.4	8.1	21.2	9.9	12.5	13.3	11.5	12.9	6.2	8.2	9.3	9.9	8.0	10.2	11.9	5.0	8.5	9.5	13.3	8.5	8.9	18.9	20.9	13.4	25.7	21.3	18.7	23.0	16.4	18.5	16.8	11.9	14.7	8.0	19.3	14.4	23.0	20.5	25.5	8.1	6.8	21.0	13.7	39.7	23.2	22.8	0.6	17.7	66.7	23.3	37.0	40.6	24.2	23.6	5.7	27.2	26.3	20.6	16.8	20.3	14.9	1.6	31.1	13.9	32.1	19.0	45.1	25.5	24.3	49.1	27.6	26.2	15.2	6.5	16.0	3.7	8.6	18.4	59.6	19.3	33.2	20.3
FAM3B	"2-21, C21orf11, C21orf76, D21M16SJHU19e, ORF9, PANDER, PRED44"	ENSG00000183844	"Family with sequence similarity 3 member B"	P58499	21	41304212-41357431	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 83.8;pancreas: 120.3;salivary gland: 67.9"	"Cell type enhanced"	"Detected in many"	11	"Cytotrophoblasts: 242.6;Exocrine glandular cells: 349.6;Pancreatic endocrine cells: 184.9;Syncytiotrophoblasts: 134.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 40.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"eosinophil: 3.0;neutrophil: 6.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 9.3;CAPAN-2: 6.0;Hep G2: 15.3;OE19: 13.2;RPMI-8226: 42.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA015885, HPA029777, CAB034131"	Enhanced		Approved	Vesicles	"Secreted to blood"	2080000	57000	Vesicles		"CAB034131: AB_2231472, HPA015885: AB_1848396, HPA029777: AB_2673194"	"unprognostic (2.88e-1)"	"unprognostic (3.31e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.62e-1)"	"unprognostic (6.32e-3)"	"unprognostic (1.41e-1)"	"unprognostic (8.79e-3)"	"unprognostic (9.38e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.65e-1)"	"unprognostic (3.78e-1)"	"unprognostic (5.60e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.55e-3)"	0.6	0.2	0.2	4.5	0.4	0.0	4.3	0.2	0.3	1.8	38.5	0.4	29.9	38.2	0.2	8.8	17.4	4.5	6.9	0.4	0.2	0.2	5.2	0.6	2.0	0.7	0.3	0.2	0.7	120.3	0.0	1.9	7.9	0.4	10.0	0.0	0.2	67.9	36.0	0.2	0.9	83.8	2.0	0.3	0.5	30.8	2.0	0.2	2.3	3.9	7.4	17.6	17.5	4.7	0.2	1.3	6.9	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	9.3	6.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.4	13.2	0.0	0.0	0.0	42.4	0.0	2.8	0.2	0.2	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	3.0	0.0	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	6.9	0.0	0.6	1.3	0.0	0.0	0.2	0.4	0.2	0.3	0.2	0.2	0.3	0.2	0.4	0.2	20.8	18.8	0.0	11.2	1.1	0.0	0.1	81.5	22.7	50.0	62.8	0.0	242.6	21.6	113.7	19.2	1.0	0.0	0.0	349.6	6.2	5.7	99.4	1.1	0.0	23.0	0.0	0.0	0.0	2.5	7.0	0.6	8.1	5.0	3.6	0.9	0.0	184.9	0.0	0.4	0.4	0.0	0.0	0.9	26.7	7.2	1.1	134.9	0.0	0.0	104.8
FAM3D	"EF7, OIT1"	ENSG00000198643	"Family with sequence similarity 3 member D"	Q96BQ1	3	58633946-58666848	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 61.2;intestine: 69.2;salivary gland: 146.0;seminal vesicle: 88.6"	"Group enriched"	"Detected in some"	6	"Enterocytes: 558.6;Mucus-secreting cells: 1112.4;Paneth cells: 854.0;Undifferentiated cells: 821.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 151.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	4	"neutrophil: 6.7"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 6.7"	"Cell line enriched"	"Detected in single"	72	"OE19: 38.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA013844	Approved				"Secreted to digestive system"		8200			"HPA013844: AB_2668897"	"prognostic favorable (7.51e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.08e-2)"	"unprognostic (9.67e-2)"	"unprognostic (5.51e-2)"	"prognostic favorable (1.89e-4)"	"unprognostic (7.97e-2)"	"unprognostic (6.54e-2)"	"unprognostic (7.43e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.00e-1)"	"unprognostic (6.97e-4)"	"unprognostic (2.34e-2)"	0.3	0.2	0.3	8.5	0.3	0.0	2.2	0.2	0.2	4.4	48.2	0.3	26.1	11.2	0.5	0.3	61.2	0.3	20.0	0.2	0.2	0.2	0.5	0.2	1.5	0.2	0.3	0.2	0.2	0.8	0.0	0.3	0.5	0.3	3.3	69.2	0.3	146.0	88.6	0.4	0.8	26.1	0.8	0.2	0.3	9.5	0.3	0.2	0.3	0.6	15.2	47.1	2.2	13.1	0.0	0.7	6.7	1.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	38.6	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	6.7	0.0	0.5	0.0	0.0	0.9	0.3	0.3	0.2	0.2	0.2	0.2	0.3	0.2	0.3	0.2	0.0	0.6	0.0	7.9	0.0	0.0	0.2	56.0	28.1	9.1	14.0	0.0	0.0	0.0	0.6	0.4	0.6	558.6	0.0	0.0	0.0	0.0	70.7	9.2	0.0	0.3	0.0	146.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1112.4	0.0	1.9	854.0	0.0	0.5	0.0	0.0	0.0	0.1	0.2	0.1	0.3	0.0	821.7	144.0
FAS	"APO-1, APT1, CD95, FAS1, TNFRSF6"	ENSG00000026103	"Fas cell surface death receptor"	P25445	10	88990582-89015785	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	"Calmodulin-binding, Receptor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 100.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 40.1"	"Group enriched"	"Detected in all"	5	"granulocytes: 40.1;T-cells: 30.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 28.0;Karpas-707: 44.7"					"Low region specificity"	"Detected in all"			HPA027444	Uncertain		Supported	"Nuclear bodies,Plasma membrane,Cytosol"	"Secreted to blood"	11900000	450000	"Plasma membrane"	"Nuclear bodies, Cytosol"	"HPA027444: AB_10601378"	"unprognostic (6.84e-2)"	"unprognostic (2.88e-3)"	"unprognostic (8.38e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.35e-2)"	"unprognostic (9.56e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.01e-1)"	"unprognostic (7.70e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.52e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.32e-2)"	"unprognostic (4.95e-3)"	"unprognostic (1.65e-1)"	13.5	26.3	6.1	17.3	7.7	12.4	10.6	2.1	7.2	15.6	14.2	6.1	7.0	5.9	15.7	16.6	14.1	14.2	14.5	8.9	8.2	2.7	11.7	21.9	28.6	15.6	6.0	3.9	24.7	4.1	4.5	4.6	9.0	7.5	22.3	21.3	4.4	7.1	8.5	4.3	9.6	16.3	12.5	10.2	15.3	5.0	7.3	5.1	12.5	10.0	15.8	14.4	14.8	21.4	3.0	4.0	40.1	6.8	1.2	30.9	3.9	8.7	3.4	1.8	5.6	14.5	21.4	0.0	19.2	19.5	0.7	3.8	0.0	9.5	1.7	7.4	18.0	3.2	1.4	0.3	16.2	1.3	28.0	2.8	0.1	1.8	5.7	13.9	0.9	0.4	26.5	14.5	12.0	26.0	9.4	1.7	6.4	0.0	44.7	19.6	0.8	2.8	1.4	0.2	0.0	0.9	0.2	0.1	1.8	27.1	2.8	0.1	0.1	2.8	0.0	0.3	2.8	6.1	0.3	4.2	6.2	3.4	5.7	4.4	17.5	1.8	0.1	5.1	3.5	1.8	11.3	3.2	9.4	3.3	3.9	4.8	3.0	10.4	7.2	4.0	0.7	1.2	3.4	40.1	1.2	6.8	0.0	30.9	3.9	6.1	7.7	2.1	7.2	8.2	2.7	6.0	3.9	7.5	5.1	53.6	14.4	3.7	100.3	40.8	0.0	1.2	15.3	21.4	21.6	8.7	0.0	0.4	0.0	6.7	5.4	8.4	12.0	0.0	3.8	0.2	34.9	22.7	3.5	15.3	5.0	1.6	8.1	2.5	6.9	3.5	17.5	12.7	11.8	20.8	15.0	17.1	4.3	0.0	13.1	11.5	0.7	6.5	33.4	4.8	1.3	38.3	0.3	37.9	23.2	22.7
FASLG	"APT1LG1, CD178, FasL, TNFSF6"	ENSG00000117560	"Fas ligand"	P48023	1	172659018-172666874	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Apoptosis, Transcription, Transcription regulation"	"Cytokine, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 25.6;lymphoid tissue: 13.4"	"Cell type enriched"	"Detected in some"	7	"T-cells: 30.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 25.6"	"Group enriched"	"Detected in many"	12	"NK-cells: 16.0;T-cells: 25.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 1.0;LHCN-M2: 2.5;NB-4: 1.2;RPTEC TERT1: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA054959	Approved				"Secreted to blood"	73600				"HPA054959: AB_2682650"	"unprognostic (1.09e-3)"	"unprognostic (1.41e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.54e-7)"	"unprognostic (3.29e-1)"	"unprognostic (2.23e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.67e-2)"	"unprognostic (4.76e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (1.59e-6)"	"unprognostic (3.49e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.82e-3)"	0.9	1.1	0.5	1.9	0.7	3.6	1.8	0.5	0.8	0.7	2.6	0.6	0.0	3.0	3.9	1.2	1.0	0.8	1.6	1.2	0.5	0.5	1.2	2.2	6.8	7.7	1.4	0.0	1.5	0.6	0.0	0.7	2.4	0.6	4.7	1.2	2.8	1.9	0.3	0.4	0.5	3.8	1.9	1.7	13.4	2.1	0.4	0.0	1.2	1.1	0.0	10.1	1.4	0.9	0.0	0.0	1.6	0.0	16.0	25.6	5.5	0.0	0.0	0.3	0.1	1.0	0.0	0.5	0.2	0.0	0.0	0.1	0.0	0.5	0.5	0.1	0.0	0.0	0.8	0.0	0.3	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.2	0.4	0.7	0.1	0.0	0.1	0.3	0.6	2.5	0.0	0.0	1.2	0.4	0.2	0.0	0.0	0.0	0.1	1.0	0.2	0.0	0.1	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.1	0.1	0.3	0.3	0.8	0.0	0.0	0.0	0.1	0.1	1.6	0.0	0.0	25.6	0.0	15.8	0.0	5.4	13.7	0.0	0.0	1.1	11.7	0.8	16.0	0.0	0.0	0.1	5.5	0.5	0.7	0.5	0.8	0.5	0.5	1.4	0.0	0.6	0.0	0.0	4.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.2	1.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	30.5	0.0	0.0
FCER2	"CD23, CD23A, CLEC4J, FCE2"	ENSG00000104921	"Fc fragment of IgE receptor II"	P06734	19	7688758-7702146	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"IgE-binding protein, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"blood: 87.2;lymphoid tissue: 38.4"	"Cell type enriched"	"Detected in some"	57	"B-cells: 110.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"memory B-cell: 28.2;naive B-cell: 87.2"	"Lineage enriched"	"Detected in many"	34	"B-cells: 87.2"	"Cell line enriched"	"Detected in some"	14	"HDLM-2: 99.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB002624, HPA008928, HPA067430"	Enhanced				"Secreted to blood"		59000			"CAB002624: , HPA008928: AB_1846285, HPA067430: "	"unprognostic (3.20e-4)"	"unprognostic (1.87e-3)"	"unprognostic (1.95e-2)"	"unprognostic (2.44e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.89e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.04e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.46e-4)"	"unprognostic (2.99e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.89e-2)"	"unprognostic (5.17e-2)"	2.4	0.3	0.5	17.1	0.5	2.3	1.2	0.3	1.1	0.3	1.0	0.1	0.4	1.3	0.3	2.3	1.0	0.4	0.5	0.8	0.3	0.3	0.6	0.6	0.8	21.1	0.3	0.0	0.4	0.3	0.0	0.3	0.3	0.1	0.3	0.8	0.0	7.5	0.7	0.4	0.6	7.7	0.4	0.3	38.4	0.8	0.5	0.0	6.3	0.7	0.0	33.8	2.0	0.5	87.2	0.7	0.2	2.5	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	99.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.5	0.0	0.0	2.5	0.0	28.2	0.0	0.0	0.7	87.2	0.0	0.0	0.2	0.0	0.7	0.1	0.0	3.0	0.5	0.5	0.3	0.3	0.3	0.3	0.3	0.0	0.1	0.0	0.0	1.1	110.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.3	0.6	0.0	0.0	1.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
FCGR3A	"CD16, CD16a, FCG3, FCGR3"	ENSG00000203747	"Fc fragment of IgG receptor IIIa"	P08637	1	161541759-161550737	"CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 223.6;lymphoid tissue: 60.8"	"Cell type enhanced"	"Detected in many"	22	"Hofbauer cells: 191.4;Kupffer cells: 556.1;Macrophages: 266.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 109.4;non-classical monocyte: 223.6"	"Group enriched"	"Detected in many"	4	"granulocytes: 73.0;monocytes: 223.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.0;HaCaT: 1.7;SH-SY5Y: 1.3;U-2197: 1.1;U-266/70: 1.8"									"CAB032435, HPA055431"	Supported				"Secreted to blood"		2500000000			"CAB032435: AB_626925, HPA055431: AB_2682815"	"unprognostic (5.27e-2)"	"unprognostic (9.95e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.24e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.98e-2)"	"unprognostic (7.52e-2)"	"prognostic unfavorable (3.22e-6)"	"unprognostic (1.14e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.03e-2)"	"unprognostic (7.51e-2)"	11.9	9.7	7.5	20.5	12.4	4.4	4.1	1.6	7.0	1.9	2.1	5.5	0.8	0.8	1.1	2.4	1.0	2.4	5.1	6.4	6.3	7.3	2.6	22.5	43.2	8.0	12.7	1.9	1.4	2.9	1.8	3.9	14.6	6.8	2.6	2.3	2.2	2.7	1.3	1.3	0.3	1.2	14.3	25.7	60.8	1.3	1.2	8.0	1.4	1.8	1.3	1.3	6.3	2.3	0.1	11.7	73.0	223.6	7.9	33.9	35.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.5	1.7	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.3	0.5	0.5	0.0	0.0	0.8	0.5	0.4	0.0	0.0	0.5	1.3	0.4	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.1	1.1	0.0	1.8	0.0	0.4	0.0	0.0	0.0	0.3	1.6	0.5	33.9	109.4	0.3	0.1	0.3	13.2	11.7	0.0	0.2	12.2	73.0	7.9	223.6	0.2	0.1	35.8	7.5	12.4	1.6	7.0	6.3	7.3	12.7	1.9	6.8	8.0	20.8	30.6	13.0	0.0	0.5	0.1	0.4	7.6	10.7	19.4	3.5	2.0	1.1	0.0	0.0	0.9	0.8	0.0	0.0	0.0	1.1	0.3	0.0	17.4	3.4	191.4	0.0	0.0	9.2	556.1	1.5	0.3	266.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.6	1.3	19.4	0.0	0.0	0.5	0.0	1.7	99.7	0.0	0.1
FCGR3B	"CD16, CD16b, FCG3, FCGR3"	ENSG00000162747	"Fc fragment of IgG receptor IIIb"	O75015	1	161623196-161631963	"CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	8	"blood: 334.5"	"Cell type enhanced"	"Detected in some"	19	"Alveolar cells type 1: 3.0;Alveolar cells type 2: 11.1;Ciliated cells: 4.0;Club cells: 5.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	95	"neutrophil: 334.5"	"Lineage enriched"	"Detected in many"	95	"granulocytes: 334.5"	"Cell line enhanced"	"Detected in single"		"K-562: 1.5"														"Secreted to blood"						"unprognostic (1.60e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.59e-3)"	"unprognostic (4.16e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.52e-2)"	"unprognostic (3.97e-2)"	"unprognostic (6.96e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.67e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.37e-3)"	"unprognostic (2.28e-1)"	"unprognostic (9.24e-2)"	9.9	0.8	1.8	30.8	1.5	13.8	1.5	0.9	1.8	0.9	0.8	0.5	0.2	0.0	0.4	0.5	1.7	2.8	6.8	4.6	1.2	0.9	0.9	2.9	15.2	16.9	5.0	0.5	1.2	1.2	0.0	0.6	4.5	1.9	1.5	0.0	1.3	0.9	0.9	0.8	1.4	0.8	2.0	4.0	44.3	1.3	1.5	0.9	0.6	0.8	0.2	0.9	11.1	4.7	0.0	0.1	334.5	3.5	0.1	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.5	0.5	1.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	334.5	0.1	3.5	0.0	0.0	0.5	1.8	1.5	0.9	1.8	1.2	0.9	5.0	0.5	1.9	0.9	3.0	11.1	0.0	0.0	0.0	0.0	0.3	0.0	4.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.8	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0
FCMR	"FAIM3, TOSO"	ENSG00000162894	"Fc fragment of IgM receptor"	O60667	1	206904386-206923247	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Immunity			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 99.6;intestine: 30.1;lymphoid tissue: 84.9"	"Group enriched"	"Detected in many"	11	"B-cells: 125.3;T-cells: 41.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 99.6;T-cells: 60.0"	"Group enriched"	"Detected in some"	5	"RPMI-8226: 53.0;U-266/70: 26.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA003910	Approved		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"	"Secreted to blood"		2400000	"Focal adhesion sites, Cytosol"	Nucleoplasm	"HPA003910: AB_1078798"	"prognostic favorable (4.23e-4)"	"unprognostic (1.16e-3)"	"unprognostic (7.48e-2)"	"unprognostic (3.06e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.69e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.85e-3)"	"unprognostic (1.03e-1)"	"unprognostic (3.97e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.15e-3)"	"unprognostic (8.06e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.74e-2)"	"unprognostic (5.05e-3)"	15.5	0.6	0.5	42.9	0.5	2.9	1.5	0.4	0.4	0.8	2.5	0.4	0.3	1.2	1.2	0.8	3.4	1.3	2.6	1.0	0.5	0.5	2.4	1.5	3.9	77.2	0.5	0.0	1.3	0.7	0.0	0.9	0.8	0.2	1.4	2.3	1.3	10.1	0.3	1.9	0.6	30.1	0.4	0.6	78.8	2.8	0.5	0.0	51.8	1.8	1.2	84.9	8.5	1.2	99.6	1.4	5.3	0.4	18.4	60.0	28.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.1	0.1	0.0	0.0	3.4	0.0	0.1	0.3	0.1	0.0	0.4	0.2	0.0	0.1	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.3	0.1	0.6	0.0	0.0	2.7	0.0	7.4	0.0	0.1	1.0	0.1	0.0	0.0	0.0	1.7	0.2	53.0	0.0	0.1	0.0	0.0	1.0	0.2	5.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	26.7	1.9	7.4	0.3	0.0	0.2	0.5	0.2	0.2	20.3	0.4	26.4	80.3	28.1	26.2	0.2	99.6	49.5	33.3	5.3	18.4	0.3	1.4	60.0	28.2	0.5	0.5	0.4	0.4	0.5	0.5	0.5	0.0	0.2	0.0	0.0	4.6	125.3	3.9	0.0	0.0	3.0	7.6	1.4	2.3	0.0	0.0	0.0	0.0	1.3	0.1	0.1	0.0	0.0	2.6	0.1	0.6	2.6	0.0	1.1	3.8	0.0	0.0	5.5	5.1	0.0	0.3	1.2	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.3	0.1	1.0	0.0	0.0	41.7	1.2	7.1
FCN1	FCNM	ENSG00000085265	"Ficolin 1"	O00602	9	134905890-134917963	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 318.5;bone marrow: 135.4"	"Cell type enriched"	"Detected in many"	9	"Kupffer cells: 627.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 318.5;intermediate monocyte: 218.1"	"Lineage enhanced"	"Detected in many"		"monocytes: 318.5"	"Group enriched"	"Detected in some"	7	"NB-4: 15.7;U-937: 23.4"									"HPA000685, HPA001295, CAB016760"	Enhanced				"Secreted to blood"	1060000000	63000000			"CAB016760: , HPA000685: AB_1078840, HPA001295: AB_1078842"	"unprognostic (1.57e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.34e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.62e-3)"	"unprognostic (3.66e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (1.73e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.28e-1)"	6.6	0.9	0.6	35.2	0.7	135.4	2.2	0.4	1.0	1.8	2.0	0.4	0.0	0.1	1.6	7.8	1.0	3.6	2.9	7.6	0.5	0.6	2.3	4.6	24.9	23.5	2.3	0.1	3.5	1.6	0.0	0.7	9.2	0.9	1.6	1.0	3.0	1.7	0.3	2.7	0.7	1.3	8.1	1.2	47.3	2.2	1.0	0.5	6.8	1.6	1.1	3.6	8.5	1.6	0.8	93.9	53.7	318.5	0.4	0.6	273.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	15.7	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.1	1.0	0.0	0.1	0.0	0.2	0.0	23.4	0.0	1.2	318.5	3.0	0.5	218.1	0.6	0.8	0.2	0.3	93.9	0.2	0.3	0.3	53.7	0.4	99.0	2.5	0.3	273.0	0.6	0.7	0.4	1.0	0.5	0.6	2.3	0.1	0.9	0.5	6.0	27.5	10.5	0.2	1.6	0.0	2.4	0.0	1.4	9.1	1.8	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	1.1	0.2	11.6	1.3	71.4	0.0	0.0	3.1	627.5	0.0	0.0	63.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.5	0.0	0.1
FCRL5	"BXMAS1, CD307e, FCRH5, IRTA2"	ENSG00000143297	"Fc receptor like 5"	Q96RD9	1	157513377-157552520	"CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 13.3;lymphoid tissue: 39.1;salivary gland: 12.4"	"Group enriched"	"Detected in some"	7	"B-cells: 61.9;Early spermatids: 51.2;Melanocytes: 21.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	18	"memory B-cell: 11.4;naive B-cell: 13.3"	"Lineage enriched"	"Detected in single"	19	"B-cells: 13.3"	"Group enriched"	"Detected in some"	5	"U-266/70: 5.8;U-698: 12.3"														"Secreted to blood"	169000000	36000000				"unprognostic (1.30e-3)"	"unprognostic (3.51e-2)"	"unprognostic (7.59e-3)"	"unprognostic (1.57e-2)"	"unprognostic (9.41e-3)"	"unprognostic (4.32e-5)"	"unprognostic (2.61e-2)"	"unprognostic (6.93e-2)"	"unprognostic (7.40e-2)"	"unprognostic (7.66e-3)"	"unprognostic (4.01e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.51e-10)"	"unprognostic (1.20e-1)"	"unprognostic (4.40e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.78e-1)"	0.7	0.4	0.3	33.9	0.3	1.1	1.3	0.3	0.3	1.6	7.4	0.1	0.0	3.6	0.5	0.1	4.6	0.8	0.8	0.4	0.3	0.3	1.6	0.8	1.6	17.4	0.3	0.0	0.6	0.4	0.0	0.3	0.0	0.0	0.5	2.7	1.0	12.4	0.8	0.3	0.3	6.4	0.1	0.3	29.5	2.5	0.9	0.0	3.1	1.1	0.7	39.1	5.3	0.6	13.3	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.1	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	4.5	61.9	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	51.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.1	0.0	0.3	0.0	0.0	0.6	0.3	4.4	0.3	0.0	21.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	1.1	0.0	0.0	0.6	0.5	0.0	0.0
FGFR2	"BEK, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25"	ENSG00000066468	"Fibroblast growth factor receptor 2"	P21802	10	121478334-121598458	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Apoptosis	"Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 74.8"	"Cell type enhanced"	"Detected in many"	16	"Cholangiocytes: 191.1;Club cells: 52.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	15	"basophil: 10.8;eosinophil: 4.6"	"Lineage enriched"	"Detected in single"	35	"granulocytes: 10.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 58.9;BEWO: 19.8;CACO-2: 15.4;HaCaT: 17.8;HAP1: 19.1;NTERA-2: 18.9;T-47d: 15.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010886, HPA035305"	Uncertain		Supported	"Nucleoplasm,Vesicles,Cell Junctions"	"Secreted - unknown location"		500000	"Cell Junctions"	"Nucleoplasm, Vesicles"	"CAB010886: AB_259379, HPA035305: AB_10672862"	"unprognostic (5.53e-2)"	"prognostic favorable (8.79e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (9.32e-4)"	"unprognostic (1.53e-1)"	"unprognostic (4.96e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.11e-2)"	"unprognostic (2.54e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.25e-1)"	2.1	8.8	16.4	3.0	30.3	0.0	9.9	15.8	21.3	6.8	14.1	55.7	5.6	4.2	22.0	6.6	10.2	12.5	12.5	1.4	20.6	11.1	11.4	16.1	13.1	1.0	41.2	13.3	7.4	12.8	25.5	2.5	6.2	30.2	11.7	8.7	16.4	23.8	24.3	0.4	45.4	4.7	18.3	74.8	0.5	9.3	2.9	32.1	0.8	23.4	1.6	3.4	6.9	8.5	0.1	0.1	10.8	0.1	0.1	0.3	0.0	2.2	0.1	9.2	58.9	0.0	0.0	19.8	0.1	0.0	0.0	0.0	15.4	0.3	0.0	4.2	0.9	0.0	17.8	19.1	4.0	0.0	0.0	4.1	0.0	0.0	0.3	0.4	0.0	3.8	0.0	8.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	18.9	2.7	0.0	0.0	0.0	2.3	5.7	5.0	0.1	0.1	0.1	10.8	0.0	11.5	15.8	0.0	0.0	0.1	2.9	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	10.8	0.1	4.6	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.0	16.4	30.3	15.8	21.3	20.6	11.1	41.2	13.3	30.2	32.1	17.9	31.8	0.0	29.5	35.6	0.0	2.7	191.1	18.7	52.4	34.9	0.0	12.6	0.0	4.0	2.9	0.5	2.6	0.0	0.2	2.7	17.5	9.8	0.0	4.3	2.0	0.0	2.4	3.1	0.3	6.5	1.1	1.3	5.0	1.0	32.0	1.6	0.6	1.4	5.6	11.5	0.1	0.0	2.1	0.9	7.7	24.2	3.3	1.5	3.0	27.7
FLT1	"FLT, VEGFR1"	ENSG00000102755	"Fms related tyrosine kinase 1"	P17948	13	28300344-28495145	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Chemotaxis, Differentiation"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"placenta: 155.3"	"Cell type enhanced"	"Detected in many"	16	"Extravillous trophoblasts: 778.4;Ito cells: 284.2;Syncytiotrophoblasts: 942.6"	"Cancer enhanced"	"Detected in all"		"renal cancer: 28.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 1.1;naive B-cell: 3.7;neutrophil: 2.1"	"Group enriched"	"Detected in many"	5	"B-cells: 3.7;granulocytes: 2.1"	"Cell line enhanced"	"Detected in some"		"BJ: 17.4;BJ hTERT+: 13.8;HMC-1: 86.4;HUVEC TERT2: 15.6;WM-115: 31.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011740, HPA014290, CAB068189, CAB068190"	Enhanced		Supported	"Plasma membrane,Actin filaments"	"Secreted to blood"	876000	54000	"Plasma membrane"	"Actin filaments"	"CAB068189: AB_2665636, CAB068190: AB_2665637, HPA011740: AB_1858737, HPA014290: AB_1858738"	"unprognostic (3.33e-2)"	"unprognostic (3.52e-3)"	"unprognostic (1.13e-3)"	"unprognostic (5.02e-2)"	"unprognostic (3.65e-1)"	"unprognostic (5.03e-2)"	"unprognostic (8.25e-2)"	"unprognostic (2.27e-3)"	"unprognostic (9.91e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (2.19e-4)"	"unprognostic (4.20e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.32e-2)"	18.9	4.0	9.9	4.0	14.3	1.2	13.5	8.0	15.9	7.1	4.6	3.5	1.7	3.5	7.2	2.2	3.4	4.0	6.9	18.3	11.4	7.3	10.3	7.6	12.3	2.5	10.3	3.2	5.1	5.4	13.4	3.7	155.3	13.8	5.1	3.1	9.1	3.0	5.0	12.5	2.6	3.4	7.3	9.6	7.2	4.6	6.8	10.2	0.0	19.1	3.8	2.8	7.6	9.2	3.7	0.5	2.1	0.1	0.2	0.4	0.2	0.0	0.0	0.0	0.1	0.1	0.2	0.0	17.4	13.8	6.3	3.7	0.0	0.0	0.0	0.0	2.2	0.0	0.0	1.6	0.0	11.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	86.4	0.1	0.0	0.0	0.2	0.0	15.6	1.4	0.4	0.0	0.0	0.0	1.0	0.8	9.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	11.4	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.5	0.2	0.0	0.1	0.0	31.0	0.2	0.1	0.1	0.1	0.1	0.0	1.1	0.1	0.1	0.0	3.7	0.4	0.4	2.1	0.2	0.1	0.5	0.2	0.2	9.9	14.3	8.0	15.9	11.4	7.3	10.3	3.2	13.8	10.2	0.0	8.9	2.2	0.5	3.7	5.9	12.6	5.1	2.7	1.2	0.0	3.9	155.4	1.7	0.0	116.6	192.1	0.0	0.0	0.0	778.4	17.5	1.1	1.1	2.1	28.1	1.6	0.0	284.2	16.1	130.7	17.3	5.3	0.0	0.0	0.0	172.0	0.0	0.0	45.6	0.0	7.3	90.5	6.6	12.9	2.8	4.3	942.6	2.9	0.0	0.5
FLT4	"PCL, VEGFR3"	ENSG00000037280	"Fms related tyrosine kinase 4"	P35916	5	180601506-180649624	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 56.3"	"Group enriched"	"Detected in some"	5	"Extravillous trophoblasts: 31.7;Ito cells: 65.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"MAIT T-cell: 7.7"	"Lineage enriched"	"Detected in single"	35	"T-cells: 7.7"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 8.3;BEWO: 10.1;HEK 293: 12.5;HUVEC TERT2: 8.1;JURKAT: 10.0;T-47d: 11.9;TIME: 12.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB000099, HPA046519, HPA067906, HPA074389"	Approved		Supported	"Nuclear speckles,Plasma membrane,Cell Junctions"	"Secreted to blood"		270000000	"Nuclear speckles, Plasma membrane"	"Cell Junctions"	"CAB000099: , HPA046519: AB_2732527, HPA067906: AB_2732775, HPA074389: "	"unprognostic (7.35e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.45e-3)"	"unprognostic (3.81e-1)"	"unprognostic (9.26e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.88e-2)"	"unprognostic (9.41e-3)"	"unprognostic (1.83e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.32e-1)"	14.8	7.1	1.6	4.9	6.0	0.7	28.5	1.3	2.7	6.3	7.3	1.9	2.1	3.1	7.3	6.2	5.7	9.2	5.3	6.4	1.7	0.9	11.7	10.2	14.1	23.6	2.0	0.8	5.8	2.3	2.3	6.2	56.3	2.1	4.9	1.4	6.7	3.3	4.4	4.8	2.8	4.7	4.7	1.5	14.5	2.4	3.5	2.0	0.3	19.4	4.4	2.3	6.1	14.7	0.0	0.1	0.2	0.0	0.0	7.7	0.2	0.1	2.0	2.7	8.3	0.0	0.0	10.1	0.2	0.1	0.0	0.0	0.3	0.3	0.2	0.8	0.1	0.5	0.3	2.8	0.1	0.2	0.1	12.5	1.0	0.4	0.4	0.1	7.4	0.2	0.2	0.0	0.1	0.3	0.3	8.1	10.0	0.3	0.3	1.7	4.5	0.1	0.4	5.8	0.2	0.5	6.5	0.0	0.1	0.1	0.2	0.2	0.9	0.1	0.2	0.0	2.7	11.9	0.2	12.6	0.1	5.9	0.2	0.1	0.2	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.9	0.0	7.7	0.0	0.4	1.6	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.2	1.6	6.0	1.3	2.7	1.7	0.9	2.0	0.8	2.1	2.0	0.0	1.7	0.9	0.2	0.8	0.0	4.5	0.0	0.0	1.2	0.0	0.0	0.3	0.0	0.0	0.2	9.2	0.0	0.0	0.0	31.7	0.6	0.2	2.3	0.4	1.1	0.0	0.0	65.1	5.7	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	4.3	1.0	0.8	0.7	0.0	0.1
FOLR1	FOLR	ENSG00000110195	"Folate receptor 1"	P15328	11	72189558-72196323	"Disease related genes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"	Transport	Receptor	Neurodegeneration	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 157.6;salivary gland: 101.2"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 461.6;Club cells: 316.2;Collecting duct cells: 301.8;Cytotrophoblasts: 307.8;Proximal tubular cells: 286.0;Syncytiotrophoblasts: 216.6"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 259.5"	"Region enriched"	"Detected in many"	20	"pons and medulla: 157.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HeLa: 83.6;RPTEC TERT1: 88.8"	"Group enriched"	"Detected in many"	5	"basal ganglia: 23.1;hippocampal formation: 49.6;pons and medulla: 45.9;thalamus: 34.0"	"Low region specificity"	"Detected in all"			HPA077030			Approved	"Nuclear membrane"	"Secreted to blood"		81000	"Nuclear membrane"		"HPA077030: "	"unprognostic (3.30e-1)"	"unprognostic (2.19e-1)"	"unprognostic (6.55e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.67e-3)"	"unprognostic (1.98e-2)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (1.18e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.87e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.69e-1)"	0.0	0.7	1.3	0.2	1.7	0.0	6.6	0.6	3.5	31.4	0.1	21.4	2.8	0.0	1.0	3.5	1.6	46.7	1.0	0.2	7.9	1.8	38.8	0.2	47.0	0.0	0.8	0.4	8.9	1.8	0.4	3.5	24.5	157.6	1.5	0.0	17.0	101.2	4.0	0.1	0.9	0.1	0.0	0.7	0.0	7.4	0.4	0.2	0.0	12.7	2.6	3.5	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	7.8	7.9	0.0	8.1	0.1	0.0	0.1	0.4	0.3	0.0	0.0	0.2	0.1	83.6	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	2.7	0.0	88.8	0.0	0.0	0.5	0.2	1.2	0.0	7.3	11.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	1.3	1.7	0.6	3.5	7.9	1.8	0.8	0.4	157.6	0.2	461.6	156.4	0.0	7.8	0.8	0.0	0.3	35.7	178.0	316.2	301.8	0.0	307.8	112.7	15.6	0.0	0.0	0.0	0.0	1.2	101.0	3.8	4.7	4.7	0.0	26.1	0.0	1.7	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	1.4	4.1	0.0	0.0	286.0	0.0	0.0	0.1	0.0	0.1	0.1	216.6	0.0	0.0	8.6
FOLR2		ENSG00000165457	"Folate receptor beta"	P14207	11	72216601-72221950	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Transport	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Hofbauer cells: 838.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 27.8;intermediate monocyte: 20.3"	"Group enriched"	"Detected in many"	4	"dendritic cells: 7.8;monocytes: 27.8"	"Cell line enriched"	"Detected in some"	5	"U-698: 20.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"								"Secreted to blood"		12000000				"unprognostic (2.03e-1)"	"unprognostic (6.58e-3)"	"prognostic unfavorable (8.42e-4)"	"unprognostic (1.47e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.36e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.51e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.91e-3)"	"unprognostic (6.16e-3)"	"unprognostic (1.14e-1)"	"prognostic favorable (8.41e-4)"	"unprognostic (7.98e-3)"	59.4	17.7	5.4	7.4	4.5	2.0	16.3	1.0	4.7	8.3	17.3	6.3	2.0	5.0	9.1	32.3	10.3	12.3	22.4	28.8	4.3	3.0	11.9	19.9	15.4	21.3	5.0	2.9	7.9	4.9	2.6	4.3	57.8	5.4	14.9	13.1	12.2	9.3	4.6	17.4	6.5	11.9	12.4	4.8	21.3	8.6	11.2	2.0	9.5	7.3	9.7	9.6	20.9	4.7	4.2	7.8	0.4	27.8	0.6	0.1	7.8	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.8	0.2	0.2	0.4	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.2	0.0	0.3	0.0	20.1	0.5	0.9	0.0	0.0	27.8	0.0	0.1	20.3	0.0	4.2	0.0	0.0	7.8	1.2	0.0	0.0	0.4	0.6	5.1	0.1	0.0	7.8	5.4	4.5	1.0	4.7	4.3	3.0	5.0	2.9	5.4	2.0	0.0	1.1	3.2	0.0	7.0	0.0	1.9	2.5	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.8	1.6	0.0	0.0	0.0	4.2	5.3	0.2	2.3	0.8	838.4	0.0	0.0	3.1	177.7	1.6	1.4	49.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.2	0.6	0.2	4.4	13.4	0.7	0.0	0.1
GHR	GHBP	ENSG00000112964	"Growth hormone receptor"	P10912	5	42423777-42721878	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins"	Endocytosis	Receptor	"Disease mutation, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 44.4;breast: 31.5;liver: 82.4;skeletal muscle: 23.4"	"Cell type enhanced"	"Detected in many"	19	"Hepatocytes: 103.6;Syncytiotrophoblasts: 33.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"HSkMC: 13.6;T-47d: 34.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045339, HPA057705"	Enhanced		Supported	"Plasma membrane,Cytosol,Cytoplasmic bodies"	"Secreted to blood"	2200000	21000000	"Plasma membrane, Cytosol, Cytoplasmic bodies"		"HPA045339: AB_2679294, HPA057705: AB_2683507"	"unprognostic (2.18e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (2.73e-6)"	"unprognostic (1.06e-1)"	"unprognostic (3.92e-2)"	"unprognostic (3.73e-2)"	"unprognostic (6.15e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.67e-3)"	"unprognostic (4.29e-4)"	"unprognostic (7.82e-2)"	"unprognostic (7.33e-4)"	"unprognostic (8.35e-6)"	44.4	2.8	0.7	5.4	1.3	0.3	31.5	0.4	1.4	4.0	6.9	0.5	1.7	0.6	5.7	3.9	2.4	2.5	3.9	6.0	1.3	1.6	5.3	82.4	2.3	2.2	1.2	1.4	5.0	1.3	3.6	2.0	4.0	2.0	8.7	2.5	2.4	2.3	7.4	23.4	3.0	2.4	5.2	1.0	2.6	3.5	1.6	0.2	0.1	2.9	4.3	0.5	3.8	8.4	0.6	0.3	1.8	0.5	0.4	0.3	0.1	0.0	0.0	0.3	3.1	2.1	0.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	2.6	0.0	0.0	1.6	0.0	0.0	0.0	0.4	0.0	0.0	13.6	4.4	0.0	0.6	0.1	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	2.1	0.4	34.7	0.0	1.8	3.0	1.3	1.6	0.3	0.3	0.0	0.0	0.3	0.0	1.6	1.8	0.3	0.4	0.2	0.2	0.1	0.3	0.2	0.1	0.1	0.6	0.2	0.3	1.7	0.4	0.5	0.3	0.2	0.1	0.7	1.3	0.4	1.4	1.3	1.6	1.2	1.4	2.0	0.2	0.0	0.3	0.0	2.8	4.1	0.6	13.6	2.5	0.0	0.0	1.8	0.0	8.6	1.7	0.0	3.3	2.9	0.0	0.0	0.2	0.9	9.3	3.5	0.0	103.6	1.6	0.0	2.9	4.9	1.9	1.8	17.3	0.3	1.7	0.0	2.0	0.8	0.2	0.0	11.3	8.8	0.2	12.9	4.4	0.0	0.3	3.1	33.6	0.0	1.5	0.9
GPI	"AMF, NLK"	ENSG00000105220	"Glucose-6-phosphate isomerase"	P06744	19	34359480-34402413	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Gluconeogenesis, Glycolysis"	"Cytokine, Growth factor, Isomerase"	"Cancer-related genes, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 321.8;Late spermatids: 797.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB018655, HPA024305, CAB040563, HPA052171"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"		140000000	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB018655: AB_2112653, CAB040563: , HPA024305: AB_1849922, HPA052171: AB_2681748"	"unprognostic (1.03e-1)"	"unprognostic (8.39e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.52e-2)"	"unprognostic (6.45e-3)"	"unprognostic (1.95e-2)"	"unprognostic (8.52e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.93e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.60e-3)"	"unprognostic (2.88e-2)"	62.1	66.6	43.4	27.6	58.2	83.3	34.8	62.6	88.7	20.6	36.6	20.8	23.7	48.2	21.1	20.6	45.3	24.2	33.5	107.2	42.0	45.6	51.3	77.9	19.6	29.6	39.3	64.3	22.5	21.4	66.9	33.7	20.4	50.2	23.7	37.2	36.2	34.6	33.9	144.7	29.4	44.3	34.2	22.8	23.1	26.7	19.7	19.0	23.8	26.1	68.5	32.6	32.5	25.2	16.2	26.3	74.8	40.9	14.5	27.5	24.6	76.8	108.3	9.5	74.2	31.2	23.2	22.7	29.7	23.5	37.5	45.2	61.0	27.3	50.7	44.1	29.0	25.5	53.6	57.3	64.5	42.6	56.3	23.2	65.0	52.2	64.2	20.2	84.2	42.4	31.8	26.7	44.2	23.0	47.4	35.0	34.4	33.1	40.1	26.3	65.2	36.6	29.5	25.7	69.7	38.4	34.3	25.1	95.7	46.9	51.8	51.9	30.2	59.8	105.5	21.6	17.8	23.9	26.9	30.1	14.2	31.2	40.1	45.7	74.2	42.1	46.0	47.2	64.1	28.6	38.5	22.9	74.8	22.5	35.2	27.5	16.2	20.7	25.5	26.3	13.3	17.5	20.7	1.6	14.5	40.9	8.7	21.6	24.6	43.4	58.2	62.6	88.7	42.0	45.6	39.3	64.3	50.2	19.0	26.8	40.2	23.1	22.0	23.0	92.5	198.3	38.2	21.4	25.0	54.1	70.7	38.6	97.8	77.9	321.8	30.6	90.3	0.0	57.9	60.0	36.8	27.8	22.0	68.1	78.6	224.1	61.2	47.9	41.6	797.8	34.2	41.9	33.7	45.9	67.6	28.6	75.7	25.9	28.7	79.1	62.2	19.4	38.7	6.9	7.6	28.7	32.8	47.1	102.1	32.5
HAPLN3	"EXLD1, HsT19883"	ENSG00000140511	"Hyaluronan and proteoglycan link protein 3"	Q96S86	15	88877288-88895626	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 25.4;lymphoid tissue: 23.6"	"Cell type enriched"	"Detected in many"	8	"Extravillous trophoblasts: 899.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 25.4"	"Lineage enriched"	"Detected in many"	5	"T-cells: 25.4"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 21.0;U-2 OS: 21.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039237	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"			"Plasma membrane, Cytosol"		"HPA039237: AB_10805357"	"unprognostic (1.67e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.21e-1)"	"unprognostic (3.82e-1)"	"unprognostic (3.37e-3)"	"unprognostic (7.37e-3)"	"unprognostic (1.13e-3)"	"unprognostic (4.30e-1)"	"prognostic unfavorable (4.18e-13)"	"unprognostic (1.95e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.12e-1)"	9.9	1.3	1.1	20.6	2.7	4.4	8.7	1.0	2.3	5.3	2.6	1.1	0.3	1.4	4.4	4.9	5.7	6.0	4.7	9.8	3.2	1.0	3.0	0.8	8.7	23.6	3.1	0.9	5.2	2.3	0.9	2.2	2.7	3.6	5.2	1.1	3.2	6.4	1.6	4.2	6.0	4.1	4.7	6.2	6.9	3.6	1.9	1.8	5.7	7.2	7.6	10.9	6.0	5.6	0.8	1.1	0.7	0.6	4.8	25.4	3.2	1.2	4.4	0.9	9.8	2.8	3.0	3.1	2.7	0.6	1.0	1.3	2.8	4.1	0.0	7.8	3.4	1.6	1.0	9.3	1.2	0.0	21.0	8.2	3.0	0.2	0.0	0.4	0.0	0.1	1.1	0.5	2.0	0.1	0.1	4.6	0.4	0.0	6.0	0.4	0.1	0.0	0.0	7.3	0.0	0.1	0.0	0.4	7.3	1.8	0.1	0.1	2.7	0.5	0.5	3.7	1.2	0.0	0.4	0.8	7.1	21.0	5.3	0.4	0.9	0.0	0.0	2.5	0.0	6.1	0.7	0.6	0.0	0.6	0.3	3.0	0.1	10.0	4.1	1.1	0.8	10.2	4.5	0.1	4.8	0.1	0.4	25.4	3.2	1.1	2.7	1.0	2.3	3.2	1.0	3.1	0.9	3.6	1.8	0.0	4.3	0.9	6.0	28.4	2.6	7.7	0.0	1.4	5.7	1.8	9.8	5.6	0.0	5.7	0.0	18.6	0.0	0.0	1.8	899.6	9.3	3.9	1.1	0.0	17.6	0.0	0.0	3.1	0.0	0.0	0.9	2.9	16.9	16.2	0.2	2.4	8.7	0.0	0.7	0.1	108.4	12.9	38.9	0.5	1.7	21.1	17.0	3.2	0.2	6.8
HBEGF	"DTR, DTS, HEGFL"	ENSG00000113070	"Heparin binding EGF like growth factor"	Q99075	5	140332843-140346631	"Predicted membrane proteins, Predicted secreted proteins"		"Growth factor, Heparin-binding, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Basal glandular cells: 536.0;Urothelial cells: 590.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 4.9;myeloid DC: 3.5;non-classical monocyte: 3.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.5;monocytes: 4.9"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 23.2;JURKAT: 30.2;TIME: 25.2;U-698: 33.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053243	Uncertain				"Secreted to blood"	118000				"HPA053243: AB_2682086"	"unprognostic (3.64e-1)"	"unprognostic (3.05e-1)"	"unprognostic (4.31e-2)"	"unprognostic (5.09e-1)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (8.44e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (7.09e-4)"	"prognostic favorable (6.00e-4)"	"unprognostic (2.20e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.87e-2)"	31.1	7.0	5.5	18.0	7.5	17.0	22.4	6.8	5.8	8.1	11.1	13.0	5.7	2.6	12.1	13.8	25.3	6.3	32.8	24.3	7.7	6.2	6.9	5.6	36.0	2.7	10.5	4.2	6.5	4.1	4.6	7.3	8.9	8.1	7.8	9.1	6.7	7.0	6.4	14.3	9.8	8.2	20.6	14.1	3.4	13.7	6.4	8.4	1.2	8.5	27.6	13.4	18.2	10.3	0.7	3.5	0.1	4.9	0.0	0.3	0.4	8.2	0.6	1.2	3.0	0.6	0.2	1.0	8.0	3.1	15.2	12.6	4.7	9.0	0.1	6.4	1.9	5.3	2.6	1.5	13.6	23.2	0.4	1.4	0.1	1.7	0.6	0.4	0.5	0.4	0.3	17.2	16.7	6.7	4.5	7.6	30.2	0.0	1.3	3.2	0.5	0.7	3.8	1.1	3.3	2.2	1.4	4.9	0.2	9.4	1.1	0.4	0.4	2.3	0.3	2.7	9.0	0.5	2.1	25.2	8.7	7.3	2.7	17.9	0.1	0.6	33.9	11.0	4.0	11.2	0.0	0.8	0.0	0.0	4.9	0.0	0.7	0.1	0.0	3.5	0.0	0.3	0.1	0.1	0.0	3.4	0.6	0.0	0.4	5.5	7.5	6.8	5.8	7.7	6.2	10.5	4.2	8.1	8.4	205.4	73.7	0.9	536.0	190.6	1.8	73.4	12.7	17.4	61.4	10.4	0.0	2.2	0.0	42.2	0.5	52.6	189.4	0.0	9.6	1.6	18.8	102.7	20.8	1.9	65.1	4.8	84.7	16.0	33.7	0.0	0.3	85.3	30.4	1.8	54.7	6.0	53.3	73.7	0.7	0.4	0.3	0.0	21.2	1.6	5.3	109.4	2.2	0.7	56.1	590.9
HHIP	"FLJ20992, HIP"	ENSG00000164161	"Hedgehog interacting protein"	Q96QV1	4	144646021-144745271	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.5;lung: 29.7"	"Cell type enhanced"	"Detected in some"	22	"Alveolar cells type 2: 177.0;Leydig cells: 126.0;Peritubular cells: 41.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 2.6"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 2.6"	"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 69.8;TIME: 80.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA012616	Uncertain		Approved	Nucleoplasm	"Secreted in other tissues"			Nucleoplasm		"HPA012616: AB_1850687"	"unprognostic (3.86e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.02e-2)"	"unprognostic (7.12e-3)"	"unprognostic (8.18e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.95e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.66e-3)"	"unprognostic (7.13e-3)"	"unprognostic (1.05e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.38e-1)"	4.0	5.2	9.9	1.7	22.2	2.3	1.1	2.3	16.0	3.4	6.5	31.5	0.0	5.5	4.1	8.1	1.0	1.2	3.0	1.1	16.0	6.3	2.4	12.7	29.7	1.0	21.6	9.9	2.2	4.8	1.0	1.1	1.0	17.5	9.8	6.8	4.4	1.3	6.2	1.3	1.1	8.2	1.3	12.3	1.0	11.2	3.7	26.5	2.3	1.6	0.0	1.0	7.1	1.0	0.1	2.6	0.5	0.1	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.7	3.8	69.8	6.2	0.0	0.0	1.0	0.0	9.8	0.0	0.9	0.0	0.6	0.1	14.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	80.5	0.0	0.8	0.0	0.5	0.4	0.0	2.1	0.0	0.0	0.4	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	2.6	0.0	0.0	9.9	22.2	2.3	16.0	16.0	6.3	21.6	9.9	17.5	26.5	11.9	177.0	0.0	0.0	0.0	1.4	1.1	0.0	8.1	6.8	0.0	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.3	0.0	0.4	0.0	16.1	0.0	0.1	0.0	0.0	16.0	0.0	1.8	126.0	1.0	1.7	0.0	0.0	0.2	0.1	0.0	41.4	0.0	3.5	0.0	0.4	0.2	0.2	0.5	0.0	0.0	0.0	0.0
HLA-G		ENSG00000204632	"Major histocompatibility complex, class I, G"	P17693	6	29826967-29831125	"Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins"	Immunity		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"placenta: 66.0"	"Cell type enriched"	"Detected in many"	15	"Extravillous trophoblasts: 586.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 1.2;SuSa: 3.9"									CAB016158	Enhanced				"Secreted to blood"	32800000				"CAB016158: AB_627938"	"unprognostic (1.13e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.40e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.51e-1)"	"prognostic favorable (3.91e-5)"	"unprognostic (6.34e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.03e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.19e-3)"	0.2	0.1	0.0	0.5	0.1	0.2	0.3	0.1	0.1	0.2	0.5	0.1	0.0	1.2	0.2	0.6	0.1	0.1	0.2	0.3	0.2	0.0	0.5	0.2	2.8	0.7	0.1	0.1	0.3	1.9	0.1	15.2	66.0	0.1	0.2	0.2	0.3	0.4	0.6	0.2	0.2	0.8	0.1	0.2	1.2	0.9	2.2	0.2	1.3	0.4	0.2	0.2	0.2	0.3	0.3	0.3	2.2	0.9	0.2	1.2	5.7	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.2	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.6	0.9	1.2	0.7	0.5	1.2	0.3	0.1	0.5	0.3	0.3	0.6	1.2	2.2	0.2	0.6	0.1	0.5	5.7	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.0	1.1	1.4	6.4	20.3	0.0	0.8	5.1	0.0	0.0	0.0	0.0	7.8	0.0	2.8	16.1	5.2	2.6	0.0	4.7	586.1	11.7	5.5	0.0	1.1	21.9	0.0	16.8	8.0	11.0	5.3	2.3	3.3	11.8	0.0	39.2	0.0	15.5	20.1	2.5	0.2	0.0	0.0	3.3	4.7	3.0	30.7	33.9	6.9	9.7	6.7
HSD11B1L	"SCDR10, SDR26C2"	ENSG00000167733	"Hydroxysteroid 11-beta dehydrogenase 1 like"	Q7Z5J1	19	5680604-5688523	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"brain: 34.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 17.2"					"Low region specificity"	"Detected in all"			HPA049078			Supported	Vesicles	"Secreted in brain"			Vesicles		"HPA049078: AB_2680622"	"unprognostic (2.34e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.73e-3)"	"unprognostic (5.26e-2)"	"unprognostic (9.37e-2)"	"prognostic favorable (4.38e-4)"	"unprognostic (4.81e-3)"	"unprognostic (6.63e-3)"	"unprognostic (2.63e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.77e-2)"	"unprognostic (4.52e-1)"	"unprognostic (1.73e-2)"	3.9	8.8	34.4	2.1	19.2	4.7	5.0	10.3	29.7	3.9	2.9	5.4	3.7	2.6	3.6	8.5	2.2	7.6	4.8	3.8	25.4	16.1	6.7	3.5	4.4	2.3	11.7	20.4	6.1	6.2	5.8	8.5	2.5	10.7	4.0	1.9	3.2	9.1	6.9	15.0	6.9	2.9	2.7	6.0	2.6	3.3	4.3	7.5	0.0	6.6	1.3	1.8	2.5	2.2	2.5	4.8	2.5	5.8	1.4	4.5	1.7	2.9	2.8	10.4	1.9	4.9	5.3	2.1	2.2	4.5	1.0	4.5	1.3	2.9	0.7	4.9	1.9	0.8	1.5	1.2	1.6	1.0	2.4	3.1	1.9	2.5	1.8	3.4	0.7	7.1	5.2	3.5	1.6	1.5	9.6	1.6	4.4	1.9	2.8	4.2	0.4	1.8	2.0	2.8	12.5	3.3	3.3	0.4	2.5	8.7	0.7	2.8	17.2	0.5	1.5	11.0	3.8	2.4	0.6	2.8	2.6	4.6	4.4	1.8	6.9	2.3	0.8	7.2	1.1	2.0	1.7	2.5	0.2	1.2	5.8	1.6	1.2	3.2	3.6	2.3	2.5	4.5	3.9	2.5	1.4	2.9	4.8	0.9	1.7	34.4	19.2	10.3	29.7	25.4	16.1	11.7	20.4	10.7	7.5	0.0	1.6	0.8	7.6	7.2	11.2	2.0	5.1	13.4	4.5	22.7	13.7	4.0	13.3	8.9	6.8	3.8	3.8	0.0	4.1	3.9	8.9	8.0	10.3	3.2	4.2	7.9	24.6	8.0	2.8	9.6	6.6	3.6	5.0	2.8	4.3	17.0	4.8	2.8	12.0	23.7	11.7	0.0	9.9	10.3	10.6	8.9	2.4	3.3	3.5	7.5
IFNAR2	IFNABR	ENSG00000159110	"Interferon alpha and beta receptor subunit 2"	P48551	21	33229901-33265675	"Cancer-related genes, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 52.3;U-266/70: 66.4;U-266/84: 34.4"														"Secreted to blood"		610000				"unprognostic (2.00e-2)"	"unprognostic (7.83e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.50e-3)"	"unprognostic (8.05e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.11e-2)"	"unprognostic (7.65e-2)"	"unprognostic (4.42e-1)"	"prognostic unfavorable (7.54e-7)"	"unprognostic (9.70e-3)"	"unprognostic (2.39e-1)"	"unprognostic (5.12e-3)"	"unprognostic (1.85e-2)"	16.9	8.7	9.9	28.1	11.3	19.1	18.3	10.7	13.0	10.2	12.2	10.6	9.6	12.8	12.0	10.1	8.1	11.1	15.5	13.6	10.3	9.7	13.4	20.5	21.6	41.7	13.3	8.3	11.9	10.2	11.2	10.9	15.7	10.2	9.9	13.2	7.9	14.4	11.6	6.6	6.6	14.1	13.0	13.2	40.9	9.9	4.6	12.1	34.7	11.3	6.6	25.3	24.2	10.7	9.9	37.6	37.1	25.3	12.2	23.7	14.2	4.1	4.7	2.5	5.7	3.0	7.1	4.1	4.2	11.2	3.6	3.8	6.3	4.7	6.5	3.1	6.5	5.5	2.6	3.5	2.3	3.5	4.1	5.3	23.8	5.2	5.8	4.4	4.0	8.9	5.0	2.2	4.0	4.9	6.4	11.4	10.2	7.5	52.3	3.5	2.4	10.3	4.9	4.5	5.5	3.1	3.5	12.9	12.8	7.6	8.3	6.5	3.7	7.2	6.4	6.1	2.7	1.1	7.6	7.5	3.7	2.2	2.9	2.3	66.4	34.4	16.1	5.3	14.4	8.6	13.7	14.5	22.7	12.2	23.7	12.8	9.9	15.2	11.5	13.6	6.7	11.2	12.3	37.1	12.2	25.3	37.6	23.7	14.2	9.9	11.3	10.7	13.0	10.3	9.7	13.3	8.3	10.2	12.1	56.6	17.3	28.9	40.1	6.1	5.2	2.5	25.5	28.1	20.5	10.4	5.9	24.6	3.3	61.4	2.4	32.2	8.1	0.0	54.3	61.5	11.8	37.0	31.1	17.4	40.5	19.1	2.9	38.6	68.7	2.4	6.9	46.3	18.6	33.3	3.7	5.7	58.2	3.6	8.5	8.4	5.4	0.0	13.3	2.9	22.4	5.0	19.7	40.3	3.8	62.9
IGF2	"C11orf43, FLJ44734, IGF-II"	ENSG00000167244	"Insulin like growth factor 2"	P01344	11	2129112-2149603	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Carbohydrate metabolism, Glucose metabolism, Osteogenesis"	"Growth factor, Hormone, Mitogen"	"Cancer-related genes, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"placenta: 330.5"	"Group enriched"	"Detected in some"	9	"Cytotrophoblasts: 871.9;Extravillous trophoblasts: 2792.3;Syncytiotrophoblasts: 1348.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 115.4;Hep G2: 79.2;LHCN-M2: 45.5;RH-30: 56.5;SH-SY5Y: 68.8"	"Low region specificity"	"Detected in all"							"HPA007556, HPA007993"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted to blood"	609000000	1700000000	Vesicles	"Nucleoplasm, Cytosol"	"HPA007556: AB_2667860, HPA007993: AB_1851474"	"unprognostic (1.54e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.08e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.59e-1)"	"prognostic favorable (7.12e-4)"	"unprognostic (7.92e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.00e-2)"	"unprognostic (8.98e-2)"	"unprognostic (8.93e-3)"	"unprognostic (5.78e-2)"	16.6	8.0	1.3	4.5	2.0	0.5	23.3	2.3	1.9	23.4	5.0	3.4	4.7	1.0	9.9	32.0	5.2	17.2	4.5	20.5	1.5	1.6	8.1	39.7	1.9	1.1	3.5	1.6	20.4	5.5	0.7	5.0	330.5	7.6	10.4	1.0	33.2	2.6	6.7	21.9	1.7	2.3	7.5	17.0	2.0	3.2	12.4	0.2	1.8	2.6	14.5	1.8	15.2	14.1	0.0	0.1	0.5	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	15.2	0.1	0.4	0.0	115.4	0.0	0.0	1.1	0.0	0.3	0.0	0.1	0.9	1.1	0.0	0.0	0.0	0.0	79.2	20.3	0.0	0.0	24.7	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	45.5	0.3	0.0	0.1	0.1	0.0	0.2	0.0	56.5	0.1	0.0	0.1	4.5	68.8	0.0	0.0	0.0	12.0	0.5	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.0	1.3	2.0	2.3	1.4	1.5	1.6	3.5	1.6	7.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	871.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2792.3	0.0	0.0	0.0	0.0	192.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1348.9	0.0	0.0	0.0
IGFALS	ALS	ENSG00000099769	"Insulin like growth factor binding protein acid labile subunit"	P35858	16	1790413-1794971	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"liver: 107.6"	"Group enriched"	"Detected in some"	4	"Cholangiocytes: 12.7;Hepatocytes: 39.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 11.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 5.3;T-47d: 2.1;U-266/70: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA040692, HPA040948"	Supported				"Secreted to blood"	14700000000	44000000000			"HPA040692: AB_10794067, HPA040948: AB_10794999"	"unprognostic (2.74e-3)"	"unprognostic (1.95e-1)"	"unprognostic (9.13e-2)"	"prognostic unfavorable (6.06e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-2)"	"prognostic favorable (5.97e-4)"	"unprognostic (5.54e-4)"	"unprognostic (3.00e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.39e-1)"	"unprognostic (5.51e-2)"	0.1	0.0	0.1	0.1	0.2	0.2	0.1	0.8	0.2	0.1	0.4	0.1	0.1	0.2	0.2	0.1	0.1	0.2	7.4	0.1	0.1	0.2	0.2	107.6	0.4	0.1	0.1	0.1	0.1	0.8	0.0	0.2	0.1	0.4	0.1	0.0	1.4	0.6	0.1	0.2	0.2	0.1	0.1	0.3	0.1	5.0	0.5	0.1	1.7	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.4	0.3	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.9	5.3	0.0	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.9	1.0	0.0	1.3	0.2	0.5	0.2	0.1	0.0	1.3	0.5	1.6	0.0	0.0	0.4	0.3	0.3	0.0	0.7	0.1	2.1	0.2	0.2	0.4	1.5	0.2	0.2	5.2	1.8	0.3	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.8	0.2	0.1	0.2	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.1	0.1	0.2	1.6	12.7	0.0	0.0	0.0	5.9	0.0	0.0	1.4	0.9	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	39.9	0.0	0.0	0.0	0.6	0.3	0.5	0.0	0.0	1.7	0.0	5.0	0.2	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.2	0.0
IL12A	"CLMF, IL-12A, NFSK, NKSF1, p35"	ENSG00000168811	"Interleukin 12A"	P29459	3	159988750-159996019	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction"	"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 10.1"	"Cell type enhanced"	"Detected in some"	13	"Ciliated cells: 8.1;Sertoli cells: 6.5;Spermatogonia: 2.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 5.1"	"Group enriched"	"Detected in many"	7	"B-cells: 5.1;granulocytes: 1.3;T-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 7.5;HDLM-2: 11.4;SK-BR-3: 17.1"	"Region enhanced"	"Detected in single"		"cerebral cortex: 2.7"	"Low region specificity"	"Detected in some"			HPA001886	Uncertain				"Secreted to blood"					"HPA001886: AB_1079132"	"unprognostic (6.23e-2)"	"unprognostic (7.82e-5)"	"unprognostic (1.25e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.22e-1)"	"unprognostic (7.18e-2)"	"unprognostic (4.18e-5)"	"unprognostic (2.22e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.31e-2)"	"unprognostic (9.57e-10)"	"unprognostic (1.62e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.61e-2)"	0.7	1.4	3.4	1.6	6.2	3.3	2.0	2.6	5.6	0.5	1.6	1.0	0.0	1.5	1.2	0.8	10.1	5.7	0.6	1.4	3.1	2.2	1.2	0.6	5.2	2.9	3.2	1.7	1.6	1.1	0.1	1.0	0.4	5.4	0.9	1.3	0.2	2.1	1.1	0.4	0.2	1.5	0.8	2.7	2.8	1.2	0.9	4.1	0.0	0.5	0.5	2.1	0.9	1.1	5.1	0.1	1.3	0.3	0.0	1.6	0.3	2.8	0.3	0.4	2.4	0.0	0.1	0.2	3.1	1.9	3.6	7.5	1.2	0.1	0.0	0.2	0.5	4.2	0.3	0.8	0.5	3.4	11.4	3.9	0.1	0.1	0.8	2.6	0.6	5.3	0.6	0.9	6.4	2.5	2.5	1.2	0.3	0.0	2.0	2.2	0.0	0.1	0.0	0.4	0.1	1.7	2.2	0.0	0.4	0.4	0.2	0.1	1.2	0.0	17.1	0.4	0.6	0.8	1.2	0.8	0.9	0.8	2.1	5.8	1.2	0.0	0.0	1.4	5.2	0.7	0.0	0.1	1.3	0.9	0.3	1.4	1.3	0.4	1.6	0.1	5.1	0.0	0.5	0.0	0.0	0.0	0.0	1.4	0.3	3.4	6.2	2.6	5.6	3.1	2.2	3.2	1.7	5.4	4.1	0.0	1.1	1.9	1.1	0.1	0.0	0.2	0.0	8.1	1.2	0.0	0.0	0.0	0.0	1.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	6.5	0.0	0.0	2.5	0.1	0.0	0.0	0.5	1.6
IL15RA	"CD215, IL-15RA"	ENSG00000134470	"Interleukin 15 receptor subunit alpha"	Q13261	10	5943639-5978187	"CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Exocrine glandular cells: 48.0;monocytes: 89.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 30.0;EFO-21: 18.2;HDLM-2: 32.7;HHSteC: 18.7"									CAB026215	Approved				"Secreted to blood"					"CAB026215: "	"unprognostic (2.86e-2)"	"unprognostic (8.41e-2)"	"unprognostic (6.13e-2)"	"unprognostic (4.45e-2)"	"unprognostic (7.87e-2)"	"unprognostic (5.49e-2)"	"prognostic unfavorable (2.67e-6)"	"unprognostic (5.09e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (5.35e-4)"	"unprognostic (6.18e-3)"	"prognostic unfavorable (1.27e-12)"	"unprognostic (4.43e-2)"	"unprognostic (4.69e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.75e-2)"	20.5	5.6	2.2	13.0	4.1	6.4	33.9	1.4	2.6	12.7	15.6	1.6	7.7	10.1	10.9	9.4	14.3	10.6	18.7	19.2	2.6	1.9	7.8	17.5	35.7	15.2	4.0	2.0	8.7	9.6	0.9	3.9	15.5	3.6	13.2	7.4	6.4	8.9	9.4	9.2	7.6	18.8	10.8	2.7	18.8	10.3	5.0	2.7	3.5	13.9	7.5	9.8	12.9	17.3	7.0	4.2	6.3	19.5	6.8	18.7	6.7	7.0	1.0	0.0	0.3	9.3	2.2	1.9	3.6	7.8	4.8	5.0	0.1	30.0	0.8	18.2	6.8	2.6	6.7	0.8	5.3	1.0	32.7	1.4	0.8	1.8	0.5	18.7	0.4	0.2	1.9	1.8	2.5	0.1	1.8	11.7	0.6	8.7	10.0	0.1	3.7	1.4	3.4	0.2	2.5	3.3	4.2	0.0	5.7	1.1	0.5	0.0	0.0	5.5	0.5	0.2	0.0	2.6	3.2	4.5	0.1	0.5	13.0	4.8	9.0	2.4	0.1	2.2	5.3	0.3	6.3	16.0	3.9	12.3	19.5	18.7	7.0	9.5	12.5	4.2	3.3	4.1	7.1	4.7	6.8	11.7	0.0	10.2	6.7	2.2	4.1	1.4	2.6	2.6	1.9	4.0	2.0	3.6	2.7	6.0	5.3	7.5	4.2	5.0	0.0	5.3	25.5	2.7	0.0	0.0	0.0	0.6	0.0	30.4	1.5	20.4	6.9	23.3	48.0	1.6	12.7	6.8	3.5	6.4	6.3	0.0	5.2	34.4	12.7	1.5	4.6	6.2	3.3	89.2	7.1	0.0	29.3	13.5	0.7	0.0	0.0	0.0	5.1	0.2	0.2	5.6	0.1	5.7	7.5	6.5
IL17RA	"CD217, CDw217, hIL-17R, IL-17RA, IL17R"	ENSG00000177663	"Interleukin 17 receptor A"	Q96F46	22	17084954-17115694	"CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 50.0"	"Cell type enhanced"	"Detected in many"	8	"Kupffer cells: 84.8;Macrophages: 43.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 15.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HL-60: 27.6;NB-4: 24.3;THP-1: 35.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB024996	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"		20000	"Nucleoplasm, Cytosol"		"CAB024996: "	"unprognostic (1.92e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.83e-2)"	"unprognostic (7.66e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.96e-2)"	"prognostic favorable (8.35e-4)"	"unprognostic (2.16e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.51e-3)"	17.7	7.6	6.5	13.6	13.8	40.5	24.7	4.0	6.7	8.6	8.1	7.7	4.6	6.2	7.4	9.4	6.8	7.8	7.4	8.8	6.1	4.9	8.3	11.6	16.8	39.2	10.3	2.0	7.7	7.7	6.9	5.4	6.2	8.3	6.9	5.7	5.3	7.0	5.3	5.3	8.6	9.1	8.3	11.2	23.4	7.3	5.3	9.7	50.0	7.9	3.2	11.0	6.3	12.8	0.5	3.6	15.6	6.9	1.4	2.4	2.0	3.6	2.1	1.9	2.5	3.9	2.3	2.5	5.5	3.6	2.6	3.3	2.0	2.4	3.3	2.3	5.5	3.4	6.0	2.7	2.6	1.8	5.4	3.2	0.0	1.2	1.3	4.5	27.6	8.6	3.4	3.8	2.3	1.8	2.5	2.7	2.7	1.4	3.5	2.6	3.1	3.3	24.3	1.1	4.7	2.1	0.7	0.4	0.6	2.4	2.7	1.3	0.0	3.8	3.3	2.7	2.3	2.5	35.0	7.5	2.0	2.9	3.0	2.0	2.8	1.5	1.6	2.9	13.4	2.1	6.7	6.9	6.1	1.1	3.2	0.9	0.4	1.5	1.1	3.6	0.5	2.4	1.8	15.6	1.4	2.9	1.7	0.9	2.0	6.5	13.8	4.0	6.7	6.1	4.9	10.3	2.0	8.3	9.7	11.9	13.1	6.7	5.5	7.8	2.0	4.5	15.3	5.3	3.4	5.2	7.9	5.4	0.0	8.0	2.5	9.3	15.1	0.0	10.8	10.6	8.2	8.5	7.0	9.6	29.2	3.2	12.7	20.9	84.8	1.4	8.3	43.1	8.5	3.6	13.1	3.8	10.5	11.8	4.2	3.1	3.2	12.9	9.0	1.4	14.7	5.9	5.4	20.0	10.6	9.3
IL19	"IL-10C, IL-19, MDA1, NG.1, ZMDA1"	ENSG00000142224	"Interleukin 19"	Q9UHD0	1	206798870-206842981	"Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"cervix, uterine: 17.8;esophagus: 6.0;salivary gland: 6.7"	"Cell type enriched"	"Detected in single"	4	"Exocrine glandular cells: 1.5"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.8"					"Cell type enhanced"	"Detected in single"		"basophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	9	"BJ hTERT+: 11.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	172000					"unprognostic (6.21e-2)"	"unprognostic (3.84e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.17e-2)"		"unprognostic (2.48e-5)"		"unprognostic (1.07e-1)"	"unprognostic (8.72e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.04e-3)"			"unprognostic (9.17e-2)"	"unprognostic (7.20e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.78e-1)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0			0.0	0.1	0.0	6.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.5	0.0		0.0	0.0	0.0	0.2	0.0		0.0	0.0		6.7	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.2			0.3		0.3	0.9	0.8	0.7	0.6	1.4	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	11.8	0.2	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.2	0.1	0.0	0.1	0.2	0.0	0.2	0.3	0.1	0.1	0.0	0.0	0.2	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	1.4	0.2	0.1	0.2	0.1	0.2	0.7	0.1	0.6	0.1	0.3	0.4	0.2	0.1	0.0	0.2	0.6	0.0	0.0											0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3
IL1R1	"CD121A, D2S1473, IL1R, IL1RA"	ENSG00000115594	"Interleukin 1 receptor type 1"	P14778	2	102064544-102179874	"Cancer-related genes, CD markers, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	"Hydrolase, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Club cells: 93.3;Ito cells: 139.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 95.6;ASC TERT1: 42.7;HHSteC: 30.0;HSkMC: 117.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001237, HPA005823, CAB007779, HPA029560"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"	"Secreted to blood"		1000000	"Nucleoplasm, Vesicles"	"Plasma membrane, Cytosol"	"CAB007779: AB_562073, HPA001237: , HPA005823: AB_2667445, HPA029560: AB_2673094"	"unprognostic (6.16e-3)"	"unprognostic (3.55e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.26e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.26e-2)"	"unprognostic (7.77e-2)"	"prognostic unfavorable (6.92e-6)"	"unprognostic (2.48e-2)"	"unprognostic (6.95e-2)"	"unprognostic (4.83e-2)"	"unprognostic (7.73e-2)"	48.6	25.2	2.6	18.2	5.2	4.0	92.4	2.4	3.9	47.8	21.0	2.5	34.3	5.2	15.2	30.2	18.2	17.1	25.8	27.0	4.2	2.5	23.7	74.8	40.5	28.0	5.6	1.1	25.1	17.1	16.9	7.3	66.2	10.9	26.0	8.4	8.6	12.7	36.4	15.5	13.5	13.0	15.1	10.0	19.2	15.6	13.4	2.8	3.5	33.6	9.0	9.6	32.0	36.4	0.1	0.1	4.0	0.5	0.8	1.8	0.2	0.2	1.8	0.0	1.5	95.6	42.7	0.6	4.0	18.2	2.8	4.3	0.8	0.5	0.0	2.9	8.0	5.0	0.8	0.0	0.3	2.4	7.9	0.0	0.1	0.4	4.4	30.0	0.0	0.0	117.7	0.3	3.2	0.7	1.2	1.2	0.0	0.5	0.1	4.1	0.8	0.0	0.1	0.1	0.8	0.1	0.0	0.3	0.0	2.7	1.9	0.0	0.0	1.8	1.1	0.0	0.5	1.6	0.1	0.0	8.2	0.5	13.7	0.3	0.0	0.0	0.0	3.2	0.0	0.5	0.6	0.5	0.1	0.0	0.0	0.7	0.1	1.1	0.0	0.1	0.1	0.0	0.1	4.0	0.8	0.0	0.1	1.8	0.2	2.6	5.2	2.4	3.9	4.2	2.5	5.6	1.1	10.9	2.8	23.8	55.6	3.7	27.6	27.6	0.0	3.9	28.1	40.2	93.3	5.2	0.0	5.3	3.3	21.6	6.4	58.3	0.0	0.0	18.7	76.6	77.2	84.5	1.1	43.2	5.1	0.0	1.2	139.3	12.4	9.4	25.9	21.6	18.6	9.0	0.7	7.3	15.4	0.0	1.4	6.2	1.0	6.5	23.1	0.7	0.9	33.8	20.0	2.6	0.9	19.6
IL1R2	"CD121b, IL1RB"	ENSG00000115590	"Interleukin 1 receptor type 2"	P27930	2	101991844-102028544	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 73.2;lymphoid tissue: 74.1"	"Group enriched"	"Detected in many"	5	"Basal keratinocytes: 131.3;Kupffer cells: 197.6;Macrophages: 236.7;Mucus-secreting cells: 105.1;Pancreatic endocrine cells: 123.7;Suprabasal keratinocytes: 73.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"midbrain: 9.2"	"Cell type enriched"	"Detected in some"	25	"neutrophil: 73.2"	"Lineage enriched"	"Detected in many"	25	"granulocytes: 73.2"	"Cell line enriched"	"Detected in some"	8	"HDLM-2: 102.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA027597, HPA027598"	Uncertain				"Secreted to blood"	7130000	21000000			"HPA027597: AB_10600768, HPA027598: AB_10601229"	"unprognostic (3.54e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.83e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.36e-2)"	"unprognostic (4.82e-3)"	"unprognostic (1.62e-2)"	"unprognostic (7.15e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (5.58e-12)"	"unprognostic (1.92e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.62e-2)"	9.1	3.2	1.2	16.4	1.9	22.3	1.6	1.2	1.9	6.4	13.4	0.4	0.1	0.1	1.3	1.3	20.4	9.7	3.4	15.1	1.2	0.5	5.8	8.2	25.5	74.1	9.2	0.2	2.5	1.4	0.0	2.4	24.9	2.2	1.1	20.0	1.8	4.3	0.8	2.8	14.1	2.2	1.3	4.4	47.5	14.6	1.6	1.1	1.6	1.8	8.5	25.1	3.2	9.1	0.0	2.8	73.2	0.8	0.0	1.1	0.2	1.5	0.2	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	3.3	0.0	0.0	0.6	0.0	0.1	0.0	102.2	0.1	0.0	0.0	0.8	0.5	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	5.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.0	73.2	0.0	0.0	0.0	1.1	0.2	1.2	1.9	1.2	1.9	1.2	0.5	9.2	0.2	2.2	1.1	6.0	0.6	5.4	8.6	131.3	0.0	0.4	17.8	4.0	0.0	1.8	0.0	0.4	5.0	8.0	2.6	1.9	8.6	0.0	7.3	28.9	9.3	2.5	2.3	14.4	5.9	0.0	6.4	4.3	197.6	1.5	0.3	236.7	30.4	1.0	105.1	0.0	123.7	31.7	0.0	0.4	0.0	6.5	8.9	0.0	1.4	73.4	23.2	1.0	20.4	7.1
IL1RAP	"C3orf13, IL-1RAcP, IL1R3"	ENSG00000196083	"Interleukin 1 receptor accessory protein"	Q9NPH3	3	190514051-190659750	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 36.5;liver: 91.8;placenta: 35.9"	"Cell type enhanced"	"Detected in many"	13	"Extravillous trophoblasts: 100.2;Hepatocytes: 172.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 36.5"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 36.5"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 72.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035293	Uncertain		Approved	Vesicles,Cytosol	"Secreted to blood"		260000000	"Vesicles, Cytosol"		"HPA035293: AB_10671511"	"unprognostic (6.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.84e-3)"	"unprognostic (2.35e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (2.16e-7)"	"unprognostic (4.02e-3)"	"unprognostic (9.06e-2)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (6.29e-4)"	3.4	1.7	3.7	5.2	4.5	7.8	2.8	0.8	6.0	2.9	1.8	3.4	0.7	1.1	2.6	1.7	9.1	3.2	5.7	3.3	7.4	2.9	1.9	91.8	6.3	12.6	3.5	2.5	2.2	2.0	1.0	1.4	35.9	5.5	2.1	1.4	1.6	4.7	2.0	1.2	5.8	1.5	3.1	6.3	7.1	2.3	1.0	2.9	2.3	2.2	3.8	3.4	3.3	4.4	0.9	1.4	36.5	2.2	0.1	1.3	0.5	3.9	1.0	1.6	0.2	2.9	2.4	3.1	1.7	3.5	4.1	4.0	1.7	8.8	0.7	18.3	4.8	9.5	10.2	0.9	17.1	5.7	0.7	1.0	0.8	1.7	4.2	6.1	5.8	2.8	3.2	7.0	5.9	18.9	8.6	1.8	1.8	0.1	0.0	1.9	1.8	0.5	2.6	2.6	1.7	1.8	2.8	2.5	1.4	1.5	4.2	0.3	0.0	8.0	4.4	72.7	1.6	2.9	4.2	2.4	3.2	3.2	9.7	7.9	1.5	0.0	0.1	5.4	5.3	18.6	3.5	1.5	8.5	0.7	1.7	1.3	0.9	0.8	0.9	1.4	0.9	0.8	0.5	36.5	0.1	2.2	0.2	0.8	0.5	3.7	4.5	0.8	6.0	7.4	2.9	3.5	2.5	5.5	2.9	0.0	14.3	1.4	14.3	39.8	5.4	4.0	43.3	2.7	20.5	3.5	7.9	3.1	0.0	6.5	2.3	7.1	1.3	0.0	6.4	100.2	7.0	5.6	7.0	172.7	6.9	0.0	5.2	8.0	33.0	0.0	4.0	18.3	8.5	1.0	1.3	0.9	14.8	0.0	2.5	0.8	0.6	0.0	3.1	0.0	0.6	32.5	20.3	2.5	1.2	12.8
IL1RL1	"DER4, FIT-1, IL33R, ST2, ST2L, ST2V, T1"	ENSG00000115602	"Interleukin 1 receptor like 1"	Q01638	2	102311502-102352037	"Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 49.7;lung: 77.2;placenta: 95.0"	"Cell type enriched"	"Detected in many"	11	"granulocytes: 477.2"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 7.9"	"Group enriched"	"Detected in many"	5	"basal ganglia: 11.4;cerebral cortex: 6.6;hippocampal formation: 5.6;midbrain: 3.8;pons and medulla: 14.6"	"Group enriched"	"Detected in some"	59	"basophil: 17.1;eosinophil: 17.0"	"Lineage enriched"	"Detected in single"	59	"granulocytes: 17.1"	"Group enriched"	"Detected in some"	6	"HHSteC: 55.4;HMC-1: 82.4;HUVEC TERT2: 40.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA007406, HPA007917"	Uncertain		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"	"Secreted to blood"	19100000	1700000	"Plasma membrane"	"Focal adhesion sites, Cytosol"	"HPA007406: AB_1079128, HPA007917: AB_1079129"	"unprognostic (7.25e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.28e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.25e-3)"	"unprognostic (2.07e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.50e-2)"	"unprognostic (8.58e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.60e-3)"	10.7	7.5	1.4	2.0	11.4	0.9	6.9	0.5	6.6	2.6	3.1	0.1	0.1	1.3	1.7	0.9	2.7	0.8	7.8	16.6	5.6	1.8	49.7	6.2	77.2	1.4	3.8	0.0	0.7	2.8	0.8	1.8	95.0	14.6	1.9	2.3	1.0	0.7	5.7	2.8	1.1	2.0	3.3	5.0	1.0	6.7	0.8	0.3	0.0	5.6	0.7	0.9	6.0	2.6	0.0	0.0	17.1	0.0	0.2	0.2	0.0	0.2	0.0	0.1	0.0	3.4	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	1.3	0.1	0.0	0.0	9.7	0.1	0.1	55.4	0.4	82.4	1.1	0.3	1.3	8.9	0.1	40.2	0.0	0.2	0.1	0.1	0.0	0.1	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	3.3	0.1	0.1	0.7	0.1	0.0	0.0	0.0	0.1	0.1	0.1	17.1	0.0	17.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.4	11.4	0.5	6.6	5.6	1.8	3.8	0.0	14.6	0.3	8.9	22.8	0.0	15.1	7.6	0.0	1.8	0.0	12.0	13.6	1.8	0.0	0.0	0.0	0.0	0.2	29.2	0.0	0.0	0.4	0.1	4.2	8.9	477.2	0.0	0.0	0.0	0.0	44.2	0.3	0.9	0.9	11.2	3.3	0.0	0.0	0.0	21.7	0.0	0.0	0.0	0.2	38.8	5.2	0.0	0.0	4.4	0.0	4.3	0.0	11.1
IL4R	CD124	ENSG00000077238	"Interleukin 4 receptor"	P24394	16	27313668-27364778	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Immunity	Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"granulocytes: 107.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 34.4"	"Group enriched"	"Detected in all"	6	"B-cells: 34.4;granulocytes: 11.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 36.5;HBEC3-KT: 35.1;U-698: 34.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004451, HPA050124, HPA070380"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Centriolar satellite"	"Secreted to blood"		49000	"Nucleoplasm, Plasma membrane"	"Centriolar satellite"	"CAB004451: AB_626889, HPA050124: AB_2681026, HPA070380: "	"unprognostic (6.80e-2)"	"unprognostic (6.35e-2)"	"unprognostic (2.84e-1)"	"prognostic favorable (6.43e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (1.23e-5)"	"unprognostic (1.49e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.58e-2)"	20.7	14.8	8.7	31.6	10.6	36.9	12.0	4.4	7.7	20.8	30.3	5.9	11.5	10.9	18.0	12.8	24.7	13.6	25.1	12.3	6.7	4.4	13.3	39.1	40.9	44.8	10.8	1.7	14.7	11.3	3.8	5.5	16.1	10.1	18.8	15.1	12.3	7.7	11.5	7.2	9.9	18.6	39.6	13.6	31.8	21.1	10.4	9.8	9.1	8.6	13.7	38.4	31.6	15.4	34.4	1.6	11.9	2.6	3.3	4.0	1.8	11.5	3.0	2.0	3.9	1.0	4.6	4.2	7.3	8.5	2.9	2.4	6.2	32.0	36.5	9.1	11.5	5.7	12.3	2.1	35.1	2.5	31.6	1.0	6.8	1.8	9.5	13.2	1.8	19.4	7.0	14.2	13.5	8.0	15.5	15.7	2.1	2.9	3.1	4.7	5.1	0.1	5.5	2.4	10.4	2.7	0.1	15.2	2.9	13.6	13.2	0.6	0.3	1.0	7.0	1.6	5.3	2.7	7.0	23.5	6.7	3.0	5.9	5.1	1.8	0.5	34.0	0.7	6.1	0.0	0.5	2.6	4.7	1.7	1.1	1.3	7.7	2.6	1.7	1.6	34.4	4.0	1.9	11.9	3.3	0.6	1.6	1.8	1.8	8.7	10.6	4.4	7.7	6.7	4.4	10.8	1.7	10.1	9.8	26.8	51.7	49.6	35.5	11.7	0.0	2.2	20.4	17.4	30.7	1.8	0.0	15.0	0.0	31.7	0.1	31.5	27.6	0.0	28.2	3.5	13.9	27.2	107.5	47.4	22.9	0.0	22.4	54.6	31.1	0.2	0.3	21.3	13.5	40.5	32.8	0.0	35.6	22.1	0.0	1.1	0.0	38.8	27.4	0.5	1.9	13.0	20.8	20.3	15.0	38.2
IL6ST	"CD130, GP130"	ENSG00000134352	"Interleukin 6 signal transducer"	P40189	5	55935095-55994993	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction"	Receptor	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	10	"Ito cells: 851.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 21.0"	"Lineage enriched"	"Detected in many"	5	"T-cells: 21.0"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 57.7;BJ hTERT+: 58.7;HHSteC: 65.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010558, CAB025784"	Approved		Supported	"Golgi apparatus,Plasma membrane"	"Secreted to blood"		100000000	"Plasma membrane"	"Golgi apparatus"	"CAB025784: , HPA010558: AB_1078439"	"unprognostic (1.81e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.61e-2)"	"unprognostic (3.95e-2)"	"unprognostic (8.93e-2)"	"unprognostic (3.99e-2)"	"unprognostic (5.18e-2)"	"unprognostic (9.53e-3)"	"unprognostic (1.89e-2)"	"unprognostic (2.29e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (5.05e-4)"	"unprognostic (3.69e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.25e-1)"	44.8	34.2	24.7	25.5	23.4	8.8	76.9	15.9	22.9	38.1	23.9	15.0	29.0	8.7	26.1	24.9	22.7	23.1	31.1	31.9	21.9	19.7	37.2	71.2	36.3	70.0	25.8	14.7	42.1	16.4	35.8	36.2	97.0	22.5	31.9	17.1	20.0	26.3	33.0	27.1	12.5	20.6	36.6	33.8	35.5	19.7	13.7	20.3	19.4	37.6	12.5	18.7	33.7	51.1	0.7	2.1	0.9	3.8	0.8	21.0	4.0	9.5	11.9	3.9	9.2	27.6	57.7	15.9	28.5	58.7	15.4	22.9	16.7	9.2	0.3	21.4	17.6	35.0	4.1	3.0	8.5	31.6	0.8	3.1	2.2	9.8	13.7	65.6	0.2	4.6	50.5	4.6	33.4	16.3	22.9	35.1	0.8	1.6	40.2	17.7	1.6	0.4	0.4	0.6	1.2	3.9	0.5	10.8	5.5	8.4	5.6	2.1	3.4	11.5	3.8	11.7	10.7	19.2	1.5	56.4	5.9	6.7	24.1	15.0	9.9	4.2	0.3	15.9	0.4	15.5	0.2	3.8	0.1	0.8	3.5	0.4	0.7	4.9	0.8	2.1	0.6	21.0	5.9	0.9	0.8	0.6	1.8	3.4	4.0	24.7	23.4	15.9	22.9	21.9	19.7	25.8	14.7	22.5	20.3	125.0	112.6	23.8	82.7	92.3	54.8	67.9	140.1	99.0	149.0	64.6	33.4	63.8	6.6	64.2	9.5	210.0	31.1	23.3	53.6	60.1	240.2	110.2	31.3	186.2	46.3	15.9	19.0	851.3	103.7	11.5	98.1	51.0	75.9	21.6	29.0	179.7	66.2	30.6	122.7	46.2	33.9	97.0	142.0	37.1	34.3	73.0	85.1	35.0	13.3	89.2
JAM3	"JAM-C, JAMC"	ENSG00000166086	"Junctional adhesion molecule 3"	Q9BX67	11	134068925-134152001	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion, Differentiation, Spermatogenesis"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 77.0"	"Cell type enhanced"	"Detected in many"	7	"Peritubular cells: 60.5;Rod photoreceptor cells: 71.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 8.2"	"Group enriched"	"Detected in many"	7	"B-cells: 8.2;T-cells: 4.0"	"Cell line enhanced"	"Detected in many"		"RH-30: 38.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003417, HPA050434"	Approved		Enhanced	"Golgi apparatus"	"Secreted to blood"		570000	"Golgi apparatus"		"HPA003417: AB_1851981, HPA050434: AB_2681126"	"unprognostic (1.04e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.06e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (3.23e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.06e-3)"	"prognostic unfavorable (2.68e-4)"	14.0	14.9	17.6	7.9	34.1	2.2	9.9	7.0	28.7	15.5	23.4	77.0	6.9	5.9	25.0	12.9	16.3	11.9	17.8	21.4	26.1	16.9	6.7	3.0	13.7	6.2	40.3	17.4	32.0	4.4	14.5	19.5	68.8	29.6	26.2	9.7	17.5	9.4	32.5	4.1	9.1	11.7	29.7	34.8	8.7	12.0	24.8	34.1	5.1	7.6	4.6	5.6	22.7	22.6	8.2	0.2	0.8	0.1	0.1	4.0	2.9	0.2	0.4	28.4	14.6	26.5	19.7	23.8	12.1	14.3	4.5	4.5	0.4	0.2	0.3	12.5	15.7	18.3	0.4	20.4	0.2	8.6	0.2	10.2	0.8	0.1	1.8	7.9	0.5	12.6	13.4	0.0	3.2	2.9	11.4	29.5	13.2	0.3	0.2	19.5	0.3	8.7	1.0	6.7	0.3	1.2	0.2	38.8	0.2	0.2	0.1	19.1	10.7	0.2	0.3	0.4	12.6	0.3	0.3	0.2	8.5	6.2	13.3	8.2	0.1	0.1	0.2	9.4	1.2	16.2	0.4	0.1	0.3	2.2	0.0	2.6	8.2	2.8	1.6	0.2	4.8	4.0	2.6	0.8	0.1	0.0	0.2	0.1	2.9	17.6	34.1	7.0	28.7	26.1	16.9	40.3	17.4	29.6	34.1	0.0	8.9	6.9	5.7	4.5	16.1	14.9	0.0	2.7	1.2	5.2	7.9	4.8	1.7	0.4	1.9	26.3	0.0	0.0	0.2	40.4	29.1	1.6	1.1	0.0	6.8	7.9	0.0	16.0	0.8	3.6	39.7	0.9	16.9	0.0	0.0	18.1	0.3	0.0	60.5	0.0	71.5	25.8	29.8	12.5	19.0	3.3	5.1	0.7	0.0	0.7
KIAA0319	NMIG	ENSG00000137261	KIAA0319	Q5VV43	6	24544104-24646155	"Disease related genes, Predicted membrane proteins, Predicted secreted proteins"	Neurogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 23.5"	"Group enriched"	"Detected in some"	5	"Early spermatids: 57.8;Late spermatids: 47.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"memory B-cell: 1.4;neutrophil: 5.0"	"Group enriched"	"Detected in many"	32	"B-cells: 1.4;granulocytes: 5.0"	"Cell line enhanced"	"Detected in some"		"A549: 4.1;GAMG: 4.3;HDLM-2: 4.8;SCLC-21H: 7.8;U-266/84: 6.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015607, HPA076313"	Enhanced	Supported	Approved	Vesicles	"Secreted in brain"			Vesicles		"HPA015607: AB_1852299, HPA076313: AB_2732308"	"unprognostic (1.64e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.72e-2)"	"unprognostic (4.65e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.21e-5)"	"unprognostic (7.88e-4)"	"unprognostic (9.53e-4)"	"unprognostic (1.44e-6)"	"unprognostic (1.20e-1)"	"unprognostic (6.97e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.41e-2)"	0.9	1.9	9.9	1.3	10.2	0.9	1.1	10.7	23.5	0.9	1.6	4.0	0.0	0.9	0.9	0.9	0.8	4.8	1.4	0.8	9.7	7.7	0.9	0.8	2.2	0.9	5.8	12.1	0.8	3.0	0.8	3.8	1.1	10.2	1.7	1.7	0.0	0.8	0.9	0.8	2.4	1.1	1.1	1.4	1.1	3.2	3.5	2.3	0.0	0.8	0.0	1.1	0.9	0.1	1.4	0.0	5.0	0.0	0.0	0.0	0.0	3.6	4.1	0.2	2.6	0.0	0.0	0.1	0.0	0.1	0.1	0.3	0.2	1.5	1.1	2.0	0.0	4.3	1.7	0.7	0.0	0.0	4.8	1.8	0.0	3.5	0.2	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.3	0.0	1.9	0.0	0.2	0.0	1.2	0.1	0.0	0.5	0.2	0.3	0.2	0.0	0.8	0.1	0.2	7.8	0.5	0.1	2.2	0.0	0.1	0.8	0.0	0.0	0.0	0.6	0.4	0.8	0.6	6.3	0.3	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	9.9	10.2	10.7	14.9	9.7	7.7	5.8	12.1	10.2	2.3	3.0	0.3	0.0	0.0	0.0	1.8	1.2	0.0	10.7	2.3	0.0	0.0	0.0	0.0	0.2	57.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	9.8	0.0	0.0	47.2	0.6	0.0	0.0	1.0	0.7	0.2	0.5	0.0	0.7	0.0	1.1	0.0	0.0	0.9	1.4	0.0	0.6	0.0	0.3	0.2
KL		ENSG00000133116	Klotho	Q9UEF7	13	33016433-33066145	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Glycosidase, Hormone, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 64.3;parathyroid gland: 76.9;placenta: 25.5"	"Cell type enriched"	"Detected in some"	6	"Proximal tubular cells: 99.7"	"Group enriched"	"Detected in many"	6	"prostate cancer: 5.9;renal cancer: 17.8"	"Region enhanced"	"Detected in some"		"pons and medulla: 11.6"	"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.0"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"HMC-1: 5.1;SK-BR-3: 9.6"	"Low region specificity"	"Detected in many"												"Secreted to blood"	510000					"unprognostic (1.32e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.73e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.15e-4)"	"unprognostic (3.06e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.60e-1)"	"prognostic favorable (4.44e-4)"	"unprognostic (9.46e-2)"	"prognostic favorable (1.29e-9)"	"unprognostic (4.76e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.07e-1)"	4.8	0.6	0.8	0.9	4.3	0.1	7.4	0.0	0.8	0.7	2.1	3.3	0.2	1.0	1.0	3.2	0.8	0.7	0.9	0.9	2.4	0.8	64.3	0.2	10.4	0.9	0.5	0.3	0.4	1.6	76.9	0.3	25.5	11.6	3.3	0.4	0.3	0.7	1.0	0.9	0.4	3.2	0.7	0.4	3.1	1.9	0.6	0.3	0.0	1.4	1.3	0.3	1.5	1.1	0.0	0.0	0.0	1.0	0.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	9.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.8	4.3	0.0	0.8	2.4	0.8	0.5	0.3	11.6	0.3	0.0	0.3	0.0	0.1	0.1	0.0	0.8	0.0	1.4	1.2	12.2	0.0	0.1	5.0	0.0	1.7	1.8	0.9	0.0	0.0	0.1	0.7	4.4	0.0	0.0	2.1	0.0	15.6	0.0	0.8	0.0	0.3	0.7	0.0	1.0	0.0	0.0	0.0	0.0	0.4	99.7	0.0	0.0	0.3	0.5	0.2	0.1	0.1	0.0	0.6	0.1
LAG3	CD223	ENSG00000089692	"Lymphocyte activating 3"	P18627	12	6772512-6778455	"CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 58.1;ovary: 28.4"	"Cell type enhanced"	"Detected in many"	13	"Intestinal endocrine cells: 20.8;Leydig cells: 36.2;Peritubular cells: 65.0;T-cells: 29.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in single"		"pons and medulla: 2.7"	"Cell type enhanced"	"Detected in many"		"gdT-cell: 11.3;MAIT T-cell: 9.2;memory CD8 T-cell: 10.0"	"Lineage enriched"	"Detected in single"	56	"T-cells: 11.3"	"Cell line enriched"	"Detected in single"	144	"HDLM-2: 57.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002301, HPA013967"	Enhanced				"Secreted - unknown location"					"CAB002301: AB_564101, HPA013967: AB_1846277"	"unprognostic (9.39e-2)"	"prognostic favorable (3.89e-4)"	"unprognostic (8.88e-2)"	"unprognostic (7.00e-3)"	"unprognostic (1.08e-1)"	"unprognostic (6.74e-3)"	"unprognostic (8.85e-2)"	"unprognostic (4.63e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.97e-3)"	"unprognostic (8.71e-2)"	"unprognostic (9.93e-2)"	"prognostic unfavorable (4.62e-11)"	"unprognostic (3.07e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.13e-2)"	"unprognostic (8.19e-3)"	1.7	0.4	0.3	33.2	0.3	1.0	1.0	0.8	0.7	7.7	4.4	0.5	2.7	2.9	6.4	3.3	2.4	3.8	3.0	2.2	0.3	0.4	1.2	5.9	3.8	12.4	0.4	0.0	28.4	0.4	0.1	1.0	1.3	2.7	2.8	1.8	1.1	2.0	6.8	0.8	0.6	9.6	1.7	0.9	58.1	2.0	6.1	0.1	4.1	1.0	1.3	23.5	2.6	3.6	0.0	0.2	0.0	0.0	0.0	11.3	0.8	0.0	0.2	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	57.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	9.2	0.0	2.2	10.0	0.0	0.0	0.6	4.0	0.0	0.0	0.0	0.2	1.7	0.8	0.3	0.3	0.8	0.7	0.3	0.4	0.4	0.0	2.7	0.1	0.0	3.5	0.9	0.8	4.5	4.0	1.2	0.0	0.0	5.7	0.0	9.8	0.2	0.0	0.1	0.3	1.9	1.1	0.0	0.0	0.2	2.1	1.9	0.0	2.5	8.7	0.0	20.8	5.5	3.5	1.1	36.2	0.3	1.7	4.6	4.5	1.3	0.3	0.0	65.0	0.2	6.2	6.5	2.5	0.3	2.0	2.6	0.1	29.6	2.5	0.3
LEPR	"CD295, OBR"	ENSG00000116678	"Leptin receptor"	P48357	1	65420652-65641559	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Cancer-related genes, FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 82.8"	"Cell type enhanced"	"Detected in many"	18	"Endothelial cells: 59.1;Hepatocytes: 196.4"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 13.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 6.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 15.7;K-562: 46.5;RPTEC TERT1: 22.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030899	Approved	Supported			"Secreted to blood"	8240000	8300000			"HPA030899: AB_10610003"	"unprognostic (1.59e-2)"	"unprognostic (1.09e-3)"	"unprognostic (3.09e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.59e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.41e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.73e-1)"	15.9	5.5	3.8	3.7	4.3	3.3	23.5	2.5	3.9	15.0	9.2	5.6	5.4	3.2	20.6	7.3	10.9	11.7	10.1	9.2	4.3	4.9	14.6	82.8	20.3	9.0	4.9	3.3	18.4	16.7	3.9	13.1	12.8	8.2	10.8	4.1	18.1	12.0	5.7	5.6	10.2	7.3	12.9	7.0	6.4	11.9	6.6	3.1	1.9	13.1	11.2	6.9	13.6	8.6	0.6	1.8	6.9	1.9	1.1	2.3	1.8	1.3	0.8	1.1	1.2	5.0	4.7	3.9	5.9	3.4	2.0	1.9	0.6	3.2	0.5	4.4	7.5	0.5	1.1	0.9	5.2	5.5	7.0	1.5	7.7	3.6	0.1	3.0	0.5	0.6	13.2	3.0	1.2	4.7	15.7	5.9	0.6	46.5	0.9	9.5	0.3	0.6	0.1	1.8	0.8	0.1	0.1	0.9	0.3	22.5	0.6	0.7	11.4	1.4	0.6	1.6	6.7	2.1	2.1	2.2	2.1	4.4	0.4	3.2	1.3	0.9	0.2	4.5	2.2	2.0	6.9	1.9	2.8	1.3	1.5	1.3	0.6	1.1	1.1	1.8	0.3	0.9	1.5	1.1	1.1	1.7	1.2	2.3	1.8	3.8	4.3	2.5	3.9	4.3	4.9	4.9	3.3	8.2	3.1	0.0	16.5	3.0	1.9	31.4	4.9	3.5	10.2	2.7	4.5	8.7	0.0	1.2	3.3	1.5	1.0	59.1	0.4	0.0	0.9	2.3	20.2	3.3	1.1	196.4	1.9	1.6	0.0	27.6	6.5	1.5	31.9	5.8	33.7	2.8	0.9	0.0	1.6	1.7	7.1	6.8	0.9	0.0	17.7	1.1	0.6	25.7	2.2	0.5	0.8	1.4
LILRA2	"CD85h, ILT1, LIR-7, LIR7"	ENSG00000239998	"Leukocyte immunoglobulin like receptor A2"	Q8N149	19	54572920-54590287	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 21.6;bone marrow: 21.7;lymphoid tissue: 39.9"	"Group enriched"	"Detected in some"	8	"Hofbauer cells: 21.6;Kupffer cells: 82.8;Macrophages: 28.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 21.6"	"Group enriched"	"Detected in many"	7	"granulocytes: 21.6;monocytes: 7.1"	"Cell line enhanced"	"Detected in some"		"NB-4: 2.5;REH: 3.0;THP-1: 6.1;U-937: 13.6"														"Secreted to blood"		130000000				"unprognostic (2.04e-1)"	"unprognostic (7.72e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.65e-2)"	"unprognostic (8.45e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.53e-5)"	"unprognostic (2.67e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.43e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.30e-4)"	"unprognostic (4.21e-2)"	"unprognostic (6.59e-2)"	2.8	1.5	1.4	4.7	1.1	21.7	0.9	0.1	2.0	0.6	0.8	3.0	0.0	0.6	0.5	1.0	0.5	2.3	1.0	3.7	1.1	1.1	1.2	3.8	6.8	14.6	2.9	0.4	1.1	0.6	0.5	0.4	1.7	1.4	0.6	0.6	1.1	0.8	0.5	0.6	0.7	0.7	1.0	3.7	39.9	0.7	0.7	2.3	0.7	0.6	0.0	0.8	0.9	1.8	0.2	2.1	21.6	7.1	0.3	0.1	3.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.1	2.5	0.0	0.1	0.0	3.0	0.1	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	6.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	13.6	0.1	2.4	4.9	1.8	0.1	7.1	0.0	0.1	0.1	0.1	2.1	0.2	0.1	0.1	21.6	0.3	6.8	0.4	0.0	3.0	1.4	1.1	0.1	2.0	1.1	1.1	2.9	0.4	1.4	2.3	3.0	4.8	0.0	0.7	0.2	0.4	0.4	2.5	2.7	3.4	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.3	0.9	5.8	0.0	21.6	0.0	0.0	0.6	82.8	0.0	0.0	28.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.4	0.1	0.3	0.0	0.0	0.4
LILRA5	"CD85, CD85f, ILT11, LILRB7, LIR9"	ENSG00000187116	"Leukocyte immunoglobulin like receptor A5"	A6NI73	19	54307070-54313139	"CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 30.2;lymphoid tissue: 67.3"	"Group enriched"	"Detected in some"	4	"Kupffer cells: 84.9;Macrophages: 23.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	8	"classical monocyte: 10.6;intermediate monocyte: 27.0;neutrophil: 14.5;non-classical monocyte: 30.2"	"Group enriched"	"Detected in many"	8	"granulocytes: 14.5;monocytes: 30.2"	"Cell line enriched"	"Detected in single"	11	"RPMI-8226: 4.1"														"Secreted to blood"		370000				"unprognostic (8.52e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.57e-2)"	"unprognostic (6.56e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.11e-1)"	"unprognostic (6.61e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (7.78e-4)"	"unprognostic (3.61e-2)"	"unprognostic (6.51e-3)"	"unprognostic (4.68e-2)"	"unprognostic (6.21e-2)"	3.4	0.6	0.3	9.9	0.3	19.1	0.7	0.1	0.3	0.4	0.6	0.1	0.0	0.8	0.4	2.0	0.6	2.0	0.9	7.0	0.2	0.2	1.7	10.8	14.4	24.2	0.5	0.0	1.5	0.4	0.1	0.4	1.3	0.6	0.6	0.7	0.6	0.5	0.3	0.9	0.1	1.8	1.3	0.7	67.3	1.0	0.6	0.0	0.1	1.4	0.4	0.4	2.7	2.8	0.0	2.6	14.5	30.2	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	10.6	0.0	0.0	27.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	14.5	0.0	30.2	2.1	0.0	5.1	0.3	0.3	0.1	0.3	0.2	0.2	0.5	0.0	0.6	0.0	0.0	13.3	1.4	0.1	0.1	0.0	0.0	0.0	4.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	10.5	0.2	6.5	0.0	0.0	0.6	84.9	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LRCH3	MGC4126	ENSG00000186001	"Leucine rich repeats and calponin homology domain containing 3"	Q96II8	3	197791226-197888436	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012380, HPA017299"	Uncertain		Enhanced	Cytosol	"Secreted - unknown location"			Cytosol		"HPA012380: AB_1853260, HPA017299: AB_2669576"	"unprognostic (1.25e-1)"	"unprognostic (4.92e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.69e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.26e-2)"	"prognostic unfavorable (2.95e-4)"	"unprognostic (3.29e-1)"	"unprognostic (4.13e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.79e-3)"	"unprognostic (3.29e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.32e-1)"	16.4	14.0	19.3	23.4	19.1	11.0	18.0	37.5	19.1	21.9	19.0	28.2	15.6	11.0	24.7	14.8	15.6	18.3	16.7	18.2	15.9	14.5	12.6	14.2	14.8	23.4	19.7	13.1	27.5	12.9	23.7	26.0	15.2	15.4	20.4	16.7	23.6	15.6	22.4	23.0	15.7	15.9	28.3	15.9	18.7	15.0	20.2	20.4	27.0	13.5	9.5	26.0	20.3	18.0	6.9	2.8	22.6	4.8	4.9	6.0	3.3	18.1	6.5	17.5	10.8	21.2	24.1	6.8	13.2	16.0	16.1	18.9	15.3	9.6	9.9	20.7	16.2	22.9	11.9	14.6	12.8	21.7	7.9	9.1	16.5	9.7	13.0	14.5	12.6	13.0	16.5	7.8	15.3	19.6	15.6	19.0	8.8	10.4	16.5	15.2	15.4	9.5	5.5	12.0	9.3	13.6	10.0	10.9	7.1	8.5	10.7	8.7	9.4	16.0	12.1	12.7	16.8	21.2	11.1	18.5	13.4	7.7	16.2	13.2	15.3	13.7	9.0	12.7	18.0	12.6	22.6	3.4	7.0	5.9	4.8	4.5	6.9	4.6	5.0	2.8	5.7	4.3	6.0	2.3	4.9	4.6	2.6	4.4	3.3	19.3	19.1	37.5	19.1	15.9	14.5	19.7	13.1	15.4	20.4	29.8	24.8	15.9	14.0	9.4	55.4	14.2	17.8	16.0	19.4	8.7	53.0	7.0	1.7	10.1	9.5	20.2	6.8	0.0	8.4	5.5	19.9	12.7	10.5	13.0	7.6	36.5	5.8	41.7	13.0	7.1	23.3	15.3	16.9	28.9	8.2	26.6	11.3	7.0	26.9	4.2	44.4	19.4	17.0	16.3	16.6	9.3	5.0	14.0	9.2	13.1
LRP8	"APOER2, HSZ75190, LRP-8, MCI1"	ENSG00000157193	"LDL receptor related protein 8"	Q14114	1	53242364-53328070	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 22.5;thyroid gland: 48.7"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 39.8;Ciliated cells: 14.7;Horizontal cells: 25.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 3.2;T-cells: 1.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073031	Enhanced				"Secreted in other tissues"		240000			"HPA073031: AB_2732217"	"unprognostic (3.83e-2)"	"unprognostic (6.06e-2)"	"unprognostic (6.36e-2)"	"prognostic unfavorable (3.46e-6)"	"unprognostic (3.46e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.03e-3)"	"prognostic unfavorable (7.02e-4)"	"unprognostic (6.65e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.11e-2)"	"unprognostic (8.88e-16)"	"unprognostic (7.73e-3)"	"unprognostic (5.47e-2)"	"unprognostic (6.98e-2)"	"unprognostic (3.00e-2)"	2.6	1.9	7.0	5.5	7.1	5.8	1.9	13.0	15.1	1.8	1.8	2.7	0.3	1.4	2.0	2.8	6.1	3.6	2.3	1.9	7.6	8.0	1.4	0.8	3.2	5.6	5.8	7.9	1.3	0.9	0.8	4.2	5.0	6.6	1.5	2.4	11.9	1.4	1.6	0.8	1.5	1.5	2.9	3.8	2.3	1.3	22.5	3.4	1.7	48.7	2.4	4.9	1.7	2.0	0.3	3.2	0.0	0.4	0.0	1.6	0.2	10.0	21.4	8.4	12.1	5.8	5.6	10.8	12.4	10.3	18.8	13.1	5.8	12.0	16.4	14.4	8.3	27.9	17.1	6.6	14.2	8.9	12.0	6.5	9.2	24.4	10.2	6.0	16.6	16.6	1.6	1.6	20.5	11.2	2.9	14.7	12.7	3.6	7.2	2.7	12.5	10.2	7.8	15.6	9.8	15.6	18.2	12.3	14.2	7.3	8.5	19.2	7.3	5.9	33.5	7.9	5.3	4.0	11.3	11.8	4.9	7.9	10.7	24.7	11.5	17.8	6.8	24.5	23.1	28.1	0.0	0.4	0.0	1.0	0.0	1.6	0.3	0.6	0.4	0.5	0.2	0.2	0.2	0.0	0.0	0.0	3.2	1.4	0.2	7.0	7.1	13.0	12.7	7.6	8.0	5.8	7.9	6.6	3.4	0.0	6.7	3.0	1.7	1.3	39.8	2.3	0.0	14.7	6.8	0.0	0.0	2.0	0.0	2.3	2.1	1.9	0.0	0.0	2.1	1.6	0.9	5.1	1.1	0.0	1.7	25.4	2.4	0.0	6.2	3.8	0.6	2.0	0.0	10.0	1.2	1.4	2.9	0.0	2.5	0.0	1.8	0.0	2.7	3.2	0.9	1.3	8.1	2.5	0.5	4.6
LY6G5C	"C6orf20, G5c, NG33"	ENSG00000204428	"Lymphocyte antigen 6 family member G5C"	Q5SRR4	6	31676684-31684040	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 4.6"	"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 17.4;Spermatocytes: 12.9;Spermatogonia: 13.4"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.1;HDLM-2: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA038690	Approved		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"			Nucleoplasm	Cytosol	"HPA038690: AB_10673286"	"unprognostic (1.51e-2)"	"unprognostic (7.26e-2)"	"unprognostic (7.19e-2)"	"prognostic favorable (1.07e-4)"	"unprognostic (4.83e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.27e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.74e-5)"	"unprognostic (5.84e-2)"	"unprognostic (3.78e-4)"	"unprognostic (1.53e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.39e-2)"	0.4	0.0	0.5	2.1	2.5	1.1	0.3	4.6	3.8	0.0	0.0			0.2	0.3	0.4	0.0	0.5	2.0	0.8	0.4	0.7	0.0	0.9	0.5	1.2	0.3		0.4	2.5	0.0	1.0	0.4		0.1	0.0		0.2	0.0	1.3	0.3	0.3	0.0	0.4	0.8	1.2	2.1			0.2		0.0	0.3	0.0	0.0	0.8	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.4	2.1	3.1	0.1	0.1	0.1	0.3	0.3	0.8	0.0	2.4	1.5	0.1	0.1	0.0	0.6	0.0	0.0	0.9	2.7	1.4	1.1	0.0	0.5	0.0	0.3	1.2	0.0	0.0	0.7	1.7	0.1	0.0	0.9	0.0	1.5	0.1	0.0	2.3	0.4	0.1	0.1	0.0	1.0	0.4	0.8	0.1	0.5	0.3	0.2	0.9	0.0	0.5	0.0	0.1	1.8	0.0	0.2	1.1	1.8	0.1	0.4	0.5	0.5	2.3	1.5	0.6	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.1	1.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.8	0.0	0.0											3.0	1.0	0.0	1.7	1.4	3.1	0.8	2.5	17.4	1.2	1.8	2.0	0.4	3.3	1.5	9.4	4.3	2.9	0.0	4.3	0.1	1.2	2.4	4.7	1.7	5.2	0.0	3.4	7.4	6.5	4.4	1.1	2.2	1.7	1.8	1.7	5.7	3.7	2.5	1.4	3.8	0.9	0.0	1.9	12.9	13.4	0.6	0.2	4.4	2.5	0.9
LY6K	"CT97, FLJ35226, HSJ001348"	ENSG00000160886	"Lymphocyte antigen 6 family member K"	Q17RY6	8	142700111-142705127	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 39.3"	"Cell type enhanced"	"Detected in many"	18	"Extravillous trophoblasts: 132.9;Glandular cells: 88.0;Spermatocytes: 359.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	10	"neutrophil: 5.3"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 5.3"	"Cell line enhanced"	"Detected in many"		"A-431: 28.8;BJ: 31.3;HeLa: 34.1;SiHa: 49.0;U-2197: 66.2"									"HPA017770, CAB075742, CAB075743"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"	"Secreted in male reproductive system"			"Plasma membrane"	Nucleoplasm	"CAB075742: AB_2665748, CAB075743: AB_2665749, HPA017770: AB_1853414"	"unprognostic (1.25e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.23e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (9.17e-5)"	"unprognostic (4.18e-2)"	"unprognostic (6.89e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.27e-5)"	"unprognostic (1.71e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.61e-2)"	6.6	0.4	1.4	0.3	1.8	0.4	7.6	0.9	3.8	1.8	1.6	0.1	9.8	0.5	0.7	0.8	10.9	0.8	1.2	1.2	1.5	1.9	2.0	0.2	0.6	1.9	1.7	0.0	0.7	0.4	0.0	0.3	6.3	1.0	1.1	0.1	0.1	1.4	7.0	6.3	4.3	0.2	0.6	1.1	0.3	0.4	39.3	0.2	0.2	1.1	4.5	6.8	1.0	3.2	0.1	0.1	5.3	0.2	0.4	0.2	0.0	28.8	0.5	0.0	1.5	0.6	1.9	0.3	31.3	3.7	9.7	5.9	0.0	0.2	0.0	2.6	3.5	3.4	2.6	0.0	1.7	8.2	0.3	0.0	0.0	34.1	0.0	0.4	0.0	0.0	2.9	5.1	7.2	9.3	0.0	0.8	0.0	0.0	0.1	18.2	0.2	0.0	0.0	1.0	0.9	0.5	0.0	0.1	0.0	1.6	0.4	0.9	0.1	49.0	0.6	9.5	1.7	0.1	0.0	1.2	0.4	2.8	66.2	0.0	0.0	0.0	0.0	0.1	0.0	3.2	0.5	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	5.3	0.4	0.1	0.1	0.0	0.0	1.4	1.8	0.9	1.7	1.5	1.9	1.7	0.0	1.0	0.2	3.0	0.3	0.0	65.7	34.6	0.3	0.1	10.2	1.4	7.9	24.4	0.0	11.3	0.0	0.5	5.0	3.3	0.0	0.0	0.0	132.9	2.9	88.0	0.0	0.0	5.3	0.0	0.0	1.3	0.0	10.1	3.7	2.8	11.8	0.0	0.0	0.5	3.9	0.0	2.8	0.0	0.7	0.0	13.3	359.5	76.0	39.3	21.2	0.0	0.0	76.5
LYZL1	"LYC2, MGC33408"	ENSG00000120563	"Lysozyme like 1"	Q6UWQ5	10	29289061-29318328	"Enzymes, Predicted membrane proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	371	"testis: 39.5"	"Group enriched"	"Detected in some"	48	"Early spermatids: 474.4;Late spermatids: 148.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.0;SuSa: 2.9"														"Secreted in male reproductive system"												"unprognostic (1.88e-1)"						"unprognostic (8.40e-3)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	474.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	148.3	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	6.5	0.0	4.2	1.9	0.0	0.0	0.0	0.0	0.0
LYZL2		ENSG00000151033	"Lysozyme like 2"	Q7Z4W2	10	30611779-30629762	"Enzymes, Predicted membrane proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	84	"testis: 34.2"	"Group enriched"	"Detected in some"	53	"Early spermatids: 605.6;Late spermatids: 151.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"SK-BR-3: 8.2"														"Secreted in male reproductive system"						"unprognostic (2.83e-4)"																	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	605.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	151.9	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	2.6	1.6	0.0	0.0	0.0	0.0	0.0
MEP1B		ENSG00000141434	"Meprin A subunit beta"	Q16820	18	32185069-32220404	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	167	"intestine: 241.5"	"Group enriched"	"Detected in some"	6	"Early spermatids: 2.1;Enterocytes: 6.3"	"Group enriched"	"Detected in some"	5	"pancreatic cancer: 3.0;stomach cancer: 0.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 10.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA029119	Enhanced				"Secreted to digestive system"		120000			"HPA029119: AB_2672913"	"unprognostic (1.33e-1)"	"unprognostic (6.72e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.50e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.74e-2)"	"unprognostic (4.30e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.31e-4)"	"unprognostic (4.74e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.39e-2)"	"unprognostic (3.75e-2)"	0.1	0.1	0.1	0.4	0.1	0.0	0.1	0.3	0.1	0.1	78.8	0.0	0.0	54.5	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	1.2	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.1	241.5	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	1.1	0.4	0.3	0.3	0.0	1.4	0.5	0.2	0.0	0.0	0.5	0.6	0.0	2.1	1.0	0.3	0.3	0.1	0.6	1.4	1.7	0.5	0.0	0.8	0.2	0.0	0.0	0.0	0.8	1.0	1.1	0.7	0.6	0.4	1.3	0.3	0.0	0.7	0.0	0.1	0.7	0.5	1.6	1.1	0.2	0.0	1.9	1.3	4.1	1.3	0.5	0.0	1.8	1.8	2.9	0.0	0.7	10.6	2.4	0.8	0.2	0.3	0.3	0.4	3.1	0.9	1.4	0.8	3.4	0.0	0.6	2.3	0.5	2.6	0.0	0.5	0.0	0.3	0.3	1.0	0.1	1.3	1.1	0.7	1.4	0.4	0.1	1.2	0.3	0.2	0.0	0.1	0.2	0.5	0.5	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	6.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0
MET	"DFNB97, HGFR, RCCP2"	ENSG00000105976	"MET proto-oncogene, receptor tyrosine kinase"	P08581	7	116672390-116798386	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Deafness, Disease mutation, FDA approved drug targets, Non-syndromic deafness, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 78.1;Club cells: 116.0;Urothelial cells: 88.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 45.3;CAPAN-2: 49.5"	"Group enriched"	"Detected in many"	5	"amygdala: 3.5;basal ganglia: 9.9;cerebral cortex: 7.6;hippocampal formation: 8.0;olfactory region: 9.1"	"Low region specificity"	"Detected in many"			"CAB005282, CAB018577, HPA055607"	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted to blood"	179000000	70000000	"Plasma membrane, Cytosol"		"CAB005282: AB_631940, CAB018577: AB_649068, HPA055607: AB_2682860"	"unprognostic (1.60e-2)"	"unprognostic (7.71e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (6.75e-4)"	"unprognostic (1.68e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (1.21e-7)"	"unprognostic (1.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.53e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.20e-1)"	16.2	1.1	1.8	4.5	2.3	4.3	11.2	0.9	15.2	9.9	6.5	2.4	2.4	4.4	7.5	5.2	5.1	4.6	12.3	5.4	5.7	1.8	20.1	30.2	15.6	1.4	3.6	2.1	2.0	9.3	0.7	8.1	24.4	2.6	8.0	6.6	34.1	12.2	8.4	12.8	7.2	8.6	4.0	2.3	5.7	10.6	2.7	2.4	0.5	21.4	7.0	2.1	10.1	15.0	0.2	0.3	1.2	0.2	0.3	0.4	0.0	45.3	26.1	0.0	0.1	2.0	2.0	1.8	25.9	10.5	14.0	11.8	5.4	49.5	2.0	43.2	16.2	37.7	12.0	4.4	24.7	28.6	0.1	5.6	0.0	27.1	4.7	0.3	0.0	0.0	2.6	9.8	9.1	30.0	25.3	9.6	0.0	0.9	0.2	25.9	1.0	0.0	0.0	3.9	7.2	26.6	0.0	22.0	0.0	24.5	5.2	3.8	0.0	10.6	3.4	10.1	4.7	0.0	0.2	17.6	20.9	7.4	11.0	20.0	0.5	4.0	0.2	22.9	0.0	2.9	1.1	0.2	0.4	0.4	0.1	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	1.2	0.3	0.1	0.3	0.1	0.0	1.8	2.3	0.9	15.2	5.7	1.8	3.6	2.1	2.6	2.4	26.8	78.1	2.4	56.1	34.7	0.9	10.0	15.3	22.7	116.0	29.6	0.0	57.9	0.0	28.0	0.0	11.7	11.2	0.0	39.8	5.0	4.0	55.8	0.0	26.0	6.1	0.0	6.9	1.3	1.0	0.0	0.6	2.0	3.3	1.8	19.7	7.4	69.4	7.0	0.0	13.5	0.3	0.0	2.3	0.0	0.6	15.6	18.2	0.0	12.7	88.5
MMP16	"C8orf57, DKFZp761D112, MT3-MMP"	ENSG00000156103	"Matrix metallopeptidase 16"	P51512	8	88032009-88328025	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.9"	"Cell type enhanced"	"Detected in some"	11	"Bipolar cells: 3.9;Early spermatids: 4.9;Fibroblasts: 9.9;Late spermatids: 4.7"	"Cancer enhanced"	"Detected in many"		"glioma: 4.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 20.4;HUVEC TERT2: 8.8;SH-SY5Y: 11.4;U-138 MG: 9.7;WM-115: 20.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023693	Uncertain		Approved	Vesicles,Cytosol	"Secreted to extracellular matrix"			Cytosol	Vesicles	"HPA023693: AB_1854025"	"unprognostic (2.58e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.09e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.39e-3)"	"unprognostic (1.45e-3)"	"unprognostic (2.46e-1)"	"unprognostic (2.61e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.09e-8)"	"unprognostic (6.90e-3)"	"unprognostic (1.16e-1)"	"unprognostic (3.62e-1)"	"unprognostic (2.19e-3)"	2.4	1.3	11.0	1.4	6.8	0.5	4.9	8.3	15.9	5.3	2.2	2.9	0.7	0.8	4.9	2.1	1.7	2.1	7.3	2.7	8.7	6.9	0.8	0.9	1.0	1.0	5.5	9.1	3.3	2.1	1.5	1.7	3.0	6.3	3.2	1.7	0.6	1.2	2.4	0.7	1.1	1.3	4.0	4.6	1.5	1.4	1.5	5.5	0.0	3.2	0.7	1.0	2.6	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.5	20.4	0.7	1.4	0.0	7.5	1.1	2.1	1.3	0.0	0.0	0.0	0.0	3.3	1.2	0.0	4.0	0.0	2.6	0.0	2.4	0.0	0.0	0.0	1.7	0.0	0.3	1.0	0.0	3.1	0.9	3.8	8.8	0.0	0.0	0.7	1.1	0.0	0.0	0.0	1.2	0.0	2.0	0.2	0.4	0.0	0.4	0.0	0.1	11.4	0.0	0.0	0.1	1.6	0.8	0.0	4.9	9.7	5.5	0.1	2.8	0.0	0.0	0.0	3.9	0.0	20.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	6.8	8.3	14.1	8.7	6.9	5.5	9.1	6.3	5.5	0.0	0.0	0.0	0.0	1.0	3.9	0.6	0.0	0.0	0.0	0.0	2.0	0.0	1.7	0.0	4.9	2.9	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.3	1.6	0.0	0.6	0.0	4.7	0.9	0.6	1.7	0.0	0.0	3.2	0.2	0.0	1.1	0.0	0.3	0.0	1.3	0.0	0.9	0.1	0.0	0.0	0.0	0.0
MMP24	MT5-MMP	ENSG00000125966	"Matrix metallopeptidase 24"	Q9Y5R2	20	35226654-35277000	"Enzymes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 38.5"	"Cell type enhanced"	"Detected in some"	10	"Alveolar cells type 1: 14.9;Cholangiocytes: 12.7;Ductal cells: 7.5;Horizontal cells: 14.3;Proximal tubular cells: 7.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 38.5"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 20.1;CACO-2: 30.6;EFO-21: 9.0;RPTEC TERT1: 13.8;U-2 OS: 10.4"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 91.3"	"HPA049280, HPA078816"	Approved		Approved	"Nucleoli,Plasma membrane"	"Secreted to extracellular matrix"			"Nucleoli, Plasma membrane"		"HPA049280: , HPA078816: "	"unprognostic (1.52e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.51e-4)"	"unprognostic (2.47e-2)"	"unprognostic (7.61e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.32e-2)"	"unprognostic (8.82e-2)"	"unprognostic (9.20e-3)"	"unprognostic (7.12e-2)"	"prognostic favorable (8.17e-11)"	"unprognostic (3.32e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.69e-2)"	"unprognostic (9.90e-4)"	1.6	1.3	4.0	0.4	7.8	0.6	0.4	38.5	8.9	0.7	0.3	1.3	0.2	2.8	1.6	0.9	0.2	2.8	0.6	1.0	2.7	3.2	8.6	0.9	6.1	0.3	1.8	1.5	0.9	8.0	0.0	3.8	0.6	1.7	2.2	0.1	0.5	0.4	6.0	0.2	1.5	1.7	2.5	0.9	0.6	0.7	0.4	1.4	0.2	0.8	0.2	0.2	0.5	0.2	0.8	0.4	2.2	0.8	0.6	1.2	0.3	0.3	20.1	0.0	0.1	0.1	0.0	0.6	1.1	1.3	2.1	1.1	30.6	5.4	0.0	9.0	1.4	0.7	0.3	4.7	0.0	0.9	0.1	0.2	1.1	0.6	0.3	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.6	0.0	0.1	0.0	0.3	0.2	0.2	0.1	0.1	7.7	0.0	1.4	0.0	0.1	0.0	13.8	0.1	8.0	5.5	1.4	0.5	0.2	1.8	0.3	0.1	0.3	4.3	10.4	1.0	0.4	0.1	0.1	0.0	0.9	0.1	0.6	1.0	0.6	0.1	1.0	0.7	1.2	0.6	0.7	0.8	0.4	0.8	0.6	0.6	2.2	0.6	0.8	0.2	0.0	0.3	4.0	7.8	38.5	5.3	2.7	3.2	1.8	1.5	1.7	1.4	14.9	1.0	0.0	0.1	0.1	3.6	0.6	12.7	0.0	2.3	1.8	0.0	0.0	5.0	7.5	0.6	0.7	0.3	0.0	0.8	0.1	0.2	0.4	0.0	0.2	0.0	14.3	0.0	0.0	0.3	0.0	0.3	0.0	1.7	0.0	0.0	0.2	2.1	0.0	0.0	7.3	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0
MUC1	"ADMCKD, ADMCKD1, CD227, MCD, MCKD, MCKD1, PEM, PUM"	ENSG00000185499	"Mucin 1, cell surface associated"	P15941	1	155185824-155192916	"Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"			"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 168.1;kidney: 158.5;lung: 143.5"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 2: 1308.2;Collecting duct cells: 465.9;Exocrine glandular cells: 994.6;Pancreatic endocrine cells: 807.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.0"	"Group enriched"	"Detected in many"	10	"granulocytes: 1.3;T-cells: 4.0"	"Group enriched"	"Detected in many"	6	"CAPAN-2: 139.4;OE19: 65.3;RPTEC TERT1: 107.0;T-47d: 47.0"									"CAB000036, CAB001986, HPA004179, HPA007235, HPA008855"	Enhanced		Supported	"Plasma membrane"	"Secreted in other tissues"		4900000	"Plasma membrane"		"CAB000036: AB_2148557, CAB001986: , HPA004179: AB_1846282, HPA007235: AB_1846281, HPA008855: AB_1846283"	"unprognostic (4.74e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.19e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.61e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.23e-1)"	"prognostic unfavorable (4.60e-4)"	"unprognostic (4.75e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.21e-1)"	1.5	0.7	0.8	12.6	1.2	0.9	12.6	0.4	0.7	31.6	15.9	1.2	2.4	2.9	10.5	9.8	51.8	18.7	168.1	0.8	0.5	0.3	158.5	2.0	143.5	0.3	0.5	0.3	14.9	74.2	0.0	4.7	15.5	2.1	6.1	16.1	0.8	17.0	5.9	0.8	1.8	3.6	2.8	0.7	0.6	105.0	4.3	0.5	0.7	15.7	10.5	47.8	12.3	5.2	0.0	0.2	1.3	0.1	0.0	4.0	0.2	1.8	0.9	0.6	0.5	0.4	0.5	0.2	0.6	1.4	0.7	1.9	0.0	139.4	0.0	10.1	1.1	0.3	2.8	0.1	0.0	0.2	1.2	0.1	0.2	11.8	0.0	0.3	0.0	4.4	1.2	0.2	0.3	0.2	1.5	0.2	0.2	1.0	1.9	0.5	14.2	0.1	0.1	0.4	65.3	0.2	0.2	0.0	3.4	107.0	0.1	0.6	0.2	3.3	5.9	0.1	0.5	47.0	0.6	0.2	0.4	0.8	1.3	0.1	2.1	1.1	0.0	0.7	0.1	0.1	1.3	0.1	0.0	0.0	0.0	0.8	0.0	2.3	0.4	0.2	0.0	0.3	0.7	0.0	0.0	0.0	0.0	4.0	0.2	0.8	1.2	0.4	0.7	0.5	0.3	0.5	0.3	2.1	0.5	402.0	1308.2	0.9	16.1	0.6	1.0	0.4	384.7	92.3	252.5	465.9	3.9	0.1	29.9	144.7	27.3	3.5	49.2	0.0	994.6	1.2	3.1	11.6	45.2	0.5	0.2	1.6	29.4	1.3	3.4	68.9	2.3	2.6	5.0	42.3	249.7	1.1	807.2	66.2	1.4	0.9	0.2	0.0	1.9	6.2	0.8	1.0	0.2	0.0	132.5	164.3
MUC13	DRCC1	ENSG00000173702	"Mucin 13, cell surface associated"	Q9H3R2	3	124905442-124953819	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"intestine: 334.4"	"Cell type enhanced"	"Detected in some"	17	"Enterocytes: 474.6;Intestinal endocrine cells: 147.6;Mucus-secreting cells: 321.7;Paneth cells: 299.5"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 198.4;stomach cancer: 152.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	16	"OE19: 70.4"									HPA045163	Enhanced				"Secreted to digestive system"					"HPA045163: AB_10960396"	"unprognostic (8.42e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.55e-3)"	"unprognostic (2.93e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.94e-1)"	"unprognostic (5.10e-2)"	"unprognostic (2.02e-1)"	"unprognostic (9.64e-2)"	"prognostic unfavorable (9.73e-5)"	"unprognostic (2.05e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.42e-1)"	0.5	0.6	0.5	16.4	0.5	0.0	0.5	0.5	0.5	0.5	83.1	0.0	0.0	79.9	0.5	0.3	0.5	0.5	16.7	0.5	0.5	0.5	3.3	8.7	0.5	0.0	0.5	0.0	0.5	1.8	0.0	0.5	0.1	0.1	0.5	40.6	0.1	0.5	0.0	0.5	0.5	334.4	1.0	0.5	0.5	4.1	0.5	0.0	0.1	0.5	0.0	0.1	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	2.0	4.4	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.3	0.0	70.4	0.3	0.0	0.0	0.8	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.0	0.1	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.3	15.3	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.6	0.1	474.6	0.0	28.4	0.0	0.0	2.1	9.2	0.0	0.0	0.0	147.6	0.0	0.3	2.7	0.0	0.0	0.0	0.0	321.7	0.0	14.3	299.5	0.7	4.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	111.9	0.1
MUC16	"CA125, FLJ14303"	ENSG00000181143	"Mucin 16, cell surface associated"	Q8WXI7	19	8848844-8981342	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adipose tissue: 6.6;cervix, uterine: 19.3;fallopian tube: 6.7;salivary gland: 6.3"	"Cell type enhanced"	"Detected in some"	27	"Ciliated cells: 49.5;Club cells: 10.3;Early spermatids: 11.7;Late spermatids: 12.8"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 21.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 15.9;CAPAN-2: 5.6;HaCaT: 5.4;HeLa: 27.6;SK-BR-3: 3.5"									"CAB055172, HPA065600"	Enhanced				"Secreted in other tissues"					"CAB055172: AB_2148831, HPA065600: AB_2732736"	"unprognostic (8.66e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.37e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.01e-3)"	"unprognostic (3.83e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.89e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.60e-8)"	"unprognostic (3.50e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.68e-3)"	6.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	19.3	0.0			0.0	2.4	0.0	0.2	6.7	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0		0.0	0.0	0.0	0.0	0.3		0.0	0.0		6.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.4	2.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	27.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.6	0.0	0.0	0.2	0.0	2.2	0.0	49.5	10.3	0.0	0.0	1.4	0.0	0.2	11.7	0.0	0.0	0.0	0.0	0.7	0.3	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	2.7	0.0	0.0	0.6
MUC4		ENSG00000145113	"Mucin 4, cell surface associated"	Q99102	3	195746765-195812277	"Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 21.5;lymphoid tissue: 57.2"	"Cell type enhanced"	"Detected in many"	16	"Ciliated cells: 85.6;Club cells: 86.4;Mucus-secreting cells: 154.7;Undifferentiated cells: 114.6;Urothelial cells: 276.8"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 16.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"BEWO: 1.6"									"HPA005895, CAB013536"	Approved				"Secreted in other tissues"					"CAB013536: , HPA005895: AB_1079427"	"unprognostic (4.16e-3)"	"unprognostic (1.00e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.16e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.22e-3)"	"unprognostic (6.68e-3)"	"unprognostic (5.30e-2)"	"unprognostic (2.43e-3)"	"unprognostic (3.19e-1)"	"unprognostic (6.78e-2)"	"unprognostic (3.46e-3)"	"unprognostic (9.97e-3)"	0.4	0.4	0.0	28.7	0.0	0.4	0.4	0.0	0.4	13.4	21.5	0.0	0.0	0.4	1.4	0.4	13.0	1.7	0.4	0.4	0.0	0.0	0.4	0.4	10.3	0.4	0.0	0.0	0.5	0.4	0.4	0.0	6.2	0.2	10.0	1.9	0.0	5.5	0.4	0.4	0.4	1.7	0.4	0.0	0.4	2.4	0.5	0.0	0.5	0.4	6.1	57.2	6.5	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	6.0	14.1	0.0	11.3	0.0	0.0	2.0	0.0	85.6	86.4	0.0	0.0	0.1	0.0	0.2	2.4	0.0	53.1	0.0	4.7	4.0	0.0	10.6	2.3	0.0	0.1	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	154.7	0.0	22.6	40.3	0.4	0.0	0.0	0.0	0.0	0.7	1.3	0.0	0.1	0.0	114.6	276.8
NECTIN1	"CD111, CLPED1, ED4, HIgR, HVEC, OFC7, PRR, PRR1, PVRL1, PVRR1, SK-12"	ENSG00000110400	"Nectin cell adhesion molecule 1"	Q15223	11	119623408-119729084	"CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 55.3;skin 1: 73.5"	"Cell type enhanced"	"Detected in some"	10	"Club cells: 7.9;Ductal cells: 6.5;Exocrine glandular cells: 10.7;Pancreatic endocrine cells: 12.5;Syncytiotrophoblasts: 7.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 59.2;hTCEpi: 36.9;RT4: 40.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016135, HPA026846"	Approved				"Secreted in other tissues"		97000000			"CAB016135: AB_626865, HPA026846: AB_1846226"	"unprognostic (1.62e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.76e-2)"	"unprognostic (3.42e-1)"	"unprognostic (3.58e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.59e-3)"	"unprognostic (2.13e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.62e-2)"	3.1	3.0	7.7	3.0	11.1	11.9	5.3	8.4	20.8	6.6	7.3	27.3	2.4	9.6	2.3	2.0	55.3	2.9	2.5	3.0	16.1	8.2	3.0	2.4	2.5	1.7	12.7	10.6	1.8	10.8	2.4	4.1	8.2	10.1	5.9	7.8	6.3	8.7	4.4	1.6	73.5	6.9	3.1	14.3	2.2	3.2	1.3	12.4	2.5	1.8	25.3	20.8	17.3	14.8	0.1	4.8	1.0	1.5	0.1	0.1	0.2	4.1	3.4	3.3	4.7	1.7	0.5	23.2	1.6	1.5	1.4	1.0	7.3	14.2	5.5	6.9	1.9	2.8	59.2	8.4	30.2	0.6	12.9	1.3	0.7	1.1	3.3	0.7	3.7	9.3	0.5	36.9	4.4	16.5	0.5	4.2	1.6	0.1	29.4	1.8	10.8	0.0	2.2	10.8	14.0	4.8	0.3	19.8	6.6	1.3	40.1	8.0	18.0	5.6	14.9	0.5	5.2	13.5	0.5	2.3	1.2	4.7	10.2	1.5	5.4	6.8	0.0	0.4	3.0	2.8	0.0	0.3	0.2	0.1	0.5	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	1.0	0.1	1.5	4.8	0.0	0.2	7.7	11.1	8.4	20.8	16.1	8.2	12.7	10.6	10.1	12.4	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	2.7	7.9	1.8	0.0	3.5	0.0	6.5	0.0	0.0	0.0	0.0	10.7	0.9	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.0	12.5	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0
NECTIN4	"LNIR, nectin-4, PRR4, PVRL4"	ENSG00000143217	"Nectin cell adhesion molecule 4"	Q96NY8	1	161070995-161089599	"Disease related genes, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.1;placenta: 46.6;skin 1: 39.3"	"Cell type enriched"	"Detected in some"	7	"Syncytiotrophoblasts: 321.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"basophil: 1.5;eosinophil: 1.2;neutrophil: 3.6"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 3.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 28.2;HaCaT: 18.2;MCF7: 11.4;OE19: 11.8;SK-BR-3: 23.7;T-47d: 15.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA010775	Enhanced		Supported	"Plasma membrane"	"Secreted in other tissues"		11000	"Plasma membrane"		"HPA010775: AB_1079720"	"unprognostic (1.09e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.11e-2)"	"unprognostic (5.69e-3)"	"unprognostic (2.09e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.24e-8)"	"unprognostic (2.98e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.68e-2)"	"unprognostic (4.97e-2)"	0.2	0.1	0.1	0.8	0.1	0.1	7.7	0.1	0.1	9.8	0.6	0.1	5.4	0.2	1.5	3.7	40.1	1.4	5.6	0.1	0.1	0.1	1.3	0.2	3.1	0.0	0.1	0.0	0.5	4.4	0.0	0.3	46.6	0.1	7.8	0.7	0.1	13.5	5.5	0.1	39.3	0.4	2.0	0.1	0.1	4.5	0.2	0.0	0.5	0.1	22.7	23.1	12.6	18.5	0.2	0.3	3.6	0.1	0.1	0.2	0.0	5.2	0.1	0.0	0.0	0.0	0.0	28.2	0.0	0.0	0.0	0.1	0.0	7.1	0.0	0.1	0.0	0.0	18.2	0.0	0.6	0.1	0.0	0.2	0.0	0.4	5.3	0.0	0.0	0.3	0.0	7.2	1.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.1	0.1	23.7	0.0	3.3	15.3	0.0	0.0	0.0	1.2	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	1.5	0.1	1.2	0.2	0.0	0.1	0.2	0.2	0.0	0.3	0.2	0.1	0.1	3.6	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	6.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	18.7	14.8	15.7	0.0	24.1	0.0	34.7	0.0	0.0	0.0	0.0	26.2	43.5	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.8	0.0	0.0	47.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	321.3	0.0	0.0	0.0
NELL2	NRP2	ENSG00000184613	"Neural EGFL like 2"	Q99435	12	44508275-44921848	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 36.8;brain: 73.3;fallopian tube: 35.1"	"Group enriched"	"Detected in many"	6	"Bipolar cells: 38.4;Ciliated cells: 40.2;Club cells: 11.4;Cone photoreceptor cells: 31.4;Rod photoreceptor cells: 43.8"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 33.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 24.5;naive CD8 T-cell: 36.8"	"Lineage enriched"	"Detected in many"	11	"T-cells: 36.8"	"Cell line enhanced"	"Detected in some"		"AF22: 41.8;HEK 293: 10.9;NTERA-2: 16.4;SCLC-21H: 30.4;U-266/70: 11.1;U-266/84: 11.1;U-698: 15.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035714, HPA035715"	Uncertain		Approved	Vesicles	"Secreted to blood"		4700000	Vesicles		"HPA035714: AB_2674746, HPA035715: AB_10669602"	"unprognostic (4.25e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.10e-2)"	"unprognostic (3.01e-2)"	"unprognostic (7.18e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.80e-1)"	"prognostic favorable (5.56e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.71e-5)"	"unprognostic (8.45e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.60e-3)"	"unprognostic (3.75e-2)"	2.0	10.5	22.4	6.1	24.8	4.2	1.6	15.7	73.3	14.9	2.9	3.6	0.0	15.3	1.9	0.8	1.3	35.1	1.7	0.8	40.2	20.4	1.2	1.1	3.4	11.2	6.6	27.0	1.0	1.1	0.6	18.4	0.8	7.5	18.8	1.8	9.3	1.5	1.8	0.7	5.0	8.6	2.2	2.6	3.8	2.1	2.2	2.4	0.4	4.4	0.0	9.1	2.3	2.0	0.0	0.0	0.1	0.0	3.3	36.8	8.5	0.1	0.0	41.8	1.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	3.2	5.0	0.0	0.0	0.1	9.9	0.0	0.0	0.0	10.9	0.1	3.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.1	0.0	0.1	16.4	0.0	5.4	0.0	5.0	0.0	0.0	0.0	30.4	0.7	0.0	0.1	0.0	0.5	0.0	0.2	0.0	0.2	1.5	0.0	0.7	11.1	11.1	15.1	0.1	0.1	0.2	0.0	0.0	0.0	1.6	0.0	8.5	0.0	10.3	18.1	0.0	0.0	24.5	36.8	0.1	3.3	0.0	0.0	0.1	8.5	22.4	24.8	15.7	50.4	40.2	20.4	6.6	27.0	7.5	2.4	0.0	2.2	0.0	0.0	1.0	38.4	0.4	0.0	40.2	11.4	0.0	31.4	0.1	0.0	0.0	0.2	0.5	5.4	0.0	0.2	0.2	1.4	0.2	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	5.2	0.3	0.0	0.4	0.1	43.8	0.0	1.4	1.5	3.4	1.0	0.1	5.3	0.6	0.0
NRG1	"GGF, HGL, HRG, NDF, NRG1-IT2"	ENSG00000157168	"Neuregulin 1"	Q02297	8	31639386-32767959	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.3"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 35.7;Basal glandular cells: 36.6;Early spermatids: 31.2;Horizontal cells: 27.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 4.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"classical monocyte: 22.8"	"Lineage enriched"	"Detected in many"	5	"monocytes: 22.8"	"Cell line enhanced"	"Detected in many"		"A549: 38.0;BJ: 26.0;fHDF/TERT166: 29.1;GAMG: 40.0;HBF TERT88: 25.6;hTEC/SVTERT24-B: 27.3;hTERT-HME1: 28.6"	"Low region specificity"	"Detected in all"							HPA010964	Uncertain		Approved	Nucleoplasm	"Secreted to blood"			Nucleoplasm		"HPA010964: AB_1854641"	"unprognostic (5.76e-3)"	"unprognostic (8.60e-2)"	"unprognostic (1.96e-4)"	"unprognostic (2.67e-1)"	"unprognostic (1.94e-4)"	"unprognostic (4.99e-2)"	"unprognostic (6.69e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.98e-1)"	"unprognostic (5.65e-2)"	"unprognostic (7.99e-2)"	"unprognostic (8.49e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.88e-1)"	"unprognostic (5.40e-2)"	"unprognostic (7.83e-2)"	0.7	2.1	4.6	5.0	3.3	1.2	8.8	14.8	8.1	10.6	4.2	0.3	2.1	3.5	2.5	1.1	3.7	2.0	4.8	2.2	4.7	15.4	11.5	23.6	5.7	0.6	6.2	3.5	2.9	0.9	0.8	23.9	0.2	28.3	3.2	5.4	3.6	2.5	1.6	0.2	4.3	5.7	1.1	2.5	1.7	3.1	6.4	0.8	0.2	13.8	7.2	2.2	7.2	3.5	0.0	4.9	0.8	22.8	0.0	0.0	4.6	0.1	38.0	0.6	0.0	0.3	0.7	0.0	26.0	18.4	21.6	16.6	0.0	0.8	0.0	4.8	29.1	40.0	20.5	0.1	10.4	25.6	0.0	0.2	0.5	0.5	0.5	0.1	0.0	0.0	0.3	1.1	27.3	28.6	1.9	12.4	0.0	0.0	0.1	7.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	16.0	1.1	1.1	1.3	1.9	0.0	0.0	2.1	0.0	0.0	9.0	15.0	4.6	23.9	14.5	0.0	0.0	0.2	7.7	0.0	1.8	0.0	22.8	0.2	0.0	2.1	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	4.6	4.6	3.3	14.8	8.1	4.7	15.4	6.2	3.5	28.3	0.8	35.7	2.4	0.5	36.6	23.1	11.2	1.7	10.2	4.0	13.6	3.5	7.9	0.0	8.3	1.8	31.2	1.4	0.0	0.0	0.2	0.0	0.7	14.3	1.1	6.6	0.5	27.0	0.0	6.7	16.0	14.6	0.3	1.8	1.7	0.0	0.0	4.8	0.8	0.0	0.4	14.6	3.0	0.0	0.9	1.4	1.0	5.4	0.0	0.0	0.0	5.6
NRG2	"Don-1, HRG2, NTAK"	ENSG00000158458	"Neuregulin 2"	O14511	5	139846779-140043299	"Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.3"	"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 9.0;Bipolar cells: 15.1;Leydig cells: 8.9;Muller glia cells: 9.7;Peritubular cells: 9.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.1"	"Lineage enriched"	"Detected in single"	4	"T-cells: 2.1"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 8.4;Karpas-707: 5.6;PC-3: 14.8;RPTEC TERT1: 7.5;SCLC-21H: 5.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038935, HPA047973"	Approved		Supported	Nucleoplasm,Nucleoli	"Secreted to blood"			Nucleoplasm	Nucleoli	"HPA038935: AB_10672833, HPA047973: AB_2680226"	"unprognostic (8.66e-4)"	"unprognostic (2.17e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.04e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.96e-2)"	"unprognostic (8.66e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.26e-3)"	"unprognostic (4.00e-2)"	"unprognostic (7.79e-3)"	"unprognostic (3.64e-3)"	"unprognostic (9.54e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.07e-2)"	4.5	4.5	4.0	1.4	7.0	0.6	4.4	27.3	5.1	13.1	2.3	3.8	2.6	1.0	3.0	2.9	3.7	7.6	7.6	1.5	4.2	3.5	1.3	0.6	1.2	2.1	5.2	3.4	15.9	3.2	15.8	7.7	1.1	4.1	4.5	0.9	2.9	13.6	4.7	6.0	5.0	1.0	5.1	3.6	3.3	1.1	2.7	4.9	0.0	0.8	1.0	1.5	4.8	3.7	0.4	0.1	0.0	0.1	0.0	2.1	0.1	0.0	2.0	0.2	8.4	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.1	0.0	0.4	0.0	4.0	2.4	0.4	0.2	0.1	4.8	3.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.5	0.9	0.2	0.2	0.0	5.6	0.0	0.4	0.0	0.0	0.1	0.0	14.8	0.1	0.0	0.0	7.5	1.8	5.6	3.4	0.0	3.2	3.3	0.0	0.0	0.0	0.2	2.6	0.4	0.0	1.6	1.1	0.0	0.0	3.7	0.0	0.7	0.0	0.0	0.0	2.1	0.1	0.5	0.1	0.2	0.4	0.0	0.4	0.4	1.2	0.0	0.0	0.0	0.1	0.0	0.1	4.0	7.0	27.3	5.1	4.2	3.5	5.2	3.4	4.1	4.9	0.0	0.0	0.0	9.0	2.5	15.1	1.4	0.0	0.0	0.0	1.8	0.0	0.1	1.7	0.3	0.5	0.9	0.0	0.0	1.9	0.0	1.8	1.3	0.0	0.0	0.1	6.4	0.0	0.0	0.0	0.6	8.9	0.0	3.3	0.0	0.0	9.7	0.8	0.0	9.6	1.5	0.7	6.5	1.1	3.0	4.3	0.3	0.0	0.8	0.0	5.9
NRG3		ENSG00000185737	"Neuregulin 3"	P56975	10	81875314-82987179	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 30.6"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 13.7;Cholangiocytes: 5.1;Early spermatids: 17.6;Ito cells: 7.4;Late spermatids: 7.9;Muller glia cells: 5.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.5;HEK 293: 3.4;HUVEC TERT2: 1.7;SK-MEL-30: 7.3;U-2 OS: 6.4"	"Low region specificity"	"Detected in all"							HPA075789			Uncertain	Vesicles	"Secreted in brain"			Vesicles		"HPA075789: "	"unprognostic (6.15e-3)"		"unprognostic (2.43e-2)"	"unprognostic (1.65e-5)"	"unprognostic (1.89e-1)"	"unprognostic (7.03e-4)"	"unprognostic (1.85e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.05e-2)"	"unprognostic (9.33e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.75e-2)"	"unprognostic (3.31e-4)"	"unprognostic (1.04e-1)"	"unprognostic (7.68e-3)"	"unprognostic (7.27e-4)"	0.9	1.5	15.6	1.2	8.2	0.6	2.8	1.9	30.6	0.8	0.9	4.8	0.0	0.8	0.7	0.7	0.9	8.0	5.3	0.9	14.5	6.2	1.2	1.5	1.6	0.8	4.9	8.0	0.7	0.9	0.7	1.6	1.2	6.5	0.9	0.9	3.1	5.0	1.1	0.7	0.8	0.9	0.9	5.6	0.8	0.8	3.3	6.0	0.0	0.9	0.0	0.8	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.0	7.3	0.5	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.6	8.2	1.9	12.8	14.5	6.2	4.9	8.0	6.5	6.0	0.0	0.0	0.0	0.0	0.0	13.7	0.8	5.1	0.0	0.0	0.0	2.0	0.0	0.0	0.9	17.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	7.9	0.6	0.0	0.0	0.0	0.0	5.4	0.1	0.0	0.7	0.0	1.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1
NRG4	HRG4	ENSG00000169752	"Neuregulin 4"	Q8WWG1	15	75935969-76059795	"Predicted membrane proteins, Predicted secreted proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"pancreas: 36.6"	"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 14.7;Cone photoreceptor cells: 13.7;Exocrine glandular cells: 20.5;Pancreatic endocrine cells: 14.0;Rod photoreceptor cells: 22.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 8.7;HL-60: 3.2;THP-1: 2.9;U-698: 2.9;U-937: 5.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	4	"cerebellum: 282.0"	HPA010957	Uncertain				"Secreted to digestive system"					"HPA010957: AB_1079504"	"unprognostic (1.25e-1)"	"unprognostic (1.54e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.67e-2)"	"unprognostic (5.66e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.82e-5)"	"unprognostic (1.91e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.90e-5)"	"unprognostic (8.28e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.06e-1)"	0.4	0.5	3.5	0.2	1.3	0.8	0.3	6.9	2.7	0.3	0.4	0.5	0.0	0.2	0.3	2.1	0.8	2.2	0.2	0.4	1.4	1.0	0.5	1.1	0.7	0.2	0.5	1.8	0.3	36.6	0.2	2.5	0.8	2.1	1.2	0.3	0.0	1.5	0.3	4.8	0.6	0.3	0.2	0.5	0.4	3.0	6.3	0.3	0.0	0.4	0.5	0.2	0.5	0.3	0.6	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.1	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	1.8	0.8	0.0	0.0	1.3	0.4	0.1	0.0	0.1	1.5	0.1	8.7	0.4	0.0	3.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.5	0.1	2.9	0.3	0.0	0.0	0.0	0.1	0.0	0.0	2.9	0.0	5.3	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	1.3	6.9	2.7	1.4	1.0	0.5	1.8	2.1	0.3	0.0	0.0	2.2	0.9	6.6	2.2	0.2	0.0	14.7	3.4	1.8	13.7	2.0	1.7	0.2	12.2	0.3	0.3	0.0	20.5	1.9	0.4	1.7	2.3	2.9	0.3	6.4	1.2	1.3	0.0	7.0	0.6	0.3	1.7	0.0	0.0	1.5	14.0	2.9	0.0	0.0	22.2	0.0	0.1	6.1	0.7	1.1	0.7	0.0	0.3	3.8
NRP1	"CD304, NRP, VEGF165R"	ENSG00000099250	"Neuropilin 1"	O14786	10	33177492-33336262	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation, Neurogenesis"	"Developmental protein, Heparin-binding, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Ito cells: 238.8;Sertoli cells: 278.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	14	"plasmacytoid DC: 24.0"	"Lineage enriched"	"Detected in many"	14	"dendritic cells: 24.0"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 69.4;hTERT-RPE1: 59.9;TIME: 57.7;U-87 MG: 69.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004511, HPA030278"	Approved				"Secreted in other tissues"		720000000			"CAB004511: AB_2282634, HPA030278: AB_10601976"	"unprognostic (3.19e-1)"	"prognostic unfavorable (7.10e-5)"	"unprognostic (1.50e-2)"	"unprognostic (3.80e-2)"	"prognostic unfavorable (5.79e-4)"	"unprognostic (6.17e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.66e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.78e-2)"	"prognostic unfavorable (3.87e-4)"	"prognostic unfavorable (1.22e-5)"	"unprognostic (3.83e-2)"	"unprognostic (5.48e-2)"	"unprognostic (7.79e-2)"	69.9	15.0	4.9	13.6	4.9	0.7	53.8	1.3	5.6	25.1	17.6	2.4	16.4	6.7	29.8	21.9	14.7	17.0	23.3	50.5	17.2	5.9	47.1	27.4	47.1	30.1	3.5	3.2	27.1	14.1	11.7	6.4	44.3	3.6	25.2	7.8	24.3	11.8	31.6	22.3	9.1	14.6	19.1	5.5	38.7	9.8	15.6	2.8	5.9	30.4	24.6	7.9	22.3	23.8	0.4	24.0	0.3	1.7	0.6	0.4	0.4	8.6	33.8	1.7	0.1	33.0	37.0	0.2	35.0	34.1	17.6	19.0	4.2	20.8	0.1	4.2	69.4	18.7	2.4	2.1	10.2	14.4	0.1	1.7	0.0	3.9	7.2	11.7	3.1	0.2	44.2	1.7	41.9	19.0	59.9	47.9	0.2	0.1	0.2	34.4	14.6	0.2	0.5	0.8	1.8	32.1	1.4	3.8	0.1	16.6	0.1	0.7	0.4	3.5	2.7	0.1	1.5	0.1	0.4	57.7	25.2	5.9	30.3	23.5	0.1	0.1	0.1	69.1	4.0	22.7	0.2	1.7	0.3	0.3	0.3	0.4	0.4	0.3	0.3	1.4	0.3	0.4	0.3	0.3	0.6	0.1	24.0	0.3	0.4	4.9	4.9	1.3	5.6	17.2	5.9	3.5	3.2	3.6	2.8	0.0	22.7	8.1	9.5	14.0	8.7	57.4	35.7	8.1	13.6	17.4	3.9	48.5	1.7	46.0	0.7	84.2	1.0	0.0	16.8	10.8	38.6	3.8	7.0	11.4	109.4	0.0	4.1	238.8	53.2	2.6	39.1	27.1	11.8	9.0	0.3	3.5	10.9	0.0	19.8	29.4	0.6	278.1	64.5	0.2	0.7	9.3	56.2	2.5	0.1	2.8
NRP2	VEGF165R2	ENSG00000118257	"Neuropilin 2"	O60462	2	205681990-205798133	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Differentiation, Host-virus interaction, Neurogenesis"	"Developmental protein, Heparin-binding, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Ito cells: 162.7;monocytes: 389.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.8;naive B-cell: 1.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 34.5;HUVEC TERT2: 30.2;TIME: 28.8;U-251 MG: 58.9;U-87 MG: 27.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA039980, HPA054974"	Enhanced		Approved	"Nucleoplasm,Vesicles,Plasma membrane"	"Secreted in other tissues"		15000000	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA039980: AB_10795517, HPA054974: AB_2682657"	"unprognostic (4.28e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.12e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.57e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.15e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.56e-3)"	"unprognostic (4.17e-1)"	"prognostic unfavorable (7.68e-7)"	"unprognostic (2.22e-3)"	"unprognostic (5.45e-2)"	"unprognostic (6.41e-3)"	"prognostic unfavorable (7.80e-5)"	24.3	14.5	8.7	11.4	7.4	2.6	7.8	1.2	7.0	34.4	35.4	3.9	8.4	3.5	33.7	4.6	24.8	13.1	25.8	4.4	11.5	8.3	3.4	6.2	15.8	4.9	8.9	3.9	33.0	1.4	2.5	6.6	29.9	9.0	18.6	7.0	27.7	2.6	21.0	2.5	3.3	8.2	44.7	8.6	4.7	17.1	3.4	5.2	2.6	7.3	6.0	3.0	39.3	24.6	1.4	0.5	0.0	1.8	0.0	0.0	0.5	0.7	14.2	9.1	0.0	8.2	2.6	2.7	2.2	4.3	2.8	2.7	13.4	34.5	0.0	3.4	7.1	5.6	5.5	0.4	4.4	4.7	0.0	1.9	0.1	0.6	0.1	22.4	0.0	0.5	19.7	3.4	3.9	3.5	17.4	30.2	0.0	0.0	0.0	1.9	0.0	0.0	0.0	11.4	0.0	2.5	0.0	0.5	3.1	5.7	0.0	8.2	0.3	0.3	0.0	20.3	24.3	0.0	0.1	28.8	12.5	0.1	3.2	58.9	0.0	0.0	0.8	27.8	0.0	26.1	0.0	1.8	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	8.7	7.4	1.2	3.8	11.5	8.3	8.9	3.9	9.0	5.2	83.4	48.1	3.9	13.9	17.2	25.2	4.8	7.6	64.3	72.8	1.8	0.0	68.2	0.0	2.1	5.6	84.5	0.0	0.0	3.3	4.0	46.3	4.7	3.5	0.9	113.5	0.0	1.2	162.7	27.7	10.2	2.6	22.5	18.6	389.5	0.1	4.3	31.6	0.0	4.6	0.6	2.4	0.0	10.3	1.7	0.7	11.0	21.5	0.7	0.0	44.5
PAM	"PAL, PHM"	ENSG00000145730	"Peptidylglycine alpha-amidating monooxygenase"	P19021	5	102753981-103031105	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Lyase, Monooxygenase, Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 304.2"	"Group enriched"	"Detected in many"	6	"Cardiomyocytes: 852.6;Intestinal endocrine cells: 308.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 75.3;fHDF/TERT166: 96.5;hTERT-RPE1: 78.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026119, HPA042260"	Enhanced		Approved	"Golgi apparatus,Cytosol"	"Secreted in other tissues"		59000000	"Golgi apparatus, Cytosol"		"CAB026119: , HPA042260: AB_2677919"	"unprognostic (4.30e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (1.63e-4)"	"unprognostic (4.23e-2)"	"unprognostic (6.30e-2)"	"prognostic unfavorable (6.20e-4)"	"unprognostic (7.58e-2)"	"unprognostic (6.62e-2)"	"unprognostic (2.71e-1)"	"unprognostic (9.91e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.79e-2)"	"unprognostic (5.51e-2)"	"unprognostic (8.80e-3)"	16.5	24.5	8.2	6.5	16.4	0.8	17.3	6.6	16.5	74.9	14.0	5.4	9.5	5.8	21.3	83.8	11.7	10.6	11.5	304.2	8.8	23.5	13.7	2.1	13.2	5.8	10.0	7.6	17.0	16.4	49.5	18.3	26.3	15.5	13.4	9.5	8.7	53.8	29.4	22.0	8.5	8.5	18.5	4.8	8.9	17.2	7.2	4.6	1.8	21.7	13.2	7.3	15.8	15.3	0.5	2.0	10.1	5.3	16.2	14.1	6.3	14.7	2.2	27.1	12.0	75.3	45.1	10.8	41.8	62.6	12.4	37.8	7.1	19.5	0.0	9.0	96.5	17.5	5.0	1.5	18.4	34.3	1.8	6.1	3.0	8.8	2.3	11.4	0.9	3.3	24.6	7.9	9.1	6.9	78.8	25.5	1.2	0.1	2.0	35.1	3.0	0.0	0.4	4.8	2.6	8.1	1.1	15.1	8.1	47.8	1.7	12.8	8.9	17.8	1.1	10.9	16.6	4.6	0.9	19.6	39.4	10.2	18.4	12.4	4.6	1.1	0.0	45.2	4.1	33.9	1.9	5.3	0.1	14.1	0.9	10.0	0.5	8.5	10.4	2.0	0.3	2.9	4.8	10.1	16.2	1.9	1.1	12.1	6.3	8.2	16.4	6.6	16.5	8.8	23.5	10.0	7.6	15.5	4.6	50.6	28.7	3.7	10.4	25.0	10.9	852.6	0.0	10.7	27.3	57.6	2.0	0.7	6.6	11.6	5.0	54.1	6.8	0.0	18.6	37.1	102.7	20.4	9.2	2.4	5.5	7.9	308.8	70.0	12.0	4.7	55.8	6.7	35.4	5.4	12.6	13.0	34.7	2.9	55.2	41.6	2.8	19.4	47.4	1.6	2.1	20.7	5.6	15.3	6.6	13.1
PAPPA2	"PAPP-A2, PAPPE, PLAC3"	ENSG00000116183	"Pappalysin 2"	Q9BXP8	1	176463171-176845605	"Enzymes, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"placenta: 406.4"	"Group enriched"	"Detected in many"	7	"Intestinal endocrine cells: 135.4;Muller glia cells: 47.6;Syncytiotrophoblasts: 61.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-87 MG: 21.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA018412, HPA018430"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted in female reproductive system"			"Endoplasmic reticulum, Vesicles"		"HPA018412: AB_1854962, HPA018430: AB_1854961"	"unprognostic (2.90e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.00e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.52e-4)"	"unprognostic (1.85e-1)"	"unprognostic (8.18e-4)"	"unprognostic (4.35e-2)"	0.6	0.0	0.6	0.2	0.2	0.0	3.0	0.8	0.3	5.0	0.6	0.2	0.2	0.0	0.3	0.2	0.2	0.2	1.1	0.2	0.2	0.1	11.6	0.7	0.2	0.2	0.2	0.2	0.2	1.5	0.0	1.2	406.4	0.3	0.2	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.3	0.5	0.2	1.0	0.3	0.2	0.2	0.5	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.1	0.3	0.0	0.5	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.3	4.6	2.2	3.8	0.9	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.8	0.5	0.5	0.2	0.0	0.0	0.1	0.8	0.0	0.0	0.3	1.7	1.4	0.1	0.6	0.3	0.4	0.0	21.2	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.8	0.3	0.2	0.1	0.2	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	2.7	0.6	0.0	0.0	0.0	5.2	0.0	0.8	10.0	0.0	1.9	0.0	0.0	0.0	0.2	11.6	0.6	0.0	0.0	0.2	1.2	0.0	135.4	0.0	0.0	1.3	10.6	0.0	0.0	0.0	0.2	47.6	1.2	0.0	10.3	0.3	1.1	6.5	0.5	1.2	1.9	0.0	61.9	0.0	0.0	0.0
PCDH12	VE-cadherin-2	ENSG00000113555	"Protocadherin 12"	Q9NPG4	5	141943585-141969741	"Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"		"Disease mutation, Epilepsy, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 17.9"	"Group enriched"	"Detected in some"	5	"Endothelial cells: 24.8;Hofbauer cells: 25.9;Ito cells: 56.4"	"Low cancer specificity"	"Detected in all"							"Cell type enriched"	"Detected in some"	6	"non-classical monocyte: 7.0"	"Lineage enriched"	"Detected in single"	35	"monocytes: 7.0"	"Group enriched"	"Detected in some"	4	"HUVEC TERT2: 14.2;Karpas-707: 35.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA051242	Uncertain				"Secreted to blood"		720000			"HPA051242: AB_2681402"	"unprognostic (6.62e-2)"	"unprognostic (6.94e-2)"	"unprognostic (4.74e-3)"	"unprognostic (4.12e-2)"	"unprognostic (3.99e-1)"	"unprognostic (3.25e-1)"	"unprognostic (4.35e-1)"	"unprognostic (1.88e-2)"	"unprognostic (4.29e-2)"	"unprognostic (2.76e-1)"	"unprognostic (9.99e-2)"	"unprognostic (3.87e-1)"	"prognostic unfavorable (2.56e-4)"	"unprognostic (1.11e-2)"	"unprognostic (5.21e-2)"	"unprognostic (9.37e-2)"	"unprognostic (9.33e-2)"	7.9	2.9	0.5	0.7	0.6	0.0	3.1	2.2	0.6	1.3	0.8			0.7	1.3	0.0	0.7	1.2	1.8	4.6	0.5	0.4	3.7	2.1	9.0	0.7	0.4		0.9	0.6	1.4	2.5	17.9		1.1	0.4		0.6	1.0	1.6	0.5	1.0	2.6	0.3	11.3	1.0	0.1			4.8		0.1	2.1	1.1	0.1	0.2	0.0	7.0	0.0	0.1	0.2	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.8	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.2	0.0	0.2	14.2	0.1	0.0	35.1	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.3	0.1	1.5	0.0	0.1	0.2	0.3	0.0	0.0	0.2	0.1	0.0	0.9	0.9	0.2	0.0	0.5	0.0	0.2	0.1	0.0	0.2	5.7	1.2	0.0	0.4	0.0	0.0	1.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.1	0.2											0.0	1.4	0.0	0.0	0.6	1.0	4.4	0.0	0.0	0.0	0.0	2.0	0.2	3.3	0.0	1.4	24.8	0.0	0.0	0.0	0.2	0.2	0.0	1.1	0.0	25.9	0.0	0.0	56.4	7.5	0.8	0.0	0.1	1.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.3	0.5	0.0	0.0	0.1
PCDHA1		ENSG00000204970	"Protocadherin alpha 1"	Q9Y5I3	5	140786136-141012347	"Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 7.1;testis: 3.1"	"Cell type enhanced"	"Detected in some"	24	"Alveolar cells type 1: 3.0;Alveolar cells type 2: 2.1;Ito cells: 1.3;Sertoli cells: 6.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"T-47d: 14.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035969	Enhanced		Approved	"Plasma membrane"	"Secreted - unknown location"			"Plasma membrane"		"HPA035969: AB_10673492"	"unprognostic (2.76e-5)"	"unprognostic (1.19e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.09e-4)"	"unprognostic (7.38e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.26e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.81e-1)"	"unprognostic (9.01e-5)"	"unprognostic (2.46e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.29e-1)"	0.2	1.5	4.6	0.2	4.4	0.1	0.2	3.3	7.1	0.2	0.3			0.7	0.5	0.1	0.2	0.2	0.4	0.1	5.0	3.7	0.6	0.1	0.2	0.3	3.4		0.2	0.2	1.0	1.4	0.1		0.2	0.2		0.1	0.1	0.1	0.1	0.6	0.2	3.4	0.2	0.3	3.1			0.2		0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.4	1.0	0.0	0.2	1.8	0.3	14.4	0.5	0.0	1.6	1.0	0.7	0.1	0.0	0.1	0.0	0.4	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											3.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0
PCDHA10	"CNR8, CNRN8, CNRS8, CRNR8, PCDH-ALPHA10"	ENSG00000250120	"Protocadherin alpha 10"	Q9Y5I2	5	140855883-141012344	"Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.3"	"Cell type enhanced"	"Detected in some"	10	"Bipolar cells: 7.0;Cone photoreceptor cells: 7.9;Horizontal cells: 7.9"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"EFO-21: 20.2"	"Low region specificity"	"Detected in all"												"Secreted - unknown location"						"unprognostic (4.24e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.70e-2)"	"unprognostic (4.19e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.46e-2)"	"unprognostic (8.24e-2)"	"unprognostic (8.10e-2)"	"unprognostic (5.28e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.14e-3)"	"unprognostic (1.93e-2)"	"unprognostic (3.57e-3)"	"unprognostic (5.21e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.10e-1)"	2.1	1.7	6.1	1.1	6.6	0.6	2.4	8.0	20.3	3.0	0.9	4.9	0.9	1.1	4.5	6.3	0.5	2.7	3.1	0.8	7.1	2.7	4.3	0.6	2.1	0.7	7.2	3.6	2.8	7.8	0.8	11.2	0.5	6.1	1.6	0.9	1.9	3.2	1.0	0.5	0.7	1.8	4.0	6.9	0.7	1.1	1.9	8.2	0.0	5.0	0.0	0.5	0.7	0.7	0.6	0.4	1.5	0.3	0.6	0.3	0.0	0.0	0.2	0.4	2.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.3	1.6	0.8	0.0	0.1	0.0	4.1	0.3	0.0	0.0	0.4	0.4	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	1.1	0.3	0.3	0.3	0.2	0.2	0.2	0.1	0.2	0.1	0.6	0.2	0.3	1.5	0.6	0.2	0.4	0.1	0.0	6.1	6.6	8.0	6.9	7.1	2.7	7.2	3.6	6.1	8.2	0.0	1.0	0.0	0.3	0.0	7.0	0.5	2.5	0.0	0.0	0.0	7.9	0.0	0.0	0.2	1.9	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	7.9	1.7	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.0	1.7	0.0	0.0	0.4	2.6	0.0	0.3	1.0	0.2	0.0	0.0	0.0	0.0	0.2
PCSK5	"PC5, PC6, SPC6"	ENSG00000099139	"Proprotein convertase subtilisin/kexin type 5"	Q92824	9	75890644-76362339	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Pregnancy	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"blood: 157.6;intestine: 71.5"	"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 67.7;Horizontal cells: 52.4;Muller glia cells: 43.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"basophil: 157.6;neutrophil: 57.4"	"Lineage enriched"	"Detected in all"	12	"granulocytes: 157.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 15.9;HaCaT: 22.2;RH-30: 14.7;RPTEC TERT1: 20.6;U-2 OS: 32.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA031072	Approved		Supported	"Golgi apparatus"	"Secreted to blood"			"Golgi apparatus"		"HPA031072: AB_10602190"	"unprognostic (3.28e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.13e-4)"	"unprognostic (4.08e-2)"	"unprognostic (7.43e-3)"	"unprognostic (3.17e-1)"	"unprognostic (2.07e-3)"	"unprognostic (9.39e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.92e-2)"	"unprognostic (2.81e-2)"	"unprognostic (6.80e-2)"	"prognostic unfavorable (9.61e-5)"	"unprognostic (2.99e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.77e-5)"	15.8	3.8	2.9	13.7	2.8	1.5	9.5	2.4	3.2	8.5	51.8	2.9	4.5	19.7	6.5	13.9	9.6	7.8	22.9	6.7	3.8	2.4	3.7	1.9	7.7	5.6	2.3	3.1	17.2	3.4	9.5	3.2	7.7	3.5	4.5	6.7	3.3	5.0	5.8	4.0	4.8	71.5	6.9	3.5	2.5	3.3	5.1	2.4	18.0	6.4	14.2	4.5	7.1	11.4	11.7	12.2	157.6	4.4	12.6	12.7	0.8	1.1	0.8	2.4	1.6	1.5	0.5	15.9	2.2	0.2	0.1	0.0	8.4	0.9	0.3	0.6	0.3	0.0	22.2	1.1	0.6	0.1	0.2	1.9	2.9	1.6	0.7	0.4	0.8	1.3	3.0	0.2	0.5	0.2	0.1	4.6	1.5	3.3	1.0	1.6	5.3	3.3	5.0	10.8	1.9	0.9	0.6	14.7	0.9	20.6	1.2	0.2	0.2	3.3	0.7	0.2	4.8	1.2	3.6	3.6	0.7	32.2	1.8	0.9	0.2	0.1	0.4	2.5	1.2	12.2	157.6	4.2	16.2	9.7	2.3	8.3	8.8	9.8	8.9	1.9	11.7	9.9	12.7	57.4	12.6	4.4	12.2	8.4	0.8	2.9	2.8	2.4	3.2	3.8	2.4	2.3	3.1	3.5	2.4	6.0	4.5	0.0	4.1	5.8	4.4	3.7	10.2	17.4	20.5	5.2	0.0	1.4	0.0	5.2	19.6	8.9	67.7	0.0	5.4	25.1	17.5	1.4	0.0	0.9	2.8	52.4	1.2	14.1	4.0	31.4	19.0	3.4	1.7	3.6	8.8	43.7	7.8	17.5	23.7	3.3	1.2	19.4	8.2	1.1	1.5	2.6	2.1	6.4	16.1	0.7
PDCD1LG2	"B7-DC, bA574F11.2, Btdc, CD273, PD-L2, PDL2"	ENSG00000197646	"Programmed cell death 1 ligand 2"	Q9BQ51	9	5510570-5571254	"Cancer-related genes, CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Extravillous trophoblasts: 15.1;monocytes: 45.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 25.9;BJ hTERT+: 40.8;HDLM-2: 31.1;TIME: 18.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA013411	Approved		Uncertain	Cytosol	"Secreted - unknown location"		34000000	Cytosol		"HPA013411: AB_1855102"	"unprognostic (3.93e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.51e-3)"	"unprognostic (6.68e-3)"	"unprognostic (7.66e-2)"	"unprognostic (6.77e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.37e-3)"	"unprognostic (5.79e-2)"	"unprognostic (5.29e-2)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (5.00e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.51e-3)"	15.2	1.8	1.2	7.7	1.4	0.2	9.5	0.7	1.2	7.0	1.9	2.3	0.0	0.8	2.9	7.2	3.9	3.8	4.0	5.8	1.2	1.3	2.5	6.4	13.3	10.8	1.6	0.5	4.1	1.8	0.5	1.1	12.9	1.9	5.0	2.5	2.4	2.9	1.7	5.5	3.6	2.5	4.6	3.7	19.5	1.9	4.2	1.2	8.1	3.5	3.5	8.1	6.0	5.4	0.5	0.9	4.1	3.6	0.0	3.0	0.7	2.1	0.0	0.0	0.0	1.8	2.1	0.0	25.9	40.8	12.5	15.2	0.0	0.1	0.0	0.1	10.5	1.8	0.2	0.0	3.5	12.5	31.1	0.0	0.0	0.0	0.0	10.1	0.0	0.0	1.9	0.0	5.8	6.9	3.6	8.2	0.0	0.0	3.1	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.5	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	18.0	9.0	0.5	4.3	7.1	0.4	0.0	0.0	5.1	0.0	1.1	4.1	0.9	0.0	1.4	3.6	1.9	0.5	2.2	0.9	0.9	0.3	0.0	1.0	2.0	0.0	0.5	0.0	3.0	0.7	1.2	1.4	0.7	1.2	1.2	1.3	1.6	0.5	1.9	1.2	6.0	0.3	0.8	0.0	0.9	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.1	0.0	1.9	0.0	0.0	0.2	15.1	2.1	0.1	3.5	0.0	2.8	0.0	0.0	6.7	4.3	0.0	5.5	2.2	1.7	45.9	0.0	0.0	2.1	0.0	2.1	0.0	0.0	0.0	1.4	0.0	0.0	0.9	0.7	0.0	0.0	0.0
PGLYRP2	"PGLYRPL, PGRP-L, PGRPL, tagL, tagL-alpha, tagl-beta, TAGL-like"	ENSG00000161031	"Peptidoglycan recognition protein 2"	Q96PD5	19	15468645-15498956	"Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	Immunity	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"liver: 95.8"	"Cell type enriched"	"Detected in some"	16	"Hepatocytes: 136.1"	"Cancer enriched"	"Detected in some"	16	"liver cancer: 42.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"granulocytes: 3.6;monocytes: 7.1;T-cells: 3.7"	"Group enriched"	"Detected in some"	6	"MCF7: 10.9;T-47d: 10.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB033468, HPA046311, HPA075237"	Supported		Approved	"Cell Junctions"	"Secreted to blood"		160000000000	"Cell Junctions"		"CAB033468: AB_1127187, HPA046311: AB_2679621, HPA075237: AB_2686739"	"unprognostic (7.39e-3)"	"unprognostic (1.52e-2)"	"unprognostic (5.22e-2)"	"unprognostic (8.79e-2)"	"unprognostic (3.97e-1)"	"unprognostic (4.88e-4)"	"unprognostic (5.93e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.66e-16)"	"unprognostic (6.35e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.81e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	95.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	3.6	7.1	0.6	3.7	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.9	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	10.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	3.6	0.7	0.3	2.6	2.4	2.5	0.3	1.6	1.3	0.2	0.0	3.6	3.7	2.5	0.6	7.1	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	136.1	0.3	0.0	0.0	3.1	1.3	2.5	0.3	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	2.9	0.0	0.0
PI16	"CD364, dJ90K10.5, MGC45378, MSMBBP"	ENSG00000164530	"Peptidase inhibitor 16"	Q6UXB8	6	36948263-36964837	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 87.2"	"Cell type enhanced"	"Detected in many"	20	"Fibroblasts: 45.7;Leydig cells: 190.7;Peritubular cells: 140.7"	"Cancer enhanced"	"Detected in many"		"glioma: 15.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 29.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 29.9"	"Cell line enriched"	"Detected in some"	6	"JURKAT: 26.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA076574	Approved				"Secreted to blood"		3600000000			"HPA076574: AB_2732314"	"unprognostic (6.24e-3)"	"unprognostic (6.00e-3)"	"unprognostic (7.34e-2)"	"unprognostic (9.53e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.71e-2)"	"unprognostic (5.06e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.25e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.59e-3)"	"unprognostic (5.82e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.76e-2)"	22.2	1.7	2.9	1.4	8.8	0.3	27.9	0.7	4.5	62.7	4.5	21.4	22.5	0.8	11.1	27.0	10.5	5.3	17.4	43.1	4.6	3.5	0.8	0.5	3.7	1.1	9.0	3.9	2.8	2.5	0.6	3.3	1.2	9.3	15.0	3.4	87.2	4.0	14.2	5.5	19.8	2.0	55.5	13.7	0.8	8.5	8.3	9.3	0.1	8.3	8.7	4.8	32.7	49.8	0.7	0.2	0.2	0.0	5.7	29.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	4.3	0.2	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	26.2	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.9	0.3	9.8	2.9	0.0	0.7	3.4	1.0	0.2	5.7	0.0	0.2	29.9	1.7	2.9	8.8	0.7	4.5	4.6	3.5	9.0	3.9	9.3	9.3	0.0	1.0	0.0	0.1	19.2	0.0	3.2	0.0	0.0	1.2	1.8	0.0	0.0	1.7	0.0	10.5	2.7	0.0	0.0	0.0	0.0	45.7	0.1	0.0	0.0	0.1	0.0	0.0	17.2	0.0	14.4	190.7	1.0	10.1	0.0	0.0	0.0	0.1	0.0	140.7	0.2	0.0	0.0	2.2	1.9	1.1	16.2	0.1	0.0	0.0	0.1
PILRA	FDF03	ENSG00000085514	"Paired immunoglobin like type 2 receptor alpha"	Q9UKJ1	7	100367530-100400099	"Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"blood: 138.4"	"Cell type enhanced"	"Detected in many"	12	"Hofbauer cells: 82.8;Kupffer cells: 85.3;Leydig cells: 48.6;Macrophages: 111.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 138.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 138.4;monocytes: 87.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 21.0;HMC-1: 18.8;NB-4: 14.2"									HPA056132	Approved				"Secreted to blood"					"HPA056132: AB_2683048"	"unprognostic (5.53e-2)"	"prognostic favorable (2.99e-4)"	"unprognostic (7.61e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.20e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.01e-3)"	"unprognostic (9.95e-2)"	"unprognostic (8.57e-2)"	"unprognostic (4.56e-2)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (3.47e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.80e-2)"	18.6	5.4	7.2	32.3	7.2	19.4	8.2	15.6	6.2	6.1	4.5	10.6	2.3	3.8	4.8	10.0	2.6	7.5	8.4	6.5	7.7	4.4	8.5	8.0	31.9	30.1	11.0	2.6	5.7	5.1	4.3	9.2	13.2	11.9	6.6	4.9	7.1	3.1	4.1	2.5	2.6	3.9	8.6	18.4	29.5	3.1	6.4	10.7	3.3	5.3	1.1	3.3	9.8	5.4	0.1	24.0	138.4	87.3	0.5	0.2	22.9	0.2	0.3	0.4	0.5	21.0	1.4	0.1	0.1	1.0	0.1	0.3	0.0	0.3	0.4	1.2	0.3	0.2	0.6	0.1	0.1	0.0	1.0	0.7	0.4	0.8	0.1	0.2	0.8	18.8	1.5	0.3	0.1	0.4	0.0	0.2	1.7	0.2	1.2	0.1	0.6	1.4	14.2	0.4	0.3	0.2	0.4	0.0	0.3	0.8	0.4	0.5	0.2	0.0	5.2	0.4	0.1	0.1	4.3	0.4	0.9	0.9	0.6	0.2	1.8	1.4	0.4	0.2	1.6	0.3	21.3	48.4	1.4	0.2	70.2	0.1	0.1	0.0	0.0	24.0	0.0	0.0	0.1	138.4	0.5	87.3	0.4	0.1	22.9	7.2	7.2	15.6	6.2	7.7	4.4	11.0	2.6	11.9	10.7	3.0	14.3	5.9	0.2	1.5	3.3	0.4	5.1	4.0	5.7	1.8	3.9	0.4	23.2	0.1	0.4	1.4	0.0	0.0	0.3	0.6	1.3	0.5	9.3	1.5	82.8	1.6	0.0	3.1	85.3	1.5	48.6	111.8	1.7	19.8	1.1	1.9	0.3	0.0	20.1	0.6	2.4	0.0	0.3	0.5	1.3	0.6	0.7	0.8	0.9	0.2
PLA2R1	"CLEC13C, PLA2-R, PLA2G1R, PLA2IR"	ENSG00000153246	"Phospholipase A2 receptor 1"	Q13018	2	159932006-160062610	"Predicted membrane proteins, Predicted secreted proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 46.1"	"Cell type enhanced"	"Detected in many"	7	"Collecting duct cells: 31.4;Muller glia cells: 30.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"cerebellum: 19.5"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 9.2;ASC TERT1: 12.5;BJ hTERT+: 9.9;hTERT-RPE1: 16.5;TIME: 28.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB068217, CAB068218"	Approved		Approved	Cytosol	"Secreted to blood"		99000	Cytosol		"CAB068217: AB_2665660, CAB068218: AB_2665661"	"unprognostic (2.04e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.39e-2)"	"unprognostic (4.91e-3)"	"unprognostic (6.01e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.40e-2)"	"unprognostic (9.38e-3)"	"unprognostic (4.30e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (2.62e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.02e-1)"	4.6	2.1	0.6	2.3	1.1	0.0	9.4	19.5	1.9	11.3	7.0	1.0	2.4	2.4	17.8	4.7	4.7	4.8	6.9	2.7	0.7	1.0	15.0	0.9	2.3	1.8	0.8	0.7	8.7	0.8	14.5	2.6	6.6	3.3	3.3	2.0	7.8	46.1	2.0	0.8	9.6	9.4	5.7	2.5	3.0	1.6	1.3	0.2	0.3	27.6	6.6	5.1	4.5	9.4	0.6	0.6	2.3	0.8	1.0	0.6	0.2	0.1	1.0	0.3	0.0	9.2	12.5	0.0	4.1	9.9	0.8	1.1	0.0	2.1	0.0	0.2	4.3	0.9	2.0	0.0	3.0	0.8	0.0	0.0	0.0	6.9	0.0	0.7	0.0	0.0	5.0	3.3	1.2	1.3	16.5	5.7	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.9	0.4	0.0	0.0	7.2	1.3	0.0	1.1	1.6	0.1	28.7	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.5	0.5	0.5	0.5	0.6	0.5	0.4	0.3	0.3	0.6	0.6	0.6	2.3	1.0	0.8	0.6	0.4	0.2	0.6	1.1	19.5	1.9	0.7	1.0	0.8	0.7	3.3	0.2	6.0	3.2	0.0	2.2	8.4	0.8	3.6	5.1	6.7	2.3	31.4	0.0	4.3	0.0	0.7	0.0	3.6	2.6	0.0	1.8	1.1	6.7	2.3	1.1	0.0	0.5	15.9	1.2	8.0	0.0	0.9	15.0	0.0	6.8	0.0	6.1	30.3	3.2	5.8	15.6	1.1	1.1	6.5	2.2	0.0	0.6	4.6	1.3	0.0	6.5	2.2
PROS1	PROS	ENSG00000184500	"Protein S"	P07225	3	93873033-93974066	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis"		"Disease mutation, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 114.6"	"Cell type enhanced"	"Detected in many"	13	"Hepatocytes: 266.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	6	"pons and medulla: 24.2"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 42.8;ASC TERT1: 31.9;HSkMC: 28.9;hTERT-RPE1: 24.2;SK-MEL-30: 46.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007724, HPA023974, CAB032610"	Approved				"Secreted to blood"	22500000000	3400000000			"CAB032610: AB_2237647, HPA007724: AB_1079688, HPA023974: AB_1855738"	"unprognostic (2.00e-2)"	"unprognostic (2.81e-2)"	"unprognostic (9.21e-2)"	"unprognostic (8.03e-3)"	"unprognostic (3.35e-2)"	"unprognostic (2.41e-1)"	"unprognostic (6.48e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.18e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (8.35e-4)"	"unprognostic (4.90e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (4.42e-5)"	16.0	3.9	2.5	3.8	3.8	0.1	15.5	0.8	2.8	7.4	8.0	4.1	2.8	3.9	7.6	9.5	10.9	8.5	11.3	30.2	4.0	3.1	17.6	114.6	17.3	13.7	4.3	1.8	23.9	2.7	10.1	6.2	10.2	24.2	6.8	8.5	9.3	5.6	4.3	5.6	8.5	6.5	8.3	4.8	8.8	4.9	5.5	2.2	0.1	10.6	6.9	3.3	8.0	9.5	0.0	0.8	1.9	0.8	0.1	0.4	6.8	0.3	2.4	2.5	10.3	42.8	31.9	0.8	1.5	3.5	0.8	3.1	6.1	0.9	0.2	9.3	2.3	7.8	0.1	0.8	0.6	1.1	0.1	2.7	16.6	1.1	17.0	3.6	0.6	0.8	28.9	0.6	1.8	0.6	24.2	3.5	2.1	11.5	0.2	16.6	0.2	0.1	0.0	2.0	1.5	2.4	0.3	2.0	0.0	9.0	0.0	3.8	7.0	1.8	0.0	46.2	0.8	0.1	8.1	3.0	6.8	1.5	3.7	0.8	0.0	0.1	0.0	21.2	10.6	9.9	0.0	0.8	0.7	0.1	0.6	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	1.9	0.1	0.2	0.0	0.2	6.8	2.5	3.8	0.8	2.8	4.0	3.1	4.3	1.8	24.2	2.2	59.6	29.8	3.7	2.9	13.2	0.6	40.3	12.7	76.3	12.5	1.8	9.8	0.6	3.3	5.6	2.3	47.0	2.6	0.0	4.0	0.6	62.0	4.7	29.0	266.4	9.9	1.6	15.1	69.3	24.7	4.0	26.4	7.7	18.6	1.0	14.6	22.0	3.9	7.0	34.6	36.2	7.8	12.9	26.2	0.2	0.5	29.1	1.4	4.5	13.3	2.0
PRSS48	ESSPL	ENSG00000189099	"Serine protease 48"	Q7RTY5	4	151277171-151291453	"Enzymes, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"brain: 1.0;skin 1: 1.9;testis: 4.1"	"Cell type enriched"	"Detected in some"	6	"Sertoli cells: 6.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 1.4;LHCN-M2: 1.4;PC-3: 1.5;RT4: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA053801	Uncertain				"Secreted in male reproductive system"					"HPA053801: AB_2682267"			"unprognostic (9.68e-2)"		"unprognostic (1.35e-2)"			"unprognostic (2.15e-1)"		"unprognostic (2.18e-2)"				"unprognostic (3.76e-2)"	"unprognostic (4.10e-2)"			0.0	0.0	0.5	0.0	1.0	0.0	0.0	0.0	0.9	0.0	0.1			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.1	0.0	0.2		0.0	0.0	0.0	0.0	0.1		0.0	0.0		0.0	0.3	0.0	1.9	0.0	0.0	0.5	0.0	0.0	4.1			0.0		0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.6	0.0	1.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	6.5	0.0	1.1	1.1	0.0	0.0	0.0	0.0	0.0
PRSS8		ENSG00000052344	"Serine protease 8"	Q16651	16	31131433-31135762	"Enzymes, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 123.2;salivary gland: 143.7"	"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 330.0;Extravillous trophoblasts: 497.6;Syncytiotrophoblasts: 376.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	4	"pons and medulla: 3.4"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 58.3;CACO-2: 38.3;CAPAN-2: 26.3;hTCEpi: 37.6;SK-BR-3: 44.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA030436	Uncertain				"Secreted - unknown location"		3500000			"HPA030436: AB_10602291"	"unprognostic (1.88e-1)"	"unprognostic (2.97e-1)"	"unprognostic (9.34e-2)"	"unprognostic (4.08e-1)"	"unprognostic (6.83e-2)"	"unprognostic (5.07e-3)"	"unprognostic (5.78e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.26e-1)"	"unprognostic (4.51e-2)"	"unprognostic (8.74e-3)"	"unprognostic (1.58e-1)"	"prognostic favorable (2.05e-10)"	"unprognostic (1.89e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.63e-3)"	0.3	0.2	0.3	11.5	0.3	0.0	7.6	0.7	0.4	8.0	72.6	0.6	12.8	31.6	3.4	46.7	37.2	2.8	45.3	0.3	0.4	0.3	48.0	20.3	30.0	0.3	0.3	0.3	1.3	46.3	2.7	2.6	93.1	3.4	11.4	14.7	1.1	143.7	7.4	0.3	29.7	123.2	0.5	0.3	0.3	37.0	1.8	0.3	11.3	33.4	18.4	26.7	2.6	13.4	0.2	0.0	1.0	0.3	0.0	0.2	0.0	14.4	0.0	0.0	0.0	0.0	0.0	58.3	0.0	0.0	0.0	0.0	38.3	26.3	0.0	0.3	0.0	0.0	17.3	0.0	16.2	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	37.6	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	15.5	0.1	0.3	4.8	18.3	0.0	0.1	0.0	0.2	1.8	3.0	0.2	0.1	0.0	44.2	0.0	4.7	10.1	0.2	0.0	0.0	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.7	0.4	0.4	0.3	0.3	0.3	3.4	0.3	92.3	62.1	0.9	60.6	33.7	0.6	0.3	53.5	9.4	53.4	40.1	0.0	127.8	24.9	145.8	0.0	0.7	330.0	23.3	197.1	497.6	3.6	80.0	6.9	12.8	20.5	0.0	9.2	0.0	0.3	0.0	0.6	2.5	3.3	7.2	109.4	0.3	182.1	150.8	0.0	24.9	0.0	0.0	3.1	0.0	0.1	47.2	376.9	1.3	110.4	79.5
PSG9	"PSG11, PSGII"	ENSG00000183668	"Pregnancy specific beta-1-glycoprotein 9"	Q00887	19	43211791-43269530	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	205	"placenta: 299.0"	"Cell type enriched"	"Detected in some"	109	"Syncytiotrophoblasts: 231.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"eosinophil: 1.4"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 1.4"	"Cell line enhanced"	"Detected in some"		"BJ: 5.0;GAMG: 16.0;HBF TERT88: 9.2;SuSa: 11.0;U-2197: 9.5"									HPA046327	Supported				"Secreted in female reproductive system"					"HPA046327: AB_2679624"	"unprognostic (9.32e-2)"	"unprognostic (3.28e-1)"				"unprognostic (2.15e-1)"												0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.6	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.2	299.0	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.4	0.2	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	5.0	2.8	4.4	2.3	0.1	0.1	0.0	0.2	1.3	16.0	0.3	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.5	11.0	4.2	0.0	0.2	0.1	2.1	9.5	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.5	0.5	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	231.8	0.0	0.0	0.0
PTK7	CCK4	ENSG00000112655	"Protein tyrosine kinase 7 (inactive)"	Q13308	6	43076268-43161719	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Wnt signaling pathway"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"Early spermatids: 314.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	9	"plasmacytoid DC: 13.8"	"Lineage enriched"	"Detected in many"	9	"dendritic cells: 13.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003222	Approved				"Secreted to blood"		10000000			"HPA003222: AB_1079713"	"unprognostic (1.80e-1)"	"unprognostic (7.49e-3)"	"unprognostic (6.22e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.85e-3)"	"unprognostic (9.81e-3)"	"unprognostic (1.47e-3)"	"unprognostic (7.15e-2)"	"unprognostic (5.11e-3)"	"unprognostic (8.17e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.61e-1)"	"unprognostic (9.12e-2)"	"unprognostic (5.70e-3)"	5.4	1.8	1.4	3.5	3.4	0.8	12.2	3.5	4.9	30.9	4.8	3.4	8.9	2.1	37.7	36.9	11.7	14.3	14.5	3.5	2.2	3.9	10.1	0.8	18.7	4.3	1.3	2.7	42.6	16.3	9.0	9.0	20.9	4.2	18.2	3.3	13.9	15.0	10.9	0.4	13.6	3.4	16.4	3.2	12.4	4.6	14.9	1.4	28.7	19.3	8.1	6.2	9.5	17.6	0.0	13.8	0.3	0.0	0.7	1.5	0.8	2.1	0.6	21.1	35.0	22.7	23.3	30.0	22.6	36.5	19.8	25.4	19.0	7.6	0.0	17.9	26.3	14.4	24.5	9.4	21.5	12.6	0.1	11.7	2.0	4.3	25.5	34.5	0.0	0.1	33.3	19.5	26.1	8.3	34.6	2.5	8.5	1.3	0.0	9.0	1.6	7.6	3.0	9.8	0.2	1.7	7.7	30.0	0.0	15.3	10.5	12.1	23.0	3.6	0.3	11.7	23.2	12.9	4.6	1.6	21.2	13.4	0.1	12.2	0.1	0.2	0.7	4.9	0.0	3.5	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.1	1.5	0.2	0.7	0.0	13.8	0.0	0.8	1.4	3.4	3.5	4.9	2.2	3.9	1.3	2.7	4.2	1.4	14.9	12.5	0.0	16.8	15.3	1.4	1.6	2.5	2.7	6.8	12.2	53.0	18.9	1.7	19.2	314.6	1.0	0.2	0.0	6.2	1.9	31.6	10.9	1.1	0.0	3.1	0.0	20.7	1.8	0.0	38.8	17.0	1.1	15.1	1.0	1.2	19.8	8.6	3.5	17.3	0.5	1.7	12.9	9.5	2.4	18.5	9.2	6.9	0.7	2.6	9.7
PTPRS		ENSG00000105426	"Protein tyrosine phosphatase, receptor type S"	Q13332	19	5158495-5340803	"Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Heparin-binding, Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 54.1;Melanocytes: 75.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	82	"plasmacytoid DC: 13.4"	"Lineage enriched"	"Detected in single"	82	"dendritic cells: 13.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 41.4;HaCaT: 42.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054747			Approved	"Plasma membrane,Cytosol"	"Secreted - unknown location"		92000000	"Plasma membrane, Cytosol"		"HPA054747: AB_2682591"	"unprognostic (8.14e-2)"	"unprognostic (4.59e-3)"	"unprognostic (2.57e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.15e-1)"	"unprognostic (6.96e-3)"	"unprognostic (6.85e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.12e-3)"	"unprognostic (1.86e-1)"	"prognostic favorable (1.07e-4)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (2.80e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.05e-1)"	"unprognostic (3.46e-2)"	59.1	17.3	14.4	9.4	14.8	3.1	32.0	27.6	53.3	28.7	11.4	29.6	14.4	4.6	21.4	15.4	13.3	24.0	22.2	18.6	15.9	15.1	10.7	6.9	13.9	8.6	20.5	12.1	29.2	38.4	10.5	16.6	4.3	12.0	23.1	3.6	28.9	21.5	20.1	11.9	23.8	6.5	17.5	13.8	8.3	12.7	10.8	18.7	4.4	21.1	7.2	7.5	19.1	22.7	0.0	13.4	0.0	0.0	0.0	0.1	0.0	3.7	21.3	19.2	41.4	8.8	7.2	2.5	6.4	7.7	7.8	6.4	0.2	2.0	0.0	15.3	10.8	6.2	42.1	5.1	0.0	3.5	0.4	8.2	0.0	8.7	13.2	4.0	0.0	4.8	7.6	1.8	1.6	0.3	10.2	0.2	2.6	5.9	0.0	3.1	15.7	1.6	4.0	10.8	0.1	9.1	0.0	4.2	0.0	1.6	7.5	14.8	20.3	6.1	1.1	11.7	3.9	7.4	1.6	0.9	7.0	12.1	16.0	7.8	2.1	0.0	12.2	3.6	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	14.4	14.8	27.6	17.6	15.9	15.1	20.5	12.1	12.0	18.7	6.0	0.6	3.2	32.4	54.1	33.8	10.9	12.7	1.4	2.3	12.2	2.0	0.5	8.3	1.4	2.3	10.2	0.0	0.0	0.8	23.7	30.9	35.7	0.0	18.3	1.5	11.1	2.9	28.3	0.3	2.9	43.1	1.4	75.9	0.0	0.0	37.3	0.5	0.0	33.9	2.4	7.7	12.9	39.2	7.2	5.3	32.0	0.8	0.0	0.0	21.1
PTPRZ1	"phosphacan, PTP18, PTPRZ, PTPZ, RPTPB"	ENSG00000106278	"Protein tyrosine phosphatase, receptor type Z1"	P23471	7	121873089-122062036	"Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 118.1"	"Cell type enhanced"	"Detected in some"	17	"Club cells: 27.3;Horizontal cells: 62.0;Muller glia cells: 107.0"	"Cancer enriched"	"Detected in many"	14	"glioma: 175.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"AF22: 94.3;NTERA-2: 26.3;WM-115: 41.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015103	Enhanced		Approved	Vesicles,Cytosol	"Secreted in brain"		950000	Cytosol	Vesicles	"HPA015103: AB_1855946"	"unprognostic (8.49e-4)"	"unprognostic (3.96e-3)"	"unprognostic (4.11e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.18e-2)"	"unprognostic (2.41e-2)"	"unprognostic (8.30e-3)"	"unprognostic (3.78e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.53e-1)"	"unprognostic (9.17e-4)"	"unprognostic (1.83e-1)"	"unprognostic (8.72e-6)"	"unprognostic (2.00e-1)"	"unprognostic (2.16e-1)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (9.36e-4)"	2.0	2.5	33.1	2.3	44.1	1.5	4.0	15.4	118.1	2.4	2.2	19.3	0.0	1.9	1.6	2.0	7.0	1.7	1.9	2.0	39.6	15.9	1.6	1.6	2.1	1.5	18.6	17.8	2.0	3.3	1.5	1.6	1.6	67.6	2.1	2.3	0.8	2.4	2.0	1.5	19.3	1.9	2.4	76.6	2.1	9.8	1.7	23.6	0.0	1.5	1.8	3.0	2.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	5.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	26.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.4	1.1	0.0	0.1	0.0	41.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.1	44.1	15.4	39.6	39.6	15.9	18.6	17.8	67.6	23.6	0.0	1.0	0.0	5.6	22.3	14.1	0.8	0.0	17.4	27.3	0.0	3.9	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.1	1.1	1.1	0.0	0.0	0.1	62.0	0.0	0.0	0.0	0.4	0.3	0.0	18.6	0.0	0.0	107.0	0.6	0.0	0.0	0.0	6.2	0.0	0.4	0.0	0.2	18.7	0.2	0.0	0.0	7.4
PVR	"CD155, HVED, Necl-5, NECL5, PVS, Tage4"	ENSG00000073008	"Poliovirus receptor"	P15151	19	44643798-44663583	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 65.6"	"Cell type enhanced"	"Detected in many"	5	"Pancreatic endocrine cells: 48.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 6.4;intermediate monocyte: 6.6;myeloid DC: 5.6;non-classical monocyte: 8.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.6;monocytes: 8.1"	"Cell line enhanced"	"Detected in many"		"TIME: 53.4"									"HPA012568, HPA064739"	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane"	"Secreted - unknown location"		940000000	"Nucleoplasm, Vesicles, Plasma membrane"		"HPA012568: AB_1846248, HPA064739: "	"unprognostic (2.90e-3)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (3.36e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.89e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.06e-2)"	"prognostic unfavorable (9.30e-4)"	"unprognostic (9.05e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.64e-3)"	"unprognostic (1.69e-1)"	"unprognostic (4.97e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-3)"	"prognostic unfavorable (2.75e-4)"	10.0	13.9	7.4	7.5	8.1	4.7	9.2	11.0	11.0	6.5	10.6	6.5	4.1	13.7	11.3	5.7	6.6	8.8	9.2	23.5	5.8	10.0	10.6	65.6	14.8	2.4	6.0	6.5	10.4	15.9	9.9	20.7	15.5	9.7	10.4	7.7	6.6	8.5	6.9	19.8	5.5	13.0	11.1	7.0	4.8	12.3	6.0	7.2	2.3	8.5	10.8	3.7	8.3	6.7	0.0	5.6	1.2	8.1	0.6	0.4	2.2	21.8	15.3	1.5	6.1	1.9	2.3	2.6	36.9	10.3	12.1	13.9	8.9	9.3	0.0	21.2	10.7	21.2	14.4	5.2	14.0	8.1	2.6	10.1	3.9	9.6	6.0	12.9	1.5	8.4	2.9	6.9	10.7	21.0	12.1	13.1	2.3	1.8	0.0	5.6	1.9	1.3	1.3	3.4	7.4	11.3	0.0	7.0	2.0	26.0	6.7	6.6	7.7	23.4	14.7	5.2	1.7	8.3	3.7	53.4	14.7	18.1	10.8	28.8	0.0	2.1	0.0	11.7	7.5	8.3	0.0	6.4	0.0	0.2	6.6	0.0	0.0	0.0	0.4	5.6	0.0	0.2	0.1	1.2	0.6	8.1	0.5	0.0	2.2	7.4	8.1	11.0	11.0	5.8	10.0	6.0	6.5	9.7	7.2	14.9	28.0	4.5	12.8	3.2	6.9	11.2	20.4	2.7	18.2	1.8	2.0	2.4	3.3	43.0	8.5	13.5	11.9	0.0	30.3	30.1	5.4	11.3	1.1	36.5	7.4	1.6	12.6	7.4	9.2	10.2	5.2	7.8	1.7	25.2	9.7	1.3	48.8	14.4	14.9	2.8	3.3	0.0	17.8	3.4	1.5	4.8	0.8	0.0	10.6	6.5
QSOX1	QSCN6	ENSG00000116260	"Quiescin sulfhydryl oxidase 1"	O00391	1	180154834-180204030	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 172.2"	"Cell type enriched"	"Detected in many"	8	"Extravillous trophoblasts: 1528.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 197.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA056243			Supported	"Golgi apparatus,Vesicles"	"Secreted to extracellular matrix"		3200000000	"Golgi apparatus"	Vesicles	"HPA056243: AB_2683077"	"unprognostic (1.13e-1)"	"unprognostic (2.62e-3)"	"unprognostic (2.46e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.94e-1)"	"unprognostic (3.12e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.80e-3)"	"prognostic unfavorable (1.86e-5)"	"unprognostic (3.25e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.40e-1)"	15.9	18.7	8.0	14.5	9.5	30.1	12.6	7.3	13.6	23.5	25.3	13.8	24.9	19.8	17.8	44.9	36.8	18.9	91.9	54.4	10.1	9.0	15.4	23.1	42.3	19.5	8.5	9.1	46.5	59.8	6.2	13.5	172.2	13.4	28.0	24.5	12.1	20.6	19.4	18.4	12.3	19.0	33.9	15.5	13.4	52.8	50.3	9.1	6.7	7.8	18.2	18.3	35.8	26.1	2.9	19.2	20.4	25.5	8.0	7.1	11.4	42.1	6.0	1.4	18.0	18.4	38.1	71.7	44.9	45.4	38.4	27.1	0.7	13.6	0.6	27.9	35.9	5.3	9.2	1.7	12.1	18.8	2.5	2.7	1.3	3.5	1.8	197.7	4.6	13.0	20.3	5.5	40.9	49.1	50.6	56.5	3.1	1.9	6.6	25.2	7.3	0.9	8.6	4.9	29.2	17.3	1.8	3.3	1.1	6.3	12.0	5.2	5.3	13.1	17.9	8.7	3.4	3.2	21.9	66.5	48.1	18.9	32.2	37.9	4.8	7.9	1.1	18.3	14.8	14.4	5.8	25.5	9.5	7.1	14.7	5.3	2.9	4.8	5.0	19.2	1.8	4.4	4.3	20.4	8.0	13.1	3.9	5.5	11.4	8.0	9.5	7.3	13.6	10.1	9.0	8.5	9.1	13.4	9.1	53.6	87.2	7.8	26.2	12.2	9.8	43.7	68.8	14.7	43.3	68.0	23.6	13.2	0.0	189.3	48.3	38.6	47.7	0.0	114.6	1528.4	54.2	30.1	25.3	1.5	63.8	6.4	44.4	101.9	45.4	16.5	164.5	43.6	42.2	44.1	163.8	43.9	172.2	143.8	66.8	9.5	6.5	32.3	17.5	20.9	25.4	8.7	129.1	15.0	96.4	58.0
RAET1G	ULBP5	ENSG00000203722	"Retinoic acid early transcript 1G"	Q6H3X3	6	149916878-149923121	"Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 21.2;tongue: 18.4"	"Cell type enhanced"	"Detected in some"	17	"Basal glandular cells: 4.2;Basal keratinocytes: 2.7;Melanocytes: 3.3;Urothelial cells: 9.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 23.4;hTCEpi: 18.7;SiHa: 9.2;U-87 MG: 7.6"									HPA062673			Approved	Vesicles	"Secreted - unknown location"			Vesicles		"HPA062673: "	"unprognostic (4.46e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.49e-1)"	"unprognostic (4.61e-3)"	"prognostic unfavorable (5.35e-4)"	"unprognostic (3.05e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.85e-2)"	"unprognostic (9.11e-2)"	2.5	10.0	0.3	0.6	0.3	0.0	2.5	0.2	1.0	5.6	0.6	0.5	1.4	0.2	0.8	4.3	21.2	0.5	1.2	0.9	0.4	0.2	2.3	0.2	1.3	0.1	0.3	0.1	1.9	0.1	0.1	1.2	0.1	0.5	2.9	0.1	0.8	3.9	2.2	0.4	4.3	0.5	1.8	0.9	0.2	0.6	0.5	0.2	0.2	0.7	18.4	10.7	2.8	5.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.8	1.0	0.0	1.3	1.9	1.8	0.0	0.6	2.4	1.1	1.5	0.0	1.2	0.0	0.5	1.3	1.1	2.0	0.7	4.1	0.8	0.2	1.3	0.4	23.4	0.0	0.5	0.0	0.0	2.7	18.7	2.8	1.3	1.3	0.4	0.6	0.2	0.2	0.4	1.0	0.0	0.0	0.0	0.2	1.9	0.0	0.0	0.0	0.8	2.5	0.3	0.2	9.2	0.4	0.0	0.1	0.3	0.3	1.3	0.5	0.4	1.1	0.6	0.0	0.0	0.0	7.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	1.0	0.4	0.2	0.3	0.1	0.5	0.2	0.0	0.0	0.0	4.2	2.7	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	1.2	0.0	0.7	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	3.3	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.1	0.0	0.0	9.5
RTBDN	FLJ36353	ENSG00000132026	Retbindin	Q9BSG5	19	12825478-12835428	"Predicted membrane proteins, Predicted secreted proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 17.3;pituitary gland: 25.8;retina: 57.0"	"Group enriched"	"Detected in some"	7	"Cone photoreceptor cells: 329.9;Rod photoreceptor cells: 289.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 1.7;neutrophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 8.2;SH-SY5Y: 5.4;U-266/84: 21.1;U-87 MG: 4.8"					"Not detected"	"Not detected"			HPA052511			Approved	"Endoplasmic reticulum"	"Secreted in other tissues"			"Endoplasmic reticulum"		"HPA052511: AB_2797243"	"unprognostic (4.55e-4)"	"unprognostic (3.94e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.54e-4)"	"unprognostic (3.33e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.55e-1)"	"unprognostic (6.48e-2)"	"unprognostic (7.04e-3)"	"unprognostic (7.66e-9)"	"unprognostic (3.55e-2)"	"unprognostic (1.00e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.24e-2)"	0.3	6.9	10.2	0.5	3.4	0.9	0.3	2.7	17.3	0.2	0.9	0.4	0.0	1.0	0.3	1.5	0.3	0.3	0.4	0.3	7.3	5.1	0.2	0.4	0.5	0.4	2.8	2.8	0.3	2.5	0.2	25.8	0.3	4.0	0.4	0.9	57.0	0.3	0.3	0.3	0.5	1.0	0.6	1.0	0.4	2.5	3.5	0.0	7.0	0.4	0.0	0.4	0.3	0.0	0.3	0.2	1.8	0.2	0.4	0.2	0.0	0.9	0.1	0.1	0.6	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.3	0.1	0.9	0.9	0.0	0.6	0.2	0.3	0.0	0.0	0.1	0.1	0.0	0.4	0.9	0.0	0.1	2.4	0.0	0.0	0.4	0.2	0.0	0.0	0.1	1.2	2.7	0.0	0.1	0.0	0.0	0.9	0.7	1.1	0.7	0.1	1.0	0.0	0.0	8.2	5.4	0.1	0.1	0.4	0.4	2.7	0.7	0.0	0.8	1.0	0.7	0.1	1.2	21.1	4.0	4.8	0.0	0.0	1.7	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.3	0.2	0.2	1.8	0.4	0.2	0.2	0.1	0.0	10.2	3.4	2.7	8.6	7.3	5.1	2.8	2.8	4.0	0.0	0.0	0.0	0.0	0.0	0.0	47.1	1.4	0.0	0.0	0.0	0.0	329.9	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	27.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	45.9	0.1	0.0	0.0	0.0	289.4	0.0	0.0	11.5	5.1	0.0	0.0	0.0	0.0	0.0
SDC1	"CD138, SDC, SYND1, syndecan"	ENSG00000115884	"Syndecan 1"	P18827	2	20200797-20225433	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 113.2;placenta: 228.8"	"Cell type enhanced"	"Detected in many"	9	"Cholangiocytes: 298.1;Hepatocytes: 520.4;Urothelial cells: 356.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	17	"memory B-cell: 3.9"	"Lineage enriched"	"Detected in single"	40	"B-cells: 3.9"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 62.1;hTCEpi: 57.5;U-251 MG: 59.2;U-266/70: 61.4;U-266/84: 129.2"	"Group enriched"	"Detected in some"	4	"cerebellum: 10.7;olfactory region: 5.9"	"Not detected"	"Not detected"			"CAB002424, HPA006185, HPA067477"	Enhanced		Approved	"Focal adhesion sites"	"Secreted to blood"	63100000	1600000	"Focal adhesion sites"		"CAB002424: AB_442050, HPA006185: AB_1857705, HPA067477: "	"prognostic unfavorable (2.22e-4)"	"unprognostic (6.80e-3)"	"unprognostic (6.80e-2)"	"unprognostic (7.84e-2)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.02e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.27e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.94e-2)"	"unprognostic (4.27e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.52e-1)"	0.8	3.4	0.5	5.4	0.6	0.0	4.5	0.8	0.7	21.4	18.3	0.5	3.5	14.3	2.3	8.7	103.7	1.6	55.3	0.3	0.4	0.5	68.5	113.2	15.8	6.3	1.9	0.4	1.6	7.0	0.6	0.6	228.8	0.7	13.3	6.2	1.5	16.0	5.2	0.5	69.5	21.9	4.3	0.4	3.7	16.3	2.6	0.4	1.5	3.5	62.3	48.4	30.0	37.7	3.9	0.0	0.0	0.0	0.0	0.0	0.5	31.4	17.6	5.6	14.0	1.5	0.2	17.7	8.8	8.5	8.2	7.0	3.7	19.2	0.0	3.2	6.2	4.5	31.1	2.4	62.1	5.5	0.1	1.6	0.0	1.6	18.8	1.3	1.3	0.1	0.8	57.5	7.4	17.6	11.5	0.9	0.0	0.7	12.3	4.4	18.8	0.0	0.3	5.0	24.0	34.2	0.6	2.0	23.8	10.6	47.2	1.6	13.1	6.6	44.8	2.0	2.3	4.4	0.3	1.3	32.7	10.5	1.2	59.2	61.4	129.2	0.1	9.8	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.6	0.8	0.7	0.4	0.5	1.9	0.4	0.7	0.4	86.4	91.4	3.0	135.6	101.2	0.1	0.8	298.1	2.7	63.7	40.1	0.0	2.4	26.6	54.9	0.0	1.1	102.7	23.3	19.0	43.0	9.7	42.4	5.8	520.4	2.2	20.6	10.4	6.7	9.6	0.0	0.6	5.4	20.3	1.0	72.0	0.0	67.3	73.7	1.1	68.3	0.0	0.0	7.1	0.7	12.8	200.1	209.7	4.4	66.5	356.0
SDC4	"amphiglycan, ryudocan, SYND4"	ENSG00000124145	"Syndecan 4"	P31431	20	45325288-45348424	"Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 141.1"	"Cell type enhanced"	"Detected in many"	4	"Exocrine glandular cells: 450.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 75.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005716, CAB013240"	Enhanced		Approved	"Golgi apparatus,Plasma membrane"	"Secreted to blood"			"Golgi apparatus"	"Plasma membrane"	"CAB013240: AB_2533250, HPA005716: AB_1080160"	"unprognostic (1.34e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.59e-3)"	"unprognostic (1.16e-1)"	"unprognostic (5.93e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.95e-2)"	"prognostic unfavorable (4.20e-4)"	"unprognostic (1.97e-1)"	"prognostic favorable (2.44e-7)"	"unprognostic (3.00e-1)"	"unprognostic (2.18e-1)"	"prognostic favorable (2.67e-4)"	"unprognostic (7.42e-2)"	15.9	26.2	19.9	15.7	24.3	3.5	40.5	6.9	20.1	20.4	24.8	19.2	9.0	13.3	17.6	14.7	42.4	27.4	26.2	19.5	19.8	12.1	56.6	141.1	56.7	4.8	23.5	20.5	14.7	36.6	6.2	12.5	23.0	30.9	19.5	22.3	21.8	47.6	17.5	25.5	45.5	13.8	38.7	23.0	9.0	46.9	33.7	15.7	2.0	26.5	25.2	23.5	34.4	16.4	0.7	2.8	2.0	3.1	1.4	8.1	1.2	23.0	3.0	1.6	0.1	41.2	25.4	71.1	29.5	40.3	33.5	24.0	35.1	58.9	0.0	13.2	37.1	33.8	30.0	1.2	75.0	40.8	6.6	1.1	0.7	2.4	13.7	44.9	0.1	1.2	34.1	50.4	13.8	33.8	18.6	4.4	0.5	1.1	0.0	19.2	22.9	0.0	2.0	3.0	20.1	9.3	0.0	14.9	0.0	55.0	30.8	0.6	2.3	40.6	25.2	7.2	19.6	18.2	1.4	8.2	25.6	21.3	2.5	19.0	1.2	0.9	0.1	40.2	2.3	15.2	2.0	3.1	0.7	1.3	1.1	4.1	0.6	4.1	1.6	2.8	0.7	0.9	1.1	1.6	1.4	1.1	2.5	8.1	1.2	19.9	24.3	6.9	20.1	19.8	12.1	23.5	20.5	30.9	15.7	271.0	364.7	7.8	299.2	332.0	10.3	49.5	201.2	113.8	195.7	179.7	11.8	27.4	54.7	239.6	0.5	9.0	87.8	0.0	450.4	202.4	50.9	254.2	12.8	232.3	18.5	0.0	52.9	14.7	15.1	2.9	3.7	36.5	72.6	56.9	103.4	8.5	443.3	93.4	4.9	128.2	23.3	0.0	42.6	0.9	2.8	413.3	56.3	18.8	79.5	364.0
SECTM1	K12	ENSG00000141574	"Secreted and transmembrane 1"	Q8WVN6	17	82321024-82334074	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 45.9;intestine: 103.1"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 42.8;Kupffer cells: 39.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 45.9"	"Group enriched"	"Detected in many"	13	"granulocytes: 45.9;monocytes: 16.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 27.3;BJ hTERT+: 27.5;BJ hTERT+ SV40 Large T+: 21.2;BJ hTERT+ SV40 Large T+ RasG12V: 20.9;PC-3: 21.8;SiHa: 37.5;SK-BR-3: 20.4;U-2197: 28.6"									HPA051214	Approved				"Secreted - unknown location"		26000000			"HPA051214: AB_2732565"	"unprognostic (2.42e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.69e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.55e-2)"	"unprognostic (9.39e-2)"	"unprognostic (3.17e-3)"	"unprognostic (7.75e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.31e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.01e-1)"	13.5	1.8	1.1	15.7	2.1	3.7	10.6	0.7	2.1	6.4	33.2	1.0	1.3	26.2	6.1	4.9	6.1	6.5	4.7	6.1	2.3	0.8	16.8	3.9	11.2	21.7	1.5	0.6	7.8	2.5	0.0	1.3	6.1	3.5	8.6	9.4	2.1	20.2	2.2	4.9	6.6	103.1	5.5	4.2	24.0	9.4	2.1	1.4	2.3	5.1	7.0	7.7	7.8	16.2	0.0	2.3	45.9	16.2	0.0	0.1	1.1	6.0	1.3	0.0	0.4	10.7	27.3	0.5	3.0	27.5	21.2	20.9	0.6	12.5	0.0	0.1	8.9	0.3	18.5	0.0	1.2	0.8	1.9	0.0	2.5	9.5	1.7	8.3	0.0	0.0	11.6	2.8	1.1	0.5	1.5	0.6	0.0	0.0	0.0	13.4	0.2	0.0	0.0	0.0	1.6	21.8	0.0	0.1	0.3	6.1	0.0	1.4	0.1	37.5	20.4	0.4	0.0	1.6	0.5	0.1	2.3	0.2	28.6	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.0	9.6	0.0	0.1	16.2	0.1	0.0	0.1	0.0	2.3	0.0	0.0	0.0	45.9	0.0	14.8	1.0	0.0	1.1	1.1	2.1	0.7	2.1	2.3	0.8	1.5	0.6	3.5	1.4	11.9	3.7	3.9	4.6	8.4	0.0	0.8	0.0	2.7	2.3	1.8	0.0	0.1	0.0	5.2	0.0	1.6	42.8	0.0	8.3	0.7	6.8	16.9	1.1	0.0	6.9	0.0	0.0	1.8	39.9	0.2	4.9	17.6	1.7	1.8	2.3	0.0	8.7	17.5	0.0	2.2	0.0	0.0	3.3	0.0	0.2	3.0	0.2	0.0	1.0	12.0
SELENOP	"SELP, SeP, SEPP, SEPP1"	ENSG00000250722	"Selenoprotein P"	P49908	5	42799880-42887392	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 248.3;liver: 403.8"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 416.9;Alveolar cells type 2: 429.0;Hofbauer cells: 658.5;Proximal tubular cells: 719.9"	"Cancer enhanced"	"Detected in all"		"liver cancer: 116.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Hep G2: 92.9;HSkMC: 81.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036287	Approved		Uncertain	"Nucleoplasm,Golgi apparatus"	"Secreted to blood"	2220000000	2300000000	"Nucleoplasm, Golgi apparatus"		"HPA036287: AB_10794618"	"unprognostic (7.96e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.28e-3)"	"unprognostic (1.19e-3)"	"unprognostic (6.67e-2)"	"unprognostic (6.37e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (6.97e-6)"	"unprognostic (1.35e-2)"	"unprognostic (4.19e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.42e-1)"	53.8	31.4	17.5	13.5	54.6	2.2	41.1	11.9	24.0	34.9	56.8	52.8	24.2	40.9	22.3	39.0	20.5	26.2	44.4	26.6	27.6	17.5	57.5	403.8	55.0	30.4	106.2	16.1	49.1	15.3	18.2	21.4	62.7	63.6	30.5	48.5	27.1	19.5	41.2	16.4	18.1	248.3	16.1	137.1	87.1	21.6	19.6	70.3	6.3	24.5	14.7	11.3	30.0	33.0	2.2	3.6	2.2	0.7	2.7	2.4	1.4	0.1	0.3	1.4	0.1	7.7	2.1	1.4	0.6	1.9	0.0	0.0	2.0	11.0	0.3	6.9	0.2	0.2	0.3	0.0	0.0	0.0	0.4	8.9	0.5	0.0	92.9	4.7	0.5	0.0	81.3	0.1	0.0	0.0	0.3	0.0	0.3	1.0	2.2	4.0	0.2	0.1	1.1	5.4	3.1	0.1	0.2	0.3	15.9	2.1	1.3	0.3	0.5	0.5	2.8	0.2	10.6	21.7	0.1	0.1	0.5	0.3	0.9	0.1	1.5	0.2	0.3	0.3	1.0	0.2	0.3	0.6	1.8	2.2	0.6	2.4	1.6	1.6	1.7	1.2	2.2	2.4	2.0	2.2	2.7	0.7	3.6	1.5	1.4	17.5	54.6	11.9	24.0	27.6	17.5	106.2	16.1	63.6	70.3	416.9	429.0	0.0	0.0	0.0	0.0	0.0	0.0	96.4	187.7	118.7	0.0	169.8	167.5	38.5	0.0	0.0	0.0	0.0	45.9	18.4	0.0	0.0	24.4	0.0	658.5	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	1.8	0.0	0.0	47.6	0.0	0.0	719.9	0.0	0.0	0.0	0.0	0.0	0.0	94.4	0.0	0.0	0.0
SERPINA10	"PZI, ZPI"	ENSG00000140093	"Serpin family A member 10"	Q9UK55	14	94280455-94293271	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	223	"liver: 169.5"	"Cell type enriched"	"Detected in some"	9	"Hepatocytes: 200.2"	"Cancer enriched"	"Detected in some"	51	"liver cancer: 40.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	8	"Hep G2: 21.2"	"Not detected"	"Not detected"							HPA048739			Approved	Nucleoplasm,Cytosol	"Secreted to blood"	3960000000	5900000000	Nucleoplasm	Cytosol	"HPA048739: AB_2797237"	"unprognostic (7.14e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (9.00e-4)"	"unprognostic (6.11e-2)"		"unprognostic (2.81e-4)"	"unprognostic (2.31e-4)"	"unprognostic (2.77e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.93e-3)"	0.1	0.0	0.1	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	169.5	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.7	0.1	0.1	0.2	0.0	0.6	0.3	2.1	0.8	0.8	0.8	0.5	0.6	0.6	1.0	0.9	2.6	0.6	2.3	0.4	0.4	0.2	0.3	2.4	0.6	1.5	0.9	1.5	2.1	0.7	21.2	0.5	1.7	1.2	0.7	0.5	0.3	0.8	1.2	1.1	1.1	0.6	1.4	1.1	0.3	1.4	1.1	0.9	0.2	0.6	1.0	1.1	0.9	0.6	0.7	1.0	0.9	0.5	0.5	0.2	1.2	1.5	0.9	0.6	0.8	0.4	0.7	0.6	1.2	0.5	1.0	1.0	1.9	0.5	0.7	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	1.9	0.0	0.0	0.2	0.4	2.5	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	200.2	0.0	0.0	6.3	4.3	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLAMF1	"CD150, SLAM"	ENSG00000117090	"Signaling lymphocytic activation molecule family member 1"	Q13291	1	160608100-160647295	"CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Cell adhesion, Host-virus interaction, Immunity, Innate immunity, Phagocytosis"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 97.8"	"Cell type enhanced"	"Detected in some"	18	"Melanocytes: 13.5;monocytes: 38.7;T-cells: 20.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 24.1"	"Group enriched"	"Detected in many"	10	"B-cells: 8.8;T-cells: 24.1"	"Cell line enriched"	"Detected in single"	111	"HDLM-2: 58.4"									"CAB002438, HPA069319"	Enhanced				"Secreted to blood"		590000			"CAB002438: AB_564011, HPA069319: AB_2732129"	"unprognostic (2.99e-3)"	"unprognostic (3.33e-4)"	"unprognostic (2.93e-4)"	"unprognostic (1.38e-4)"	"unprognostic (5.87e-2)"	"unprognostic (6.06e-5)"	"unprognostic (1.64e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.69e-2)"	"unprognostic (2.74e-4)"	"unprognostic (6.12e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.24e-7)"	"unprognostic (2.46e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.18e-2)"	2.5	0.3	0.3	14.2	0.3	4.4	1.4	0.2	0.3	1.2	2.3	0.4	0.5	2.2	0.5	1.2	2.2	0.8	2.3	1.3	0.2	0.2	2.0	1.0	4.0	14.8	0.2	0.1	0.6	0.9	0.0	0.5	2.3	0.3	1.1	2.1	0.6	4.1	0.6	0.8	1.1	7.6	1.0	0.5	10.6	2.4	0.4	0.2	97.8	1.5	1.9	26.3	3.5	1.1	8.8	1.6	0.2	0.1	0.0	24.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.5	0.0	0.0	0.1	0.0	4.2	0.0	24.1	6.2	17.2	12.1	0.1	8.8	6.6	1.6	0.2	0.0	0.0	1.6	21.5	3.5	0.3	0.3	0.2	0.3	0.2	0.2	0.2	0.1	0.3	0.2	0.0	6.9	8.1	0.1	1.8	0.0	0.2	0.0	0.0	1.2	1.8	0.0	0.0	0.0	0.0	3.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	1.1	0.0	0.3	0.0	0.0	0.0	1.2	6.2	0.0	5.0	13.5	38.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	1.5	0.1	20.2	0.0	0.0
SLIT2	"SLIL3, Slit-2"	ENSG00000145147	"Slit guidance ligand 2"	O94813	4	20253260-20620561	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Chemotaxis, Differentiation, Neurogenesis"	"Developmental protein, Heparin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	12	"Bipolar cells: 46.7;Fibroblasts: 64.7;Leydig cells: 24.5;Peritubular cells: 25.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.4"	"Lineage enriched"	"Detected in single"	4	"monocytes: 1.4"	"Cell line enhanced"	"Detected in many"		"BJ: 28.5;BJ hTERT+: 57.2;BJ hTERT+ SV40 Large T+: 27.8;fHDF/TERT166: 32.3;HBF TERT88: 32.2;HEK 293: 25.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB007590, HPA019511, HPA023088"	Uncertain				"Secreted in other tissues"					"CAB007590: , HPA019511: AB_1857226, HPA023088: AB_1857227"	"unprognostic (1.44e-1)"	"unprognostic (4.54e-2)"	"unprognostic (3.26e-2)"	"unprognostic (6.13e-2)"	"unprognostic (9.01e-3)"	"unprognostic (6.49e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.16e-3)"	"unprognostic (5.32e-2)"	"unprognostic (4.30e-2)"	"prognostic favorable (6.51e-4)"	"unprognostic (4.93e-3)"	"unprognostic (6.80e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.16e-4)"	4.7	18.1	2.8	3.8	9.8	0.0	6.3	0.6	11.5	18.3	7.1	1.2	5.0	1.5	16.7	6.5	6.9	9.1	6.3	5.2	4.5	6.7	8.6	1.0	22.8	1.2	2.4	6.2	6.1	1.7	0.5	6.5	16.8	4.2	9.1	3.6	3.5	4.5	11.6	1.5	2.4	3.0	17.1	1.5	23.1	6.5	3.3	1.0	0.6	6.3	0.7	1.2	8.6	11.0	0.0	0.0	0.3	1.4	0.0	0.0	0.1	0.0	0.0	15.5	0.0	11.0	10.2	0.5	28.5	57.2	27.8	10.5	0.1	0.0	0.0	0.9	32.3	0.0	0.3	4.2	2.1	32.2	0.0	25.5	0.0	0.1	0.0	2.2	0.2	0.0	2.4	0.0	18.0	5.4	0.6	9.5	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.5	0.0	2.0	16.4	0.1	0.0	0.2	0.0	1.0	0.2	0.0	0.0	0.1	0.6	0.0	0.0	0.5	10.4	1.4	10.0	15.5	0.0	0.0	0.0	0.2	0.0	5.6	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.0	0.0	0.1	2.8	9.8	0.6	11.5	4.5	6.7	2.4	6.2	4.2	1.0	0.0	13.6	0.0	1.8	7.1	46.7	3.7	0.0	13.4	2.3	0.0	0.0	1.0	1.7	1.5	0.4	1.8	0.0	0.0	0.4	0.9	64.7	1.6	2.3	0.0	1.7	0.0	1.2	6.2	1.0	1.1	24.5	0.7	8.5	0.0	0.0	0.7	0.2	0.0	25.1	11.4	1.1	6.5	8.2	0.1	1.0	5.8	1.7	0.0	0.0	1.8
SLITRK1	"KIAA1910, LRRC12"	ENSG00000178235	"SLIT and NTRK like family member 1"	Q96PX8	13	83877205-83882393	"Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 30.6"	"Cell type enriched"	"Detected in some"	6	"Bipolar cells: 6.6"	"Cancer enriched"	"Detected in single"	8	"glioma: 1.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A-431: 7.6;AF22: 3.2;LHCN-M2: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074835	Enhanced				"Secreted in brain"		270000			"HPA074835: "	"unprognostic (2.29e-1)"				"unprognostic (4.32e-1)"					"unprognostic (4.71e-2)"	"unprognostic (1.01e-1)"			"unprognostic (1.65e-2)"	"unprognostic (7.95e-2)"			0.9	1.3	16.7	0.9	9.5	0.9	1.0	2.0	30.6	1.2	1.0	6.3	0.0	1.0	1.0	1.0	0.9	0.9	1.0	0.9	16.9	7.3	1.0	0.9	0.9	0.9	7.3	14.9	0.9	3.1	0.9	3.1	0.9	5.8	0.9	1.0	0.1	1.0	1.4	1.0	0.9	0.9	0.9	3.7	0.9	1.0	1.0	8.5	0.0	0.9	0.0	0.9	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	3.2	0.0	0.1	0.8	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	9.5	2.0	21.5	16.9	7.3	7.3	14.9	5.8	8.5	0.0	0.0	0.0	0.0	0.0	6.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SMOC2	SMAP2	ENSG00000112562	"SPARC related modular calcium binding 2"	Q9H3U7	6	168441151-168673445	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Leydig cells: 298.0;Peritubular cells: 723.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"naive B-cell: 3.3"	"Lineage enriched"	"Detected in single"	7	"B-cells: 3.3"	"Cell line enhanced"	"Detected in some"		"AF22: 9.5;EFO-21: 3.3;RPMI-8226: 12.6;RPTEC TERT1: 4.5;SuSa: 11.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"								"Secreted to extracellular matrix"						"unprognostic (3.23e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.77e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.44e-2)"	"prognostic unfavorable (1.16e-6)"	"unprognostic (3.50e-2)"	"unprognostic (2.68e-1)"	"unprognostic (6.35e-2)"	"unprognostic (6.20e-3)"	17.9	3.4	1.9	17.2	5.0	0.0	26.2	0.8	2.3	37.3	11.7	2.5	5.0	5.1	57.7	40.6	17.9	34.4	73.2	25.3	1.9	1.7	3.0	1.3	5.3	4.8	2.7	2.9	45.0	8.5	1.8	1.5	5.4	6.0	22.3	6.4	76.2	6.9	15.1	21.8	8.0	9.4	53.9	1.6	1.3	50.0	31.1	1.3	2.3	13.6	12.3	3.5	36.8	11.4	3.3	0.4	0.0	0.0	0.0	0.0	0.0	2.7	0.0	9.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.4	1.2	0.0	0.0	0.0	0.0	12.6	4.5	0.0	2.0	0.4	0.0	0.4	0.1	11.2	0.0	0.0	0.0	0.0	2.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.9	5.0	0.8	2.3	1.9	1.7	2.7	2.9	6.0	1.3	0.0	1.7	0.0	6.1	9.8	2.8	7.0	0.0	4.0	3.4	10.4	0.0	2.0	0.0	0.0	2.3	3.5	1.6	0.0	0.0	1.6	18.5	5.5	0.0	0.0	1.2	0.0	18.9	4.3	0.0	5.7	298.0	0.6	3.3	0.0	3.0	0.4	0.1	0.0	723.1	0.0	0.6	45.3	73.7	2.7	4.5	2.4	2.2	0.0	12.5	0.6
SORL1	"C11orf32, gp250, LR11, LRP9, SorLA, SorLA-1"	ENSG00000137642	"Sortilin related receptor 1"	Q92673	11	121452203-121633693	"Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Endocytosis, Transport"	Receptor	"Alzheimer disease, Amyloidosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Cone photoreceptor cells: 365.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 43.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 43.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 44.0;Daudi: 20.6;OE19: 28.1;RT4: 31.1;U-698: 42.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011500, HPA031321"	Uncertain				"Secreted to blood"					"CAB011500: AB_443414, HPA031321: AB_2673826"	"unprognostic (1.54e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.08e-2)"	"unprognostic (9.53e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.80e-7)"	"unprognostic (2.48e-1)"	"unprognostic (1.87e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.21e-2)"	5.6	5.0	17.3	17.0	24.9	30.7	10.5	28.3	40.8	34.8	12.7	36.0	9.9	8.6	4.5	7.2	5.7	29.4	5.8	3.0	22.4	18.7	15.0	41.4	10.0	14.8	28.6	21.9	7.3	6.1	19.9	17.7	2.1	24.0	16.0	12.7	6.4	14.7	20.0	1.5	3.9	13.0	3.8	27.8	21.3	7.9	4.1	23.4	11.1	10.3	0.2	16.3	15.8	6.7	2.0	5.6	43.8	5.4	6.7	10.8	6.1	0.4	2.4	2.2	0.3	0.0	0.0	2.3	0.1	0.7	0.1	0.0	3.6	44.0	20.6	2.6	0.5	3.3	14.6	2.8	2.1	0.0	0.0	0.8	0.0	3.2	5.0	0.0	8.7	0.0	0.0	2.4	0.0	8.1	1.2	0.0	2.6	0.0	0.2	0.0	2.9	2.0	4.5	2.7	28.1	3.3	2.3	0.1	0.4	4.9	31.1	1.6	0.4	4.6	6.6	0.0	5.2	6.5	2.8	0.1	0.0	1.6	0.3	0.0	0.0	0.0	42.8	0.0	11.7	0.1	13.0	5.4	19.1	8.0	2.3	10.8	0.7	9.0	7.2	2.2	2.0	8.6	7.6	43.8	6.7	2.8	5.6	6.3	6.1	17.3	24.9	28.3	40.8	22.4	18.7	28.6	21.9	24.0	23.4	6.0	24.6	10.4	32.9	3.9	40.9	9.0	25.5	10.7	27.3	75.0	365.2	0.4	0.0	6.5	0.9	3.2	87.9	0.0	0.6	0.6	5.9	40.6	11.5	98.3	41.1	47.7	5.8	27.0	56.2	1.8	72.2	49.6	3.3	19.8	48.5	34.5	4.5	87.7	54.5	0.9	28.0	0.0	12.0	0.7	21.5	2.0	0.3	55.8	35.3	25.8
SPACA3	"ALLP17, CT54, LYC3, LYZL3, SLLP1"	ENSG00000141316	"Sperm acrosome associated 3"	Q8IXA5	17	32970376-32997877	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"pancreas: 15.0;testis: 45.6"	"Group enriched"	"Detected in some"	70	"Early spermatids: 974.2;Late spermatids: 721.4"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 0.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"memory B-cell: 3.9"	"Lineage enriched"	"Detected in single"	4	"B-cells: 3.9"	"Cell line enriched"	"Detected in some"	17	"U-266/70: 47.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA023633	Enhanced				"Secreted in male reproductive system"					"HPA023633: AB_1857407"	"unprognostic (6.48e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.31e-2)"		"unprognostic (3.37e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.70e-4)"			"unprognostic (3.86e-2)"	"unprognostic (1.79e-1)"		"unprognostic (4.63e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	15.0	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	45.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	3.9	0.9	0.2	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	47.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.9	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	974.2	0.0	0.7	0.0	0.9	0.0	0.1	0.0	3.5	0.0	0.1	0.0	0.0	0.0	0.0	721.4	12.0	0.0	1.7	0.0	0.6	0.0	0.7	0.3	4.6	0.0	0.0	6.5	0.0	8.8	5.1	0.0	0.0	0.0	0.6	0.0
SPINT1	"HAI, MANSC2"	ENSG00000166145	"Serine peptidase inhibitor, Kunitz type 1"	O43278	15	40844018-40858207	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 121.0"	"Cell type enhanced"	"Detected in many"	13	"Cytotrophoblasts: 913.5;Syncytiotrophoblasts: 1399.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 52.1;HaCaT: 59.5;hTCEpi: 42.4;RT4: 48.2;SK-BR-3: 89.3;T-47d: 42.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA006903, HPA031178"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"		3400000	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA006903: AB_1079038, HPA031178: AB_2732463"	"prognostic unfavorable (6.97e-4)"	"unprognostic (1.00e-3)"	"unprognostic (3.00e-3)"	"unprognostic (5.03e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.19e-1)"	"unprognostic (5.94e-2)"	"unprognostic (6.04e-2)"	"unprognostic (8.24e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.37e-7)"	"unprognostic (5.37e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.17e-2)"	2.2	0.5	0.9	11.6	1.2	0.0	12.6	2.9	0.8	12.9	64.4	1.2	38.6	31.9	3.6	25.5	71.1	6.4	30.7	0.8	0.8	0.7	27.9	1.5	18.5	3.7	0.9	0.6	3.4	25.0	28.8	9.7	85.5	1.3	17.5	17.9	3.2	50.8	24.0	0.6	39.1	121.0	2.3	1.0	3.1	17.6	1.9	0.7	4.8	15.4	26.9	44.3	12.8	21.5	5.1	19.0	15.3	10.9	3.6	1.8	3.8	19.0	0.1	0.0	0.1	0.0	0.0	52.1	0.3	0.4	0.6	0.3	30.4	32.0	0.0	22.8	0.0	0.5	59.5	4.9	28.6	0.4	0.1	1.6	0.8	0.5	1.6	0.3	3.3	15.1	0.0	42.4	0.6	2.7	0.5	2.3	1.9	0.4	0.1	0.0	14.8	0.1	2.5	5.9	32.2	2.8	1.9	0.0	3.7	28.8	48.2	12.8	0.6	1.4	89.3	2.3	9.6	42.7	2.5	0.0	0.0	0.3	0.1	0.0	0.1	3.6	0.1	0.1	2.5	0.1	0.0	10.9	7.9	0.3	9.3	0.5	5.1	1.8	0.8	19.0	3.9	0.7	0.2	15.3	3.6	9.6	2.3	0.2	3.8	0.9	1.2	2.9	0.8	0.8	0.7	0.9	0.6	1.3	0.7	53.6	17.1	2.7	86.0	67.5	0.0	0.4	109.5	4.0	18.2	127.4	0.0	913.5	21.6	354.0	0.5	0.7	428.8	0.0	224.2	67.1	7.5	132.0	10.3	0.4	125.6	0.0	141.5	0.0	13.6	0.8	3.4	17.8	13.5	101.8	147.7	0.0	241.9	199.9	0.0	40.0	0.1	0.0	5.2	0.6	5.2	76.9	1399.8	2.2	145.0	168.6
SPTY2D1OS	SPTY2D1-AS1	ENSG00000247595	"SPTY2D1 opposite strand"		11	18588781-18610255	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	18	"testis: 70.2"	"Cell type enhanced"	"Detected in some"	18	"Collecting duct cells: 5.2;Distal tubular cells: 19.9;Proximal tubular cells: 6.7"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 7.0;HeLa: 10.2"														"Secreted in male reproductive system"						"unprognostic (1.07e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.60e-3)"	"unprognostic (5.14e-2)"	"unprognostic (6.61e-2)"	"unprognostic (9.32e-2)"	"unprognostic (4.44e-7)"	"unprognostic (1.75e-1)"	"unprognostic (1.39e-2)"	"unprognostic (7.83e-2)"	"unprognostic (5.36e-2)"	"unprognostic (6.50e-3)"	"unprognostic (5.41e-4)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.48e-2)"	0.1	0.2	0.1	0.1	0.1	0.0	0.4	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.2	1.4	0.1	0.1	0.1	0.1	0.1		0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.2	0.3	0.2	0.1	0.1	0.1	3.9	0.1	0.1	0.1	0.1	0.0	70.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.9	0.6	2.6	1.0	1.0	2.4	0.8	0.7	7.0	2.8	3.8	2.5	3.7	3.5	0.5	0.8	1.4	1.7	5.2	2.0	1.2	0.4	0.6	1.5	1.4	0.0	0.0	0.0	2.1	2.5	0.7	10.2	6.5	0.4	0.9	2.3	1.4	0.5	0.3	2.3	1.9	1.4	0.0	1.9	0.6	0.5	2.4	0.4	2.6	1.9	1.6	4.3	0.3	0.9	0.4	2.8	2.8	0.9	0.5	2.6	0.1	0.1	1.0	1.4	0.4	1.4	2.7	2.2	1.5	0.3	0.1	0.3	0.0	1.1	1.3	1.8	1.3	1.0	2.6	1.0	0.2	2.4	0.3	0.6	0.3	0.2	0.9	0.4	0.6	2.4	1.0	0.5	0.6	1.5	0.8											3.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.3	5.2	0.0	0.8	19.9	2.9	0.0	0.0	0.0	0.0	4.1	0.9	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.8	0.0	0.0	2.7	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0
TECTA	"DFNA12, DFNA8, DFNB21"	ENSG00000109927	"Tectorin alpha"	O75443	11	121101173-121191493	"Disease related genes, Predicted membrane proteins, Predicted secreted proteins"	Hearing		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 5.5"	"Cell type enhanced"	"Detected in some"	15	"Alveolar cells type 1: 3.0;Cone photoreceptor cells: 3.9;Early spermatids: 5.6;Ito cells: 9.8"	"Low cancer specificity"	"Detected in single"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 3.5;SH-SY5Y: 5.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA018870	Approved				"Secreted in other tissues"					"HPA018870: AB_1857879"	"unprognostic (1.12e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.45e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.00e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.39e-6)"	"unprognostic (1.22e-1)"	"unprognostic (4.15e-3)"	"unprognostic (6.97e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.28e-2)"	"unprognostic (4.19e-2)"	0.6	1.6	1.1	0.4	3.5	0.4	0.6	2.9	5.5	0.4	0.5			0.2	0.6	1.8	0.1	0.6	0.7	2.1	1.3	2.6	0.7	0.9	1.1	0.2	1.4		1.6	0.7	4.2	2.5	0.6		0.9	0.3		0.5	1.6	1.0	0.2	0.2	0.6	1.0	0.4	0.4	2.0			1.4		0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.1	3.5	1.8	0.1	0.2	0.5	0.5	0.3	0.1	0.2	0.3	0.0	0.2	1.7	0.2	0.2	0.0	0.7	0.0	0.2	0.7	0.9	0.5	0.1	0.0	0.3	0.5	0.3	0.4	0.6	0.1	0.0	0.5	0.4	0.7	0.0	1.2	0.4	0.2	0.2	1.3	0.7	0.0	0.1	0.1	0.6	0.1	0.5	0.1	2.4	5.5	0.3	0.2	0.3	2.3	0.3	0.5	0.0	0.4	0.5	0.2	0.4	1.3	1.3	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.3											3.0	0.3	0.0	0.1	0.0	1.9	1.7	0.0	0.0	1.2	0.0	3.9	0.0	0.0	0.3	5.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	9.8	0.3	1.6	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0
TECTB		ENSG00000119913	"Tectorin beta"	Q96PL2	10	112283400-112305035	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	4	"retina: 15.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"Hep G2: 7.4;U-2197: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"								"Secreted in other tissues"								"unprognostic (3.14e-2)"		"unprognostic (2.84e-2)"		"unprognostic (9.75e-3)"				"unprognostic (1.65e-1)"	"unprognostic (1.32e-2)"		"unprognostic (5.54e-2)"	"unprognostic (2.80e-2)"	"unprognostic (8.10e-2)"		0.1	0.0	0.8	0.1	1.3	0.0	0.1	0.1	0.8	0.1	0.1	0.1	0.1	0.1	0.1	3.5	0.1	0.0	0.1	0.1	0.4	0.2	0.1	2.4	0.1	0.1	0.9	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.0	15.8	0.1	0.1	0.1	0.0	0.3	0.1	0.5	0.1	0.0	0.2	0.1	0.1	1.4	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.3	0.1	0.3	0.4	0.2	0.9	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
TEK	"CD202b, TIE-2, TIE2, VMCM, VMCM1"	ENSG00000120156	"TEK receptor tyrosine kinase"	Q02763	9	27109141-27230175	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"Endothelial cells: 58.3;Ito cells: 110.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.2"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.2"	"Group enriched"	"Detected in some"	4	"HUVEC TERT2: 36.5;NTERA-2: 18.2;TIME: 39.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010359, HPA073265"	Approved		Supported	"Plasma membrane,Centriolar satellite"	"Secreted to blood"	7750000	8300000	"Plasma membrane"	"Centriolar satellite"	"CAB010359: AB_2203226, HPA073265: AB_2686592"	"unprognostic (2.24e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.26e-3)"	"prognostic favorable (2.31e-5)"	"unprognostic (7.48e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.72e-1)"	"prognostic favorable (7.81e-4)"	"unprognostic (7.50e-3)"	"unprognostic (6.87e-3)"	"unprognostic (1.83e-1)"	"unprognostic (5.24e-3)"	28.6	7.8	8.1	4.6	5.9	0.4	17.9	3.4	5.4	10.8	4.7	4.6	3.4	3.2	14.5	5.3	6.7	5.9	9.1	13.0	7.1	6.1	25.4	8.7	27.8	2.9	6.9	3.4	6.1	4.5	3.5	4.0	36.3	6.9	5.4	4.7	12.4	3.4	5.5	7.8	3.0	5.3	10.6	5.3	23.4	4.0	3.7	3.5	0.3	9.7	8.4	2.4	6.4	12.4	0.0	0.1	2.2	0.6	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.2	2.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	1.0	0.0	0.7	0.0	0.0	0.7	0.0	0.9	0.3	0.0	36.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.8	0.0	0.0	39.6	0.0	0.2	3.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	8.1	5.9	3.4	5.4	7.1	6.1	6.9	3.4	6.9	3.5	3.0	2.2	0.0	0.0	1.3	0.0	7.8	0.0	0.0	1.2	1.8	0.0	0.4	0.0	0.0	0.6	58.3	0.0	0.0	0.0	1.5	2.4	0.2	0.0	0.8	0.2	0.0	0.0	110.5	10.4	0.4	0.6	0.9	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.2	0.0	0.4	0.0	0.2	1.1	1.1	0.0	0.0	0.0
TEX101	"CT131, MGC4766, SGRG, SPATA44"	ENSG00000131126	"Testis expressed 101"	Q9BY14	19	43401496-43418597	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	62	"blood: 24.5;testis: 56.6"	"Cell type enriched"	"Detected in some"	15	"Spermatocytes: 911.6"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	246	"basophil: 24.5"	"Lineage enriched"	"Detected in single"	246	"granulocytes: 24.5"	"Cell line enhanced"	"Detected in many"		"THP-1: 4.9"									"HPA041915, HPA042513"	Enhanced				"Secreted in male reproductive system"					"HPA041915: AB_10795268, HPA042513: AB_10795507"	"unprognostic (2.50e-2)"	"unprognostic (5.67e-4)"	"unprognostic (2.64e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.78e-4)"		"unprognostic (1.70e-1)"	"unprognostic (2.84e-2)"	"unprognostic (6.54e-2)"	"unprognostic (4.06e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.67e-7)"	"unprognostic (8.83e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.49e-2)"	"unprognostic (7.04e-2)"	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.5	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.5	0.2	0.1	0.1	0.1	0.0	56.6	0.1	0.1	0.1	0.1	0.4	0.1	0.3	0.0	0.0	24.5	0.0	0.0	0.0	0.0	0.9	0.6	1.3	0.7	1.0	2.4	0.7	0.4	0.6	1.0	1.0	0.2	0.4	0.4	1.0	1.6	1.1	0.4	0.4	1.0	0.7	1.2	0.0	0.3	1.3	0.4	2.0	0.4	0.9	1.2	1.6	0.1	1.0	0.9	2.0	1.1	0.3	1.0	1.1	0.2	0.6	1.0	0.7	0.8	1.0	2.7	0.2	1.3	2.3	0.2	0.9	0.4	0.3	0.8	2.3	0.7	0.3	4.9	0.4	0.8	0.8	0.8	1.4	1.0	1.2	0.6	0.9	0.7	0.6	24.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.7	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	32.3	0.0	911.6	62.4	0.0	0.0	0.0	0.0	0.0
TEX264	"FLJ13935, ZSIG11"	ENSG00000164081	"Testis expressed 264"	Q9Y6I9	3	51662693-51704323	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 310.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005002, HPA017739"	Enhanced		Approved	Nucleoli,Cytosol	"Secreted - unknown location"			"Nucleoli, Cytosol"		"CAB005002: AB_425976, HPA017739: AB_1857910"	"unprognostic (2.80e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.79e-3)"	"unprognostic (8.11e-2)"	"unprognostic (8.26e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.06e-3)"	"unprognostic (2.30e-1)"	"unprognostic (5.19e-2)"	"prognostic favorable (5.67e-4)"	"unprognostic (1.83e-1)"	"prognostic favorable (7.95e-9)"	"unprognostic (4.99e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.17e-1)"	"unprognostic (4.67e-2)"	15.7	34.6	15.1	15.3	18.7	9.0	20.0	8.6	22.8	17.5	21.3	15.0	36.0	18.7	20.1	25.5	17.7	21.9	24.8	19.0	14.6	15.6	35.9	30.7	17.0	22.6	15.7	17.9	15.8	29.0	29.9	12.3	24.5	12.2	20.3	16.7	22.6	43.6	44.3	16.3	29.5	20.8	16.6	15.8	18.6	19.0	90.8	11.5	16.6	33.9	18.5	15.9	16.7	16.3	33.1	34.5	24.7	36.7	22.8	50.7	41.1	11.8	21.8	3.9	20.1	40.7	19.8	8.0	10.2	24.2	17.0	17.2	11.6	28.2	17.1	7.5	14.6	28.8	11.6	11.0	20.6	8.3	13.7	17.6	16.3	13.6	15.4	36.3	10.2	18.3	26.1	32.9	19.2	19.7	15.5	12.4	13.0	8.5	29.9	17.5	13.7	16.3	23.8	4.3	19.6	24.5	7.9	5.2	32.2	26.8	16.5	5.6	9.2	12.5	34.5	15.7	5.6	16.8	21.7	9.1	17.2	7.2	18.0	13.5	20.9	22.5	8.4	21.0	21.6	17.1	24.7	36.7	21.7	41.9	36.7	41.9	32.2	43.5	39.7	34.5	33.1	36.5	37.0	7.7	22.8	34.7	30.5	50.7	41.1	15.1	18.7	8.6	22.8	14.6	15.6	15.7	17.9	12.2	11.5	32.8	15.0	27.5	46.0	30.9	30.1	22.8	53.5	25.4	28.4	94.2	55.0	125.5	53.0	63.6	30.2	49.7	69.9	0.0	67.2	73.8	45.6	36.2	16.1	51.7	92.2	39.7	31.6	28.3	36.7	48.4	47.2	49.0	62.4	55.9	51.0	59.8	56.9	65.4	46.0	101.0	46.9	25.8	20.0	310.0	58.8	30.9	63.8	52.4	81.7	32.5
TFRC	"CD71, p90, TFR1"	ENSG00000072274	"Transferrin receptor"	P02786	3	196027183-196082189	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Endocytosis, Host-virus interaction"	"Host cell receptor for virus entry, Receptor, Transducer"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 110.0"	"Cell type enhanced"	"Detected in many"	10	"Erythroid cells: 560.6;Syncytiotrophoblasts: 420.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000153, HPA028598"	Enhanced		Supported	Endosomes,Lysosomes	"Secreted to blood"	1310000000	14000000	"Endosomes, Lysosomes"		"CAB000153: AB_2533029, HPA028598: AB_10601599"	"unprognostic (2.95e-2)"	"prognostic unfavorable (3.67e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.48e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.88e-3)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (6.92e-2)"	"unprognostic (3.30e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.63e-3)"	"unprognostic (3.65e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (2.96e-4)"	"unprognostic (2.62e-2)"	24.3	11.9	11.9	20.6	11.3	73.8	7.6	9.6	17.8	11.8	25.0	9.5	3.8	11.9	12.1	7.5	18.5	11.7	11.4	18.7	9.5	8.3	15.3	13.6	28.1	8.1	7.4	9.5	50.0	7.8	18.0	6.9	110.0	26.5	7.2	19.4	8.5	8.3	5.0	25.6	9.9	37.4	10.9	13.2	7.9	10.0	8.3	6.1	14.3	7.0	10.5	12.9	11.2	8.0	5.7	7.5	2.2	12.4	1.8	6.5	2.1	22.2	20.2	9.3	18.9	20.6	12.0	58.3	31.8	24.2	22.4	37.2	49.3	20.5	22.8	60.4	11.8	49.0	34.3	31.9	10.5	27.5	109.0	10.8	86.4	17.3	22.9	16.3	70.8	17.5	13.5	10.4	19.3	17.4	6.4	7.4	12.6	36.0	21.9	17.5	20.6	23.2	15.0	28.4	29.3	41.5	12.3	13.8	27.3	20.1	56.3	21.3	8.8	30.7	80.8	7.2	16.1	78.4	14.8	9.5	26.7	21.7	23.3	47.6	6.2	48.1	35.6	31.2	19.2	16.1	0.0	1.6	2.2	2.5	7.9	1.7	5.7	2.7	1.7	3.7	3.2	2.5	1.9	0.3	1.8	12.4	7.5	6.5	2.1	11.9	11.3	9.6	17.8	9.5	8.3	7.4	9.5	26.5	6.1	41.7	27.2	29.6	33.6	53.5	48.1	81.5	45.9	28.1	26.1	19.2	139.4	104.0	0.0	43.1	2.6	17.8	72.1	560.6	36.6	18.5	33.8	15.8	22.0	94.1	70.3	12.7	53.9	6.7	33.3	3.9	10.6	89.7	16.9	72.1	50.0	17.3	38.9	52.6	8.1	9.1	42.4	25.8	34.8	22.3	19.3	31.2	420.4	21.8	70.2	22.9
TGFA		ENSG00000163235	"Transforming growth factor alpha"	P01135	2	70447280-70554193	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Ductal cells: 36.6;Pancreatic endocrine cells: 47.6;Urothelial cells: 56.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 6.3;eosinophil: 14.0;neutrophil: 14.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 14.7"	"Cell line enhanced"	"Detected in many"		"A-431: 24.0;CAPAN-2: 29.7;HBEC3-KT: 25.9;OE19: 19.0;RPTEC TERT1: 26.1;U-87 MG: 24.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042297	Approved		Approved	Vesicles	"Secreted to blood"	57900		Vesicles		"HPA042297: AB_10793878"	"unprognostic (1.23e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.57e-3)"	"unprognostic (6.39e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.49e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.00e-3)"	"unprognostic (6.69e-2)"	"unprognostic (9.21e-2)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (7.74e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.21e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (9.19e-2)"	2.0	0.5	8.4	4.3	10.7	1.2	6.2	3.5	7.9	5.7	9.4	21.4	0.3	7.4	1.2	2.8	23.8	5.7	14.6	0.8	10.7	6.9	12.4	4.0	3.5	4.2	10.9	5.2	0.5	12.0	1.0	0.8	1.7	9.4	2.2	7.3	9.7	6.3	1.2	0.4	10.8	13.7	1.3	22.5	5.1	7.6	2.3	12.8	0.2	7.4	17.4	12.1	5.4	10.8	0.0	0.6	14.7	0.4	0.2	2.7	0.4	24.0	3.8	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.1	0.0	0.0	29.7	0.0	15.3	0.1	4.1	12.9	0.2	25.9	0.0	0.0	0.6	0.0	0.6	2.0	0.0	0.3	0.0	0.0	10.4	0.0	10.2	1.2	0.0	1.9	0.0	0.1	0.0	0.9	0.0	0.5	0.4	19.0	7.3	0.0	0.1	6.3	26.1	9.3	0.2	0.0	2.0	0.0	0.0	0.0	3.3	0.2	0.2	0.1	1.8	0.0	5.3	0.1	0.1	0.0	24.6	0.8	8.9	6.3	0.4	14.0	1.0	0.1	2.7	0.0	0.6	0.6	0.6	0.0	0.3	0.2	14.7	0.2	0.0	0.0	0.0	0.4	8.4	10.7	3.5	7.9	10.7	6.9	10.9	5.2	9.4	12.8	6.0	2.4	0.0	6.5	14.3	1.4	1.4	28.1	12.0	6.8	24.4	0.0	0.0	1.7	36.6	14.8	1.2	14.9	0.0	8.8	0.0	0.5	11.0	5.7	1.5	3.0	0.0	1.2	0.0	2.2	1.4	0.3	3.1	0.0	30.7	5.8	8.6	47.6	8.5	0.0	6.1	0.7	0.0	0.9	0.0	0.2	21.8	0.0	2.2	4.7	56.3
TGFBR3	"betaglycan, BGCAN"	ENSG00000069702	"Transforming growth factor beta receptor 3"	Q03167	1	91680343-91906335	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Fibroblasts: 105.0;Ito cells: 311.2;Leydig cells: 135.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 21.3;MAIT T-cell: 11.6;memory CD4 T-cell: 5.4;memory CD8 T-cell: 11.4;naive CD8 T-cell: 8.0;NK-cell: 9.0"	"Group enriched"	"Detected in many"	22	"NK-cells: 9.0;T-cells: 21.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 67.2;ASC TERT1: 32.8;U-2197: 22.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008257, CAB018971"	Supported		Approved	Cytosol	"Secreted to blood"		29000000	Cytosol		"CAB018971: , HPA008257: AB_1080258"	"unprognostic (7.57e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (3.36e-4)"	"unprognostic (9.39e-3)"	"prognostic favorable (4.84e-4)"	"unprognostic (2.07e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.79e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (4.99e-4)"	"unprognostic (2.46e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (1.08e-2)"	40.1	15.9	3.2	6.8	3.1	1.6	63.5	1.8	4.4	30.1	15.2	3.5	30.0	3.4	17.6	21.0	22.2	17.6	23.3	16.3	3.9	1.9	12.5	11.9	18.4	18.1	2.6	2.0	62.4	8.9	4.4	4.4	25.1	4.5	21.7	5.6	8.8	14.7	46.5	19.2	13.4	9.8	34.4	4.1	27.1	11.1	14.0	3.0	1.1	7.5	6.5	3.1	39.2	42.1	0.0	0.6	0.6	0.6	9.0	21.3	3.9	2.7	2.7	4.1	0.7	67.2	32.8	13.0	2.0	10.2	2.4	2.9	1.2	0.4	0.0	0.5	3.7	1.9	0.4	1.0	0.3	1.8	9.5	2.2	0.0	3.4	11.3	1.4	0.1	0.0	7.9	1.3	5.2	1.2	0.3	1.2	0.0	6.5	0.2	0.7	0.0	0.0	0.0	1.7	1.2	0.9	0.1	1.4	0.5	0.9	16.4	0.1	0.0	1.0	0.0	5.7	1.7	0.3	1.0	3.6	4.0	1.0	22.8	0.4	10.1	0.9	0.0	0.8	0.5	0.5	0.6	0.0	0.0	21.3	0.1	11.6	0.0	5.4	11.4	0.0	0.0	1.7	8.0	0.3	9.0	0.6	0.6	2.4	3.9	3.2	3.1	1.8	4.4	3.9	1.9	2.6	2.0	4.5	3.0	8.9	11.9	3.0	10.4	33.4	0.2	17.3	28.1	6.7	6.8	29.6	2.0	23.5	3.3	1.7	48.3	64.2	0.7	23.3	4.2	9.3	105.0	7.3	2.3	17.8	9.7	0.0	23.1	311.2	19.6	18.5	135.4	3.8	33.7	0.0	0.5	2.2	3.5	0.0	70.0	15.9	0.2	12.9	35.4	0.7	1.7	29.7	48.5	30.5	2.3	5.4
THSD4	"ADAMTSL6, FLJ13710, FVSY9334, PRO34005"	ENSG00000187720	"Thrombospondin type 1 domain containing 4"	Q6ZMP0	15	71096952-71783383	"Predicted membrane proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 60.5"	"Cell type enhanced"	"Detected in many"	9	"Basal glandular cells: 104.8;Cardiomyocytes: 53.7;Glandular cells: 73.8;Peritubular cells: 70.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 19.3;ASC TERT1: 18.1;BJ hTERT+: 23.0;T-47d: 18.8;TIME: 28.5;U-2197: 19.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted - unknown location"						"unprognostic (1.59e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.80e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.01e-3)"	2.4	4.6	1.5	3.6	2.7	0.2	8.5	1.4	3.0	60.5	8.7	2.4	5.1	4.3	19.9	12.8	36.9	20.3	18.7	17.4	2.1	2.0	5.1	3.3	5.0	2.3	2.7	4.2	8.0	8.7	1.2	4.5	12.4	5.3	19.0	4.0	29.7	6.5	8.8	1.6	4.4	8.4	10.6	6.4	1.2	6.2	3.9	1.4	0.0	6.6	13.3	5.3	7.2	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	19.3	0.3	5.6	3.0	18.1	0.0	9.4	23.0	4.9	2.5	0.1	3.7	0.0	7.8	3.3	17.0	7.2	0.7	3.9	3.0	0.8	0.8	0.0	2.0	0.0	1.9	0.0	0.0	1.3	2.9	2.9	11.8	13.4	8.9	0.0	0.0	0.2	4.0	3.8	0.0	0.0	1.7	0.0	3.4	0.0	0.3	0.3	13.0	2.6	0.3	2.4	3.7	4.7	0.0	2.3	18.8	0.0	28.5	0.1	0.4	19.4	5.0	0.0	0.1	0.0	4.6	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.7	1.4	3.0	2.1	2.0	2.7	4.2	5.3	1.4	17.9	7.0	0.0	104.8	12.4	2.6	53.7	45.9	13.4	5.7	5.2	5.9	0.3	1.7	16.1	6.1	11.9	10.5	0.0	1.6	0.2	10.3	73.8	0.0	10.6	0.2	0.0	2.9	6.7	0.0	11.4	16.1	0.9	8.5	0.0	3.6	0.0	8.6	5.8	70.0	0.3	0.8	0.0	3.8	1.0	1.5	9.5	0.7	0.0	10.9	25.5
THSD7A	KIAA0960	ENSG00000005108	"Thrombospondin type 1 domain containing 7A"	Q9UPZ6	7	11370357-11832198	"Predicted membrane proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 22.5"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 104.8;Cone photoreceptor cells: 106.0;Horizontal cells: 197.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	76	"basophil: 7.5"	"Lineage enriched"	"Detected in single"	76	"granulocytes: 7.5"	"Cell line enhanced"	"Detected in some"		"A549: 9.7;HUVEC TERT2: 6.5;REH: 6.6;SH-SY5Y: 9.9;THP-1: 17.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000923	Supported				"Secreted to blood"		3000000			"HPA000923: AB_1080271"	"unprognostic (3.01e-1)"	"unprognostic (7.90e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.88e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.66e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.75e-2)"	"prognostic favorable (2.24e-6)"	"unprognostic (2.13e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.28e-2)"	"unprognostic (3.33e-2)"	9.6	2.2	4.7	2.1	5.7	0.6	5.2	2.0	7.2	8.4	2.7	1.0	0.9	1.2	8.3	2.7	1.7	4.8	6.2	2.1	3.8	4.7	17.7	2.0	3.0	1.2	4.6	3.6	6.4	1.4	2.6	9.4	22.5	3.5	8.4	2.1	4.4	1.7	5.5	0.9	1.7	1.5	5.9	4.3	2.3	1.7	2.2	1.9	0.0	4.9	2.5	1.1	4.5	6.8	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	9.7	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.0	1.7	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	1.5	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	6.6	0.0	0.0	0.3	0.1	0.7	9.9	0.0	0.3	0.0	1.6	0.1	17.9	3.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	5.7	2.0	7.2	3.8	4.7	4.6	3.6	3.5	1.9	20.8	8.0	0.0	1.6	2.4	104.8	1.1	22.9	0.0	4.5	52.4	106.0	14.0	6.6	5.5	1.0	31.5	0.0	0.0	1.9	4.9	9.8	2.1	0.0	1.0	2.0	197.0	40.1	21.5	1.9	0.2	22.5	0.8	11.8	0.0	0.0	22.3	4.4	1.5	1.4	8.6	7.4	0.0	1.4	1.7	0.4	2.0	43.4	0.0	0.5	0.6
TMEFF2	"CT120.2, HPP1, TENB2, TPEF, TR"	ENSG00000144339	"Transmembrane protein with EGF like and two follistatin like domains 2"	Q9UIK5	2	191949043-192195709	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.6;prostate: 46.3;seminal vesicle: 17.5"	"Group enriched"	"Detected in some"	6	"Horizontal cells: 96.9;Leydig cells: 24.5"	"Cancer enriched"	"Detected in some"	21	"prostate cancer: 57.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 17.3;LHCN-M2: 49.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015587	Approved				"Secreted in male reproductive system"					"HPA015587: AB_1858069"	"unprognostic (2.12e-3)"	"unprognostic (5.37e-1)"	"unprognostic (3.10e-1)"	"unprognostic (5.89e-7)"	"unprognostic (4.96e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.79e-2)"	"unprognostic (4.17e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.20e-1)"	1.1	3.8	20.2	1.1	14.7	1.0	1.1	7.4	29.6	1.1	2.0	18.4	1.7	1.7	1.0	11.1	2.4	1.1	3.0	1.4	17.7	18.5	1.0	1.0	1.1	1.0	15.7	17.7	1.1	1.1	1.1	0.4	1.0	11.1	46.3	2.8	2.8	1.1	17.5	1.3	1.1	1.7	1.1	11.1	1.1	1.4	1.8	15.9	0.0	1.1	0.0	1.2	1.4	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	17.3	0.0	2.7	2.8	0.0	0.0	0.3	0.8	1.0	0.0	0.0	0.0	0.0	4.7	2.1	0.0	1.0	0.0	3.3	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	7.5	0.0	0.9	5.1	4.2	0.0	0.0	0.0	0.0	49.6	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.1	1.3	0.0	0.0	0.0	3.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	14.7	7.4	22.7	17.7	18.5	15.7	17.7	11.1	15.9	0.0	0.0	0.0	0.1	0.1	9.9	1.6	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.2	4.0	0.0	0.0	0.0	96.9	0.0	0.0	0.0	0.7	24.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	8.1	0.0	1.3	6.5	0.4	1.2	2.5	0.3	0.0	0.0	0.0	0.0
TNFRSF18	"AITR, CD357, GITR"	ENSG00000186891	"TNF receptor superfamily member 18"	Q9Y5U5	1	1203508-1206691	"CD markers, Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 46.6;skin 1: 28.9"	"Group enriched"	"Detected in many"	5	"Basal keratinocytes: 167.9;granulocytes: 46.0;Melanocytes: 47.2;Suprabasal keratinocytes: 131.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"NK-cell: 46.6"	"Group enriched"	"Detected in many"	11	"NK-cells: 46.6;T-cells: 19.0"	"Group enriched"	"Detected in some"	11	"RPMI-8226: 62.6;SCLC-21H: 45.0"									HPA008025	Approved				"Secreted to blood"					"HPA008025: AB_1849696"	"unprognostic (1.20e-3)"	"unprognostic (4.61e-2)"	"unprognostic (4.59e-2)"	"prognostic favorable (7.72e-6)"	"unprognostic (2.73e-4)"	"prognostic favorable (4.12e-4)"	"unprognostic (3.43e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (4.40e-11)"	"unprognostic (1.02e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.74e-1)"	"unprognostic (2.08e-1)"	1.4	0.5	1.0	8.9	1.0	1.9	4.2	4.9	2.5	14.3	8.3	0.3	0.1	5.7	2.1	1.1	4.7	1.0	3.7	0.2	0.5	0.3	1.1	1.7	3.0	9.1	0.4	2.4	0.3	2.7	9.4	3.8	1.3	1.7	1.9	1.2	0.5	9.0	2.6	1.0	28.9	5.0	0.2	0.3	6.7	3.8	0.8	0.1	4.4	0.9	2.7	8.2	1.5	2.2	2.9	0.0	0.2	0.0	46.6	19.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	4.7	0.0	0.0	62.6	0.1	0.0	45.0	0.0	0.0	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.0	0.0	3.6	1.3	8.5	1.2	0.0	2.9	0.3	0.4	0.2	46.6	0.0	0.0	19.0	2.1	1.0	1.0	4.9	2.5	0.5	0.3	0.4	2.4	1.7	0.1	0.0	2.2	7.5	10.8	167.9	0.0	2.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.7	0.0	1.0	0.0	0.0	0.5	0.9	11.2	7.3	46.0	0.0	0.8	0.0	3.4	1.3	0.8	0.0	0.0	1.8	47.2	21.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	131.6	0.0	20.8	0.0	3.3
TNFRSF1A	"CD120a, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR60"	ENSG00000067182	"TNF receptor superfamily member 1A"	P19438	12	6328757-6342114	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Apoptosis, Host-virus interaction"	Receptor	"Amyloidosis, Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 86.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004102, CAB010309"	Approved				"Secreted to blood"		170000			"CAB010309: AB_2206639, HPA004102: AB_1846232"	"unprognostic (2.19e-2)"	"unprognostic (3.76e-2)"	"unprognostic (8.14e-2)"	"prognostic favorable (8.22e-4)"	"unprognostic (3.07e-2)"	"prognostic unfavorable (3.68e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.00e-1)"	"unprognostic (8.05e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (2.70e-7)"	"unprognostic (1.43e-2)"	"unprognostic (2.92e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.74e-1)"	55.1	43.9	16.8	28.9	16.8	13.7	40.6	7.2	15.6	40.3	41.5	14.1	22.6	39.2	38.2	27.5	39.4	34.2	37.1	26.8	14.0	7.5	49.3	61.6	40.9	37.2	19.2	6.4	59.5	21.4	20.3	19.9	45.3	18.3	37.0	23.0	31.1	25.7	22.2	34.2	30.9	81.7	38.8	25.1	43.6	28.2	21.8	15.7	31.6	42.7	25.4	22.3	49.1	58.5	0.0	20.8	86.5	27.1	1.8	11.6	15.9	7.4	57.8	8.1	11.5	56.0	57.3	15.3	15.9	27.5	21.4	18.6	6.9	29.7	0.6	5.5	34.3	17.1	20.8	2.5	18.6	14.8	0.1	4.8	4.1	16.0	15.3	49.7	19.3	13.0	59.0	18.7	17.7	26.1	49.7	26.0	8.0	6.2	5.7	24.5	10.6	6.1	18.2	19.7	27.7	16.9	5.3	12.9	5.7	16.5	13.5	0.0	0.4	22.5	11.8	11.8	21.7	3.2	21.1	28.3	16.8	14.4	12.6	14.7	0.0	1.8	2.4	20.1	18.0	20.8	2.2	27.1	15.0	11.6	21.8	11.1	0.0	4.9	9.5	20.8	0.0	4.5	6.6	86.5	1.8	17.5	6.0	4.8	15.9	16.8	16.8	7.2	15.6	14.0	7.5	19.2	6.4	18.3	15.7	47.6	42.8	9.0	92.6	109.3	0.1	8.4	63.7	10.7	42.1	26.2	0.0	53.2	13.3	86.6	0.6	80.7	166.1	23.3	104.3	104.8	112.3	113.8	7.0	128.2	148.0	0.0	32.3	138.1	133.7	3.3	94.6	103.1	67.4	101.0	44.9	16.3	93.0	210.5	61.9	94.3	0.3	122.9	122.4	0.5	1.1	117.7	124.3	45.7	42.3	123.4
TNFRSF1B	"CD120b, p75, TNF-R-II, TNF-R75, TNFBR, TNFR2, TNFR80"	ENSG00000028137	"TNF receptor superfamily member 1B"	P20333	1	12167003-12209228	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 70.1"	"Cell type enhanced"	"Detected in many"	10	"Kupffer cells: 168.8;Macrophages: 143.1;monocytes: 73.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 70.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 17.5;K-562: 21.4;THP-1: 25.1;U-87 MG: 17.2;U-937: 18.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA004796	Approved				"Secreted to blood"	3230000	2500000			"HPA004796: AB_1078436"	"unprognostic (4.45e-2)"	"unprognostic (2.27e-3)"	"unprognostic (7.62e-2)"	"unprognostic (3.82e-3)"	"unprognostic (6.30e-2)"	"unprognostic (4.47e-3)"	"unprognostic (5.28e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.73e-2)"	"unprognostic (7.26e-2)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (8.35e-5)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (3.26e-2)"	"unprognostic (1.10e-1)"	43.4	4.7	4.6	44.3	13.8	29.2	42.3	2.1	6.1	13.3	13.1	6.6	1.9	11.9	9.7	10.2	6.5	11.3	11.6	21.8	8.5	6.2	6.2	22.2	24.5	60.6	9.1	2.2	9.4	4.2	2.3	4.4	24.9	15.0	7.3	8.2	8.3	5.7	3.7	11.5	6.2	17.3	11.5	22.6	48.3	10.5	6.0	6.1	10.9	6.2	5.6	16.2	18.3	8.4	2.7	13.2	25.7	70.1	2.5	12.7	19.9	0.0	0.1	2.1	0.0	5.6	7.7	4.4	0.5	1.0	2.0	2.2	0.8	17.5	0.1	0.3	1.8	2.9	0.0	0.4	0.0	1.1	6.9	0.0	0.0	0.1	0.0	13.2	0.1	1.9	7.6	0.0	7.0	0.0	3.6	10.6	0.1	21.4	3.2	0.9	0.0	0.0	4.0	0.1	2.7	0.6	0.5	0.2	12.3	0.0	0.4	0.0	0.0	0.3	0.1	0.6	3.3	0.0	25.1	3.7	3.0	0.1	13.3	0.0	1.0	0.0	0.0	17.2	18.1	0.7	0.0	20.7	3.0	9.4	49.3	5.4	2.7	6.6	7.7	13.2	1.7	2.0	3.0	25.7	2.5	70.1	2.8	12.7	19.9	4.6	13.8	2.1	6.1	8.5	6.2	9.1	2.2	15.0	6.1	8.9	22.3	30.3	2.5	14.9	0.1	2.8	7.6	2.7	11.4	3.5	0.0	0.7	0.0	0.4	0.3	40.2	11.8	23.3	0.5	4.3	9.7	4.3	2.3	14.0	63.4	0.0	0.0	22.7	168.8	0.4	2.0	143.1	15.1	73.9	3.1	0.3	0.5	1.4	0.4	0.3	1.0	32.3	13.7	0.0	0.9	9.3	25.2	58.9	3.9	9.8
TNFRSF25	"APO-3, DDR3, DR3, LARD, TNFRSF12, TR3, TRAMP, WSL-1, WSL-LR"	ENSG00000215788	"TNF receptor superfamily member 25"	Q93038	1	6461151-6466195	"Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 19.2;lymphoid tissue: 26.0;skin 1: 24.1"	"Cell type enhanced"	"Detected in many"	7	"Suprabasal keratinocytes: 25.0;T-cells: 36.2;Undifferentiated cells: 28.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	11	"cerebellum: 19.2"	"Cell type enhanced"	"Detected in many"		"T-reg: 9.5"	"Lineage enriched"	"Detected in single"	10	"T-cells: 9.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 20.2;NB-4: 8.0;RPMI-8226: 19.7"	"Group enriched"	"Detected in some"	6	"amygdala: 1.2;cerebral cortex: 1.3;hippocampal formation: 2.3"	"Not detected"	"Not detected"			HPA069834			Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites"	"Secreted - unknown location"			"Plasma membrane, Actin filaments, Focal adhesion sites"	Nucleoplasm	"HPA069834: "	"unprognostic (8.09e-3)"	"unprognostic (6.91e-3)"	"prognostic unfavorable (4.46e-4)"	"unprognostic (1.97e-1)"	"unprognostic (9.63e-3)"	"prognostic favorable (3.09e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.07e-1)"	"unprognostic (6.01e-2)"	"unprognostic (3.98e-2)"	"prognostic unfavorable (1.65e-7)"	"unprognostic (1.21e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.44e-1)"	"unprognostic (8.68e-3)"	2.2	1.6	1.2	20.3	1.6	0.4	1.4	19.2	1.8	1.4	13.4	0.7	0.6	2.8	1.2	0.6	4.1	2.4	2.1	2.3	1.8	0.9	1.4	2.3	6.3	13.9	1.1	0.6	1.1	0.6	1.4	14.0	4.1	1.3	1.9	1.3	1.1	10.5	2.3	0.8	24.1	11.2	0.6	0.6	18.9	0.8	1.0	0.8	11.7	1.1	3.2	26.0	3.2	1.5	0.0	0.4	0.0	0.9	0.6	9.5	1.3	1.4	0.3	0.8	1.6	0.0	0.4	0.8	0.6	0.4	0.2	0.0	1.3	2.2	0.0	3.0	0.0	1.0	3.2	0.4	3.7	0.0	20.2	1.5	0.8	1.1	0.0	0.6	0.0	0.0	0.0	2.4	1.2	3.2	1.9	3.2	0.9	0.0	0.0	0.0	1.6	0.0	8.0	1.0	1.1	5.5	0.6	0.2	19.7	0.8	0.5	3.9	5.4	0.0	1.9	0.1	0.3	1.7	2.2	1.7	1.0	1.5	0.0	1.5	0.0	3.6	0.0	1.9	0.0	0.0	0.0	0.0	0.0	1.7	0.3	8.0	0.0	6.9	3.2	0.4	0.0	6.4	1.1	0.0	0.6	0.9	0.0	9.5	1.3	1.2	1.6	19.2	1.8	1.8	0.9	1.1	0.6	1.3	0.8	3.0	5.3	0.5	1.8	21.9	0.8	0.8	2.5	2.7	2.3	1.8	2.0	0.4	0.0	0.1	0.3	5.5	16.9	0.0	0.4	1.6	3.2	1.1	6.9	1.1	3.2	4.8	6.4	9.8	1.6	0.0	2.6	2.1	6.8	1.0	17.6	11.2	0.9	11.5	8.9	0.3	9.3	0.0	0.8	0.5	1.1	25.0	0.1	36.2	28.4	6.7
TNFSF10	"Apo-2L, CD253, TL2, TRAIL"	ENSG00000121858	"TNF superfamily member 10"	P50591	3	172505508-172523507	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 115.1"	"Cell type enhanced"	"Detected in many"	6	"Ductal cells: 542.5;Exocrine glandular cells: 368.6;Proximal tubular cells: 449.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 42.4;classical monocyte: 25.6;intermediate monocyte: 39.5;neutrophil: 50.3;non-classical monocyte: 38.3"	"Group enriched"	"Detected in all"	5	"granulocytes: 50.3;monocytes: 39.5"	"Cell line enhanced"	"Detected in many"		"BEWO: 21.0;CAPAN-2: 14.9;HaCaT: 14.7;HMC-1: 69.1;RPTEC TERT1: 34.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054938	Uncertain				"Secreted to blood"	67400				"HPA054938: AB_2682643"	"unprognostic (9.16e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.69e-3)"	"unprognostic (2.52e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.71e-2)"	"prognostic unfavorable (9.43e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.27e-2)"	30.9	22.1	3.4	14.6	4.7	2.0	23.3	3.0	5.4	31.4	25.8	4.4	17.1	20.6	13.0	10.3	33.3	9.6	10.7	9.9	3.8	3.2	115.1	44.4	91.5	23.5	5.5	3.4	13.5	11.6	10.9	6.7	100.8	6.7	37.6	19.5	12.0	50.6	12.9	13.9	13.0	54.0	7.9	5.6	35.8	9.5	6.0	4.6	8.3	28.2	17.7	16.1	22.4	24.0	3.4	9.5	50.3	39.5	9.3	7.0	11.9	3.4	0.1	0.0	0.0	2.4	1.8	21.0	0.0	0.1	1.0	1.6	0.0	14.9	2.1	10.1	0.0	0.9	14.7	0.0	1.8	0.2	5.3	0.0	0.0	0.4	0.3	0.1	3.9	69.1	2.4	2.4	0.4	0.0	0.0	7.6	0.4	0.0	2.5	0.0	0.0	0.5	5.2	0.0	0.1	0.1	0.8	0.0	0.9	34.8	1.3	0.1	0.1	7.7	0.3	0.1	0.1	4.2	2.2	0.3	0.0	0.0	0.0	0.2	2.6	0.3	2.6	0.2	2.2	0.0	42.4	25.6	2.7	2.3	39.5	3.1	3.2	6.4	3.5	9.5	3.4	4.7	1.8	50.3	9.3	38.3	0.6	7.0	11.9	3.4	4.7	3.0	5.4	3.8	3.2	5.5	3.4	6.7	4.6	65.5	119.9	15.2	153.0	19.6	0.1	4.5	63.7	99.0	113.7	62.8	0.0	1.1	38.1	542.5	3.9	163.8	223.5	23.3	368.6	166.3	27.9	96.6	248.5	58.7	22.3	1.6	46.3	140.0	77.7	2.8	17.0	51.4	6.8	16.2	96.5	21.7	249.5	190.0	4.6	449.0	0.8	0.0	10.3	0.0	0.2	22.3	9.2	43.6	68.5	109.1
TNFSF11	"CD254, ODF, OPGL, RANKL, TRANCE"	ENSG00000120659	"TNF superfamily member 11"	O14788	13	42562736-42608013	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Differentiation	"Cytokine, Developmental protein, Receptor"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 14.3;lymphoid tissue: 19.8"	"Cell type enhanced"	"Detected in some"	22	"Ductal cells: 3.3;Early spermatids: 5.8;Late spermatids: 14.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	8	"NK-cell: 14.3"	"Lineage enriched"	"Detected in many"	8	"NK-cells: 14.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.8;HSkMC: 5.4;NTERA-2: 7.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB009193, HPA045142"	Enhanced				"Secreted to blood"	17200				"CAB009193: , HPA045142: AB_2679231"	"unprognostic (3.97e-4)"	"unprognostic (1.40e-1)"	"unprognostic (9.01e-3)"	"unprognostic (3.81e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.09e-2)"	"unprognostic (7.70e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.94e-5)"	"unprognostic (1.87e-1)"	"unprognostic (9.67e-2)"	"unprognostic (5.46e-2)"	"unprognostic (7.74e-2)"	0.5	0.2	0.2	19.5	0.2	0.0	4.6	0.1	0.2	0.8	0.8	0.1	2.4	0.2	0.2	0.1	3.7	0.2	1.3	0.3	0.1	0.7	0.6	5.3	0.4	19.8	0.1	0.1	0.1	0.6	0.0	0.3	0.3	0.4	0.5	2.2	0.1	1.6	1.0	0.2	0.5	6.0	0.1	0.1	0.8	0.3	3.3	0.1	2.8	0.4	0.1	5.2	2.3	0.7	0.0	0.1	1.8	0.0	14.3	0.1	0.1	0.0	0.3	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.8	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.5	0.0	0.6	0.0	0.1	5.4	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.5	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.2	0.1	0.7	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	3.3	5.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.2	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.3	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0
TNFSF13B	"BAFF, BLYS, CD257, TALL-1, TALL1, THANK, TNFSF20"	ENSG00000102524	"TNF superfamily member 13b"	Q9Y275	13	108251240-108308484	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Immunity	Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 76.5;lymphoid tissue: 39.6"	"Cell type enhanced"	"Detected in many"	23	"Hofbauer cells: 88.9;Kupffer cells: 144.9;Macrophages: 141.3;monocytes: 457.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 76.5"	"Group enriched"	"Detected in many"	10	"dendritic cells: 31.0;granulocytes: 76.5;monocytes: 53.7"	"Cell line enriched"	"Detected in some"	7	"U-937: 61.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB009188, HPA030526"	Enhanced		Supported	"Vesicles,Plasma membrane,Focal adhesion sites"	"Secreted to blood"	393000	530000	"Plasma membrane"	"Vesicles, Focal adhesion sites"	"CAB009188: , HPA030526: "	"unprognostic (6.48e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.99e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (2.53e-11)"	"unprognostic (1.23e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.25e-1)"	7.2	8.2	3.0	18.5	8.2	13.2	3.4	1.4	5.2	1.6	4.2	2.1	1.0	7.8	1.2	6.5	3.5	2.9	9.4	9.4	5.7	2.9	3.1	5.0	13.2	39.6	7.2	2.6	2.9	2.7	0.5	2.1	6.4	5.7	3.7	6.4	2.6	5.4	1.8	1.6	1.6	6.8	3.5	11.6	23.5	3.4	1.0	4.9	7.2	5.1	1.7	12.7	8.5	3.8	1.0	31.0	76.5	53.7	0.6	5.3	20.8	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.1	0.3	0.2	0.8	0.0	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.3	0.1	0.0	0.1	3.6	0.1	0.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	1.9	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.5	0.1	0.0	0.0	0.1	0.1	0.0	8.1	0.0	0.1	0.0	0.0	0.1	3.8	0.1	0.0	3.9	61.0	0.6	1.2	53.7	14.4	0.8	39.8	5.3	0.6	3.5	0.7	31.0	1.0	1.7	0.5	76.5	0.6	31.7	11.5	2.8	20.8	3.0	8.2	1.4	5.2	5.7	2.9	7.2	2.6	5.7	4.9	14.9	17.5	3.7	0.7	6.4	0.3	0.5	12.7	2.7	5.7	5.2	0.0	0.5	1.7	2.0	1.0	1.3	0.5	0.0	29.2	0.9	13.3	1.6	4.7	1.5	88.9	0.0	1.2	4.9	144.9	0.2	4.9	141.3	8.5	457.1	0.2	0.4	1.9	0.0	1.8	1.0	0.0	6.5	5.0	0.1	0.1	4.1	0.9	6.2	1.2	1.3
TNFSF14	"CD258, HVEM-L, LIGHT, LTg"	ENSG00000125735	"TNF superfamily member 14"	O43557	19	6661253-6670588	"CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 50.8;liver: 50.6"	"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 2: 22.9;granulocytes: 26.4;T-cells: 51.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.4"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 50.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 50.8;T-cells: 16.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 21.6;NB-4: 4.8;THP-1: 3.4;U-937: 12.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA012700	Approved				"Secreted to blood"	41000				"HPA012700: AB_1852870"	"unprognostic (2.78e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.35e-3)"	"unprognostic (3.82e-4)"	"unprognostic (4.51e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.05e-2)"	"unprognostic (9.23e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.59e-1)"	"prognostic unfavorable (6.07e-13)"	"unprognostic (1.09e-1)"	"unprognostic (9.56e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.62e-2)"	11.2	0.9	0.6	4.6	0.6	2.5	1.3	1.2	1.5	0.8	2.4	0.4	0.2	2.8	2.7	2.3	1.8	3.6	2.0	2.1	0.6	0.1	1.0	50.6	4.3	8.3	3.8	0.2	2.9	2.5	0.0	0.9	1.8	1.4	1.2	1.8	1.9	1.4	1.5	0.2	0.7	3.8	1.6	0.3	8.2	1.8	1.6	0.2	1.5	1.4	0.9	5.9	2.1	14.1	0.3	1.7	50.8	4.5	7.2	16.6	2.9	0.0	0.3	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.5	0.0	0.0	0.0	21.6	0.0	0.1	0.2	1.1	0.0	0.6	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	3.4	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.7	12.3	0.0	28.3	4.5	27.4	11.4	1.0	16.6	0.1	4.9	9.2	1.7	0.3	0.8	4.2	50.8	7.2	0.1	0.1	3.9	2.9	0.6	0.6	1.2	1.5	0.6	0.1	3.8	0.2	1.4	0.2	8.9	22.9	0.9	0.5	2.6	0.0	0.8	10.2	1.4	7.9	0.0	0.0	0.1	0.0	2.3	1.0	0.3	0.0	0.0	3.2	0.2	2.4	0.5	26.4	10.6	13.5	0.0	0.0	1.8	3.0	0.0	0.3	8.4	3.3	2.8	0.0	0.0	9.8	0.0	0.0	0.3	0.0	0.0	1.6	0.2	0.2	2.9	0.0	51.1	0.0	0.3
TREML4	TLT4	ENSG00000188056	"Triggering receptor expressed on myeloid cells like 4"	Q6UXN2	6	41228324-41238882	"Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Innate immunity"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	11	"blood: 10.3;bone marrow: 3.1;lung: 3.1;lymphoid tissue: 9.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"eosinophil: 5.4;neutrophil: 10.3"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 10.3"	"Cell line enriched"	"Detected in some"	4	"HEL: 4.6"									HPA065044	Uncertain				"Secreted - unknown location"					"HPA065044: AB_2685411"	"unprognostic (1.49e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.58e-2)"		"unprognostic (2.07e-1)"	"unprognostic (2.12e-1)"		"unprognostic (1.03e-1)"		"unprognostic (5.50e-2)"	"unprognostic (9.50e-3)"		"unprognostic (1.18e-4)"	"unprognostic (1.05e-3)"	"unprognostic (1.32e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.21e-2)"	0.3	0.1	0.1	1.2	0.3	3.1	0.1	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.6	0.3	0.2	0.1	0.2	0.1	0.2	3.1	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.3	0.1	0.2	0.0	0.0	0.1	0.0	0.4	9.5	0.1	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	1.3	0.9	10.3	1.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	5.4	0.0	0.5	0.0	0.1	0.0	0.0	0.5	1.3	0.0	0.0	10.3	0.0	0.4	0.9	0.0	0.3	0.1	0.3	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TXNDC16	KIAA1344	ENSG00000087301	"Thioredoxin domain containing 16"	Q9P2K2	14	52430590-52552522	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Peritubular cells: 49.1;Rod photoreceptor cells: 45.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 22.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002543	Approved		Approved	Mitochondria	"Secreted - unknown location"			Mitochondria		"HPA002543: AB_1079199"	"unprognostic (1.37e-1)"	"unprognostic (7.79e-3)"	"unprognostic (5.95e-3)"	"unprognostic (2.36e-1)"	"unprognostic (5.95e-3)"	"unprognostic (9.73e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.43e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (6.79e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.55e-3)"	"unprognostic (2.04e-1)"	7.0	5.2	10.2	5.9	12.5	5.4	8.6	20.5	15.0	12.1	7.0	7.4	16.1	5.1	8.5	18.4	4.8	5.4	6.5	5.6	9.2	9.4	6.4	8.9	6.1	5.0	9.5	11.3	13.4	7.8	8.6	9.4	7.0	8.9	32.8	7.4	8.1	5.6	24.2	4.2	6.5	5.9	5.6	14.0	11.5	7.4	8.2	10.5	9.7	5.1	3.4	4.8	7.8	7.3	1.2	5.3	3.6	6.3	1.1	4.7	2.2	6.1	0.6	6.9	3.8	5.1	3.8	5.4	2.0	2.7	3.5	6.8	2.2	5.0	10.0	6.9	1.6	2.1	5.8	7.9	2.8	5.4	4.1	10.3	4.6	5.1	2.0	3.7	5.4	2.2	7.0	2.6	4.4	3.3	3.1	3.8	4.4	5.8	15.6	3.0	2.9	6.7	3.8	7.6	4.1	3.7	13.6	13.0	9.0	4.4	6.3	22.5	7.8	9.9	10.4	2.8	6.0	6.6	4.0	2.1	4.7	2.4	5.3	3.4	4.3	5.8	10.1	1.3	5.7	2.7	2.4	6.3	2.5	2.7	4.8	2.9	1.2	2.8	2.0	5.3	0.8	1.4	1.4	3.6	1.1	5.2	2.2	4.7	2.2	10.2	12.5	20.5	15.0	9.2	9.4	9.5	11.3	8.9	10.5	8.9	5.4	5.2	5.3	6.0	35.7	7.9	7.6	5.3	6.8	7.0	7.9	1.7	1.7	3.1	3.3	6.3	5.2	23.3	3.5	1.5	3.3	19.5	2.3	10.5	3.0	9.5	17.7	12.9	15.9	2.7	25.6	5.0	1.7	1.0	17.2	8.4	1.5	9.5	49.1	2.6	45.5	0.0	4.4	9.8	8.4	7.3	0.9	5.7	8.7	3.5
ULBP2	RAET1H	ENSG00000131015	"UL16 binding protein 2"	Q9BZM5	6	149942000-149949235	"Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 10.8"	"Cell type enhanced"	"Detected in many"	6	"Ductal cells: 6.9;Exocrine glandular cells: 7.4;Ito cells: 9.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"gdT-cell: 5.5;memory CD4 T-cell: 1.8;memory CD8 T-cell: 3.2;naive CD8 T-cell: 3.9;T-reg: 3.0"	"Lineage enriched"	"Detected in single"	7	"T-cells: 5.5"	"Cell line enhanced"	"Detected in many"		"SiHa: 32.0;U-2197: 23.1"									CAB018974	Approved		Supported	"Vesicles,Plasma membrane"	"Secreted in other tissues"			"Vesicles, Plasma membrane"		"CAB018974: "	"unprognostic (2.09e-5)"	"prognostic unfavorable (8.07e-4)"	"unprognostic (2.38e-3)"	"unprognostic (3.90e-1)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (1.26e-2)"	"unprognostic (2.38e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.42e-4)"	"unprognostic (1.68e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.86e-1)"	3.3	1.7	4.5	1.9	2.3	4.3	5.9	5.3	6.5	1.6	0.6	0.0	0.0	0.9	0.6	0.5	10.8	0.5	1.6	4.1	4.4	1.0	1.9	1.7	6.2	1.1	1.0	2.1	0.2	1.6	0.3	1.1	4.4	3.9	0.6	0.7	0.3	1.5	0.4	0.6	1.0	0.4	2.0	0.6	0.5	0.7	3.6	0.1	0.5	3.5	4.6	2.4	4.1	5.2	0.0	0.0	0.0	0.0	0.8	5.5	0.9	9.2	0.8	0.2	2.9	0.5	2.8	1.6	9.6	5.6	10.1	8.3	3.5	5.3	0.0	14.7	10.9	14.5	6.6	3.6	8.8	5.8	4.2	1.9	0.5	1.4	0.0	3.6	0.0	0.7	1.3	6.8	8.9	3.9	8.2	5.7	8.0	1.1	0.0	7.4	6.4	0.8	0.0	0.0	1.7	4.9	1.4	2.2	0.0	14.3	2.7	0.3	0.0	32.0	0.7	0.9	1.6	0.9	4.0	8.9	6.6	8.3	23.1	11.0	0.0	0.0	0.4	9.5	5.1	4.7	0.0	0.0	0.0	5.5	0.0	0.6	0.0	1.8	3.2	0.0	0.0	0.6	3.9	0.0	0.8	0.0	0.0	3.0	0.9	4.5	2.3	5.3	6.5	4.4	1.0	1.0	2.1	3.9	0.1	0.0	2.2	0.0	5.4	3.3	0.0	0.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	6.9	6.3	3.8	0.0	0.0	7.4	0.2	0.9	0.9	0.0	0.0	1.8	0.0	0.0	9.2	1.2	6.4	0.0	1.7	1.7	0.0	0.0	0.2	4.8	0.0	0.0	0.0	0.0	0.0	1.0	2.3	3.2	2.5	0.0	2.9	0.0	3.2
UMOD		ENSG00000169344	Uromodulin	P07911	16	20333052-20356301	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"			"Ciliopathy, Disease mutation, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	417	"kidney: 237.4"	"Group enriched"	"Detected in some"	383	"Collecting duct cells: 235.5;Distal tubular cells: 805.7"	"Cancer enriched"	"Detected in single"	39	"renal cancer: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	32	"EFO-21: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB009446, HPA043420, HPA054721"	Enhanced				"Secreted in other tissues"	55000000	83000000			"CAB009446: AB_2212378, HPA043420: AB_2678474, HPA054721: AB_2682585"	"unprognostic (2.51e-2)"										"unprognostic (1.33e-1)"	"unprognostic (6.45e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.43e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	237.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	235.5	0.0	0.0	805.7	0.0	1.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
VASN	SLITL2	ENSG00000168140	Vasorin	Q6EMK4	16	4371848-4383528	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Fibroblasts: 108.9;Peritubular cells: 57.3;Sertoli cells: 97.0;Smooth muscle cells: 96.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	12	"U-2197: 126.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011246, HPA016992"	Uncertain		Approved	Nucleoplasm,Nucleoli,Mitochondria	"Secreted - unknown location"		2400000000	Mitochondria	"Nucleoplasm, Nucleoli"	"HPA011246: AB_1858720, HPA016992: AB_2732418"	"unprognostic (2.20e-1)"	"unprognostic (2.75e-1)"	"unprognostic (9.22e-2)"	"prognostic unfavorable (6.24e-5)"	"unprognostic (2.35e-3)"	"unprognostic (8.91e-3)"	"unprognostic (3.15e-3)"	"unprognostic (5.92e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.82e-3)"	"unprognostic (4.23e-2)"	"unprognostic (4.95e-3)"	"unprognostic (5.27e-2)"	22.4	10.2	4.9	7.7	6.7	3.8	28.6	1.6	6.5	19.9	5.1	5.6	6.4	5.1	14.3	13.6	16.2	9.9	10.2	12.9	4.4	1.8	21.6	14.1	17.2	5.2	2.7	2.9	21.0	9.8	1.7	5.9	30.2	4.8	12.9	2.0	33.6	7.9	13.1	7.0	16.0	4.0	9.4	3.6	7.9	6.5	14.7	3.5	0.0	15.2	5.5	8.2	16.6	19.0	0.3	0.2	0.4	0.0	0.0	0.2	0.0	0.3	0.5	0.0	0.0	2.8	3.2	1.2	5.3	5.2	1.6	2.7	0.3	0.6	0.0	1.9	3.5	0.2	0.0	0.0	0.1	0.2	1.2	0.1	0.1	1.5	1.6	10.2	0.0	0.0	3.3	0.0	4.0	0.1	2.7	0.0	0.0	0.2	0.0	0.2	1.8	0.0	0.4	0.3	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.1	0.9	2.5	4.2	0.0	0.2	0.9	0.2	0.0	4.9	1.3	126.7	0.6	0.0	0.0	0.0	1.5	0.0	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.9	6.7	1.6	6.5	4.4	1.8	2.7	2.9	4.8	3.5	6.0	12.5	0.9	6.0	8.5	0.0	12.9	35.7	1.4	3.4	22.7	0.0	3.0	6.6	10.3	1.0	3.3	0.2	0.0	2.6	6.4	108.9	7.4	3.5	12.9	2.8	0.0	0.0	4.9	0.3	1.8	46.3	1.2	13.5	0.0	0.4	16.3	17.4	0.0	57.3	12.5	0.7	97.0	96.8	0.5	5.1	6.6	8.4	1.8	0.2	3.3
VSTM1	UNQ3033	ENSG00000189068	"V-set and transmembrane domain containing 1"	Q6UX27	19	54040825-54063953	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Immunity	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"blood: 53.5;bone marrow: 39.4"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 15.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	15	"eosinophil: 53.5"	"Lineage enriched"	"Detected in many"	15	"granulocytes: 53.5"	"Group enriched"	"Detected in some"	7	"EFO-21: 1.0;HMC-1: 2.5;hTERT-HME1: 4.0;U-2 OS: 3.6"									HPA059365			Approved	Vesicles	"Secreted to blood"			Vesicles		"HPA059365: "	"unprognostic (5.13e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.30e-1)"		"unprognostic (1.09e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.31e-5)"	"unprognostic (3.73e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.74e-2)"	"unprognostic (4.67e-2)"	0.9	0.2	0.7	0.1	0.2	39.4	0.1	0.0	0.5	0.2	0.1	1.3	0.0	0.1	0.3	0.1	0.1	0.6	0.1	4.2	0.7	0.2	0.5	1.2	4.0	7.2	0.6	0.0	0.2	1.1	0.1	8.7	2.0	0.2	0.1	0.1	0.2	0.1	0.1	2.1	0.1	0.8	0.3	0.1	7.9	0.1	0.5	0.3	3.0	0.4	0.0	0.1	0.8	0.0	0.0	0.0	53.5	3.6	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	3.0	53.5	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	3.6	0.0	0.0	2.1	0.7	0.2	0.0	0.5	0.7	0.2	0.6	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	2.2	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
VSTM4	"C10orf72, FLJ31737"	ENSG00000165633	"V-set and transmembrane domain containing 4"	Q8IW00	10	49014245-49115509	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 81.0;Late spermatids: 104.4;Sertoli cells: 58.2"	"Cancer enriched"	"Detected in all"	5	"thyroid cancer: 22.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"K-562: 6.9;RH-30: 8.0;SH-SY5Y: 6.8;U-138 MG: 9.1;U-2197: 20.4;U-87 MG: 10.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017279	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted - unknown location"			"Nucleoplasm, Vesicles"		"HPA017279: AB_10959519"	"unprognostic (8.46e-2)"	"unprognostic (5.41e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.56e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (4.25e-4)"	13.0	31.6	7.2	3.4	6.7	0.4	10.5	3.3	7.1	18.2	6.2	9.3	3.1	2.0	13.2	5.9	6.1	6.5	11.7	10.3	7.2	4.4	9.3	3.0	8.9	7.0	8.9	5.4	27.2	1.3	22.8	4.6	7.7	10.1	11.2	4.4	15.1	2.8	9.2	3.8	4.2	4.1	12.5	7.9	2.8	5.4	7.8	6.0	2.9	20.8	6.9	3.4	9.4	8.6	1.8	0.9	2.7	0.9	1.7	0.7	0.2	0.0	0.1	2.7	0.1	1.1	0.6	0.1	2.1	3.5	0.8	0.2	0.1	0.1	0.1	0.1	5.0	2.9	0.1	0.1	0.0	0.4	2.6	1.2	0.1	0.0	0.1	0.1	0.1	0.0	4.1	0.0	3.6	0.0	0.0	0.0	0.7	6.9	0.1	0.6	0.1	0.0	0.1	0.5	0.0	0.0	0.0	8.0	4.1	0.0	0.1	0.1	6.8	0.1	0.1	0.0	0.3	0.1	0.2	0.0	9.1	1.1	20.4	0.1	0.0	5.5	0.0	10.0	0.1	0.1	1.9	0.9	0.4	0.6	0.3	0.5	0.8	0.4	0.3	0.2	1.8	0.7	0.6	2.7	1.7	0.5	0.9	0.3	0.2	7.2	6.7	3.3	7.1	7.2	4.4	8.9	5.4	10.1	6.0	3.0	17.4	0.0	1.7	5.8	5.0	12.1	0.0	6.7	17.0	0.0	2.0	0.4	1.7	0.1	81.0	6.4	0.0	0.0	0.0	0.3	22.4	0.7	11.6	3.2	0.5	4.8	0.0	3.7	1.9	104.4	8.9	4.0	6.8	1.0	0.0	10.9	0.2	0.0	13.8	6.1	2.7	58.2	30.0	1.4	3.4	3.8	0.3	1.3	0.0	0.6
WNT10A		ENSG00000135925	"Wnt family member 10A"	Q9GZT5	2	218880363-218899581	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Disease mutation, Ectodermal dysplasia, Hypotrichosis, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 24.8"	"Cell type enhanced"	"Detected in some"	9	"B-cells: 11.1;Basal glandular cells: 7.2;Basal keratinocytes: 15.1;Bipolar cells: 15.4;Collecting duct cells: 8.7;Melanocytes: 6.8"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 17.9"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	6	"plasmacytoid DC: 8.4"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 8.4"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 16.4;HaCaT: 47.3;HDLM-2: 19.5;RPTEC TERT1: 9.1;U-266/70: 24.8"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"basal ganglia: 2.2"	HPA013898	Uncertain				"Secreted to extracellular matrix"					"HPA013898: AB_1858847"	"unprognostic (2.99e-4)"	"unprognostic (4.31e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.87e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.23e-3)"	"unprognostic (9.52e-2)"	"unprognostic (6.64e-9)"	"unprognostic (1.22e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.89e-3)"	"unprognostic (1.82e-1)"	0.9	0.4	0.5	10.6	2.5	0.6	0.8	0.1	1.7	2.0	4.2	0.3	2.3	5.5	0.3	1.7	10.5	1.8	0.9	0.6	1.5	0.9	3.6	0.3	1.9	3.3	0.3	0.0	1.0	0.1	0.0	6.0	5.0	0.1	2.2	1.5	3.4	8.0	7.5	0.9	12.4	3.0	1.1	0.1	4.2	3.7	0.6	0.6	2.1	0.3	24.8	10.2	8.0	3.7	1.1	8.4	0.0	0.0	0.0	1.4	0.1	5.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	16.4	0.9	3.7	0.0	1.2	47.3	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	9.1	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	24.8	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	1.1	0.4	0.1	0.0	0.0	0.0	8.4	1.4	0.1	0.5	2.5	0.1	1.7	1.5	0.9	0.3	0.0	0.1	0.6	0.0	0.0	11.1	7.2	15.1	15.4	1.2	0.0	0.0	0.0	8.7	2.0	0.2	0.0	0.3	0.7	0.1	0.0	0.0	0.0	0.4	2.9	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	6.8	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.3	0.0	0.5	0.5	0.6	4.1	0.1	1.9	0.0	1.3
WNT2B	"WNT13, XWNT2"	ENSG00000134245	"Wnt family member 2B"	Q93097	1	112466541-112530165	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 66.7"	"Group enriched"	"Detected in many"	4	"Leydig cells: 74.2;Peritubular cells: 185.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 4.4"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 6.8;HSkMC: 13.0;SuSa: 5.3;TIME: 5.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047274, HPA066368"			Approved	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"			Vesicles	Nucleoplasm	"HPA047274: AB_2732539, HPA066368: AB_2685664"	"unprognostic (2.08e-3)"	"unprognostic (2.06e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.42e-2)"	"unprognostic (4.90e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.37e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.65e-4)"	"unprognostic (5.41e-2)"	"unprognostic (7.64e-2)"	"unprognostic (4.80e-2)"	"unprognostic (2.49e-2)"	3.4	1.9	1.7	3.4	4.6	0.2	2.1	2.6	2.9	9.2	12.0	0.8	3.7	3.9	7.5	5.4	7.6	4.4	8.0	3.6	1.6	1.7	1.8	0.5	5.2	0.9	2.0	2.4	28.7	2.0	1.2	1.9	6.0	1.5	7.3	6.8	66.7	1.7	18.3	1.3	13.4	9.1	12.9	3.0	1.2	4.4	16.2	0.8	0.5	1.4	5.6	1.9	10.3	8.5	2.3	1.2	1.7	0.7	0.8	1.2	0.1	0.7	0.4	3.4	0.8	3.4	6.8	0.6	1.4	1.5	0.4	0.6	0.3	0.7	1.8	0.3	1.6	0.4	2.1	1.1	0.5	0.3	0.1	0.7	0.2	1.1	0.5	2.9	0.2	0.8	13.0	1.2	0.6	0.2	1.9	1.7	0.5	0.2	0.3	0.4	0.5	0.1	0.2	0.6	0.1	0.5	0.1	0.5	0.0	2.4	0.4	0.5	0.5	1.3	0.2	1.1	5.3	0.1	0.4	5.2	0.5	2.0	1.3	0.4	0.2	0.1	0.0	1.4	0.2	1.3	0.9	0.7	1.0	0.9	0.3	0.8	1.4	1.2	1.0	0.3	2.3	0.4	0.7	1.7	0.8	0.5	1.2	0.4	0.1	1.7	4.6	2.6	2.9	1.6	1.7	2.0	2.4	1.5	0.8	11.9	3.5	0.5	1.6	9.0	13.0	3.9	2.5	4.0	2.3	1.8	25.5	1.6	0.0	0.7	3.5	8.4	2.3	0.0	1.2	0.7	7.8	1.5	2.3	0.0	1.0	4.8	8.1	4.9	1.6	2.8	74.2	5.7	3.3	1.8	1.7	8.2	1.6	4.2	185.6	0.6	30.4	0.0	2.8	4.2	4.2	12.2	1.6	1.9	1.5	2.0
WNT4	WNT-4	ENSG00000162552	"Wnt family member 4"	P56705	1	22117305-22143969	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 34.3;skin 1: 28.6"	"Cell type enhanced"	"Detected in some"	13	"Basal keratinocytes: 14.8;Intestinal endocrine cells: 28.3;Mucus-secreting cells: 10.2;Suprabasal keratinocytes: 9.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	6	"eosinophil: 2.8"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.8"	"Cell line enhanced"	"Detected in some"		"HaCaT: 10.2;SCLC-21H: 12.5;SK-BR-3: 10.6;T-47d: 4.2"	"Low region specificity"	"Detected in many"							HPA011397	Uncertain		Approved	Vesicles	"Secreted to extracellular matrix"			Vesicles		"HPA011397: AB_1858854"	"unprognostic (1.85e-1)"	"unprognostic (9.08e-2)"	"unprognostic (6.67e-3)"	"unprognostic (1.75e-2)"	"unprognostic (7.17e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.77e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (5.34e-4)"	"unprognostic (2.14e-2)"	"prognostic favorable (4.90e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.95e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.74e-2)"	"unprognostic (9.49e-2)"	0.5	6.5	1.0	0.3	1.0	0.0	1.4	0.6	1.7	4.3	1.7	1.1	1.0	2.0	3.1	6.6	6.9	6.4	6.4	0.6	1.5	3.1	1.1	1.2	1.4	0.3	1.0	1.7	34.3	1.9	0.0	3.7	11.8	1.7	7.7	1.0	1.7	3.0	1.8	2.7	28.6	4.1	1.2	1.5	0.3	2.8	0.9	0.8	1.4	2.2	5.4	2.8	2.0	3.5	0.0	0.0	2.8	0.0	0.0	0.4	0.0	1.5	0.1	3.1	0.1	0.1	0.0	2.7	0.6	0.0	0.0	0.0	0.0	0.8	0.0	1.0	0.1	0.3	10.2	0.0	0.8	0.0	0.3	0.3	0.3	0.3	0.0	0.2	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	1.4	0.2	0.4	0.0	0.0	0.0	1.9	12.5	0.0	0.1	10.6	0.7	0.8	4.2	0.0	0.4	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	1.0	1.0	0.6	1.7	1.5	3.1	1.0	1.7	1.7	0.8	3.0	7.5	0.0	3.4	14.8	0.0	0.6	0.0	2.7	6.8	0.0	0.0	0.6	0.0	2.2	0.0	0.0	0.3	0.0	0.5	0.1	0.9	3.8	0.0	0.4	0.1	0.0	28.3	1.3	0.0	0.0	0.0	0.0	5.0	0.0	10.2	0.0	0.9	0.0	3.5	0.0	0.0	0.0	0.2	0.0	0.0	9.2	0.2	0.0	0.5	2.6
ZP1		ENSG00000149506	"Zona pellucida glycoprotein 1"	P60852	11	60867562-60875693	"Disease related genes, Predicted membrane proteins, Predicted secreted proteins"	Fertilization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 6.5;epididymis: 2.2;pituitary gland: 3.3"	"Group enriched"	"Detected in some"	7	"Early spermatids: 25.5;Late spermatids: 62.7"	"Low cancer specificity"	"Detected in single"							"Cell type enriched"	"Detected in single"	66	"plasmacytoid DC: 6.5"	"Lineage enriched"	"Detected in single"	66	"dendritic cells: 6.5"	"Group enriched"	"Detected in some"	36	"RPMI-8226: 16.2;SK-BR-3: 4.6"	"Region enriched"	"Detected in single"	7	"basal ganglia: 0.7"										"Secreted in female reproductive system"						"unprognostic (6.40e-3)"	"unprognostic (2.18e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.02e-2)"	"unprognostic (8.27e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.94e-2)"	"unprognostic (8.15e-3)"	"unprognostic (2.52e-1)"	"unprognostic (9.25e-4)"	"unprognostic (5.31e-13)"	"unprognostic (4.13e-2)"	"unprognostic (2.38e-1)"	"unprognostic (6.27e-2)"	"unprognostic (5.61e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.7	0.0	0.0			0.0	0.0	2.2	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.8	3.3	0.0		1.3	0.0		0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1			0.0		0.0	0.2	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.1											0.0	2.2	0.0	0.0	0.1	1.4	0.4	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	25.5	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	62.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	6.5	2.0	0.5	0.0	0.1	0.2	0.0	0.0	0.0
ZP2	ZPA	ENSG00000103310	"Zona pellucida glycoprotein 2"	Q05996	16	21197450-21214510	"Predicted membrane proteins, Predicted secreted proteins"	Fertilization	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"brain: 35.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	22	"cerebellum: 35.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	35	"HDLM-2: 9.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA011296	Enhanced				"Secreted in female reproductive system"					"HPA011296: AB_1859485"	"unprognostic (2.35e-2)"		"unprognostic (3.12e-2)"			"unprognostic (6.60e-2)"		"unprognostic (9.83e-2)"			"unprognostic (3.44e-3)"	"unprognostic (3.12e-1)"		"unprognostic (1.66e-1)"	"unprognostic (4.41e-2)"			0.0	0.1	0.0	0.0	0.0	0.0	1.1	35.2	0.1	0.8	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.9	1.6	0.0	0.1	0.0	3.1	0.0	0.0	0.1	1.5	0.1	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.2	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZP3	"ZP3-372, ZP3-424, ZP3A, ZP3B, ZPC"	ENSG00000188372	"Zona pellucida glycoprotein 3"	P21754	7	76397518-76442071	"Disease related genes, Predicted membrane proteins, Predicted secreted proteins"	Fertilization	Receptor	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 36.5;Late spermatids: 52.3;Spermatocytes: 26.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 16.5;hTCEpi: 17.6;Karpas-707: 24.4;MCF7: 32.5"									HPA054061	Supported				"Secreted in female reproductive system"					"HPA054061: AB_2682363"	"unprognostic (6.48e-2)"	"unprognostic (3.08e-1)"	"unprognostic (7.74e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.04e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.29e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.10e-3)"	"unprognostic (1.15e-2)"	"prognostic unfavorable (1.02e-6)"	"unprognostic (1.33e-1)"	"unprognostic (1.42e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.13e-1)"	2.4	5.6	3.3	1.9	13.9	4.3	6.7	1.7	4.4	3.1	5.1	3.2	1.8	4.2	2.6	5.3	7.4	8.7	1.5	1.4	2.1	2.4	2.0	2.0	1.2	6.9	2.6	2.2	5.8	11.9	1.4	3.1	1.4	4.6	3.3	5.7	5.6	3.7	3.4	2.7	8.7	2.6	2.5	2.8	3.6	2.5	2.3	4.0	0.8	2.0	4.4	4.7	1.7	4.1	2.8	10.3	0.9	9.9	0.3	5.2	3.4	7.9	16.5	0.1	8.5	0.4	0.5	0.4	0.5	1.3	0.1	1.5	0.6	7.1	0.0	0.3	2.0	0.2	2.0	1.7	0.5	0.1	4.3	4.1	1.3	4.6	0.1	3.7	0.3	2.4	0.7	17.6	1.7	0.5	0.0	0.3	4.3	1.8	24.4	0.0	32.5	0.7	4.1	1.8	13.4	4.7	0.0	0.7	1.7	0.7	0.1	3.6	0.0	2.2	11.1	0.2	0.2	7.3	1.3	1.0	0.1	0.9	0.1	0.1	7.4	6.0	0.1	0.7	9.2	1.4	0.5	9.9	0.1	0.2	3.9	0.5	2.8	1.3	0.6	10.3	1.5	5.2	3.7	0.9	0.3	4.2	2.2	0.2	3.4	3.3	13.9	1.7	4.4	2.1	2.4	2.6	2.2	4.6	4.0	3.0	2.2	2.2	3.6	7.6	1.4	0.8	5.1	5.3	1.2	1.8	0.0	5.5	0.0	2.7	36.5	1.6	2.0	0.0	3.6	3.3	2.8	1.8	0.0	1.0	6.3	1.6	4.1	2.5	6.5	52.3	4.0	4.8	3.3	1.8	3.8	4.6	3.0	8.4	5.3	1.6	1.6	6.5	1.2	26.6	14.0	8.7	7.8	2.2	7.4	12.0
ZP4	ZPB	ENSG00000116996	"Zona pellucida glycoprotein 4"	Q12836	1	237877864-237890922	"Predicted membrane proteins, Predicted secreted proteins"	Fertilization	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 2.1;ovary: 2.3;placenta: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"BJ hTERT+: 8.5"					"Not detected"	"Not detected"			HPA008547	Supported				"Secreted in female reproductive system"					"HPA008547: AB_1080766"						"unprognostic (7.12e-2)"			"unprognostic (2.70e-1)"						"unprognostic (4.59e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		2.3	0.0	0.0	0.0	1.0		0.0	0.0		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
